Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23412.Phospholipids in VLDL,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,28916,0.23401928155651,0.00549726405019651,0.223244644018125,0.244793919094895,0
NMR metabolomics,X23412.Phospholipids in VLDL,AGRP,Agouti-related protein,29786,0.255944336456845,0.00325817188309071,0.249558319565987,0.262330353347702,0
NMR metabolomics,X23412.Phospholipids in VLDL,APCS,Serum amyloid P-component,24726,0.115604352943305,0.00224338245361689,0.111207323334216,0.120001382552394,0
NMR metabolomics,X23412.Phospholipids in VLDL,BCHE,Cholinesterase,24528,0.0818618600971524,0.00183541704903818,0.0782644426810375,0.0854592775132672,0
NMR metabolomics,X23412.Phospholipids in VLDL,CCL23,C-C motif chemokine 23,29581,0.131148373030915,0.00270863781059323,0.125839442922152,0.136457303139677,0
NMR metabolomics,X23412.Phospholipids in VLDL,CCL27,C-C motif chemokine 27,29478,0.22760319527542,0.00393139095536883,0.219897669002897,0.235308721547943,0
NMR metabolomics,X23412.Phospholipids in VLDL,CCN1,CCN family member 1,29301,0.358925762630319,0.00466260569746886,0.34978705546328,0.368064469797358,0
NMR metabolomics,X23412.Phospholipids in VLDL,CD4,T-cell surface glycoprotein CD4,29383,0.0898406587104788,0.00195583674021687,0.0860072186996538,0.0936740987213039,0
NMR metabolomics,X23412.Phospholipids in VLDL,CDKN1A,Cyclin-dependent kinase inhibitor 1,29349,0.30030394284144,0.00694470485538346,0.286692321324889,0.313915564357992,0
NMR metabolomics,X23412.Phospholipids in VLDL,CES1,Liver carboxylesterase 1,29489,0.272547632539433,0.00523429860782854,0.262288407268089,0.282806857810777,0
NMR metabolomics,X23412.Phospholipids in VLDL,CFH,Complement factor H,23693,0.0636191394166983,0.00153485155844509,0.0606108303621459,0.0666274484712507,0
NMR metabolomics,X23412.Phospholipids in VLDL,CFI,Complement factor I,24966,0.0532888302667764,0.00131207696919733,0.0507171594071496,0.0558605011264031,0
NMR metabolomics,X23412.Phospholipids in VLDL,CFP,Properdin,24966,0.0702272964466548,0.00150264587076304,0.0672821105399593,0.0731724823533504,0
NMR metabolomics,X23412.Phospholipids in VLDL,CHMP6,Charged multivesicular body protein 6,24922,0.153347983764395,0.00371572098915318,0.146065170625654,0.160630796903135,0
NMR metabolomics,X23412.Phospholipids in VLDL,CNTN3,Contactin-3,29443,0.0881203906074378,0.00212371855859425,0.083957902232593,0.0922828789822825,0
NMR metabolomics,X23412.Phospholipids in VLDL,CPM,Carboxypeptidase M,29584,0.0883997723010798,0.00226326871987197,0.0839637656101307,0.0928357789920288,0
NMR metabolomics,X23412.Phospholipids in VLDL,CRIP2,Cysteine-rich protein 2,29218,0.0951085015552131,0.00239536915015081,0.0904135780209175,0.0998034250895087,0
NMR metabolomics,X23412.Phospholipids in VLDL,CXCL6,C-X-C motif chemokine 6,29786,0.215683822770968,0.00505054727885102,0.20578475010442,0.225582895437516,0
NMR metabolomics,X23412.Phospholipids in VLDL,DEFB4A_DEFB4B,Beta-defensin 4A,29036,0.420681402005259,0.0096723667906312,0.401723563095622,0.439639240914896,0
NMR metabolomics,X23412.Phospholipids in VLDL,DNAJB1,DnaJ homolog subfamily B member 1,29349,0.264477110351459,0.00567771699661758,0.253348785038089,0.275605435664829,0
NMR metabolomics,X23412.Phospholipids in VLDL,DSG2,Desmoglein-2,29443,-0.0704597312802559,0.0017820012144658,-0.0739524536606088,-0.0669670088999029,0
NMR metabolomics,X23412.Phospholipids in VLDL,ERBB2,Receptor tyrosine-protein kinase erbB-2,29566,0.0666810639558244,0.00163437563688474,0.0634776877075303,0.0698844402041185,0
NMR metabolomics,X23412.Phospholipids in VLDL,ERBB3,Receptor tyrosine-protein kinase erbB-3,29369,0.0620770253219605,0.00126940517864394,0.0595889911718184,0.0645650594721026,0
NMR metabolomics,X23412.Phospholipids in VLDL,F7,Coagulation factor VII,29544,0.112643645710577,0.00196760502299022,0.108787139865516,0.116500151555638,0
NMR metabolomics,X23412.Phospholipids in VLDL,FGFBP1,Fibroblast growth factor-binding protein 1,29566,0.112246458709742,0.00212395247208172,0.108083511864462,0.116409405555022,0
NMR metabolomics,X23412.Phospholipids in VLDL,FURIN,Furin,29566,0.111506671326198,0.00217410681941747,0.10724542196014,0.115767920692256,0
NMR metabolomics,X23412.Phospholipids in VLDL,GCG,Pro-glucagon,28797,0.360869427860136,0.00815889674998499,0.344877990230166,0.376860865490107,0
NMR metabolomics,X23412.Phospholipids in VLDL,GHR,Growth hormone receptor,24381,0.0958127346558675,0.00185476169881388,0.0921774017261923,0.0994480675855427,0
NMR metabolomics,X23412.Phospholipids in VLDL,GPR37,Prosaposin receptor GPR37,28916,0.176961535837817,0.00436350729266627,0.168409061544191,0.185514010131443,0
NMR metabolomics,X23412.Phospholipids in VLDL,GUSB,Beta-glucuronidase,29604,0.156098739642991,0.00394101215942554,0.148374355810517,0.163823123475465,0
NMR metabolomics,X23412.Phospholipids in VLDL,HHEX,Hematopoietically-expressed homeobox protein HHEX,24845,0.273533405418782,0.00488281650848794,0.263963085062145,0.283103725775418,0
NMR metabolomics,X23412.Phospholipids in VLDL,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,29725,0.104645031961165,0.00223596620178664,0.100262538205664,0.109027525716667,0
NMR metabolomics,X23412.Phospholipids in VLDL,IGSF9,Protein turtle homolog A,24922,0.236030212701774,0.00543158026742444,0.225384315377622,0.246676110025926,0
NMR metabolomics,X23412.Phospholipids in VLDL,INHBC,Inhibin beta C chain,29443,0.109122922252877,0.0027235260831175,0.103784811129967,0.114461033375788,0
NMR metabolomics,X23412.Phospholipids in VLDL,KDR,Vascular endothelial growth factor receptor 2,29566,0.066574223596286,0.00167478546350225,0.0632916440878216,0.0698568031047504,0
NMR metabolomics,X23412.Phospholipids in VLDL,KLKB1,Plasma kallikrein,24454,0.0660955081033873,0.00165788767885882,0.062846048252824,0.0693449679539506,0
NMR metabolomics,X23412.Phospholipids in VLDL,KYNU,Kynureninase,29786,0.116769959565817,0.00299669403910159,0.110896439249178,0.122643479882456,0
NMR metabolomics,X23412.Phospholipids in VLDL,LAMP2,Lysosome-associated membrane glycoprotein 2,28595,0.0556049705177016,0.00128771308452268,0.0530810528720372,0.0581288881633661,0
NMR metabolomics,X23412.Phospholipids in VLDL,LCAT,Phosphatidylcholine-sterol acyltransferase,24951,0.0837320554213573,0.00141436308526782,0.0809599037742323,0.0865042070684822,0
NMR metabolomics,X23412.Phospholipids in VLDL,LDLR,Low-density lipoprotein receptor,29500,0.408071004221107,0.00266547032209336,0.402846682389804,0.41329532605241,0
NMR metabolomics,X23412.Phospholipids in VLDL,LPL,Lipoprotein lipase,29478,-0.147581794863311,0.00306410857967392,-0.153587447679472,-0.14157614204715,0
NMR metabolomics,X23412.Phospholipids in VLDL,MEGF9,Multiple epidermal growth factor-like domains protein 9,29736,0.0528971719725256,0.0013540843920606,0.0502431665640868,0.0555511773809644,0
NMR metabolomics,X23412.Phospholipids in VLDL,MFGE8,Lactadherin,29443,0.199445608116433,0.00273255321822271,0.194089803808716,0.204801412424149,0
NMR metabolomics,X23412.Phospholipids in VLDL,NPY,Pro-neuropeptide Y,29725,0.32401076449761,0.00404131734419776,0.316089782502983,0.331931746492238,0
NMR metabolomics,X23412.Phospholipids in VLDL,NRP1,Neuropilin-1,29628,-0.0805014039871905,0.00182323007588405,-0.0840749349359232,-0.0769278730384578,0
NMR metabolomics,X23412.Phospholipids in VLDL,P4HB,Protein disulfide-isomerase,29313,0.107083334728699,0.00254706592362562,0.102091085518393,0.112075583939006,0
NMR metabolomics,X23412.Phospholipids in VLDL,PAMR1,Inactive serine protease PAMR1,29443,0.0836669553049949,0.00180338041091116,0.0801323296996091,0.0872015809103808,0
NMR metabolomics,X23412.Phospholipids in VLDL,PLA2G10,Group 10 secretory phospholipase A2,29218,-0.173990999081546,0.00386874218831462,-0.181573733770642,-0.166408264392449,0
NMR metabolomics,X23412.Phospholipids in VLDL,PLA2G7,Platelet-activating factor acetylhydrolase,29443,0.180178427908132,0.00188328247832414,0.176487194250617,0.183869661565648,0
NMR metabolomics,X23412.Phospholipids in VLDL,PLAT,Tissue-type plasminogen activator,29736,0.131510327156498,0.00331632646912275,0.125010327277018,0.138010327035979,0
NMR metabolomics,X23412.Phospholipids in VLDL,PRAP1,Proline-rich acidic protein 1,24938,0.105564039458163,0.00269523653275872,0.100281375853956,0.11084670306237,0
NMR metabolomics,X23412.Phospholipids in VLDL,PROC,Vitamin K-dependent protein C,29545,0.0964549812324695,0.00165864390461679,0.0932040391794206,0.0997059232855184,0
NMR metabolomics,X23412.Phospholipids in VLDL,PROS1,Vitamin K-dependent protein S,24966,0.0678043324932456,0.00168144242129941,0.0645087053474988,0.0710999596389925,0
NMR metabolomics,X23412.Phospholipids in VLDL,PTH,Parathyroid hormone,24195,0.264515111782927,0.00523592239417646,0.254252703890341,0.274777519675513,0
NMR metabolomics,X23412.Phospholipids in VLDL,RARRES2,Retinoic acid receptor responder protein 2,29628,0.157240707480109,0.0030621402459007,0.151238912598143,0.163242502362074,0
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINA4,Kallistatin,24557,0.0660771280875528,0.00156855220857018,0.0630027657587552,0.0691514904163504,0
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINA5,Plasma serine protease inhibitor,24644,0.0918946284284962,0.00208593517165781,0.0878061954920469,0.0959830613649455,0
NMR metabolomics,X23412.Phospholipids in VLDL,SLC39A5,Zinc transporter ZIP5,29434,0.14699862348583,0.00351031058240381,0.140118414744318,0.153878832227341,0
NMR metabolomics,X23412.Phospholipids in VLDL,SMAD1,Mothers against decapentaplegic homolog 1,28797,0.252429775725873,0.00536341602507366,0.241917480316729,0.262942071135018,0
NMR metabolomics,X23412.Phospholipids in VLDL,SMOC1,SPARC-related modular calcium-binding protein 1,29725,0.117113503444057,0.00211670248248862,0.112964766578379,0.121262240309734,0
NMR metabolomics,X23412.Phospholipids in VLDL,SNCA,Alpha-synuclein,24381,0.324305569549497,0.00759792187507532,0.30941364267435,0.339197496424645,0
NMR metabolomics,X23412.Phospholipids in VLDL,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,29433,0.301893404344539,0.00752929590481965,0.287135984371092,0.316650824317985,0
NMR metabolomics,X23412.Phospholipids in VLDL,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,29594,0.153615591599271,0.00273621096818111,0.148252618101636,0.158978565096906,0
NMR metabolomics,X23412.Phospholipids in VLDL,SYAP1,Synapse-associated protein 1,24381,0.149330520151374,0.00379215556603636,0.141897895241943,0.156763145060805,0
NMR metabolomics,X23412.Phospholipids in VLDL,TFPI,Tissue factor pathway inhibitor,29435,0.125311952832814,0.00201613336237044,0.121360331442568,0.12926357422306,0
NMR metabolomics,X23412.Phospholipids in VLDL,TMPRSS15,Enteropeptidase,29349,0.236106660350047,0.00596277719839583,0.224419617041191,0.247793703658903,0
NMR metabolomics,X23412.Phospholipids in VLDL,TTR,Transthyretin,24707,0.073309629463229,0.00166138245630749,0.0700533198488663,0.0765659390775916,0
NMR metabolomics,X23412.Phospholipids in VLDL,VMO1,Vitelline membrane outer layer protein 1 homolog,29349,0.193684882068405,0.0044680097888619,0.184927582882236,0.202442181254574,0
NMR metabolomics,X23412.Phospholipids in VLDL,VPS37A,Vacuolar protein sorting-associated protein 37A,29349,0.225416954933763,0.00522359049536994,0.215178717562838,0.235655192304688,0
NMR metabolomics,X23412.Phospholipids in VLDL,FLI1,Friend leukemia integration 1 transcription factor,28797,0.282972346466019,0.00727253828072999,0.268718171435788,0.29722652149625,1.1125369292536e-308
NMR metabolomics,X23412.Phospholipids in VLDL,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,29694,0.133974602124075,0.00344828861808847,0.127215956432622,0.140733247815528,1.11253692925362e-308
NMR metabolomics,X23412.Phospholipids in VLDL,ATRN,"Attractin, Isoform 2",24966,0.0427276711934953,0.0010975393562256,0.0405764940552931,0.0448788483316975,1.11253692925363e-308
NMR metabolomics,X23412.Phospholipids in VLDL,TNFSF10,Tumor necrosis factor ligand superfamily member 10,29786,0.066607860781455,0.00171943496386083,0.0632377682522878,0.0699779533106222,1.11253692925488e-308
NMR metabolomics,X23412.Phospholipids in VLDL,IGFBP3,Insulin-like growth factor-binding protein 3,29594,0.0762235954314527,0.0019681705083486,0.0723659812350894,0.0800812096278159,1.11253692925569e-308
NMR metabolomics,X23412.Phospholipids in VLDL,AGR3,Anterior gradient protein 3,28764,0.150557606686933,0.00393264484213987,0.142849622796339,0.158265590577527,1.11257760677699e-308
NMR metabolomics,X23412.Phospholipids in VLDL,NCS1,Neuronal calcium sensor 1,29725,0.0723678184931572,0.00189115009945582,0.0686611642982238,0.0760744726880906,1.112580635066e-308
NMR metabolomics,X23412.Phospholipids in VLDL,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,29218,0.184575200159201,0.00487170910420465,0.17502665031496,0.194123750003442,1.12392696429092e-306
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINF2,Alpha-2-antiplasmin,24515,0.0340891482171475,0.000901520489448343,0.0323221680578287,0.0358561283764662,3.77383467869939e-304
NMR metabolomics,X23412.Phospholipids in VLDL,ENO3,Beta-enolase,24240,0.150414579479681,0.00397875319144428,0.14261622322445,0.158212935734912,6.36891841254078e-304
NMR metabolomics,X23412.Phospholipids in VLDL,ADIPOQ,Adiponectin,24966,-0.167959150539081,0.00446716004676671,-0.176714784230744,-0.159203516847419,5.58716316952471e-301
NMR metabolomics,X23412.Phospholipids in VLDL,SORT1,Sortilin,29433,0.0920572698624744,0.00246279425029206,0.087230193131902,0.0968843465930469,8.40284410939189e-299
NMR metabolomics,X23412.Phospholipids in VLDL,F10,Coagulation factor X,24951,0.0682141758456588,0.00182112158615607,0.0646447775367929,0.0717835741545247,8.61200740689068e-299
NMR metabolomics,X23412.Phospholipids in VLDL,GSTA3,Glutathione S-transferase A3,28797,0.18855546333288,0.0050673987498964,0.178623361783083,0.198487564882677,4.9844139538656e-296
NMR metabolomics,X23412.Phospholipids in VLDL,FGFBP3,Fibroblast growth factor-binding protein 3,24845,0.0907974738598022,0.00243895486241652,0.0860171223294658,0.0955778253901386,3.09913392276763e-295
NMR metabolomics,X23412.Phospholipids in VLDL,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,24381,0.0536051733458018,0.00144664196076932,0.0507697551026939,0.0564405915889097,1.9272957718001e-292
NMR metabolomics,X23412.Phospholipids in VLDL,PSRC1,Proline/serine-rich coiled-coil protein 1,28797,0.144831791105302,0.00391784416414832,0.137152816543571,0.152510765667032,2.66150438230586e-292
NMR metabolomics,X23412.Phospholipids in VLDL,AFM,Afamin,24966,0.0476923632065763,0.00128989874654694,0.0451641616633443,0.0502205647498084,2.18447381291743e-291
NMR metabolomics,X23412.Phospholipids in VLDL,APOM,Apolipoprotein M,29545,0.0676151312154487,0.0018372561164555,0.0640141092271959,0.0712161532037015,6.09960048719131e-290
NMR metabolomics,X23412.Phospholipids in VLDL,SERPIND1,Heparin cofactor 2,24914,0.0688439822972116,0.00186748745366409,0.0651837068880299,0.0725042577063932,1.0396570950634e-289
NMR metabolomics,X23412.Phospholipids in VLDL,GSTA1,Glutathione S-transferase A1,29426,0.204860318044447,0.00557113453437189,0.193940894357078,0.215779741731816,1.89290664576905e-289
NMR metabolomics,X23412.Phospholipids in VLDL,ERP44,Endoplasmic reticulum resident protein 44,29301,0.0625510720214299,0.00171196554353114,0.0591956195561088,0.0659065244867509,7.43162827043164e-286
NMR metabolomics,X23412.Phospholipids in VLDL,SMAD2,Mothers against decapentaplegic homolog 2,24793,0.167780357591932,0.00459062501071085,0.158782732570939,0.176777982612925,6.8401221799066e-285
NMR metabolomics,X23412.Phospholipids in VLDL,LATS1,Serine/threonine-protein kinase LATS1,24229,0.206672555149874,0.00565542136076734,0.19558792928277,0.217757181016978,1.17525564971434e-284
NMR metabolomics,X23412.Phospholipids in VLDL,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,24805,0.337953769366316,0.00926208193223729,0.319800088779131,0.356107449953501,5.54830782013503e-284
NMR metabolomics,X23412.Phospholipids in VLDL,ANGPTL2,Angiopoietin-related protein 2,29491,0.095824656997139,0.00263737653957475,0.0906553989795725,0.100993915014706,8.43253274176091e-283
NMR metabolomics,X23412.Phospholipids in VLDL,IGFBP2,Insulin-like growth factor-binding protein 2,29757,-0.149495852795517,0.0041239608612754,-0.157578816083617,-0.141412889507418,1.32423889613421e-281
NMR metabolomics,X23412.Phospholipids in VLDL,SNAPIN,SNARE-associated protein Snapin,24867,0.138732846867172,0.00383360958355823,0.131218972083398,0.146246721650946,1.6397481777702e-279
NMR metabolomics,X23412.Phospholipids in VLDL,ACY1,Aminoacylase-1,29478,0.147398900113661,0.0040841541126702,0.139393958052828,0.155403842174495,3.87684759791941e-279
NMR metabolomics,X23412.Phospholipids in VLDL,NUMB,Protein numb homolog,24229,0.200343242101197,0.00554213059436069,0.18948066613625,0.211205818066144,9.71207461886567e-279
NMR metabolomics,X23412.Phospholipids in VLDL,LAT2,Linker for activation of T-cells family member 2,29349,0.296050631767945,0.00822671203161236,0.279926276185985,0.312174987349905,1.49042708373541e-277
NMR metabolomics,X23412.Phospholipids in VLDL,STAB2,Stabilin-2,24938,0.0671877573844798,0.00186760601557661,0.0635272495939496,0.0708482651750099,2.35916392671377e-276
NMR metabolomics,X23412.Phospholipids in VLDL,CDHR2,Cadherin-related family member 2,29349,0.172021618500886,0.00480888585725711,0.162596202220662,0.18144703478111,2.41816144862711e-274
NMR metabolomics,X23412.Phospholipids in VLDL,F9,Coagulation factor IX,29545,0.0429670189260587,0.00120497375346014,0.0406052703692768,0.0453287674828405,1.08455179588187e-272
NMR metabolomics,X23412.Phospholipids in VLDL,GRP,Gastrin-releasing peptide,24240,0.127815393968097,0.00357820120807574,0.120802119600268,0.134828668335925,2.18186644755509e-272
NMR metabolomics,X23412.Phospholipids in VLDL,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,28797,0.159877092396927,0.00449613885941464,0.151064660232474,0.168689524561379,4.50184597412299e-271
NMR metabolomics,X23412.Phospholipids in VLDL,FCN2,Ficolin-2,29381,0.0966791789497433,0.00272084989344174,0.0913463131585975,0.102012044740889,8.42596970015827e-271
NMR metabolomics,X23412.Phospholipids in VLDL,APOC1,Apolipoprotein C-I,24914,0.0883950089553012,0.00248491762379314,0.0835245704126666,0.0932654474979357,2.16294451354599e-270
NMR metabolomics,X23412.Phospholipids in VLDL,RBP5,Retinol-binding protein 5,29349,0.131542094693848,0.00372344094005303,0.124244150451345,0.138840038936352,8.98120224638797e-268
NMR metabolomics,X23412.Phospholipids in VLDL,DTYMK,Thymidylate kinase,24922,0.160672662197368,0.00454025843184437,0.151773755670953,0.169571568723783,1.08756397042765e-267
NMR metabolomics,X23412.Phospholipids in VLDL,FGFR2,Fibroblast growth factor receptor 2,29566,0.0514565033100379,0.00146461271166048,0.0485858623951834,0.0543271442248924,5.99330759393894e-265
NMR metabolomics,X23412.Phospholipids in VLDL,IGSF8,Immunoglobulin superfamily member 8,29478,0.0707577040505097,0.00202082998486243,0.0667968772801793,0.0747185308208401,3.4272682910277e-263
NMR metabolomics,X23412.Phospholipids in VLDL,HEG1,Protein HEG homolog 1,24381,0.0634006833943354,0.00180851029890242,0.0598560032084867,0.0669453635801841,1.02124764665219e-262
NMR metabolomics,X23412.Phospholipids in VLDL,FN1,Fibronectin,24966,0.0622655714912719,0.0017770147358666,0.0587826226089734,0.0657485203735705,1.30052587525417e-262
NMR metabolomics,X23412.Phospholipids in VLDL,CPB2,Carboxypeptidase B2,24914,0.052576009735765,0.00150046415365056,0.0496350999946099,0.0555169194769201,1.3215209437072e-262
NMR metabolomics,X23412.Phospholipids in VLDL,PRCP,Lysosomal Pro-X carboxypeptidase,29655,0.0726636497160942,0.002084504730726,0.0685780204438712,0.0767492789883171,5.85472418737001e-261
NMR metabolomics,X23412.Phospholipids in VLDL,SOST,Sclerostin,29433,0.0890276861016992,0.0025684588701859,0.0839935067161348,0.0940618654872636,4.63308008292047e-258
NMR metabolomics,X23412.Phospholipids in VLDL,CDHR5,Cadherin-related family member 5,29478,0.0893598575492756,0.00258213485335384,0.084298873236702,0.0944208418618491,2.83706346998553e-257
NMR metabolomics,X23412.Phospholipids in VLDL,IL16,Pro-interleukin-16,29786,0.0947555480588629,0.00274427877058458,0.0893767616685172,0.100134334449209,3.43474000938873e-256
NMR metabolomics,X23412.Phospholipids in VLDL,NAA80,N-alpha-acetyltransferase 80,24195,0.277358741805371,0.0080214092336159,0.261636779707484,0.293080703903258,9.29705233359333e-256
NMR metabolomics,X23412.Phospholipids in VLDL,CCL22,C-C motif chemokine 22,29169,0.117377178575503,0.00342955226116758,0.110655256143614,0.124099101007391,9.85824164408722e-252
NMR metabolomics,X23412.Phospholipids in VLDL,NOMO1,Nodal modulator 1,29443,0.0534125368059196,0.00156217492632349,0.0503506739503255,0.0564743996615136,2.72878597909266e-251
NMR metabolomics,X23412.Phospholipids in VLDL,ELN,Elastin,24922,0.0798699256854115,0.00233393335540975,0.0752954163088083,0.0844444350620146,7.51197830631698e-251
NMR metabolomics,X23412.Phospholipids in VLDL,SNAP29,Synaptosomal-associated protein 29,29566,0.206524623376825,0.00606680110192451,0.194633693217053,0.218415553536597,3.52484362679296e-249
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINF1,Pigment epithelium-derived factor,24579,0.0591259359316725,0.00173799660934707,0.0557194625773522,0.0625324092859928,6.43662423155917e-248
NMR metabolomics,X23412.Phospholipids in VLDL,UPB1,Beta-ureidopropionase,24922,0.206517783747146,0.00607920100622808,0.194602549774939,0.218433017719353,2.60096158177495e-247
NMR metabolomics,X23412.Phospholipids in VLDL,EEF1D,Elongation factor 1-delta,24922,0.205968753440972,0.0060673858286371,0.194076677216843,0.2178608296651,5.73400824363308e-247
NMR metabolomics,X23412.Phospholipids in VLDL,PTPRB,Receptor-type tyrosine-protein phosphatase beta,24922,0.0665814190426861,0.00196303953639729,0.0627338615513474,0.0704289765340248,1.48700537897818e-246
NMR metabolomics,X23412.Phospholipids in VLDL,C9,Complement component C9,24951,-0.119672056583394,0.00353429442472038,-0.126599273655846,-0.112744839510942,9.38658823193591e-246
NMR metabolomics,X23412.Phospholipids in VLDL,PLTP,Phospholipid transfer protein,29702,-0.0801841750351384,0.00238682550553132,-0.0848623530259798,-0.075505997044297,7.18922156391665e-243
NMR metabolomics,X23412.Phospholipids in VLDL,ADH1B,All-trans-retinol dehydrogenase,24381,0.168597843956996,0.00502595547133019,0.158746971233189,0.178448716680803,3.20031819289593e-241
NMR metabolomics,X23412.Phospholipids in VLDL,AP1G2,AP-1 complex subunit gamma-like 2,24793,0.176928157160444,0.00528825901979719,0.166563169481641,0.187293144839246,4.48324039646053e-240
NMR metabolomics,X23412.Phospholipids in VLDL,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,29349,0.0875430044949848,0.00263397792167226,0.0823804077685071,0.0927056012214624,8.4249603761828e-238
NMR metabolomics,X23412.Phospholipids in VLDL,CXCL17,C-X-C motif chemokine 17,29786,0.092592809789934,0.0027924002095028,0.0871197053793085,0.0980659142005595,8.63695715219382e-237
NMR metabolomics,X23412.Phospholipids in VLDL,MYH9,Myosin-9,24938,0.248746986467747,0.0075090396018672,0.234029268848087,0.263464704087407,1.58441722002251e-235
NMR metabolomics,X23412.Phospholipids in VLDL,YES1,Tyrosine-protein kinase Yes,29349,0.249192786744613,0.00756555407496864,0.234364300757675,0.264021272731552,1.14975608614943e-233
NMR metabolomics,X23412.Phospholipids in VLDL,YTHDF3,YTH domain-containing family protein 3,28931,0.186467507278345,0.00566411031726501,0.175365851056506,0.197569163500184,2.26072406874974e-233
NMR metabolomics,X23412.Phospholipids in VLDL,CCL16,C-C motif chemokine 16,29820,0.114116823076125,0.00347804768750102,0.107299849608623,0.120933796543627,5.61277675528878e-232
NMR metabolomics,X23412.Phospholipids in VLDL,ABL1,Tyrosine-protein kinase ABL1,29349,0.147718415082249,0.00450389652247992,0.138890777898188,0.15654605226631,9.73585333375021e-232
NMR metabolomics,X23412.Phospholipids in VLDL,DPY30,Protein dpy-30 homolog,29604,0.129928452520942,0.00397672126295037,0.122134078845559,0.137722826196324,4.77262612385138e-230
NMR metabolomics,X23412.Phospholipids in VLDL,FYB1,FYN-binding protein 1,29400,0.198958185626602,0.00611524516996181,0.186972305093477,0.210944066159727,3.86204501370806e-228
NMR metabolomics,X23412.Phospholipids in VLDL,MAPK9,Mitogen-activated protein kinase 9,29434,0.0928074306611832,0.00285709678015457,0.0872075209720803,0.0984073403502862,1.93633669860153e-227
NMR metabolomics,X23412.Phospholipids in VLDL,ASGR1,Asialoglycoprotein receptor 1,29218,0.0643718542779692,0.00198194903354053,0.0604872341722298,0.0682564743837087,2.35140091633196e-227
NMR metabolomics,X23412.Phospholipids in VLDL,FTCD,Formimidoyltransferase-cyclodeaminase,24804,0.184451308227982,0.00567034625366474,0.173337429570799,0.195565186885165,2.47820362670616e-227
NMR metabolomics,X23412.Phospholipids in VLDL,NOS3,"Nitric oxide synthase, endothelial",28774,0.114099600043208,0.00351535118442477,0.107209511721736,0.120989688364681,5.31641581356416e-227
NMR metabolomics,X23412.Phospholipids in VLDL,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,29349,0.0942190589649763,0.00290665268093525,0.0885220197103432,0.0999160982196094,1.68432435414418e-226
NMR metabolomics,X23412.Phospholipids in VLDL,GLA,Alpha-galactosidase A,24329,0.081168024741908,0.00250352369016681,0.0762611183091811,0.086074931174635,8.72299659584116e-226
NMR metabolomics,X23412.Phospholipids in VLDL,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,29349,0.0683583573416349,0.00211621146090928,0.0642105828782527,0.0725061318050171,5.72243462103028e-225
NMR metabolomics,X23412.Phospholipids in VLDL,IL13RA1,Interleukin-13 receptor subunit alpha-1,29019,0.0480859243817666,0.00149041279128839,0.0451647153108414,0.0510071334526919,2.11940459888051e-224
NMR metabolomics,X23412.Phospholipids in VLDL,MLN,Promotilin,29434,0.191105480490429,0.00592553043717562,0.179491440833564,0.202719520147293,2.74147413554172e-224
NMR metabolomics,X23412.Phospholipids in VLDL,IPCEF1,Interactor protein for cytohesin exchange factors 1,29169,0.191919657562502,0.00595136076196854,0.180254990469044,0.20358432465596,3.27821283897717e-224
NMR metabolomics,X23412.Phospholipids in VLDL,SKAP1,Src kinase-associated phosphoprotein 1,29163,0.156128940724318,0.00484702778184861,0.146628766271895,0.165629115176742,1.03198896791095e-223
NMR metabolomics,X23412.Phospholipids in VLDL,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",24240,0.0560930157240242,0.00173835965496562,0.0526858308002916,0.0595002006477568,1.07110960331792e-223
NMR metabolomics,X23412.Phospholipids in VLDL,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,29100,0.101707956544741,0.00315772139531999,0.0955188226099137,0.107897090479568,1.11902081508591e-223
NMR metabolomics,X23412.Phospholipids in VLDL,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,24845,0.0873104488686099,0.00270904782795642,0.0820007151258153,0.0926201826114045,2.73387936252967e-223
NMR metabolomics,X23412.Phospholipids in VLDL,BTD,Biotinidase,24966,0.0444070696796485,0.00137939010623632,0.0417034650714254,0.0471106742878717,7.91059266143024e-223
NMR metabolomics,X23412.Phospholipids in VLDL,COL4A1,Collagen alpha-1(IV) chain,29478,-0.084606228080853,0.00263942471933018,-0.0897795005307402,-0.0794329556309659,1.21457435448557e-221
NMR metabolomics,X23412.Phospholipids in VLDL,SARG,Specifically androgen-regulated gene protein,24820,0.233404366269968,0.00727312401057081,0.219149043209249,0.247659689330687,1.95609413686492e-221
NMR metabolomics,X23412.Phospholipids in VLDL,MTSS1,Protein MTSS 1,24805,0.23694816855982,0.00739373948914777,0.22245643916109,0.251439897958549,7.68951811225027e-221
NMR metabolomics,X23412.Phospholipids in VLDL,ANGPTL3,Angiopoietin-related protein 3,29518,0.0757694630206657,0.00237195382486795,0.0711204335239245,0.0804184925174069,3.7176414147518e-220
NMR metabolomics,X23412.Phospholipids in VLDL,SMAD5,Mothers against decapentaplegic homolog 5,29349,0.0432336155608527,0.00135431772660052,0.0405791528167157,0.0458880783049898,7.49026984971371e-220
NMR metabolomics,X23412.Phospholipids in VLDL,TJAP1,Tight junction-associated protein 1,29566,0.175709143524363,0.00551284869153121,0.164903960088962,0.186514326959764,3.30857068598887e-219
NMR metabolomics,X23412.Phospholipids in VLDL,SORD,Sorbitol dehydrogenase,29595,0.144174686381418,0.00453217872357468,0.135291616083212,0.153057756679624,2.17131650820082e-218
NMR metabolomics,X23412.Phospholipids in VLDL,GGT1,Glutathione hydrolase 1 proenzyme,29390,0.106344220002062,0.00334909361314742,0.0997799965202928,0.112908443483831,1.37826622320222e-217
NMR metabolomics,X23412.Phospholipids in VLDL,CREG1,Protein CREG1,29079,0.0804004512241332,0.00253637270436154,0.0754291607235846,0.0853717417246818,7.93623863181974e-217
NMR metabolomics,X23412.Phospholipids in VLDL,CXCL13,C-X-C motif chemokine 13,29694,0.128267683543471,0.0040506597177535,0.120328390496674,0.136206976590267,1.84465654975988e-216
NMR metabolomics,X23412.Phospholipids in VLDL,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,24805,0.0632184844888645,0.00199764358647053,0.0593031030593822,0.0671338659183467,1.63724702118183e-215
NMR metabolomics,X23412.Phospholipids in VLDL,NOTCH3,Neurogenic locus notch homolog protein 3,29820,-0.0717048425158858,0.00227234385162341,-0.0761586364650677,-0.0672510485667039,5.23834478435387e-215
NMR metabolomics,X23412.Phospholipids in VLDL,F13B,Coagulation factor XIII B chain,24833,0.0544549061093176,0.00172384262460042,0.0510761745651008,0.0578336376535345,9.25000131233559e-215
NMR metabolomics,X23412.Phospholipids in VLDL,SHBG,Sex hormone-binding globulin,24951,-0.108127300044982,0.00344030450324487,-0.114870296871342,-0.101384303218622,1.12241650837289e-212
NMR metabolomics,X23412.Phospholipids in VLDL,TGFBI,Transforming growth factor-beta-induced protein ig-h3,29361,0.0564321162059369,0.00179911898145696,0.0529058430022812,0.0599583894095925,1.87502076776244e-212
NMR metabolomics,X23412.Phospholipids in VLDL,SCLY,Selenocysteine lyase,29632,0.101000262431538,0.00322713687281774,0.0946750741608155,0.107325450702261,1.43205237713248e-211
NMR metabolomics,X23412.Phospholipids in VLDL,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,28916,0.114502385048592,0.00366384825912826,0.107321242460701,0.121683527636484,6.82838526833509e-211
NMR metabolomics,X23412.Phospholipids in VLDL,FAM20A,Pseudokinase FAM20A,24922,0.0590342397836016,0.0018910993603513,0.055327685037313,0.0627407945298901,6.93869193226831e-210
NMR metabolomics,X23412.Phospholipids in VLDL,NT5E,5'-nucleotidase,29566,0.116227179448505,0.00374217936411298,0.108892507894844,0.123561851002166,1.96364333265527e-208
NMR metabolomics,X23412.Phospholipids in VLDL,DKK1,Dickkopf-related protein 1,29694,0.122673629284418,0.00395303400392129,0.114925682636733,0.130421575932104,4.14570304624258e-208
NMR metabolomics,X23412.Phospholipids in VLDL,EHBP1,EH domain-binding protein 1,24922,0.154481172681774,0.0049827901374188,0.144714904012433,0.164247441351115,4.23247681256377e-207
NMR metabolomics,X23412.Phospholipids in VLDL,CANT1,Soluble calcium-activated nucleotidase 1,29370,0.0416558538534604,0.00134799896043985,0.0390137758909983,0.0442979318159225,2.28357284950682e-206
NMR metabolomics,X23412.Phospholipids in VLDL,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,29594,-0.0784799713985529,0.00254093572605708,-0.0834602054216248,-0.073499737375481,3.45894305554196e-206
NMR metabolomics,X23412.Phospholipids in VLDL,GH1,Somatotropin,29433,-0.365042696919642,0.011825740135072,-0.388221147584383,-0.341864246254901,6.12984936249572e-206
NMR metabolomics,X23412.Phospholipids in VLDL,DNAJC6,Putative tyrosine-protein phosphatase auxilin,24240,0.174230492078747,0.005638818778322,0.163178407273236,0.185282576884258,1.22383618877986e-205
NMR metabolomics,X23412.Phospholipids in VLDL,CCL17,C-C motif chemokine 17,29414,0.186206955921441,0.00606056831168811,0.174328242030532,0.198085669812349,4.56216885186613e-204
NMR metabolomics,X23412.Phospholipids in VLDL,SELPLG,P-selectin glycoprotein ligand 1,29434,0.056884807575211,0.00185178309978466,0.0532553126996331,0.0605143024507889,5.33257695371302e-204
NMR metabolomics,X23412.Phospholipids in VLDL,LECT2,Leukocyte cell-derived chemotaxin-2,24922,0.134898449473239,0.00439932062783385,0.126275781042685,0.143521117903794,1.02290996273794e-202
NMR metabolomics,X23412.Phospholipids in VLDL,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,24111,0.139344886693203,0.00454857223749523,0.130429685107713,0.148260088278694,3.16491016135337e-202
NMR metabolomics,X23412.Phospholipids in VLDL,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",29434,0.198726911731144,0.00649877678826066,0.185989309226153,0.211464514236135,3.40606810101702e-202
NMR metabolomics,X23412.Phospholipids in VLDL,DNAJA2,DnaJ homolog subfamily A member 2,29704,0.166786052144345,0.00545637421227851,0.156091558688279,0.17748054560041,4.54767158907827e-202
NMR metabolomics,X23412.Phospholipids in VLDL,FGF21,Fibroblast growth factor 21,29674,0.241405535948181,0.00790064156712125,0.225920278476624,0.256890793419739,6.54089815085658e-202
NMR metabolomics,X23412.Phospholipids in VLDL,F11R,Junctional adhesion molecule A,29443,0.114186574011323,0.00374420509636077,0.106847932022456,0.12152521600019,3.88786990490453e-201
NMR metabolomics,X23412.Phospholipids in VLDL,LDLRAP1,Low density lipoprotein receptor adapter protein 1,24867,0.198566679451051,0.00650853174755279,0.185809957225848,0.211323401676255,1.00399352026781e-200
NMR metabolomics,X23412.Phospholipids in VLDL,KHK,Ketohexokinase,24240,0.130073872884644,0.00427801415403038,0.121688965142745,0.138458780626544,2.59884587888523e-199
NMR metabolomics,X23412.Phospholipids in VLDL,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,24445,0.228473313399963,0.00751680016381881,0.213740385078878,0.243206241721047,3.26386342381988e-199
NMR metabolomics,X23412.Phospholipids in VLDL,MASP1,Mannan-binding lectin serine protease 1,29163,0.04781259786081,0.00157631569614789,0.0447230190963601,0.0509021766252599,5.42050724500323e-199
NMR metabolomics,X23412.Phospholipids in VLDL,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",29820,0.0587352026765843,0.00194451695977714,0.0549239494354211,0.0625464559177475,1.90519613793596e-197
NMR metabolomics,X23412.Phospholipids in VLDL,DCXR,L-xylulose reductase,29566,0.108059541359842,0.00357769866333612,0.101047251979703,0.11507183073998,2.13441264267755e-197
NMR metabolomics,X23412.Phospholipids in VLDL,CEP20,Centrosomal protein 20,28797,0.149613220251479,0.00495757100089772,0.13989638108972,0.159330059413239,5.3063282500252e-197
NMR metabolomics,X23412.Phospholipids in VLDL,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,24805,0.16391953891589,0.0054294449053567,0.153277826901391,0.174561250930389,1.13310115196525e-196
NMR metabolomics,X23412.Phospholipids in VLDL,SEMA3F,Semaphorin-3F,29478,0.0529452406240474,0.00175737435325868,0.0495007868916604,0.0563896943564344,2.02861847920842e-196
NMR metabolomics,X23412.Phospholipids in VLDL,TXLNA,Alpha-taxilin,29218,0.177682755003102,0.00591216691055131,0.166094907858422,0.189270602147783,1.85653546425952e-195
NMR metabolomics,X23412.Phospholipids in VLDL,PLIN1,Perilipin-1,28774,0.069819871744833,0.00232570151856285,0.0652614967684498,0.0743782467212161,5.35110860387889e-195
NMR metabolomics,X23412.Phospholipids in VLDL,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,29218,0.107125889594254,0.00356943859956042,0.100129789939115,0.114121989249392,6.27792628803508e-195
NMR metabolomics,X23412.Phospholipids in VLDL,CD63,CD63 antigen,29169,0.102614408427078,0.00342565782036102,0.0959001190991702,0.109328697754985,3.36889123984817e-194
NMR metabolomics,X23412.Phospholipids in VLDL,IGFBP1,Insulin-like growth factor-binding protein 1,29761,-0.24351815439933,0.00813215257021004,-0.259457173436941,-0.227579135361718,3.89761631061969e-194
NMR metabolomics,X23412.Phospholipids in VLDL,DAB2,Disabled homolog 2,29725,0.220713931108638,0.00737085958443136,0.206267046323152,0.235160815894123,4.04215926038957e-194
NMR metabolomics,X23412.Phospholipids in VLDL,TARBP2,RISC-loading complex subunit TARBP2,28774,0.157504870884356,0.00526808085767327,0.147179432403316,0.167830309365396,1.91667008730548e-193
NMR metabolomics,X23412.Phospholipids in VLDL,HBEGF,Proheparin-binding EGF-like growth factor,29632,0.144449513174801,0.00484516194120805,0.134952995770034,0.153946030579569,1.8501855389105e-192
NMR metabolomics,X23412.Phospholipids in VLDL,EZR,Ezrin,29694,0.0477822799337721,0.00160343577638221,0.044639545812063,0.0509250140554812,2.67678448848023e-192
NMR metabolomics,X23412.Phospholipids in VLDL,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",24240,0.114249326144727,0.00382789777159384,0.106746646512403,0.121752005777051,2.94015522279916e-192
NMR metabolomics,X23412.Phospholipids in VLDL,VEGFC,Vascular endothelial growth factor C,29566,0.110584844537159,0.00371284488165597,0.103307668569113,0.117862020505205,4.31557754412468e-192
NMR metabolomics,X23412.Phospholipids in VLDL,IL18R1,Interleukin-18 receptor 1,29786,0.0650943418402993,0.00218932040975545,0.0608032738371786,0.06938540984342,1.83815352495773e-191
NMR metabolomics,X23412.Phospholipids in VLDL,TCTN3,Tectonic-3,24922,0.0592590230186397,0.00199043507615686,0.0553577702693722,0.0631602757679071,2.03630639534492e-191
NMR metabolomics,X23412.Phospholipids in VLDL,ARF6,ADP-ribosylation factor 6,24805,0.212381221267472,0.00713786286557408,0.198391010050947,0.226371432483997,3.51308401252356e-191
NMR metabolomics,X23412.Phospholipids in VLDL,GCC1,GRIP and coiled-coil domain-containing protein 1,24845,0.214519268938802,0.00721110944138587,0.200385494433686,0.228653043443918,4.09270312904814e-191
NMR metabolomics,X23412.Phospholipids in VLDL,MTSS2,Protein MTSS 2,24793,0.196947916724149,0.0066265380991844,0.183959902049748,0.209935931398551,9.1273503179715e-191
NMR metabolomics,X23412.Phospholipids in VLDL,BPIFB1,BPI fold-containing family B member 1,29333,-0.124733493773569,0.00420653249895488,-0.13297829747152,-0.116488690075617,2.0592411999326e-190
NMR metabolomics,X23412.Phospholipids in VLDL,CXCL10,C-X-C motif chemokine 10,29581,0.131944621442112,0.00445800219559459,0.123206937138747,0.140682305745478,9.53980804334018e-190
NMR metabolomics,X23412.Phospholipids in VLDL,AMBP,Protein AMBP,29683,0.0397272246546815,0.00134233763733357,0.0370962428855077,0.0423582064238553,9.80519773321716e-190
NMR metabolomics,X23412.Phospholipids in VLDL,AXIN1,Axin-1,29434,0.187827043269956,0.00634802529229933,0.17538491369705,0.200269172842863,1.27480247764082e-189
NMR metabolomics,X23412.Phospholipids in VLDL,DAAM1,Disheveled-associated activator of morphogenesis 1,24381,0.164292038250538,0.00554463466662449,0.153424554303954,0.175159522197122,1.37961324058503e-189
NMR metabolomics,X23412.Phospholipids in VLDL,BANK1,B-cell scaffold protein with ankyrin repeats,29434,0.209275520978981,0.00708277338170226,0.195393285150844,0.223157756807117,4.16068968981486e-189
NMR metabolomics,X23412.Phospholipids in VLDL,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",29349,0.191736649336587,0.00649872297498015,0.178999152305626,0.204474146367548,1.47144878773585e-188
NMR metabolomics,X23412.Phospholipids in VLDL,MME,Neprilysin,29349,0.157794409853972,0.00535855463822628,0.147291642763049,0.168297176944896,7.44015839524379e-188
NMR metabolomics,X23412.Phospholipids in VLDL,NPL,N-acetylneuraminate lyase,24922,0.0882804689987524,0.002998225604109,0.0824039468146988,0.0941569911828061,2.41788237155336e-187
NMR metabolomics,X23412.Phospholipids in VLDL,GPD1,Glycerol-3-phosphate dehydrogenase,24793,0.102986949813362,0.00350206622981844,0.0961229000029182,0.109850999623806,7.14750460872112e-187
NMR metabolomics,X23412.Phospholipids in VLDL,CXCL5,C-X-C motif chemokine 5,29384,0.222906907545893,0.00759091637597696,0.208028711448978,0.237785103642808,7.75950320009389e-187
NMR metabolomics,X23412.Phospholipids in VLDL,RNF41,E3 ubiquitin-protein ligase NRDP1,28797,0.130481555661457,0.00445296164312,0.121753750840941,0.139209360481972,5.26089330373042e-186
NMR metabolomics,X23412.Phospholipids in VLDL,EFCAB14,EF-hand calcium-binding domain-containing protein 14,24805,0.0539341984474006,0.00183974142124507,0.0503283052617603,0.057540091633041,9.52825453061561e-186
NMR metabolomics,X23412.Phospholipids in VLDL,KAZN,Kazrin,24805,0.203614954837722,0.00696325805194861,0.189966969055902,0.217262940619541,7.9439775801393e-185
NMR metabolomics,X23412.Phospholipids in VLDL,PDLIM7,PDZ and LIM domain protein 7,29581,0.243596615625165,0.00835152608643252,0.227227624495757,0.259965606754572,2.0365189384372e-184
NMR metabolomics,X23412.Phospholipids in VLDL,CES3,Carboxylesterase 3,29349,0.135810068243952,0.00465941197255346,0.126677620777748,0.144942515710157,3.81150700852182e-184
NMR metabolomics,X23412.Phospholipids in VLDL,RAB11FIP3,Rab11 family-interacting protein 3,24922,0.209213778936193,0.00717147239535979,0.195157693041287,0.223269864831098,5.29638575244469e-184
NMR metabolomics,X23412.Phospholipids in VLDL,NPPC,C-type natriuretic peptide,29434,0.0930676034092892,0.00319583687436727,0.0868037631355294,0.0993314436830491,7.82071892476751e-184
NMR metabolomics,X23412.Phospholipids in VLDL,BECN1,Beclin-1,24240,0.117411605551239,0.00402922302047382,0.109514328431111,0.125308882671368,1.63624797908927e-183
NMR metabolomics,X23412.Phospholipids in VLDL,THOP1,Thimet oligopeptidase,29343,0.0598944139805814,0.00205989045450881,0.0558570286897441,0.0639317992714186,2.84888616390365e-183
NMR metabolomics,X23412.Phospholipids in VLDL,CKB,Creatine kinase B-type,24938,-0.115235440592787,0.00395835231004559,-0.122993811120476,-0.107477070065098,2.95509127397602e-183
NMR metabolomics,X23412.Phospholipids in VLDL,PBLD,Phenazine biosynthesis-like domain-containing protein,28774,0.100091667920614,0.00344907695858771,0.0933314770817818,0.106851858759446,1.5865337389787e-182
NMR metabolomics,X23412.Phospholipids in VLDL,CD6,T-cell differentiation antigen CD6,29760,0.101603281578341,0.00351658444650016,0.0947107760632007,0.108495787093481,4.7083176144879e-181
NMR metabolomics,X23412.Phospholipids in VLDL,ZBTB16,Zinc finger and BTB domain-containing protein 16,28797,0.13769061401618,0.00477209874179992,0.128337300482252,0.147043927550108,1.71807088500922e-180
NMR metabolomics,X23412.Phospholipids in VLDL,TPD52L2,Tumor protein D54,24381,0.209097673447303,0.00724301358966254,0.194901366811564,0.223293980083041,3.17110836732742e-180
NMR metabolomics,X23412.Phospholipids in VLDL,PLXNA4,Plexin-A4,29434,0.157097795613698,0.00545025505795095,0.146415295700114,0.167780295527282,3.45168126897779e-180
NMR metabolomics,X23412.Phospholipids in VLDL,PDGFC,Platelet-derived growth factor C,28797,0.0556921321094099,0.00193252437624061,0.0519043843319783,0.0594798798868414,4.57807525760746e-180
NMR metabolomics,X23412.Phospholipids in VLDL,CLEC1B,C-type lectin domain family 1 member B,29694,0.184298210726277,0.00640550456171246,0.171743421785321,0.196852999667233,1.41563271172979e-179
NMR metabolomics,X23412.Phospholipids in VLDL,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,28797,0.121807518659936,0.00423297989156702,0.113510878072465,0.130104159247408,1.50646799165917e-179
NMR metabolomics,X23412.Phospholipids in VLDL,ATP6V1G1,V-type proton ATPase subunit G 1,24240,0.139595623788243,0.00485033198066932,0.130088973106131,0.149102274470355,3.87089588260001e-179
NMR metabolomics,X23412.Phospholipids in VLDL,AP3S2,AP-3 complex subunit sigma-2,24845,0.0907733333705113,0.00316245217515759,0.0845749271072024,0.0969717396338202,2.81405359458237e-178
NMR metabolomics,X23412.Phospholipids in VLDL,ATG16L1,Autophagy-related protein 16-1,24805,0.163521429912639,0.0057050960423118,0.152339441669708,0.17470341815557,8.91859072262482e-178
NMR metabolomics,X23412.Phospholipids in VLDL,SELP,P-selectin,29594,0.108451115040169,0.00379339112369926,0.101016068437718,0.115886161642619,2.35401421976844e-177
NMR metabolomics,X23412.Phospholipids in VLDL,MINK1,Misshapen-like kinase 1,24845,0.176972852990247,0.00620637551245691,0.164808356985831,0.189137348994662,5.28167513446849e-176
NMR metabolomics,X23412.Phospholipids in VLDL,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,24867,0.160365361717547,0.00562626355540882,0.149337885148945,0.171392838286148,7.25537895891125e-176
NMR metabolomics,X23412.Phospholipids in VLDL,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,24365,0.0900629082996904,0.00316075581087883,0.0838678269103679,0.0962579896890129,1.05761408468601e-175
NMR metabolomics,X23412.Phospholipids in VLDL,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,24381,0.0942187793602541,0.00330914532608234,0.0877328545211327,0.100704704199375,1.92556107229876e-175
NMR metabolomics,X23412.Phospholipids in VLDL,S100A4,Protein S100-A4,29566,0.107874509812673,0.00380751283065035,0.100411784664598,0.115337234960747,2.98840058087956e-174
NMR metabolomics,X23412.Phospholipids in VLDL,PTS,6-pyruvoyl tetrahydrobiopterin synthase,28643,0.104019664887612,0.00367615620383509,0.0968143987280952,0.111224931047129,9.62330475829886e-174
NMR metabolomics,X23412.Phospholipids in VLDL,DCTN1,Dynactin subunit 1,29725,0.122646007565281,0.00433634607455506,0.114146769259153,0.131145245871409,1.1156851155092e-173
NMR metabolomics,X23412.Phospholipids in VLDL,ERBIN,Erbin,29349,0.193435977446962,0.00684396174116101,0.180021812434286,0.206850142459637,2.0423414969756e-173
NMR metabolomics,X23412.Phospholipids in VLDL,ITGA5,Integrin alpha-5,29443,0.0472720028623865,0.00167311035668016,0.0439927065632933,0.0505512991614796,2.62906855758627e-173
NMR metabolomics,X23412.Phospholipids in VLDL,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",24740,0.205897688056943,0.00729615244022055,0.19159722927411,0.220198146839775,1.79690699166422e-172
NMR metabolomics,X23412.Phospholipids in VLDL,GP1BA,Platelet glycoprotein Ib alpha chain,29374,0.0617677915423931,0.00219280813155462,0.057469887604546,0.0660656954802401,2.80335667421042e-172
NMR metabolomics,X23412.Phospholipids in VLDL,RTBDN,Retbindin,29349,0.055805283477532,0.00198275121056336,0.0519190911048278,0.0596914758502362,5.29027277593583e-172
NMR metabolomics,X23412.Phospholipids in VLDL,NUCB2,Nucleobindin-2,29652,0.0700675350961255,0.00249120932399711,0.0651847648210912,0.0749503053711598,8.55984716151432e-172
NMR metabolomics,X23412.Phospholipids in VLDL,MXRA8,Matrix remodeling-associated protein 8,24381,-0.0576674936290587,0.00204906591530328,-0.0616836628230531,-0.0536513244350642,1.60151321000867e-171
NMR metabolomics,X23412.Phospholipids in VLDL,OTUD7B,OTU domain-containing protein 7B,24867,0.118842315519724,0.00422646160445903,0.110558450774984,0.127126180264464,2.78320634667743e-171
NMR metabolomics,X23412.Phospholipids in VLDL,CEP85,Centrosomal protein of 85 kDa,28797,0.119930505399824,0.0042733818203272,0.111554677031983,0.128306333767666,5.34674772871241e-171
NMR metabolomics,X23412.Phospholipids in VLDL,NTproBNP,N-terminal prohormone of brain natriuretic peptide,29478,-0.195510219528348,0.00698371041018778,-0.209198291932317,-0.18182214712438,3.15688603310879e-170
NMR metabolomics,X23412.Phospholipids in VLDL,PAXX,Protein PAXX,24381,0.08590803011395,0.00306493124885924,0.0799007648661859,0.0919152953617141,3.57008598519369e-170
NMR metabolomics,X23412.Phospholipids in VLDL,ACP5,Tartrate-resistant acid phosphatase type 5,29604,0.0612534547272604,0.00219209990032939,0.0569569389226148,0.065549970531906,1.2891850140809e-169
NMR metabolomics,X23412.Phospholipids in VLDL,STC1,Stanniocalcin-1,29694,0.0810841128190752,0.0029054232355747,0.0753894832773488,0.0867787423608016,3.29267519370736e-169
NMR metabolomics,X23412.Phospholipids in VLDL,PPP1R9B,Neurabin-2,29786,0.175609869918463,0.00630085823478132,0.163260187778292,0.187959552058634,8.89108343673027e-169
NMR metabolomics,X23412.Phospholipids in VLDL,FUOM,Fucose mutarotase,24381,0.118745569528525,0.00426453988145767,0.110387071360868,0.127104067696182,5.29947466217311e-168
NMR metabolomics,X23412.Phospholipids in VLDL,HJV,Hemojuvelin,24867,0.0824501705717501,0.00296171349850255,0.0766452121146851,0.0882551290288151,5.58017606658254e-168
NMR metabolomics,X23412.Phospholipids in VLDL,EIF4B,Eukaryotic translation initiation factor 4B,29218,0.107500000238513,0.00386916853951518,0.0999164299010634,0.115083570575963,1.03855738369109e-167
NMR metabolomics,X23412.Phospholipids in VLDL,IGF2R,Cation-independent mannose-6-phosphate receptor,29443,0.0435662062001689,0.00156845330301225,0.0404920377262649,0.0466403746740729,1.21580847531263e-167
NMR metabolomics,X23412.Phospholipids in VLDL,NCK2,Cytoplasmic protein NCK2,29581,0.195616683411714,0.00705398387243777,0.181790875021736,0.209442491801692,4.03808459949666e-167
NMR metabolomics,X23412.Phospholipids in VLDL,TNIP1,TNFAIP3-interacting protein 1,24845,0.163901906042507,0.00591796455047418,0.152302695523578,0.175501116561437,2.65317710919639e-166
NMR metabolomics,X23412.Phospholipids in VLDL,SUGP1,SURP and G-patch domain-containing protein 1,24805,0.0742811947077884,0.00268242555217257,0.0690236406255301,0.0795387487900466,2.97019729785506e-166
NMR metabolomics,X23412.Phospholipids in VLDL,YOD1,Ubiquitin thioesterase OTU1,24111,0.115621681127911,0.00417879122153566,0.107431250333701,0.123812111922121,6.51261548064589e-166
NMR metabolomics,X23412.Phospholipids in VLDL,ARHGEF12,Rho guanine nucleotide exchange factor 12,29434,0.191722719818631,0.00693960610582463,0.178121091851215,0.205324347786047,6.87682399208606e-166
NMR metabolomics,X23412.Phospholipids in VLDL,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,29566,0.0662409175399971,0.00239990582406314,0.0615371021248334,0.0709447329551609,1.35128969490796e-165
NMR metabolomics,X23412.Phospholipids in VLDL,CMIP,C-Maf-inducing protein,24793,0.153270296801067,0.00554910134164356,0.142394058171446,0.164146535430688,2.00907553051609e-165
NMR metabolomics,X23412.Phospholipids in VLDL,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,29566,0.175204255925147,0.00636017114879158,0.162738320473515,0.187670191376778,5.83878597030441e-165
NMR metabolomics,X23412.Phospholipids in VLDL,NFX1,Transcriptional repressor NF-X1,24111,0.124977320867522,0.00453286130601879,0.116092912707725,0.133861729027319,8.84044064276147e-165
NMR metabolomics,X23412.Phospholipids in VLDL,RBPMS2,RNA-binding protein with multiple splicing 2,24240,0.189531217008777,0.00687846656593688,0.176049422539541,0.203013011478013,1.35528336145266e-164
NMR metabolomics,X23412.Phospholipids in VLDL,AAMDC,Mth938 domain-containing protein,24240,0.0985251928309443,0.00357571382284149,0.091516793738175,0.105533591923714,1.36586099024836e-164
NMR metabolomics,X23412.Phospholipids in VLDL,PAK4,Serine/threonine-protein kinase PAK 4,28774,0.112640400304977,0.00409301415388891,0.104618092563355,0.120662708046599,1.37098631458941e-164
NMR metabolomics,X23412.Phospholipids in VLDL,GHRL,Appetite-regulating hormone,29478,0.148531233258045,0.0054024639451281,0.137942403925594,0.159120062590496,2.5168146472019e-164
NMR metabolomics,X23412.Phospholipids in VLDL,BCR,Breakpoint cluster region protein,29434,0.168305710181887,0.00612433814526999,0.156302007417158,0.180309412946616,3.47745358032473e-164
NMR metabolomics,X23412.Phospholipids in VLDL,NFKBIE,NF-kappa-B inhibitor epsilon,28797,0.0907956128849237,0.00330843900247322,0.0843110724400762,0.0972801533297712,1.06277122202363e-163
NMR metabolomics,X23412.Phospholipids in VLDL,CCN2,CCN family member 2,29478,0.104654979140162,0.00381481894826429,0.097177934001564,0.11213202427876,1.23885002263286e-163
NMR metabolomics,X23412.Phospholipids in VLDL,PCSK9,Proprotein convertase subtilisin/kexin type 9,29820,0.0724392036367544,0.00264134893365986,0.0672621597267811,0.0776162475467277,1.48339104242946e-163
NMR metabolomics,X23412.Phospholipids in VLDL,CD2AP,CD2-associated protein,29478,0.116370423020106,0.00424732140899421,0.108045673058478,0.124695172981735,3.18344558974232e-163
NMR metabolomics,X23412.Phospholipids in VLDL,TIMP4,Metalloproteinase inhibitor 4,29443,-0.0737771402059668,0.00269356618088549,-0.0790565299205023,-0.0684977504914312,4.00851673044927e-163
NMR metabolomics,X23412.Phospholipids in VLDL,C1S,Complement C1s subcomponent,24966,0.0384177450849295,0.00140175441877574,0.035670306424129,0.0411651837457299,5.87760199765377e-163
NMR metabolomics,X23412.Phospholipids in VLDL,STAT5B,Signal transducer and activator of transcription 5B,29349,0.2510323522006,0.00918932897055495,0.233021267418312,0.269043436982887,2.80777401229922e-162
NMR metabolomics,X23412.Phospholipids in VLDL,IRAK1,Interleukin-1 receptor-associated kinase 1,28931,0.126821328517069,0.00464407666019521,0.117718938263086,0.135923718771051,3.87834071247943e-162
NMR metabolomics,X23412.Phospholipids in VLDL,ISM1,Isthmin-1,29434,0.071712815874495,0.00262969278582108,0.0665586180142856,0.0768670137347043,9.80061599590107e-162
NMR metabolomics,X23412.Phospholipids in VLDL,SLA2,Src-like-adapter 2,24867,0.191230256201481,0.00700865914392351,0.177493284279391,0.204967228123571,1.54025506609652e-161
NMR metabolomics,X23412.Phospholipids in VLDL,AGRN,Agrin,29581,0.0625385869073436,0.00230237066692688,0.0580259404001669,0.0670512334145203,1.679774617814e-160
NMR metabolomics,X23412.Phospholipids in VLDL,MMP10,Stromelysin-2,29439,-0.107154768853453,0.00395081161698637,-0.114898359622747,-0.0994111780841601,5.02007333775472e-160
NMR metabolomics,X23412.Phospholipids in VLDL,NFE2,Transcription factor NF-E2 45 kDa subunit,24240,0.135331833612599,0.00498960886780677,0.125552200231698,0.1451114669935,1.28553063362941e-159
NMR metabolomics,X23412.Phospholipids in VLDL,DOK2,Docking protein 2,29478,0.22037468370321,0.00813688612358275,0.204426386900988,0.236322980505432,1.39422400042569e-159
NMR metabolomics,X23412.Phospholipids in VLDL,TNFSF12,Tumor necrosis factor ligand superfamily member 12,29786,0.0518959400426166,0.00191696975870445,0.0481386793155558,0.0556532007696773,1.80814322554491e-159
NMR metabolomics,X23412.Phospholipids in VLDL,CCL5,C-C motif chemokine 5,29594,0.181450231075009,0.00671412025632579,0.168290555372611,0.194609906777408,6.39100985159152e-159
NMR metabolomics,X23412.Phospholipids in VLDL,SRPK2,SRSF protein kinase 2,29434,0.151545632250272,0.00560741105565254,0.140555106581193,0.162536157919351,6.41058272485112e-159
NMR metabolomics,X23412.Phospholipids in VLDL,PHACTR2,Phosphatase and actin regulator 2,24867,0.206439448516577,0.00763630097630026,0.191472298603028,0.221406598430125,1.16291925797344e-158
NMR metabolomics,X23412.Phospholipids in VLDL,NFKB1,Nuclear factor NF-kappa-B p105 subunit,24111,0.134699996288369,0.00498469006913668,0.124930003752861,0.144469988823877,1.83693096358553e-158
NMR metabolomics,X23412.Phospholipids in VLDL,IL1R2,Interleukin-1 receptor type 2,29404,0.0359078630450754,0.00133179357000307,0.0332975476478694,0.0385181784422815,3.47597792099315e-158
NMR metabolomics,X23412.Phospholipids in VLDL,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",29307,0.188715343181306,0.00701193756743123,0.174971945549141,0.202458740813471,1.26733995071968e-157
NMR metabolomics,X23412.Phospholipids in VLDL,PCBP2,Poly(rC)-binding protein 2,24867,0.130366071976123,0.00484436733918346,0.120871111991323,0.139861031960923,2.94092757007751e-157
NMR metabolomics,X23412.Phospholipids in VLDL,CLIP2,CAP-Gly domain-containing linker protein 2,29434,0.201288533148782,0.00751331793322436,0.186562429999662,0.216014636297902,3.10108987681025e-156
NMR metabolomics,X23412.Phospholipids in VLDL,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,29786,0.176990815881782,0.00661896649857544,0.164017641544574,0.18996399021899,1.11898204788979e-155
NMR metabolomics,X23412.Phospholipids in VLDL,CDH2,Cadherin-2,29478,0.0633380738635201,0.00236921726291704,0.0586944080282027,0.0679817396988375,1.3742137309234e-155
NMR metabolomics,X23412.Phospholipids in VLDL,CES2,Cocaine esterase,29349,0.0978190030522574,0.0036598969888977,0.090645604954018,0.104992401150497,1.659014530578e-155
NMR metabolomics,X23412.Phospholipids in VLDL,USO1,General vesicular transport factor p115,29349,0.160546120651751,0.00601275398516006,0.148761122840837,0.172331118462664,3.29947093119709e-155
NMR metabolomics,X23412.Phospholipids in VLDL,CIRBP,Cold-inducible RNA-binding protein,24805,0.171561041676881,0.006421900185146,0.158974117313995,0.184147966039767,4.9378290490405e-155
NMR metabolomics,X23412.Phospholipids in VLDL,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,29497,0.0476264845352896,0.00178822459538586,0.0441215643283333,0.0511314047422459,1.87980941470258e-154
NMR metabolomics,X23412.Phospholipids in VLDL,GPC5,Glypican-5,29218,0.100318992327037,0.00376645613377948,0.0929367383048288,0.107701246349244,1.88283927221341e-154
NMR metabolomics,X23412.Phospholipids in VLDL,CD99L2,CD99 antigen-like protein 2,29443,0.0431580188530579,0.00162104352665336,0.0399807735408173,0.0463352641652985,2.44401948777244e-154
NMR metabolomics,X23412.Phospholipids in VLDL,IKBKG,NF-kappa-B essential modulator,29434,0.163210954762751,0.00613237767898246,0.151191494511945,0.175230415013556,3.09102916344286e-154
NMR metabolomics,X23412.Phospholipids in VLDL,CCL13,C-C motif chemokine 13,29732,0.12290174418125,0.00461886765767937,0.113848763572198,0.131954724790301,3.46627237628949e-154
NMR metabolomics,X23412.Phospholipids in VLDL,SNAP23,Synaptosomal-associated protein 23,29478,0.154628937765905,0.00581476018631959,0.143232007800719,0.166025867731092,5.4648926311735e-154
NMR metabolomics,X23412.Phospholipids in VLDL,CD300LG,CMRF35-like molecule 9,29443,-0.066810115964562,0.00251287353103612,-0.0717353480853928,-0.0618848838437312,6.31130751077756e-154
NMR metabolomics,X23412.Phospholipids in VLDL,CRHBP,Corticotropin-releasing factor-binding protein,29454,0.0494492893605463,0.0018613429857157,0.0458010571085435,0.0530975216125491,1.0786651469517e-153
NMR metabolomics,X23412.Phospholipids in VLDL,PDCD5,Programmed cell death protein 5,29694,0.102820781932125,0.0038733697124752,0.0952289772956733,0.110412586568576,1.79541079259293e-153
NMR metabolomics,X23412.Phospholipids in VLDL,THPO,Thrombopoietin,28916,0.0684615779358485,0.00258422416696605,0.0633964985685951,0.073526657303102,8.00577514147164e-153
NMR metabolomics,X23412.Phospholipids in VLDL,FOXO1,Forkhead box protein O1,29434,0.151535416099559,0.00572163982749788,0.140321002037663,0.162749830161455,9.0411541590962e-153
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINH1,Serpin H1,24445,0.228293414339922,0.00861835268542466,0.211401443076489,0.245185385603354,1.83599518530533e-152
NMR metabolomics,X23412.Phospholipids in VLDL,LEFTY2,Left-right determination factor 2,29674,0.0917558241161623,0.00347523081828765,0.0849443717123185,0.0985672765200061,7.26407365108121e-152
NMR metabolomics,X23412.Phospholipids in VLDL,DNAJB6,DnaJ homolog subfamily B member 6,24170,0.150208585540035,0.00568363793922766,0.139068655179149,0.161348515900921,9.32740686361458e-152
NMR metabolomics,X23412.Phospholipids in VLDL,CSNK2A1,Casein kinase II subunit alpha,24867,-0.0795512884348665,0.00301073713320843,-0.085452333215955,-0.0736502436537779,9.42498322179026e-152
NMR metabolomics,X23412.Phospholipids in VLDL,ZFYVE19,Abscission/NoCut checkpoint regulator,24805,0.160239559206991,0.00607899066895502,0.148324737495839,0.172154380918142,4.81229240446808e-151
NMR metabolomics,X23412.Phospholipids in VLDL,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,24805,0.191693121870019,0.0072739816649023,0.177436117806811,0.205950125933228,5.65829395660979e-151
NMR metabolomics,X23412.Phospholipids in VLDL,CTBS,Di-N-acetylchitobiase,24653,0.0481366640647008,0.00182745474125284,0.0445548527718453,0.0517184753575564,8.01423948732941e-151
NMR metabolomics,X23412.Phospholipids in VLDL,GFER,FAD-linked sulfhydryl oxidase ALR,28797,0.11241976195147,0.00428806536079861,0.104015153844304,0.120824370058635,9.79808481802893e-150
NMR metabolomics,X23412.Phospholipids in VLDL,ARHGEF1,Rho guanine nucleotide exchange factor 1,24845,0.158835778792907,0.00605781547447929,0.146962460462927,0.170709097122886,1.70571847359702e-149
NMR metabolomics,X23412.Phospholipids in VLDL,CXCL3,C-X-C motif chemokine 3,29453,0.164724295781566,0.006298235120204,0.152379754945967,0.177068836617166,4.48833159385104e-149
NMR metabolomics,X23412.Phospholipids in VLDL,F2,Prothrombin,24966,0.0260147458694834,0.000993933879233358,0.024066635466186,0.0279628562727808,5.46236820013246e-149
NMR metabolomics,X23412.Phospholipids in VLDL,PLSCR3,Phospholipid scramblase 3,24804,0.103246282968637,0.0039449176966541,0.0955142442831948,0.110978321654079,5.85312547919383e-149
NMR metabolomics,X23412.Phospholipids in VLDL,CRELD2,Protein disulfide isomerase CRELD2,29536,0.0904396517772817,0.00348100763398175,0.0836168768146775,0.0972624267398859,3.68450604767764e-147
NMR metabolomics,X23412.Phospholipids in VLDL,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,24922,0.111058064972915,0.00427227359859455,0.10268440871967,0.11943172122616,5.14597896415628e-147
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINC1,Antithrombin-III,24914,0.0257744633143566,0.00099224475761891,0.0238296635894235,0.0277192630392896,8.3737618592881e-147
NMR metabolomics,X23412.Phospholipids in VLDL,PDGFB,Platelet-derived growth factor subunit B,29581,0.148318679917375,0.00573282832761935,0.137082336395241,0.159555023439509,5.84032706396663e-146
NMR metabolomics,X23412.Phospholipids in VLDL,TGFB1,Transforming growth factor beta-1 proprotein,29760,0.0663903343450674,0.00256634659700658,0.0613602950149345,0.0714203736752003,6.04358954480924e-146
NMR metabolomics,X23412.Phospholipids in VLDL,SDCCAG8,Serologically defined colon cancer antigen 8,24793,0.197837083829022,0.00764687433561731,0.182849210131212,0.212824957526832,1.19425594534455e-145
NMR metabolomics,X23412.Phospholipids in VLDL,BID,BH3-interacting domain death agonist,29434,0.115247843697097,0.00446431179341603,0.106497792582002,0.123997894812193,2.48243384263242e-145
NMR metabolomics,X23412.Phospholipids in VLDL,SEC31A,Protein transport protein Sec31A,24240,0.133320486721669,0.0051587878506492,0.123209262534396,0.143431710908941,2.68947085039698e-145
NMR metabolomics,X23412.Phospholipids in VLDL,CMC1,COX assembly mitochondrial protein homolog,24922,0.156957095292485,0.00607561890035625,0.145048882247786,0.168865308337183,3.02063639436788e-145
NMR metabolomics,X23412.Phospholipids in VLDL,PLXNB3,Plexin-B3,29383,0.0817495205095528,0.00317029416863339,0.0755357439390313,0.0879632970800742,5.23357207280057e-145
NMR metabolomics,X23412.Phospholipids in VLDL,NAGK,N-acetyl-D-glucosamine kinase,24209,0.0984933995816651,0.00381644952414042,0.0910131585143499,0.10597364064898,6.65603937299114e-145
NMR metabolomics,X23412.Phospholipids in VLDL,KLK10,Kallikrein-10,29466,0.0689722270943636,0.00267959690003021,0.0637202171703044,0.0742242370184229,1.66700955786363e-144
NMR metabolomics,X23412.Phospholipids in VLDL,HCLS1,Hematopoietic lineage cell-specific protein,29786,0.0957750573288337,0.00372369767762039,0.0884766098806978,0.10307350477697,2.61186557227166e-144
NMR metabolomics,X23412.Phospholipids in VLDL,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,29218,0.163102881263621,0.00634433655704046,0.150667981611821,0.17553778091542,3.78761970830839e-144
NMR metabolomics,X23412.Phospholipids in VLDL,COL18A1,Collagen alpha-1(XVIII) chain,29559,0.0402836352333477,0.00156808739425405,0.0372101839406097,0.0433570865260856,5.82405135383992e-144
NMR metabolomics,X23412.Phospholipids in VLDL,STK11,Serine/threonine-protein kinase STK11,28916,0.125361301969365,0.0048868798546602,0.115783017454231,0.134939586484499,1.60031912689215e-143
NMR metabolomics,X23412.Phospholipids in VLDL,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,24922,0.13255846995388,0.00516696838686448,0.122431211915625,0.142685727992134,2.70346698216629e-143
NMR metabolomics,X23412.Phospholipids in VLDL,OGFR,Opioid growth factor receptor,29349,0.056103978337481,0.00219031356634341,0.051810963747448,0.0603969929275141,3.94137105671162e-143
NMR metabolomics,X23412.Phospholipids in VLDL,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",28797,0.141481679643938,0.00553099729691884,0.130640924941977,0.152322434345898,1.01002624460434e-142
NMR metabolomics,X23412.Phospholipids in VLDL,MVK,Mevalonate kinase,28931,0.13640536026596,0.00533425256862744,0.12595022523145,0.14686049530047,1.21907020488456e-142
NMR metabolomics,X23412.Phospholipids in VLDL,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,29163,0.191272532778574,0.00748405971172221,0.176603775743598,0.205941289813549,1.69367343556448e-142
NMR metabolomics,X23412.Phospholipids in VLDL,SIGLEC7,Sialic acid-binding Ig-like lectin 7,29478,0.0480572175086507,0.00188114547029064,0.044370172386881,0.0517442626304203,2.12262212889658e-142
NMR metabolomics,X23412.Phospholipids in VLDL,FKBPL,FK506-binding protein-like,24805,0.101438649148162,0.00396994926580072,0.0936575485871922,0.109219749709131,3.64676326646602e-142
NMR metabolomics,X23412.Phospholipids in VLDL,NIT2,Omega-amidase NIT2,24813,0.127599433310523,0.00499432663074512,0.117810553114262,0.137388313506783,3.90006539046511e-142
NMR metabolomics,X23412.Phospholipids in VLDL,FETUB,Fetuin-B,29545,0.056411692213984,0.00221155151757667,0.0520770512395337,0.0607463331884342,5.59126251261508e-142
NMR metabolomics,X23412.Phospholipids in VLDL,BACH1,Transcription regulator protein BACH1,29434,0.125865939254803,0.00493444015116926,0.116194436558512,0.135537441951095,5.67983160297277e-142
NMR metabolomics,X23412.Phospholipids in VLDL,DAG1,Dystroglycan,29581,0.0808935193236518,0.00317608111453893,0.0746684003391554,0.0871186383081481,1.44362930707069e-141
NMR metabolomics,X23412.Phospholipids in VLDL,PLEKHO1,Pleckstrin homology domain-containing family O member 1,24845,0.118488670189122,0.00464802549906155,0.109378540210962,0.127598800167283,1.58910926410619e-141
NMR metabolomics,X23412.Phospholipids in VLDL,RNASE4,Ribonuclease 4,24194,0.0470738004945454,0.00184631905502269,0.043455015146701,0.0506925858423899,1.61667180879746e-141
NMR metabolomics,X23412.Phospholipids in VLDL,EPHA1,Ephrin type-A receptor 1,29536,0.0567267521391802,0.00222916616081402,0.0523575864639847,0.0610959178143756,2.51771348760258e-141
NMR metabolomics,X23412.Phospholipids in VLDL,TANK,TRAF family member-associated NF-kappa-B activator,28931,0.119647391591643,0.00470521219725044,0.110425175685032,0.128869607498254,4.3272757723077e-141
NMR metabolomics,X23412.Phospholipids in VLDL,HMOX2,Heme oxygenase 2,28774,0.079540191503588,0.00312834715032237,0.0734086310889562,0.0856717519182199,4.76102571834001e-141
NMR metabolomics,X23412.Phospholipids in VLDL,SDC4,Syndecan-4,29478,0.0789137836886006,0.00310459320566917,0.072828781005489,0.0849987863717121,5.23864635401823e-141
NMR metabolomics,X23412.Phospholipids in VLDL,RGCC,Regulator of cell cycle RGCC,24867,0.128933571279314,0.00507132912169738,0.118993766200787,0.138873376357841,8.62984103090304e-141
NMR metabolomics,X23412.Phospholipids in VLDL,IL1RN,Interleukin-1 receptor antagonist protein,29379,0.091686529105223,0.00361528349661444,0.0846005734518587,0.0987724847585873,2.22100846089421e-140
NMR metabolomics,X23412.Phospholipids in VLDL,LAT,Linker for activation of T-cells family member 1,29786,0.128243916983621,0.00506821178925434,0.118310221876682,0.138177612090559,8.77946937857869e-140
NMR metabolomics,X23412.Phospholipids in VLDL,CEP43,Centrosomal protein 43,28705,0.117936980527188,0.00466456358865784,0.108794435893418,0.127079525160957,1.63444615189845e-139
NMR metabolomics,X23412.Phospholipids in VLDL,DPP4,Dipeptidyl peptidase 4,28990,0.0507599312135763,0.00201141602905318,0.0468175557966321,0.0547023066305206,5.14283409661874e-139
NMR metabolomics,X23412.Phospholipids in VLDL,AKT1S1,Proline-rich AKT1 substrate 1,28774,0.113281850192957,0.00449227382620001,0.104476993493605,0.122086706892309,8.41373139156163e-139
NMR metabolomics,X23412.Phospholipids in VLDL,CDC42BPB,Serine/threonine-protein kinase MRCK beta,24805,0.173634313814516,0.00688165143766365,0.160146276996695,0.187122350632337,1.01857974543552e-138
NMR metabolomics,X23412.Phospholipids in VLDL,AHNAK,Neuroblast differentiation-associated protein AHNAK,24240,0.0535946179899751,0.0021251961573422,0.0494292335215844,0.0577600024583658,1.53177256615707e-138
NMR metabolomics,X23412.Phospholipids in VLDL,DLK1,Protein delta homolog 1,29820,0.0940352080357501,0.00373434436964811,0.0867158930712398,0.10135452300026,1.80968423944067e-138
NMR metabolomics,X23412.Phospholipids in VLDL,FABP5,Fatty acid-binding protein 5,29624,0.114787218698128,0.00455835925067885,0.105852834566797,0.123721602829458,1.82620725751976e-138
NMR metabolomics,X23412.Phospholipids in VLDL,AP3B1,AP-3 complex subunit beta-1,24805,0.129526004942607,0.0051427555516433,0.119446204061386,0.139605805823828,3.11283107457501e-138
NMR metabolomics,X23412.Phospholipids in VLDL,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,24922,0.122513278902562,0.00486789621659176,0.112972202318042,0.132054355487081,4.81692561277298e-138
NMR metabolomics,X23412.Phospholipids in VLDL,GOLM2,Protein GOLM2,29694,0.0380678296683863,0.00151470920499711,0.0350989996265919,0.0410366597101806,6.1588723534268e-138
NMR metabolomics,X23412.Phospholipids in VLDL,PON2,Serum paraoxonase/arylesterase 2,28916,0.0584680184874039,0.00232683986547787,0.0539074123510673,0.0630286246237405,7.50671664106355e-138
NMR metabolomics,X23412.Phospholipids in VLDL,METAP2,Methionine aminopeptidase 2,29674,0.0967027842195442,0.00384959113435648,0.0891575855962055,0.104247982842883,8.26158739453133e-138
NMR metabolomics,X23412.Phospholipids in VLDL,SCAMP3,Secretory carrier-associated membrane protein 3,29349,0.142264543980455,0.00566547814197286,0.131160206822188,0.153368881138722,1.08245196431154e-137
NMR metabolomics,X23412.Phospholipids in VLDL,BTN3A2,Butyrophilin subfamily 3 member A2,29434,0.0636671556199421,0.00253576526402234,0.0586970557024583,0.0686372555374259,1.1573540756181e-137
NMR metabolomics,X23412.Phospholipids in VLDL,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",24867,0.130569373909084,0.00519589906496607,0.12038541174175,0.140753336076417,1.24447210870455e-137
NMR metabolomics,X23412.Phospholipids in VLDL,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,24445,0.17784408794231,0.00709965493333422,0.163928764272974,0.191759411611645,9.36284235492729e-137
NMR metabolomics,X23412.Phospholipids in VLDL,GIT1,ARF GTPase-activating protein GIT1,24229,0.16351899532233,0.00653961456716934,0.150701350770678,0.176336639873981,2.9328373207849e-136
NMR metabolomics,X23412.Phospholipids in VLDL,USP8,Ubiquitin carboxyl-terminal hydrolase 8,28916,0.160356572634592,0.0064256335565154,0.147762330863822,0.172950814405363,5.10553984177277e-136
NMR metabolomics,X23412.Phospholipids in VLDL,VPS53,Vacuolar protein sorting-associated protein 53 homolog,29349,0.12831656990945,0.00514337060761829,0.118235563518518,0.138397576300382,5.88902229051067e-136
NMR metabolomics,X23412.Phospholipids in VLDL,RAPGEF2,Rap guanine nucleotide exchange factor 2,24445,0.0892107351488376,0.00357455874071469,0.0822046000170368,0.0962168702806384,8.97144827605831e-136
NMR metabolomics,X23412.Phospholipids in VLDL,GMPR,GMP reductase 1,29786,0.0827334903433996,0.00332670387342542,0.0762131507514858,0.0892538299353135,3.82045713678557e-135
NMR metabolomics,X23412.Phospholipids in VLDL,KRT18,"Keratin, type I cytoskeletal 18",29349,0.135336240059714,0.00544837816966007,0.124657418847181,0.146015061272248,8.27400770519962e-135
NMR metabolomics,X23412.Phospholipids in VLDL,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,29608,0.171366027232201,0.00690642914706764,0.157829426103948,0.184902628360453,1.56081924300493e-134
NMR metabolomics,X23412.Phospholipids in VLDL,IST1,IST1 homolog,24636,0.165689589812134,0.0066712792014221,0.152613882577346,0.178765297046921,1.64751369172613e-134
NMR metabolomics,X23412.Phospholipids in VLDL,LZTFL1,Leucine zipper transcription factor-like protein 1,24381,0.119535888980047,0.0048132664444828,0.110101886748861,0.128969891211233,1.78055811046033e-134
NMR metabolomics,X23412.Phospholipids in VLDL,RABEP1,Rab GTPase-binding effector protein 1,24381,0.13015703208139,0.0052412947081421,0.119884094453432,0.140429969709349,1.85456401973476e-134
NMR metabolomics,X23412.Phospholipids in VLDL,TOP2B,DNA topoisomerase 2-beta,24229,0.132709278564314,0.00534992074264568,0.122223433908728,0.143195123219899,3.66806232748351e-134
NMR metabolomics,X23412.Phospholipids in VLDL,SNX15,Sorting nexin-15,24381,0.090082217408455,0.0036323104907725,0.0829628888465409,0.0972015459703691,4.10168615081566e-134
NMR metabolomics,X23412.Phospholipids in VLDL,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,29349,0.0632818003909068,0.00255499588454217,0.0582740084572042,0.0682895923246095,4.75497070722772e-134
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINE1,Plasminogen activator inhibitor 1,29820,0.111209826315548,0.00449126313931371,0.102406950562493,0.120012702068603,5.29974892789043e-134
NMR metabolomics,X23412.Phospholipids in VLDL,BIRC2,Baculoviral IAP repeat-containing protein 2,28797,0.104999357792375,0.00424257706114313,0.096683906752534,0.113314808832215,7.9915298094796e-134
NMR metabolomics,X23412.Phospholipids in VLDL,ARHGAP45,Rho GTPase-activating protein 45,24381,0.137387209940642,0.00554799866915076,0.126513132549106,0.148261287332177,1.00151812633218e-133
NMR metabolomics,X23412.Phospholipids in VLDL,HDGFL2,Hepatoma-derived growth factor-related protein 2,24845,0.104888029781675,0.00423695985272108,0.0965835884703416,0.113192471093008,1.13026784710236e-133
NMR metabolomics,X23412.Phospholipids in VLDL,HYOU1,Hypoxia up-regulated protein 1,29820,0.0369363205703592,0.00149371217400841,0.0340086447093027,0.0398639964314157,1.19559311428988e-133
NMR metabolomics,X23412.Phospholipids in VLDL,LEP,Leptin,29478,0.111268958030055,0.00450304660830476,0.102442986677778,0.120094929382332,1.92469941483242e-133
NMR metabolomics,X23412.Phospholipids in VLDL,PSIP1,PC4 and SFRS1-interacting protein,29434,0.105618869484635,0.00427775142218472,0.097234476697153,0.114003262272117,3.09656320049871e-133
NMR metabolomics,X23412.Phospholipids in VLDL,STAMBP,STAM-binding protein,29163,0.1055404026609,0.0042871072714119,0.0971376724089331,0.113943132912868,1.82674640363812e-132
NMR metabolomics,X23412.Phospholipids in VLDL,HEXIM1,Protein HEXIM1,29434,0.133825867884685,0.00544448072329082,0.123154685667035,0.144497050102335,4.4438200146907e-132
NMR metabolomics,X23412.Phospholipids in VLDL,SH2B3,SH2B adapter protein 3,28797,0.161471884153949,0.00657183985534602,0.148591078037471,0.174352690270427,6.02221861752388e-132
NMR metabolomics,X23412.Phospholipids in VLDL,EREG,Proepiregulin,29163,0.132189227765484,0.00538161797546848,0.121641256533566,0.142737198997402,6.88605560420386e-132
NMR metabolomics,X23412.Phospholipids in VLDL,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",24240,0.114532329513222,0.00465903016789475,0.105400630384148,0.123664028642295,7.94444113980351e-132
NMR metabolomics,X23412.Phospholipids in VLDL,TIMP3,Metalloproteinase inhibitor 3,29581,0.213792796507329,0.00870729238806147,0.196726503426728,0.230859089587929,8.35270534902245e-132
NMR metabolomics,X23412.Phospholipids in VLDL,TACC3,Transforming acidic coiled-coil-containing protein 3,29349,0.191358348115041,0.00780079054261205,0.176068798651522,0.206647897578561,1.47665031282746e-131
NMR metabolomics,X23412.Phospholipids in VLDL,LSP1,Lymphocyte-specific protein 1,29434,0.0660520940733678,0.00269438470317394,0.0607711000551469,0.0713330880915888,2.14707164535814e-131
NMR metabolomics,X23412.Phospholipids in VLDL,PPY,Pancreatic prohormone,29400,0.16729259591544,0.00682494115149338,0.153915711258513,0.180669480572367,2.30334670615717e-131
NMR metabolomics,X23412.Phospholipids in VLDL,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,29434,0.165860880037357,0.00677468349312121,0.152582500390839,0.179139259683874,4.66512804040878e-131
NMR metabolomics,X23412.Phospholipids in VLDL,SKAP2,Src kinase-associated phosphoprotein 2,29581,0.17083705555123,0.00698166559150783,0.157152990991875,0.184521120110586,6.29258374255943e-131
NMR metabolomics,X23412.Phospholipids in VLDL,DNMBP,Dynamin-binding protein,29218,0.100313997731776,0.00409963189534446,0.0922787192169013,0.108349276246652,6.58489271312565e-131
NMR metabolomics,X23412.Phospholipids in VLDL,LYN,Tyrosine-protein kinase Lyn,29349,0.138299496656859,0.0056575015314378,0.127210793655241,0.149388199658477,1.14761055277453e-130
NMR metabolomics,X23412.Phospholipids in VLDL,CTSD,Cathepsin D,27442,0.0666595719483889,0.00272731903751154,0.0613140266348663,0.0720051172619115,1.5491023760066e-130
NMR metabolomics,X23412.Phospholipids in VLDL,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,29349,0.0732784340414599,0.00300105569896632,0.0673963648714859,0.0791605032114339,2.23430886510756e-130
NMR metabolomics,X23412.Phospholipids in VLDL,ASAH2,Neutral ceramidase,29218,0.0866804563506987,0.00355151672909555,0.0797194835616715,0.093641429139726,2.94351962125815e-130
NMR metabolomics,X23412.Phospholipids in VLDL,MITD1,MIT domain-containing protein 1,29218,0.158048681763512,0.00647743375557016,0.145352911602595,0.17074445192443,3.45687028726514e-130
NMR metabolomics,X23412.Phospholipids in VLDL,SYTL4,Synaptotagmin-like protein 4,24922,0.119572167567057,0.00489850755418922,0.109971092760846,0.129173242373268,4.53107526816661e-130
NMR metabolomics,X23412.Phospholipids in VLDL,RILPL2,RILP-like protein 2,24922,0.160308065665781,0.00657709116780827,0.147416966976877,0.173199164354685,1.07526173554247e-129
NMR metabolomics,X23412.Phospholipids in VLDL,AHSG,Alpha-2-HS-glycoprotein,24951,0.0440218028813048,0.00180683135393501,0.0404804134275922,0.0475631923350174,1.34680193581116e-129
NMR metabolomics,X23412.Phospholipids in VLDL,TBCC,Tubulin-specific chaperone C,29218,0.131887261240671,0.00542211884555196,0.12125990830339,0.142514614177953,2.12641719857118e-129
NMR metabolomics,X23412.Phospholipids in VLDL,QDPR,Dihydropteridine reductase,29345,0.0702938816466202,0.00289095339330667,0.0646276129957391,0.0759601502975013,2.59142703794204e-129
NMR metabolomics,X23412.Phospholipids in VLDL,WASF1,Wiskott-Aldrich syndrome protein family member 1,28916,0.152292471345447,0.00626856353822935,0.140006086810518,0.164578855880377,4.41115712222109e-129
NMR metabolomics,X23412.Phospholipids in VLDL,TRIM21,E3 ubiquitin-protein ligase TRIM21,29434,0.125202833600638,0.00515440113811535,0.115100207369932,0.135305459831344,4.62583867030183e-129
NMR metabolomics,X23412.Phospholipids in VLDL,CNPY4,Protein canopy homolog 4,29349,0.12202337359825,0.00502737223177504,0.112169724023971,0.131877023172529,7.28061211636981e-129
NMR metabolomics,X23412.Phospholipids in VLDL,NHLRC3,NHL repeat-containing protein 3,23825,0.0523744321441377,0.00215537207322761,0.0481499028806116,0.0565989614076638,7.36294753124846e-129
NMR metabolomics,X23412.Phospholipids in VLDL,VAMP8,Vesicle-associated membrane protein 8,24229,0.144048543748521,0.00593512030682111,0.132415707947152,0.15568137954989,1.37996525768144e-128
NMR metabolomics,X23412.Phospholipids in VLDL,MAMDC4,Apical endosomal glycoprotein,24793,0.0904968781577599,0.00373045167973522,0.0831851928654788,0.0978085634500409,1.67799280023759e-128
NMR metabolomics,X23412.Phospholipids in VLDL,MYDGF,Myeloid-derived growth factor,24922,0.162481652339961,0.00671184181454051,0.149326442383462,0.17563686229646,5.49394923345782e-128
NMR metabolomics,X23412.Phospholipids in VLDL,ATP5IF1,"ATPase inhibitor, mitochondrial",29581,0.178310216526809,0.00737253628779763,0.163860045402726,0.192760387650892,5.5181965688687e-128
NMR metabolomics,X23412.Phospholipids in VLDL,IGSF3,Immunoglobulin superfamily member 3,29349,0.0582307879365646,0.00240858748064544,0.0535099564744995,0.0629516193986296,7.05667668353916e-128
NMR metabolomics,X23412.Phospholipids in VLDL,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,24805,0.144615724368216,0.00597911753516707,0.132896653999288,0.156334794737143,9.26595318750771e-128
NMR metabolomics,X23412.Phospholipids in VLDL,GIGYF2,GRB10-interacting GYF protein 2,24867,0.123289086099869,0.00510478246590591,0.113283712466694,0.133294459733045,2.10873328561736e-127
NMR metabolomics,X23412.Phospholipids in VLDL,TBC1D23,TBC1 domain family member 23,29349,0.14522962822465,0.00602264977017562,0.133425234675106,0.157034021774195,3.10040932653919e-127
NMR metabolomics,X23412.Phospholipids in VLDL,CRKL,Crk-like protein,29491,0.171149613114593,0.00710798561850796,0.157217961302317,0.185081264926868,7.07241285275929e-127
NMR metabolomics,X23412.Phospholipids in VLDL,USP25,Ubiquitin carboxyl-terminal hydrolase 25,24793,0.116801607045434,0.00484769173561712,0.107300131243624,0.126303082847243,8.26035525567184e-127
NMR metabolomics,X23412.Phospholipids in VLDL,SH3GLB2,Endophilin-B2,24845,0.107584212044506,0.00446661248768998,0.0988296515686338,0.116338772520379,9.89778888858731e-127
NMR metabolomics,X23412.Phospholipids in VLDL,ACE2,Angiotensin-converting enzyme 2,28916,0.0833615248617069,0.00346784289557767,0.0765645527863747,0.0901584969370392,1.92618006533114e-126
NMR metabolomics,X23412.Phospholipids in VLDL,DBNL,Drebrin-like protein,29581,0.148980528698098,0.00619926802127088,0.136829963376407,0.161131094019789,2.10670476231214e-126
NMR metabolomics,X23412.Phospholipids in VLDL,TIA1,Nucleolysin TIA-1 isoform p40,28538,0.196450805517866,0.00818119396804748,0.180415665340493,0.212485945695239,3.68815232877738e-126
NMR metabolomics,X23412.Phospholipids in VLDL,MSRA,Mitochondrial peptide methionine sulfoxide reductase,29566,0.116443481469438,0.00485355896507323,0.106930505897895,0.125956457040982,5.49735194016177e-126
NMR metabolomics,X23412.Phospholipids in VLDL,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",29349,0.0709300896016268,0.00295670925814948,0.0651349394556539,0.0767252397475998,5.85610961655584e-126
NMR metabolomics,X23412.Phospholipids in VLDL,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",24867,0.128939444595349,0.00537392367069025,0.118406554200797,0.139472334989902,8.75914153797544e-126
NMR metabolomics,X23412.Phospholipids in VLDL,MPRIP,Myosin phosphatase Rho-interacting protein,24729,0.0714852280085921,0.00297936666333533,0.0656456693484548,0.0773247866687293,8.94185391495648e-126
NMR metabolomics,X23412.Phospholipids in VLDL,OPHN1,Oligophrenin-1,24845,0.173180316286973,0.00722123643461544,0.159026692875127,0.187333939698819,1.1495165122667e-125
NMR metabolomics,X23412.Phospholipids in VLDL,AZI2,5-azacytidine-induced protein 2,24867,0.0890224871396379,0.00371225673766521,0.0817464639338141,0.0962985103454617,1.18435932855424e-125
NMR metabolomics,X23412.Phospholipids in VLDL,SUSD1,Sushi domain-containing protein 1,28916,0.0785855471947969,0.00328565865066079,0.0721456562395017,0.085025438150092,3.30484907698855e-125
NMR metabolomics,X23412.Phospholipids in VLDL,CLEC4G,C-type lectin domain family 4 member G,29434,0.0533755969493472,0.00223185066152548,0.0490011696527572,0.0577500242459371,3.32617203138152e-125
NMR metabolomics,X23412.Phospholipids in VLDL,HGF,Hepatocyte growth factor,29786,0.055152749293873,0.00230747234584783,0.0506301034960112,0.0596753950917347,4.43330516803567e-125
NMR metabolomics,X23412.Phospholipids in VLDL,MPHOSPH8,M-phase phosphoprotein 8,28916,0.121389983216377,0.00507949033578241,0.111434182158243,0.13134578427451,5.24681182105291e-125
NMR metabolomics,X23412.Phospholipids in VLDL,F11,Coagulation factor XI,24606,0.0498947263914739,0.00208624855213761,0.0458056792292842,0.0539837735536636,5.58504966834776e-125
NMR metabolomics,X23412.Phospholipids in VLDL,ARSB,Arylsulfatase B,29349,0.0884153833370666,0.00370066713733771,0.0811620757478847,0.0956686909262485,5.84352698495987e-125
NMR metabolomics,X23412.Phospholipids in VLDL,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,24793,0.133310022487962,0.00558168465623007,0.122369920561751,0.144250124414173,1.16685303066509e-124
NMR metabolomics,X23412.Phospholipids in VLDL,VWA1,von Willebrand factor A domain-containing protein 1,29674,0.0673315513622089,0.00282753193016368,0.0617895887790881,0.0728735139453297,3.60709519771268e-124
NMR metabolomics,X23412.Phospholipids in VLDL,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,24867,0.105303274215492,0.00442160396081361,0.0966369304522973,0.113969617978687,5.63767343433903e-124
NMR metabolomics,X23412.Phospholipids in VLDL,FGF19,Fibroblast growth factor 19,29581,0.122979022369333,0.00516905083971919,0.112847682723483,0.133110362015182,6.00403387289777e-124
NMR metabolomics,X23412.Phospholipids in VLDL,LBR,Delta(14)-sterol reductase LBR,29694,0.106474974572684,0.00447559447930709,0.0977028093932418,0.115247139752126,6.1247582066008e-124
NMR metabolomics,X23412.Phospholipids in VLDL,FAM13A,Protein FAM13A,24805,0.107919371849759,0.00454062445828715,0.0990197479115161,0.116818995788002,1.74333935583029e-123
NMR metabolomics,X23412.Phospholipids in VLDL,CDC27,Cell division cycle protein 27 homolog,28797,0.0967783467742175,0.00408171291183728,0.0887781894670164,0.104778504081419,4.29086657859076e-123
NMR metabolomics,X23412.Phospholipids in VLDL,PDLIM5,PDZ and LIM domain protein 5,24867,0.188643187620636,0.00795431587646545,0.173052728502764,0.204233646738509,5.75510283191332e-123
NMR metabolomics,X23412.Phospholipids in VLDL,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,24867,0.170431548706682,0.00719351187065501,0.156332265440198,0.184530831973166,9.91602328351069e-123
NMR metabolomics,X23412.Phospholipids in VLDL,COMMD1,COMM domain-containing protein 1,24240,0.0976071239083041,0.00412006224413218,0.0895318019098051,0.105682445906803,1.1174342551807e-122
NMR metabolomics,X23412.Phospholipids in VLDL,CTSO,Cathepsin O,29786,0.0481404511658162,0.00203597655917073,0.0441499371098416,0.0521309652217909,1.79632612400915e-122
NMR metabolomics,X23412.Phospholipids in VLDL,NSFL1C,NSFL1 cofactor p47,29694,0.102662000606543,0.00436102254494076,0.0941143964184592,0.111209604794627,2.02566497588465e-121
NMR metabolomics,X23412.Phospholipids in VLDL,IL1RL2,Interleukin-1 receptor-like 2,28931,0.0620858755395936,0.00264045323543651,0.0569105871981381,0.0672611638810492,4.08768629755373e-121
NMR metabolomics,X23412.Phospholipids in VLDL,VNN1,Pantetheinase,24951,0.115064072085259,0.00489186527989396,0.105476016136667,0.124652128033851,5.11173202429297e-121
NMR metabolomics,X23412.Phospholipids in VLDL,IFNLR1,Interferon lambda receptor 1,29434,0.0584652395316703,0.00248786761912749,0.0535890189981804,0.0633414600651602,5.30611301349145e-121
NMR metabolomics,X23412.Phospholipids in VLDL,HS1BP3,HCLS1-binding protein 3,24240,0.142630120102101,0.00606769846279528,0.130737431115023,0.15452280908918,7.89261242141586e-121
NMR metabolomics,X23412.Phospholipids in VLDL,TBL1X,F-box-like/WD repeat-containing protein TBL1X,28797,0.133619473023956,0.0056933803926363,0.122460447454389,0.144778498593523,1.14464676223705e-120
NMR metabolomics,X23412.Phospholipids in VLDL,TRIM5,Tripartite motif-containing protein 5,29434,0.135182707554697,0.00576164847896187,0.123889876535932,0.146475538573462,1.2653124473011e-120
NMR metabolomics,X23412.Phospholipids in VLDL,ANXA11,Annexin A11,29373,0.105049964882072,0.00448287688625319,0.0962635261850154,0.113836403579128,2.47679846603299e-120
NMR metabolomics,X23412.Phospholipids in VLDL,SCPEP1,Retinoid-inducible serine carboxypeptidase,24138,0.0790559114339564,0.00337165336296254,0.0724474708425498,0.085664352025363,3.12182912909272e-120
NMR metabolomics,X23412.Phospholipids in VLDL,CNST,Consortin,29478,0.170111132231655,0.00726590643569402,0.155869955617695,0.184352308845615,4.01571759927698e-120
NMR metabolomics,X23412.Phospholipids in VLDL,BRAP,BRCA1-associated protein,24565,0.172680633828631,0.00737086390975649,0.158233740565508,0.187127527091753,4.6608702968396e-120
NMR metabolomics,X23412.Phospholipids in VLDL,DDHD2,Phospholipase DDHD2,24867,0.10431486273724,0.00445377170857815,0.0955854701884266,0.113044255286053,5.13143751252313e-120
NMR metabolomics,X23412.Phospholipids in VLDL,CD36,Platelet glycoprotein 4,24229,0.0713774955939635,0.00304957860821564,0.0654003215218609,0.0773546696660662,8.00511878533971e-120
NMR metabolomics,X23412.Phospholipids in VLDL,ORM1,Alpha-1-acid glycoprotein 1,24846,0.0314304565652694,0.00134596527577084,0.0287923646247586,0.0340685485057803,2.56469560962666e-119
NMR metabolomics,X23412.Phospholipids in VLDL,EVI5,Ecotropic viral integration site 5 protein homolog,24229,0.141632155585276,0.00606913542974417,0.129736650142978,0.153527661027575,3.90644645741738e-119
NMR metabolomics,X23412.Phospholipids in VLDL,CLUL1,Clusterin-like protein 1,29435,-0.0704655091539093,0.00302609242741993,-0.0763966503116523,-0.0645343679961662,7.32352683661475e-119
NMR metabolomics,X23412.Phospholipids in VLDL,HAO1,Hydroxyacid oxidase 1,29725,0.199928305718195,0.00859167396354565,0.183088624749645,0.216767986686744,1.03079192218889e-118
NMR metabolomics,X23412.Phospholipids in VLDL,ST13,Hsc70-interacting protein,24381,0.0874755384916914,0.00375590893086092,0.080113956987204,0.0948371199961788,1.10561041825161e-118
NMR metabolomics,X23412.Phospholipids in VLDL,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,29349,0.0436449341184663,0.00187633970619923,0.0399673082943158,0.0473225599426168,1.31624796715036e-118
NMR metabolomics,X23412.Phospholipids in VLDL,GORASP2,Golgi reassembly-stacking protein 2,24805,0.0738410564796474,0.00317784424738562,0.0676124817547716,0.0800696312045232,3.59469156975269e-118
NMR metabolomics,X23412.Phospholipids in VLDL,AMN,Protein amnionless,28931,0.0739669940946858,0.00318613542055792,0.0677221686703922,0.0802118195189793,3.84920310262111e-118
NMR metabolomics,X23412.Phospholipids in VLDL,TNFSF11,Tumor necrosis factor ligand superfamily member 11,29434,0.0949694058949823,0.00410133387545588,0.0869307914990887,0.103008020290876,1.43517641920373e-117
NMR metabolomics,X23412.Phospholipids in VLDL,SPON2,Spondin-2,29311,-0.0541751242482205,0.00234067857068141,-0.058762854246756,-0.0495873942496849,1.8491412453606e-117
NMR metabolomics,X23412.Phospholipids in VLDL,NUDT5,ADP-sugar pyrophosphatase,29443,0.0793868480877901,0.00343520498913482,0.0726538463090859,0.0861198498664944,4.08165047943289e-117
NMR metabolomics,X23412.Phospholipids in VLDL,SHMT1,"Serine hydroxymethyltransferase, cytosolic",29536,0.133676824924083,0.00578514871983303,0.12233793343321,0.145015716414956,4.32638563794336e-117
NMR metabolomics,X23412.Phospholipids in VLDL,GTPBP2,GTP-binding protein 2,24195,0.125732991354343,0.00543764792626298,0.115075201418868,0.136390781289819,5.09528433594001e-117
NMR metabolomics,X23412.Phospholipids in VLDL,COCH,Cochlin,24922,0.0719460997460592,0.00311209373620024,0.0658463960231067,0.0780458034690117,5.18144159735692e-117
NMR metabolomics,X23412.Phospholipids in VLDL,TAX1BP1,Tax1-binding protein 1,24845,0.0980309909058632,0.00424502597045864,0.0897107400037642,0.106351241807962,9.22834751786447e-117
NMR metabolomics,X23412.Phospholipids in VLDL,CA5A,"Carbonic anhydrase 5A, mitochondrial",28916,0.14219862315634,0.00616421190614806,0.13011676782029,0.15428047849239,1.09063023916851e-116
NMR metabolomics,X23412.Phospholipids in VLDL,BAG4,BAG family molecular chaperone regulator 4,24229,0.0769390905515175,0.00333370120321019,0.0704050361932256,0.0834731449098095,1.35897788397356e-116
NMR metabolomics,X23412.Phospholipids in VLDL,CD22,B-cell receptor CD22,29786,0.0647372196219968,0.00280971615478882,0.0592301759586107,0.0702442632853829,1.91655371474283e-116
NMR metabolomics,X23412.Phospholipids in VLDL,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",24805,0.2274964919593,0.00986556584186563,0.208159982909243,0.246833001009357,1.9783555528566e-116
NMR metabolomics,X23412.Phospholipids in VLDL,LGALS8,Galectin-8,29694,0.0936837535509907,0.00407055597067133,0.0857054638484749,0.101662043253507,3.44130238053459e-116
NMR metabolomics,X23412.Phospholipids in VLDL,TWF2,Twinfilin-2,24938,0.129896237978389,0.00563986782221027,0.118842097046857,0.140950378909921,3.65940503468636e-116
NMR metabolomics,X23412.Phospholipids in VLDL,SEMA4D,Semaphorin-4D,29694,0.0462723597172272,0.00201172715152994,0.0423293745002285,0.0502153449342258,4.68976851552759e-116
NMR metabolomics,X23412.Phospholipids in VLDL,ASPSCR1,Tether containing UBX domain for GLUT4,24867,0.104374787712535,0.00454004704816091,0.0954762954981401,0.113273279926931,9.5152287068327e-116
NMR metabolomics,X23412.Phospholipids in VLDL,LGALS9,Galectin-9,29453,0.0491704909391979,0.00214082223178613,0.0449744793648971,0.0533665025134987,1.0144539510448e-115
NMR metabolomics,X23412.Phospholipids in VLDL,SIAE,Sialate O-acetylesterase,29495,0.0718394795109745,0.00312898976721947,0.0657066595672243,0.0779722994547247,1.23137740542443e-115
NMR metabolomics,X23412.Phospholipids in VLDL,APPL2,DCC-interacting protein 13-beta,24381,0.173272401032656,0.00754328704533104,0.158487558423807,0.188057243641505,1.55582224109629e-115
NMR metabolomics,X23412.Phospholipids in VLDL,SETMAR,Histone-lysine N-methyltransferase SETMAR,29132,0.0463095091336576,0.00202166610395852,0.0423470435698989,0.0502719746974163,4.16464248276708e-115
NMR metabolomics,X23412.Phospholipids in VLDL,FABP4,"Fatty acid-binding protein, adipocyte",29820,0.0768239766406563,0.00335435191918335,0.0702494468790569,0.0833985064022556,4.30366118036515e-115
NMR metabolomics,X23412.Phospholipids in VLDL,STAT2,Signal transducer and activator of transcription 2,24229,0.11962997770659,0.00522145309315377,0.109395929644009,0.129864025769171,5.99246204378082e-115
NMR metabolomics,X23412.Phospholipids in VLDL,CASC3,Protein CASC3,24195,0.0646312851981725,0.00282302389174447,0.0590981583703534,0.0701644120259917,8.792398011779e-115
NMR metabolomics,X23412.Phospholipids in VLDL,LGALS1,Galectin-1,29478,0.0526261789440531,0.00230092598033922,0.0481163640225883,0.057135993865518,8.89100425743751e-115
NMR metabolomics,X23412.Phospholipids in VLDL,MARS1,"Methionine--tRNA ligase, cytoplasmic",24329,0.131956829532087,0.00576819810101332,0.120651161254101,0.143262497810074,1.28927119211032e-114
NMR metabolomics,X23412.Phospholipids in VLDL,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,29426,0.0938862772396585,0.00411029506781975,0.0858300989067318,0.101942455572585,1.75340291033854e-114
NMR metabolomics,X23412.Phospholipids in VLDL,EGLN1,Egl nine homolog 1,29434,0.0832878227737448,0.00364823844726489,0.0761372754171056,0.090438370130384,2.30203211670107e-114
NMR metabolomics,X23412.Phospholipids in VLDL,SPART,Spartin,24381,0.118901650145966,0.00520828938360912,0.108693402954092,0.12910989733784,3.70080527445065e-114
NMR metabolomics,X23412.Phospholipids in VLDL,CRELD1,Protein disulfide isomerase CRELD1,24381,0.0574321462738263,0.00252442074444618,0.0524842816147118,0.0623800109329408,2.14932680592068e-113
NMR metabolomics,X23412.Phospholipids in VLDL,C4BPB,C4b-binding protein beta chain,29566,0.0612476560506924,0.00269495910511788,0.0559655362046613,0.0665297758967234,2.28843306976097e-113
NMR metabolomics,X23412.Phospholipids in VLDL,FST,Follistatin,29536,0.077075168442755,0.00339295648803542,0.0704249737262055,0.0837253631593044,2.90234780428628e-113
NMR metabolomics,X23412.Phospholipids in VLDL,SAMD9L,Sterile alpha motif domain-containing protein 9-like,29434,0.110313246973866,0.00486018596365752,0.100787282485097,0.119839211462635,4.46238598353818e-113
NMR metabolomics,X23412.Phospholipids in VLDL,PLG,Plasminogen,24421,0.0338948350891168,0.00149204041484037,0.0309704358760296,0.0368192343022039,4.51975460547569e-113
NMR metabolomics,X23412.Phospholipids in VLDL,MAX,Protein max,28774,0.160283814792348,0.00706423420923678,0.146437915742244,0.174129713842452,5.59431929005986e-113
NMR metabolomics,X23412.Phospholipids in VLDL,CLEC3B,Tetranectin,24381,0.032725361171666,0.00144189196575111,0.0298992529187939,0.0355514694245382,7.2440159218295e-113
NMR metabolomics,X23412.Phospholipids in VLDL,GPKOW,G-patch domain and KOW motifs-containing protein,28774,0.0425764257225572,0.00187771913316133,0.038896096221561,0.0462567552235534,7.80885010910419e-113
NMR metabolomics,X23412.Phospholipids in VLDL,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,28797,0.118405363111735,0.00522746981146634,0.108159522281261,0.128651203942209,1.32960584782838e-112
NMR metabolomics,X23412.Phospholipids in VLDL,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,29478,0.126559302652274,0.00558996910263706,0.115602963211105,0.137515642093442,1.584101517605e-112
NMR metabolomics,X23412.Phospholipids in VLDL,GYS1,"Glycogen [starch] synthase, muscle",28916,0.141097114261807,0.00624089149811355,0.128864966925504,0.153329261598109,3.36702976821944e-112
NMR metabolomics,X23412.Phospholipids in VLDL,DUSP13,Dual specificity protein phosphatase 13 isoform A,24793,0.0640139428546906,0.00283045347452615,0.0584662540446193,0.0695616316647618,4.10472042964409e-112
NMR metabolomics,X23412.Phospholipids in VLDL,WASHC3,WASH complex subunit 3,24845,0.114489694041691,0.00507099532285582,0.104550543208894,0.124428844874489,9.65148069630301e-112
NMR metabolomics,X23412.Phospholipids in VLDL,GAS6,Growth arrest-specific protein 6,29639,-0.0385799164404369,0.00171144944321916,-0.0419343573491464,-0.0352254755317273,1.39139903213042e-111
NMR metabolomics,X23412.Phospholipids in VLDL,RWDD1,RWD domain-containing protein 1,29694,0.0958688035472107,0.00426205986029326,0.0875151662210359,0.104222440873385,4.08319581373467e-111
NMR metabolomics,X23412.Phospholipids in VLDL,MTDH,Protein LYRIC,24229,0.140957507834556,0.00627051231149692,0.128667303704022,0.15324771196509,8.97852452239531e-111
NMR metabolomics,X23412.Phospholipids in VLDL,OGA,Protein O-GlcNAcase,24805,0.106852198793784,0.00475748800769555,0.0975275222987011,0.116176875288868,1.30415203779634e-110
NMR metabolomics,X23412.Phospholipids in VLDL,PACS2,Phosphofurin acidic cluster sorting protein 2,24111,0.0941438226167459,0.00419241064218585,0.0859266977580617,0.10236094747543,1.53168532739665e-110
NMR metabolomics,X23412.Phospholipids in VLDL,PXN,Paxillin,28774,0.0775795618163902,0.00345820396286623,0.0708014820491724,0.084357641583608,1.64930878219291e-110
NMR metabolomics,X23412.Phospholipids in VLDL,SMNDC1,Survival of motor neuron-related-splicing factor 30,24805,0.0900157478289336,0.00401020099503934,0.0821557538786565,0.0978757417792107,1.74094242689907e-110
NMR metabolomics,X23412.Phospholipids in VLDL,TRAF2,TNF receptor-associated factor 2,29434,0.105964607542275,0.00472700614166191,0.096699675504618,0.115229539579933,2.26883476791453e-110
NMR metabolomics,X23412.Phospholipids in VLDL,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,23850,0.050053874345066,0.00223074897539186,0.045681606353298,0.0544261423368341,2.32285494138004e-110
NMR metabolomics,X23412.Phospholipids in VLDL,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,24867,0.11948705923039,0.00532643364760741,0.109047249281079,0.1299268691797,2.34750074578605e-110
NMR metabolomics,X23412.Phospholipids in VLDL,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,28797,0.0670442014976398,0.00299332471118946,0.0611772850637084,0.0729111179315711,3.61115191535996e-110
NMR metabolomics,X23412.Phospholipids in VLDL,FLT4,Vascular endothelial growth factor receptor 3,29566,0.050453052061706,0.00225646984189041,0.0460303711716008,0.0548757329518111,8.00243878909861e-110
NMR metabolomics,X23412.Phospholipids in VLDL,TXNDC5,Thioredoxin domain-containing protein 5,29694,0.101781439651079,0.00455375013676297,0.0928560893830241,0.110706789919135,9.49286893520702e-110
NMR metabolomics,X23412.Phospholipids in VLDL,PRKG1,cGMP-dependent protein kinase 1,24381,0.188879747187647,0.00845524873327764,0.172307459670422,0.205452034704871,1.95092840975532e-109
NMR metabolomics,X23412.Phospholipids in VLDL,A1BG,Alpha-1B-glycoprotein,24966,0.0257100331764341,0.0011511549556275,0.0234537694634041,0.027966296889464,2.03703114709998e-109
NMR metabolomics,X23412.Phospholipids in VLDL,PPP1R2,Protein phosphatase inhibitor 2,29478,0.119639917082473,0.00536299721006772,0.10912844255074,0.130151391614206,2.46700637059374e-109
NMR metabolomics,X23412.Phospholipids in VLDL,GASK1A,Golgi-associated kinase 1A,24111,0.0647567755641389,0.00290080511673066,0.0590711975353468,0.070442353592931,2.78936038050039e-109
NMR metabolomics,X23412.Phospholipids in VLDL,DOK1,Docking protein 1,24845,0.205113530955222,0.00919212993174282,0.187096956289006,0.223130105621437,3.20194916335694e-109
NMR metabolomics,X23412.Phospholipids in VLDL,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,29510,0.0341649757555191,0.0015323933663336,0.0311614847575052,0.0371684667535329,3.29220476725965e-109
NMR metabolomics,X23412.Phospholipids in VLDL,CRADD,Death domain-containing protein CRADD,29163,0.113465406255076,0.00509188347967445,0.103485314634914,0.123445497875238,4.35168501019548e-109
NMR metabolomics,X23412.Phospholipids in VLDL,HTRA2,"Serine protease HTRA2, mitochondrial",29566,0.0915617384648507,0.00411027326825598,0.083505602859069,0.0996178740706324,4.96212936091536e-109
NMR metabolomics,X23412.Phospholipids in VLDL,RBM17,Splicing factor 45,24867,0.114634365237512,0.00514604639724655,0.104548114298909,0.124720616176116,7.31755603705952e-109
NMR metabolomics,X23412.Phospholipids in VLDL,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",29301,0.113053520609631,0.00508145697198463,0.103093864944541,0.123013176274721,9.35556679144134e-109
NMR metabolomics,X23412.Phospholipids in VLDL,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",29443,0.0687997540856332,0.00309402046493477,0.0627354739743611,0.0748640341969054,1.20209048104881e-108
NMR metabolomics,X23412.Phospholipids in VLDL,PSME1,Proteasome activator complex subunit 1,29192,0.0554160511669711,0.00249253323019879,0.0505306860357815,0.0603014162981607,1.32193096734897e-108
NMR metabolomics,X23412.Phospholipids in VLDL,UBXN1,UBX domain-containing protein 1,24381,0.103294732832442,0.00464445937412182,0.0941915924591628,0.11239787320572,1.67882397586959e-108
NMR metabolomics,X23412.Phospholipids in VLDL,IGBP1,Immunoglobulin-binding protein 1,24867,0.0907699552566496,0.00408272211946582,0.0827678199024966,0.0987720906108026,1.89397738841773e-108
NMR metabolomics,X23412.Phospholipids in VLDL,SIRT2,NAD-dependent protein deacetylase sirtuin-2,29349,0.131803721021851,0.00593401511471692,0.120173051397006,0.143434390646697,2.08291856431081e-108
NMR metabolomics,X23412.Phospholipids in VLDL,HAVCR1,Hepatitis A virus cellular receptor 1,29683,0.0939299550873555,0.0042292246703169,0.0856406747335343,0.102219235441177,2.11862340472091e-108
NMR metabolomics,X23412.Phospholipids in VLDL,GFRA1,GDNF family receptor alpha-1,29674,0.0421694111762039,0.00190119427293285,0.0384430704012556,0.0458957519511523,4.01985756968591e-108
NMR metabolomics,X23412.Phospholipids in VLDL,KYAT1,Kynurenine--oxoglutarate transaminase 1,29444,0.0845298048574672,0.00381101916183651,0.0770602073002676,0.0919994024146667,4.09382777687197e-108
NMR metabolomics,X23412.Phospholipids in VLDL,TALDO1,Transaldolase,24888,0.0664624527056399,0.00299625043821267,0.0605898018467431,0.0723351035645367,5.73008173655476e-108
NMR metabolomics,X23412.Phospholipids in VLDL,RAB27B,Ras-related protein Rab-27B,24922,0.122593689397754,0.00552913075627938,0.111756593115446,0.133430785680062,7.03270119228723e-108
NMR metabolomics,X23412.Phospholipids in VLDL,PCDH9,Protocadherin-9,24805,0.0505342153472816,0.00227995823113826,0.0460654972142506,0.0550029334803126,8.42712689842196e-108
NMR metabolomics,X23412.Phospholipids in VLDL,MED18,Mediator of RNA polymerase II transcription subunit 18,28797,0.11355593969998,0.00512692050507466,0.103507175510034,0.123604703889927,8.50599389470576e-108
NMR metabolomics,X23412.Phospholipids in VLDL,SH2D1A,SH2 domain-containing protein 1A,29434,0.0849947486483576,0.00383836473483014,0.0774715537680905,0.0925179435286246,9.16957356274074e-108
NMR metabolomics,X23412.Phospholipids in VLDL,GOLGA3,Golgin subfamily A member 3,24867,0.116161467965809,0.00524620548906767,0.105878905207236,0.126444030724381,1.36827754579097e-107
NMR metabolomics,X23412.Phospholipids in VLDL,GDF2,Growth/differentiation factor 2,29478,0.0529205930418557,0.0023959992692783,0.0482244344740702,0.0576167516096411,3.12687101697519e-107
NMR metabolomics,X23412.Phospholipids in VLDL,NIT1,Deaminated glutathione amidase,24240,0.0704365802031231,0.00318632939713698,0.0641913745847347,0.0766817858215116,3.18934277619947e-107
NMR metabolomics,X23412.Phospholipids in VLDL,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",24240,0.067594747962996,0.00305891305054443,0.0615992783839289,0.0735902175420631,3.81347025951602e-107
NMR metabolomics,X23412.Phospholipids in VLDL,ICA1,Islet cell autoantigen 1,28931,0.118016182810401,0.00534655602119559,0.107536933008857,0.128495432611944,4.37922725999479e-107
NMR metabolomics,X23412.Phospholipids in VLDL,KRT5,"Keratin, type II cytoskeletal 5",28774,0.0755224166571595,0.0034226620754351,0.0688139989893067,0.0822308343250123,5.25829317050844e-107
NMR metabolomics,X23412.Phospholipids in VLDL,PENK,Proenkephalin-A,24381,0.0458819519318717,0.00208161083366896,0.0418019946978806,0.0499619091658629,1.26848265662249e-106
NMR metabolomics,X23412.Phospholipids in VLDL,DGKA,Diacylglycerol kinase alpha,24229,0.0812796529890296,0.00368895869470527,0.0740492939474073,0.088510012030652,1.54213669074548e-106
NMR metabolomics,X23412.Phospholipids in VLDL,NUDC,Nuclear migration protein nudC,29786,0.0936607463258682,0.00425516208443563,0.0853206286403744,0.102000864011362,1.59779381217542e-106
NMR metabolomics,X23412.Phospholipids in VLDL,MGLL,Monoglyceride lipase,29536,0.128154440152657,0.00582424995059762,0.116738910249485,0.139569970055828,1.91091741768384e-106
NMR metabolomics,X23412.Phospholipids in VLDL,CCL11,Eotaxin,29786,0.0556720359178986,0.00253056988587531,0.050712118941583,0.0606319528942142,2.04113403116426e-106
NMR metabolomics,X23412.Phospholipids in VLDL,CHMP1A,Charged multivesicular body protein 1a,29218,0.117209794270157,0.00533214013954853,0.106758799596642,0.127660788943673,3.13401267269091e-106
NMR metabolomics,X23412.Phospholipids in VLDL,PARP1,Poly [ADP-ribose] polymerase 1,29434,0.0830929313138527,0.00378782329224552,0.0756687976610514,0.0905170649666539,8.1657728740906e-106
NMR metabolomics,X23412.Phospholipids in VLDL,MAVS,Mitochondrial antiviral-signaling protein,28797,0.135217299367499,0.00616380650780245,0.123136238612207,0.147298360122792,8.44038176586935e-106
NMR metabolomics,X23412.Phospholipids in VLDL,SELE,E-selectin,29820,0.0741022394648083,0.00338320303820822,0.0674711615099202,0.0807333174196964,1.65620193658792e-105
NMR metabolomics,X23412.Phospholipids in VLDL,IRAK4,Interleukin-1 receptor-associated kinase 4,29434,0.153601031444513,0.00701330458985738,0.139854954448393,0.167347108440634,1.75786095486743e-105
NMR metabolomics,X23412.Phospholipids in VLDL,ALDH1A1,Retinal dehydrogenase 1,29443,0.0783047152363227,0.00357578330000912,0.0712961799683049,0.0853132505043406,1.86466518012546e-105
NMR metabolomics,X23412.Phospholipids in VLDL,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,24381,0.0936459344051189,0.0042761999344642,0.0852645825335691,0.102027286276669,2.73362308712809e-105
NMR metabolomics,X23412.Phospholipids in VLDL,STIP1,Stress-induced-phosphoprotein 1,29386,0.0952013269649988,0.0043519954677636,0.0866714158481821,0.103731238081815,3.09392401151255e-105
NMR metabolomics,X23412.Phospholipids in VLDL,CD40,Tumor necrosis factor receptor superfamily member 5,29453,0.0733348709034414,0.00335346337937351,0.0667620826798694,0.0799076591270135,3.57705182932166e-105
NMR metabolomics,X23412.Phospholipids in VLDL,SNCG,Gamma-synuclein,29218,0.0981487463578218,0.00449237494437374,0.0893436914668493,0.106953801248794,5.65570102391378e-105
NMR metabolomics,X23412.Phospholipids in VLDL,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,24381,0.0853759900697287,0.00391200505929699,0.0777084601535066,0.0930435199859508,1.37647395625864e-104
NMR metabolomics,X23412.Phospholipids in VLDL,CETN3,Centrin-3,24805,0.113955695262557,0.00522341144860262,0.103717808823296,0.124193581701818,1.56384508216634e-104
NMR metabolomics,X23412.Phospholipids in VLDL,PHLDB1,Pleckstrin homology-like domain family B member 1,24805,0.0778308766965037,0.00356815434979995,0.0708372941708958,0.0848244592221116,1.69272924694906e-104
NMR metabolomics,X23412.Phospholipids in VLDL,KIFBP,KIF-binding protein,29349,0.120689133089856,0.0055385789844262,0.109833518280381,0.131544747899332,1.92067554798134e-104
NMR metabolomics,X23412.Phospholipids in VLDL,VASP,Vasodilator-stimulated phosphoprotein,24951,0.106378939871983,0.00488879954723009,0.096796892759412,0.115960986984554,5.1911116349743e-104
NMR metabolomics,X23412.Phospholipids in VLDL,YJU2,Splicing factor YJU2,24793,0.0475291933173137,0.00218613257634594,0.0432443734676756,0.0518140131669517,7.8205346633729e-104
NMR metabolomics,X23412.Phospholipids in VLDL,VEGFA,Vascular endothelial growth factor A,29683,0.0842527895801221,0.00387882419513349,0.0766502941576604,0.0918552850025837,8.33912308596322e-104
NMR metabolomics,X23412.Phospholipids in VLDL,DRG2,Developmentally-regulated GTP-binding protein 2,29349,0.0823038799753321,0.00379309443815489,0.0748694148765485,0.0897383450741157,1.38970756729083e-103
NMR metabolomics,X23412.Phospholipids in VLDL,DIABLO,"Diablo homolog, mitochondrial",29395,0.159462528324509,0.00735915590407415,0.145038582752523,0.173886473896494,2.61854016117708e-103
NMR metabolomics,X23412.Phospholipids in VLDL,HSPA1A,Heat shock 70 kDa protein 1A,29536,0.103153633541198,0.00476249881121037,0.093819135871226,0.112488131211171,3.14794186938191e-103
NMR metabolomics,X23412.Phospholipids in VLDL,GMPR2,GMP reductase 2,24381,0.0980991021132972,0.00452657649735656,0.0892270121784784,0.106971192048116,3.57059402363256e-103
NMR metabolomics,X23412.Phospholipids in VLDL,PON3,Serum paraoxonase/lactonase 3,29581,-0.0412136945192476,0.00190446918413641,-0.044946454120155,-0.0374809349183402,4.71489703948869e-103
NMR metabolomics,X23412.Phospholipids in VLDL,IDUA,Alpha-L-iduronidase,29725,0.0670259264544102,0.00309800804576923,0.0609538306847026,0.0730980222241179,5.23845042628537e-103
NMR metabolomics,X23412.Phospholipids in VLDL,FIS1,Mitochondrial fission 1 protein,29453,0.111915868893299,0.0051800237307572,0.101763022381015,0.122068715405583,1.00765172071069e-102
NMR metabolomics,X23412.Phospholipids in VLDL,GLB1,Beta-galactosidase,29218,0.0607736513921126,0.00281422863201741,0.0552577632733585,0.0662895395108668,1.26922339257636e-102
NMR metabolomics,X23412.Phospholipids in VLDL,SPRY2,Protein sprouty homolog 2,28931,0.133943672391197,0.00621086821909343,0.121770370681774,0.14611697410062,2.40225616366015e-102
NMR metabolomics,X23412.Phospholipids in VLDL,TDRKH,Tudor and KH domain-containing protein,28774,0.123145475078037,0.00571096792099714,0.111951977952882,0.134338972203191,2.58834259020867e-102
NMR metabolomics,X23412.Phospholipids in VLDL,TRIM58,E3 ubiquitin-protein ligase TRIM58,24793,0.125534115551996,0.00581818199480516,0.114130478842178,0.136937752261814,2.6308372181498e-102
NMR metabolomics,X23412.Phospholipids in VLDL,NT5C1A,Cytosolic 5'-nucleotidase 1A,24845,0.0455667925540108,0.00211636696329442,0.0414187133059537,0.0497148718020679,6.87386859492313e-102
NMR metabolomics,X23412.Phospholipids in VLDL,KLK13,Kallikrein-13,28845,0.0637337747086728,0.00296516799314111,0.0579220454421162,0.0695455039752294,1.11101400367064e-101
NMR metabolomics,X23412.Phospholipids in VLDL,SSNA1,Sjoegren syndrome nuclear autoantigen 1,24805,0.0739754874851646,0.00344343232694814,0.0672263601243462,0.080724614845983,1.88835020679702e-101
NMR metabolomics,X23412.Phospholipids in VLDL,GRAP2,GRB2-related adapter protein 2,29478,0.184074541677184,0.00859161236907968,0.167234981433788,0.20091410192058,4.62898606992767e-101
NMR metabolomics,X23412.Phospholipids in VLDL,MPI,Mannose-6-phosphate isomerase,29349,0.122967393257223,0.00575146057743683,0.111694530525447,0.134240255988999,1.19928084410976e-100
NMR metabolomics,X23412.Phospholipids in VLDL,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",24445,0.0712243035102176,0.00333495166232055,0.0646877982520693,0.0777608087683659,2.77901001055018e-100
NMR metabolomics,X23412.Phospholipids in VLDL,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,29604,0.0830633841506409,0.00389445219050295,0.0754302578572551,0.0906965104440267,3.50183682762197e-100
NMR metabolomics,X23412.Phospholipids in VLDL,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,24381,0.122620048126406,0.00574927841840799,0.111351462426326,0.133888633826486,5.13918795019008e-100
NMR metabolomics,X23412.Phospholipids in VLDL,CST3,Cystatin-C,29530,0.0405939660953073,0.00190548434543508,0.0368592167782545,0.0443287154123601,5.93758302118199e-100
NMR metabolomics,X23412.Phospholipids in VLDL,MOCS2,Molybdopterin synthase catalytic subunit,24381,0.0966187154763154,0.0045319923423575,0.0877360104852947,0.105501420467336,6.16097022036926e-100
NMR metabolomics,X23412.Phospholipids in VLDL,SRP14,Signal recognition particle 14 kDa protein,29349,0.0851885365599346,0.00400145038301899,0.0773456938092174,0.0930313793106519,8.11118949854552e-100
NMR metabolomics,X23412.Phospholipids in VLDL,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,24793,0.069154355794147,0.00324605073700553,0.0627920963496161,0.0755166152386778,8.17065580402389e-100
NMR metabolomics,X23412.Phospholipids in VLDL,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",24845,0.139848381242514,0.00657473291163447,0.126961904735711,0.152734857749318,1.64390971349642e-99
NMR metabolomics,X23412.Phospholipids in VLDL,RTN4R,Reticulon-4 receptor,29725,0.0482962704410205,0.00227297458652548,0.0438412402514306,0.0527513006306105,1.8915716612459e-99
NMR metabolomics,X23412.Phospholipids in VLDL,CCL7,C-C motif chemokine 7,29434,0.0838194036575243,0.0039465616100757,0.0760841429017759,0.0915546644132727,2.34527939284564e-99
NMR metabolomics,X23412.Phospholipids in VLDL,TP53,Cellular tumor antigen p53,28797,0.0623778597480159,0.00293687604799092,0.0566215826939536,0.0681341368020781,2.3878870623367e-99
NMR metabolomics,X23412.Phospholipids in VLDL,DLG4,Disks large homolog 4,24845,0.10149582077995,0.00477911577780525,0.0921287538554519,0.110862887704448,3.29353875477141e-99
NMR metabolomics,X23412.Phospholipids in VLDL,FAM172A,Cotranscriptional regulator FAM172A,24240,0.0878306889333754,0.00414219258591819,0.0797119914649757,0.0959493864017751,6.96258415583798e-99
NMR metabolomics,X23412.Phospholipids in VLDL,FAP,Prolyl endopeptidase FAP,29820,0.0391629619493977,0.00184877287957736,0.035539367105426,0.0427865567933693,7.31489526685795e-99
NMR metabolomics,X23412.Phospholipids in VLDL,C3,Complement C3,23779,0.0664335751842224,0.00313764650791519,0.0602837880287087,0.0725833623397362,1.37802790662084e-98
NMR metabolomics,X23412.Phospholipids in VLDL,AFP,Alpha-fetoprotein,29132,0.0967899595509437,0.00457878489863089,0.0878155411496272,0.10576437795226,1.9244966944451e-98
NMR metabolomics,X23412.Phospholipids in VLDL,NEXN,Nexilin,24951,0.0981658265282954,0.00464157660064082,0.0890683363910394,0.107263316665551,2.05331903014557e-98
NMR metabolomics,X23412.Phospholipids in VLDL,HARS1,"Histidine--tRNA ligase, cytoplasmic",29443,0.109600901892146,0.00518596163029999,0.0994364170967576,0.119765386687534,2.08245962348532e-98
NMR metabolomics,X23412.Phospholipids in VLDL,ADGRD1,Adhesion G-protein coupled receptor D1,24381,0.0554037257576742,0.00262003255189533,0.0502684619559594,0.0605389895593891,2.29064511036004e-98
NMR metabolomics,X23412.Phospholipids in VLDL,LPP,Lipoma-preferred partner,24111,0.0948655624520779,0.00448755675319091,0.0860699512158237,0.103661173688332,2.68245123848854e-98
NMR metabolomics,X23412.Phospholipids in VLDL,APOA2,Apolipoprotein A-II,24951,-0.0688146864536892,0.00325911670648544,-0.0752025551984007,-0.0624268177089777,4.22866434446007e-98
NMR metabolomics,X23412.Phospholipids in VLDL,NACC1,Nucleus accumbens-associated protein 1,24793,0.0784131832447535,0.0037138508390416,0.071134035600232,0.0856923308892751,4.35411426917011e-98
NMR metabolomics,X23412.Phospholipids in VLDL,EGFR,Epidermal growth factor receptor,29820,0.0232711942011068,0.00110323052325323,0.0211088623755305,0.0254335260266831,4.74080395552517e-98
NMR metabolomics,X23412.Phospholipids in VLDL,ATXN2L,Ataxin-2-like protein,24867,0.0684068825798475,0.00324217559929113,0.0620522184052369,0.0747615467544581,5.86864257131279e-98
NMR metabolomics,X23412.Phospholipids in VLDL,FARSA,Phenylalanine--tRNA ligase alpha subunit,24195,0.097991294908422,0.00464904616399816,0.0888791644269856,0.107103425389858,9.65035458684723e-98
NMR metabolomics,X23412.Phospholipids in VLDL,RRM2,Ribonucleoside-diphosphate reductase subunit M2,28797,0.0721602352742138,0.00342862653233104,0.065440127270845,0.0788803432775827,1.34325420847821e-97
NMR metabolomics,X23412.Phospholipids in VLDL,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",29132,0.0578757154704619,0.00275465053711445,0.0524766004177176,0.0632748305232062,2.79430728429397e-97
NMR metabolomics,X23412.Phospholipids in VLDL,CCL8,C-C motif chemokine 8,29683,0.0854438434255284,0.00406718213439659,0.0774721664421111,0.0934155204089457,2.82879918318181e-97
NMR metabolomics,X23412.Phospholipids in VLDL,SULT2A1,Bile salt sulfotransferase,29434,0.079123457344268,0.00376634229634685,0.0717414264434282,0.0865054882451079,2.8726222521046e-97
NMR metabolomics,X23412.Phospholipids in VLDL,XIAP,E3 ubiquitin-protein ligase XIAP,24229,0.0820157506215354,0.00390101972124058,0.0743697519679039,0.089661749275167,2.91787193578007e-97
NMR metabolomics,X23412.Phospholipids in VLDL,IL7,Interleukin-7,29434,0.0909667563960376,0.00433356059236987,0.0824729776349927,0.0994605351570826,4.07057706654426e-97
NMR metabolomics,X23412.Phospholipids in VLDL,TRIM40,E3 ubiquitin ligase TRIM40,24195,0.102229208387832,0.0048724861645202,0.0926791355053725,0.111779281270292,7.15734276723416e-97
NMR metabolomics,X23412.Phospholipids in VLDL,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,29218,0.110508540716372,0.00527173404140715,0.100175941995214,0.12084113943753,7.47478899253764e-97
NMR metabolomics,X23412.Phospholipids in VLDL,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",29434,0.135372664016414,0.00645840059068466,0.122714198858672,0.148031129174156,7.65919532555712e-97
NMR metabolomics,X23412.Phospholipids in VLDL,CDNF,Cerebral dopamine neurotrophic factor,29349,0.045925279795935,0.00219213868617829,0.0416286879710256,0.0502218716208445,9.60669464794966e-97
NMR metabolomics,X23412.Phospholipids in VLDL,PMVK,Phosphomevalonate kinase,28757,0.154541587865718,0.00737965252872173,0.140077468909423,0.169005706822012,1.18178003397326e-96
NMR metabolomics,X23412.Phospholipids in VLDL,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,28787,0.110586790502641,0.00528166999099804,0.100234717320285,0.120938863684997,1.27445105343075e-96
NMR metabolomics,X23412.Phospholipids in VLDL,SMOC2,SPARC-related modular calcium-binding protein 2,29581,0.0544730999299834,0.00260199633496956,0.0493731871134431,0.0595730127465238,1.29014765931251e-96
NMR metabolomics,X23412.Phospholipids in VLDL,ANG,Angiogenin,29435,0.04744839061965,0.00226718084528828,0.043004716162885,0.0518920650764151,1.49520821216707e-96
NMR metabolomics,X23412.Phospholipids in VLDL,MAP2,Microtubule-associated protein 2,24845,0.0651476611144719,0.00311493582623827,0.0590423868950449,0.0712529353338989,2.66987520078947e-96
NMR metabolomics,X23412.Phospholipids in VLDL,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,29694,0.0797384311922028,0.00381609103143774,0.0722588927705848,0.0872179696138207,2.91796875644799e-96
NMR metabolomics,X23412.Phospholipids in VLDL,RABGAP1L,Rab GTPase-activating protein 1-like,28931,0.0840684817452952,0.0040254263895654,0.076178646021747,0.0919583174688434,3.81322228056159e-96
NMR metabolomics,X23412.Phospholipids in VLDL,CD207,C-type lectin domain family 4 member K,28835,0.0542400979934523,0.00260180424952425,0.0491405616643848,0.0593396343225199,8.26025359750344e-96
NMR metabolomics,X23412.Phospholipids in VLDL,ELOA,Elongin-A,29349,0.0732449576954739,0.00351572638889997,0.06635413397323,0.0801357814177179,1.06215762140887e-95
NMR metabolomics,X23412.Phospholipids in VLDL,FOXJ3,Forkhead box protein J3,24229,0.0622908007327671,0.00299253473952596,0.0564254326432963,0.068156168822238,2.15036677575651e-95
NMR metabolomics,X23412.Phospholipids in VLDL,SMAD3,Mothers against decapentaplegic homolog 3,24793,0.0719645815660965,0.00345766020784106,0.065187567558728,0.078741595573465,2.15917856726066e-95
NMR metabolomics,X23412.Phospholipids in VLDL,AP2B1,AP-2 complex subunit beta,24195,0.0683952836135362,0.00328705042866828,0.0619526647733464,0.074837902453726,2.53518597500804e-95
NMR metabolomics,X23412.Phospholipids in VLDL,C2,Complement C2,29545,0.0326545955477105,0.00157068653770729,0.0295760499338042,0.0357331411616168,2.57077580882092e-95
NMR metabolomics,X23412.Phospholipids in VLDL,FUS,RNA-binding protein FUS,28765,0.0552743344051068,0.00265927446153563,0.050062156460497,0.0604865123497167,2.94248689338648e-95
NMR metabolomics,X23412.Phospholipids in VLDL,EHD3,EH domain-containing protein 3,24240,0.164653683502404,0.00791747568741288,0.149135431155075,0.180171935849733,3.18157410088731e-95
NMR metabolomics,X23412.Phospholipids in VLDL,TMED8,Protein TMED8,24805,0.144116476385755,0.00693240236276384,0.130528967754738,0.157703985016773,3.54680302393749e-95
NMR metabolomics,X23412.Phospholipids in VLDL,ELAC1,Zinc phosphodiesterase ELAC protein 1,24867,0.119305204624985,0.00574547806131571,0.108044067624806,0.130566341625164,5.74189874749763e-95
NMR metabolomics,X23412.Phospholipids in VLDL,MUC13,Mucin-13,28774,0.0717387099195196,0.00346190849332097,0.0649533692726104,0.0785240505664287,1.07391668126779e-94
NMR metabolomics,X23412.Phospholipids in VLDL,SIGLEC8,Sialic acid-binding Ig-like lectin 8,24240,0.0641453180928184,0.00309712776840869,0.0580749476667373,0.0702156885188994,1.80795277733845e-94
NMR metabolomics,X23412.Phospholipids in VLDL,PPIB,Peptidyl-prolyl cis-trans isomerase B,29467,0.132096027664719,0.00638361337877266,0.119584145442325,0.144607909887113,1.88487311920967e-94
NMR metabolomics,X23412.Phospholipids in VLDL,FNDC1,Fibronectin type III domain-containing protein 1,24845,0.0650820480866352,0.00314538962670357,0.0589170844182962,0.0712470117549742,2.59668105810664e-94
NMR metabolomics,X23412.Phospholipids in VLDL,RRAS,Ras-related protein R-Ras,24195,0.182357018566499,0.00881425682525572,0.165081075188998,0.199632961944,2.86180616287205e-94
NMR metabolomics,X23412.Phospholipids in VLDL,NUB1,NEDD8 ultimate buster 1,29434,0.116320088664321,0.00563151413618056,0.105282320957407,0.127357856371235,4.0847418619979e-94
NMR metabolomics,X23412.Phospholipids in VLDL,BLMH,Bleomycin hydrolase,29820,0.0441886417643182,0.00213973415661213,0.0399947628173584,0.048382520711278,4.32283623821229e-94
NMR metabolomics,X23412.Phospholipids in VLDL,EGF,Pro-epidermal growth factor,29379,0.143048894947991,0.00694119408447893,0.129444154542412,0.156653635353569,1.05741021939113e-93
NMR metabolomics,X23412.Phospholipids in VLDL,C19orf12,Protein C19orf12,28774,0.0893130258970308,0.00433678972653749,0.0808129180330173,0.0978131337610442,1.46374599686813e-93
NMR metabolomics,X23412.Phospholipids in VLDL,SPARC,SPARC,29566,0.0972411277604618,0.00473027959327018,0.0879697797576522,0.106512475763271,2.98686904901117e-93
NMR metabolomics,X23412.Phospholipids in VLDL,CTF1,Cardiotrophin-1,28916,0.116837189828145,0.00568346071034855,0.105697606835862,0.127976772820428,3.07359445959168e-93
NMR metabolomics,X23412.Phospholipids in VLDL,BAG6,Large proline-rich protein BAG6,28916,0.0503483192353148,0.00244967024929694,0.0455469655466928,0.0551496729239368,3.35417441193899e-93
NMR metabolomics,X23412.Phospholipids in VLDL,CD226,CD226 antigen,24229,0.0584770687872992,0.00284389969220036,0.0529030253905865,0.0640511121840119,3.73644540793211e-93
NMR metabolomics,X23412.Phospholipids in VLDL,F12,Coagulation factor XII,24966,0.0575704903422348,0.00280329704298581,0.0520760281379826,0.063064952546487,5.94545397652488e-93
NMR metabolomics,X23412.Phospholipids in VLDL,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,28595,0.119240287298874,0.00581692002392922,0.107839124051972,0.130641450545775,1.0245587276462e-92
NMR metabolomics,X23412.Phospholipids in VLDL,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,28774,0.15430161283679,0.00752772341156949,0.139547274950114,0.169055950723466,1.03756574905918e-92
NMR metabolomics,X23412.Phospholipids in VLDL,EDAR,Tumor necrosis factor receptor superfamily member EDAR,29434,0.126479278388239,0.00617158725022259,0.114382967377802,0.138575589398675,1.08711962115056e-92
NMR metabolomics,X23412.Phospholipids in VLDL,CD244,Natural killer cell receptor 2B4,29786,0.0373046560952629,0.00182057128598414,0.033736336374734,0.0408729758157918,1.13909932437661e-92
NMR metabolomics,X23412.Phospholipids in VLDL,VSNL1,Visinin-like protein 1,24845,0.0526515824746423,0.00257423107080417,0.0476060895758661,0.0576970753734184,3.23187916025455e-92
NMR metabolomics,X23412.Phospholipids in VLDL,PKD2,Polycystin-2,24111,0.0814707909924527,0.00398418518972677,0.0736617880205882,0.0892797939643171,3.75121482234815e-92
NMR metabolomics,X23412.Phospholipids in VLDL,ATOX1,Copper transport protein ATOX1,29566,0.0981106735132991,0.00480243298835592,0.0886979048561215,0.107523442170477,3.97483860169288e-92
NMR metabolomics,X23412.Phospholipids in VLDL,SCARA5,Scavenger receptor class A member 5,29694,0.0413520419177903,0.00202481321767846,0.0373834080111405,0.0453206758244401,4.52432138406705e-92
NMR metabolomics,X23412.Phospholipids in VLDL,ERP29,Endoplasmic reticulum resident protein 29,24381,0.163785121149425,0.0080194077055259,0.148067082046594,0.179503160252256,6.07912923142292e-92
NMR metabolomics,X23412.Phospholipids in VLDL,GLOD4,Glyoxalase domain-containing protein 4,29408,0.0486439527793951,0.00238359366987317,0.0439721091864437,0.0533157963723465,6.18823489436401e-92
NMR metabolomics,X23412.Phospholipids in VLDL,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,28931,0.0602647197457058,0.0029528751670834,0.0544770844182223,0.0660523550731892,6.2111487457527e-92
NMR metabolomics,X23412.Phospholipids in VLDL,SPOCK1,Testican-1,29218,0.0353426755520908,0.00173424643853033,0.0319435525325713,0.0387417985716102,1.11070169519006e-91
NMR metabolomics,X23412.Phospholipids in VLDL,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",24922,0.121661993237705,0.00596860634772673,0.109963524796161,0.13336046167925,1.30689045350216e-91
NMR metabolomics,X23412.Phospholipids in VLDL,PF4,Platelet factor 4,24822,0.133645377862606,0.0065604113109038,0.120786971693234,0.146503784031977,1.67996295809547e-91
NMR metabolomics,X23412.Phospholipids in VLDL,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,24793,0.0520987477779489,0.00255844331103933,0.0470841988883118,0.057113296667586,1.97815989933044e-91
NMR metabolomics,X23412.Phospholipids in VLDL,GP1BB,Platelet glycoprotein Ib beta chain,24111,0.0938730805902908,0.00461369485475794,0.0848302386749653,0.102915922505616,2.91010844315556e-91
NMR metabolomics,X23412.Phospholipids in VLDL,OTUD6B,Deubiquitinase OTUD6B,24805,0.0800980097779505,0.00393856275686567,0.0723784267744938,0.0878175927814072,3.36998428198546e-91
NMR metabolomics,X23412.Phospholipids in VLDL,CASP7,Caspase-7,24845,0.115132746133385,0.00566335653640547,0.10403256732203,0.126232924944739,3.90171192221716e-91
NMR metabolomics,X23412.Phospholipids in VLDL,VAV3,Guanine nucleotide exchange factor VAV3,24101,0.136106636924339,0.00669440626929459,0.122985600636522,0.149227673212156,3.95095607691201e-91
NMR metabolomics,X23412.Phospholipids in VLDL,CXCL16,C-X-C motif chemokine 16,29786,0.0321818974802547,0.0015853811833308,0.0290745503609264,0.0352892445995831,5.40984681814768e-91
NMR metabolomics,X23412.Phospholipids in VLDL,ANGPTL7,Angiopoietin-related protein 7,29725,0.0504381503230604,0.00248513918306994,0.0455672775242433,0.0553090231218774,5.79101058083275e-91
NMR metabolomics,X23412.Phospholipids in VLDL,GNPDA2,Glucosamine-6-phosphate isomerase 2,24381,0.0505682225505272,0.00249051381019584,0.0456868154825433,0.055449629618511,6.6590163839576e-91
NMR metabolomics,X23412.Phospholipids in VLDL,YWHAQ,14-3-3 protein theta,24381,0.101039650540248,0.00498501544673227,0.0912690202646525,0.110810280815843,1.35866789872075e-90
NMR metabolomics,X23412.Phospholipids in VLDL,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,24867,0.0656266379985967,0.00323971809939702,0.0592767905237785,0.0719764854734148,1.66283565072917e-90
NMR metabolomics,X23412.Phospholipids in VLDL,KITLG,Kit ligand,29478,-0.0507917832711364,0.00251060087070539,-0.055712560977719,-0.0458710055645538,2.15386901680461e-90
NMR metabolomics,X23412.Phospholipids in VLDL,CCL4,C-C motif chemokine 4,29498,0.0887510159850607,0.00438974646117521,0.0801471129211573,0.0973549190489641,2.79772584090103e-90
NMR metabolomics,X23412.Phospholipids in VLDL,TBCB,Tubulin-folding cofactor B,29218,0.136660870016531,0.00676569238409516,0.123400112943704,0.149921627089357,4.12011671555065e-90
NMR metabolomics,X23412.Phospholipids in VLDL,SERPING1,Plasma protease C1 inhibitor,24914,0.0256031622537588,0.00126797472256283,0.0231179317975356,0.0280883927099819,6.02807058923484e-90
NMR metabolomics,X23412.Phospholipids in VLDL,FHIT,Bis(5'-adenosyl)-triphosphatase,28774,0.100336875153814,0.00497203263737215,0.0905916911845647,0.110082059123063,6.13260651337795e-90
NMR metabolomics,X23412.Phospholipids in VLDL,CD69,Early activation antigen CD69,29344,0.11905503385784,0.00590073436332858,0.107489594505716,0.130620473209964,6.45389006983591e-90
NMR metabolomics,X23412.Phospholipids in VLDL,NARS1,"Asparagine--tRNA ligase, cytoplasmic",24867,0.0643421813279253,0.0031873347909356,0.0580950051376915,0.0705893575181591,6.72549732978526e-90
NMR metabolomics,X23412.Phospholipids in VLDL,VPS28,Vacuolar protein sorting-associated protein 28 homolog,24445,0.0905422415700942,0.00448600364697542,0.0817496744220224,0.0993348087181661,7.42622225056458e-90
NMR metabolomics,X23412.Phospholipids in VLDL,CACYBP,Calcyclin-binding protein,24329,0.140035879179665,0.00694355891720353,0.126426503701946,0.153645254657384,1.01962202457578e-89
NMR metabolomics,X23412.Phospholipids in VLDL,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,28797,0.133222339980222,0.0066105881748577,0.120265587157501,0.146179092802943,1.05728528228128e-89
NMR metabolomics,X23412.Phospholipids in VLDL,IMPACT,Protein IMPACT,24845,0.0756880375620916,0.00375566813771592,0.0683269280121684,0.0830491471120148,1.31974150169651e-89
NMR metabolomics,X23412.Phospholipids in VLDL,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,24922,0.0838258807171297,0.00415981721206467,0.0756726389814829,0.0919791224527764,1.35762544434703e-89
NMR metabolomics,X23412.Phospholipids in VLDL,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,28738,0.0789714145554402,0.00392363596505101,0.0712810880639402,0.0866617410469402,1.77124930519408e-89
NMR metabolomics,X23412.Phospholipids in VLDL,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,29434,0.135020644904495,0.00672679335363479,0.121836129931371,0.148205159877619,5.1151404875321e-89
NMR metabolomics,X23412.Phospholipids in VLDL,STK24,Serine/threonine-protein kinase 24,28774,0.0835804751579744,0.00416518844518708,0.0754167058054078,0.0917442445105411,5.90154522216825e-89
NMR metabolomics,X23412.Phospholipids in VLDL,DFFA,DNA fragmentation factor subunit alpha,29786,0.0909055529765035,0.00453160520588789,0.0820236067729632,0.0997874991800437,6.3521997030012e-89
NMR metabolomics,X23412.Phospholipids in VLDL,MESD,LRP chaperone MESD,29443,0.163459242555405,0.00816331158047855,0.147459151857667,0.179459333253143,1.33545523056085e-88
NMR metabolomics,X23412.Phospholipids in VLDL,PDGFA,Platelet-derived growth factor subunit A,29820,0.0967123890390584,0.00483052450168599,0.0872445610157539,0.106180217062363,1.38085621425865e-88
NMR metabolomics,X23412.Phospholipids in VLDL,LRRC59,Leucine-rich repeat-containing protein 59,24922,0.0642660535171471,0.00320801378316349,0.0579783465021467,0.0705537605321475,1.41791689581354e-88
NMR metabolomics,X23412.Phospholipids in VLDL,BGLAP,Osteocalcin,24938,0.119737708381558,0.00597782627951111,0.108021168873716,0.1314542478894,1.49303976377073e-88
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINB6,Serpin B6,29623,0.0796730018703341,0.00398278301441284,0.0718667471620849,0.0874792565785833,1.94047351376365e-88
NMR metabolomics,X23412.Phospholipids in VLDL,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,28797,0.114177509823074,0.00571312198439902,0.102979790733652,0.125375228912496,2.94822246778922e-88
NMR metabolomics,X23412.Phospholipids in VLDL,STXBP1,Syntaxin-binding protein 1,24867,0.104495127751414,0.00522918856353105,0.0942459181668932,0.114744337335935,3.81221522127141e-88
NMR metabolomics,X23412.Phospholipids in VLDL,MAPKAPK2,MAP kinase-activated protein kinase 2,24445,0.0991095110974979,0.00496358614528873,0.0893808822527319,0.108838139942264,5.34077468257999e-88
NMR metabolomics,X23412.Phospholipids in VLDL,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,29573,0.149949327677549,0.00752048885103844,0.135209169529513,0.164689485825584,7.10439096249781e-88
NMR metabolomics,X23412.Phospholipids in VLDL,IQGAP2,Ras GTPase-activating-like protein IQGAP2,29349,0.0725444289144863,0.00364157993188371,0.0654069322479943,0.0796819255809784,1.01592026640238e-87
NMR metabolomics,X23412.Phospholipids in VLDL,SUGT1,Protein SGT1 homolog,28797,0.108143547367313,0.00542850025813359,0.097503686861371,0.118783407873255,1.03593163763346e-87
NMR metabolomics,X23412.Phospholipids in VLDL,ATXN3,Ataxin-3,24845,0.0829897938626829,0.00416456743339476,0.0748272416932291,0.0911523460321366,1.13764292440761e-87
NMR metabolomics,X23412.Phospholipids in VLDL,PPP3R1,Calcineurin subunit B type 1,29218,0.0548352023609827,0.00275675011151608,0.0494319721424112,0.0602384325795542,1.84097466381429e-87
NMR metabolomics,X23412.Phospholipids in VLDL,CCL18,C-C motif chemokine 18,29166,0.0940076930167172,0.00472955208885764,0.0847377709225562,0.103277615110878,2.45862149836604e-87
NMR metabolomics,X23412.Phospholipids in VLDL,RNF5,E3 ubiquitin-protein ligase RNF5,24240,0.0983759005190911,0.00495447199215681,0.0886651354144638,0.108086665623718,4.82127905405601e-87
NMR metabolomics,X23412.Phospholipids in VLDL,COMT,Catechol O-methyltransferase,28591,0.112541316380853,0.00567159980950983,0.101424980754214,0.123657652007492,4.89410221205625e-87
NMR metabolomics,X23412.Phospholipids in VLDL,CERT,Ceramide transfer protein,28774,0.0818555565071903,0.00413393433119453,0.073753045218049,0.0899580677963316,1.10710256440372e-86
NMR metabolomics,X23412.Phospholipids in VLDL,LACTB2,Endoribonuclease LACTB2,29478,0.0878438717273389,0.00443819197679872,0.0791450154528134,0.0965427280018644,1.25888171352363e-86
NMR metabolomics,X23412.Phospholipids in VLDL,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,28931,0.0728851608479016,0.00368282130126742,0.0656668310974175,0.0801034905983858,1.34500929061432e-86
NMR metabolomics,X23412.Phospholipids in VLDL,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,24922,0.119675406134051,0.00604435780396785,0.107828464838274,0.131522347429828,1.39381878224912e-86
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINE2,Glia-derived nexin,24922,0.0859864439302278,0.00434452504914066,0.0774711748339121,0.0945017130265435,1.61741902477367e-86
NMR metabolomics,X23412.Phospholipids in VLDL,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,23623,0.144299455115578,0.00728949020484844,0.130012054314075,0.158586855917081,1.63748595777127e-86
NMR metabolomics,X23412.Phospholipids in VLDL,CETN2,Centrin-2,28774,0.0898818303087963,0.00454533750041971,0.0809729688079737,0.0987906918096189,1.8550289394999e-86
NMR metabolomics,X23412.Phospholipids in VLDL,SIT1,Signaling threshold-regulating transmembrane adapter 1,28931,0.073460079856151,0.00371505656559365,0.0661785689875874,0.0807415907247145,1.874637397962e-86
NMR metabolomics,X23412.Phospholipids in VLDL,PDIA4,Protein disulfide-isomerase A4,24938,0.0810598285237767,0.00409915056558996,0.0730254934152204,0.089094163632333,2.25737208639836e-86
NMR metabolomics,X23412.Phospholipids in VLDL,ARHGEF10,Rho guanine nucleotide exchange factor 10,24867,0.124497824483613,0.00629896886328098,0.112151845511582,0.136843803455643,2.75522554038282e-86
NMR metabolomics,X23412.Phospholipids in VLDL,TRIAP1,TP53-regulated inhibitor of apoptosis 1,29725,0.0832205256004506,0.00421666616949498,0.0749558599082405,0.0914851912926608,3.76929923019708e-86
NMR metabolomics,X23412.Phospholipids in VLDL,RFC4,Replication factor C subunit 4,24793,0.0283220972982786,0.00143435492495596,0.0255107616453649,0.0311334329511923,4.02953022948316e-86
NMR metabolomics,X23412.Phospholipids in VLDL,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,29349,0.12496449459404,0.00633858109811092,0.112540875641743,0.137388113546338,5.79338113293275e-86
NMR metabolomics,X23412.Phospholipids in VLDL,HSPB1,Heat shock protein beta-1,29039,0.0912463151845642,0.00462925203057984,0.0821729812046277,0.100319649164501,6.36002811625124e-86
NMR metabolomics,X23412.Phospholipids in VLDL,CCL24,C-C motif chemokine 24,29536,0.109835611080146,0.00557320708653178,0.0989121251905435,0.120759096969748,6.60146964239587e-86
NMR metabolomics,X23412.Phospholipids in VLDL,UROD,Uroporphyrinogen decarboxylase,24381,0.091928170178103,0.00466950987148539,0.0827759308299916,0.101080409526214,1.29344996814207e-85
NMR metabolomics,X23412.Phospholipids in VLDL,PPBP,Platelet basic protein,24816,0.11232504297781,0.00570891075207101,0.101135577903751,0.123514508051869,1.57509654080279e-85
NMR metabolomics,X23412.Phospholipids in VLDL,TRIM24,Transcription intermediary factor 1-alpha,24396,0.0860630718919988,0.00438553460689413,0.0774674240624863,0.0946587197215113,4.35193345908402e-85
NMR metabolomics,X23412.Phospholipids in VLDL,GPI,Glucose-6-phosphate isomerase,24951,0.0625503974527886,0.003188418700348,0.0563010968001065,0.0687996981054706,4.75624227571625e-85
NMR metabolomics,X23412.Phospholipids in VLDL,PLPBP,Pyridoxal phosphate homeostasis protein,29478,0.08896032086101,0.00454821963586614,0.0800458103747123,0.0978748313473076,1.18344104140854e-84
NMR metabolomics,X23412.Phospholipids in VLDL,SCRG1,Scrapie-responsive protein 1,24922,0.0362482034945305,0.00185627951750193,0.0326098956402267,0.0398865113488342,2.74743234384249e-84
NMR metabolomics,X23412.Phospholipids in VLDL,PYY,Peptide YY,24111,0.127762583997735,0.00656017049762123,0.114904649822397,0.140620518173073,7.82212457392812e-84
NMR metabolomics,X23412.Phospholipids in VLDL,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,28797,0.0759391159419223,0.00390200591220802,0.0682911843539945,0.08358704752985,8.05149949456239e-84
NMR metabolomics,X23412.Phospholipids in VLDL,RBKS,Ribokinase,28795,0.0651973275798102,0.00335173641067483,0.0586279242148875,0.0717667309447329,9.71542974984676e-84
NMR metabolomics,X23412.Phospholipids in VLDL,IL18,Interleukin-18,29335,0.0601863607792319,0.00309495172588733,0.0541202553964927,0.066252466161971,1.049465824101e-83
NMR metabolomics,X23412.Phospholipids in VLDL,ARHGAP25,Rho GTPase-activating protein 25,28797,0.0783987570831896,0.00403675201200858,0.0704867231396527,0.0863107910267264,1.7486867807669e-83
NMR metabolomics,X23412.Phospholipids in VLDL,NUDT16,U8 snoRNA-decapping enzyme,24769,0.11467957002422,0.00590464945624346,0.103106457089983,0.126252682958457,2.10543534868971e-83
NMR metabolomics,X23412.Phospholipids in VLDL,THTPA,Thiamine-triphosphatase,24755,0.11544915814337,0.00594683289780646,0.10379336566367,0.127104950623071,2.473351472169e-83
NMR metabolomics,X23412.Phospholipids in VLDL,ADD1,Alpha-adducin,24381,0.0916109934262538,0.00472509440493307,0.082349808392585,0.100872178459923,4.1094282511216e-83
NMR metabolomics,X23412.Phospholipids in VLDL,CIAPIN1,Anamorsin,29566,0.0816857498297638,0.00421775966473858,0.0734189408868762,0.0899525587726514,4.79163229419427e-83
NMR metabolomics,X23412.Phospholipids in VLDL,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,24793,0.0460361967176246,0.00237664190970389,0.041377978574605,0.0506944148606443,5.65411251933624e-83
NMR metabolomics,X23412.Phospholipids in VLDL,ASRGL1,Isoaspartyl peptidase/L-asparaginase,24240,0.133658303323687,0.00690042859136232,0.120133463284617,0.147183143362757,5.91687686760825e-83
NMR metabolomics,X23412.Phospholipids in VLDL,BIN2,Bridging integrator 2,29443,0.11723239354995,0.00605827299079737,0.105358178487987,0.129106608611913,6.58111558483139e-83
NMR metabolomics,X23412.Phospholipids in VLDL,TADA3,Transcriptional adapter 3,24793,0.0515989601039069,0.00267018038779998,0.046365406543819,0.0568325136639949,1.36506650497192e-82
NMR metabolomics,X23412.Phospholipids in VLDL,DNM3,Dynamin-3,24867,0.0715196259328861,0.00370246938067049,0.0642627859467719,0.0787764659190002,1.56598683306151e-82
NMR metabolomics,X23412.Phospholipids in VLDL,CCL3,C-C motif chemokine 3,29434,0.0786468221365838,0.00407381526705338,0.0706621442131592,0.0866315000600085,1.56796892944339e-82
NMR metabolomics,X23412.Phospholipids in VLDL,BCL2L1,Bcl-2-like protein 1,24845,0.129590275818589,0.00672249430664019,0.116414186977575,0.142766364659604,3.33705051881423e-82
NMR metabolomics,X23412.Phospholipids in VLDL,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",24381,0.135359934083053,0.00702993569706892,0.121581260116798,0.149138608049309,5.23789225477008e-82
NMR metabolomics,X23412.Phospholipids in VLDL,ESYT2,Extended synaptotagmin-2,24845,0.106862019571059,0.0055516904581474,0.0959807062730905,0.117743332869028,5.74614185531992e-82
NMR metabolomics,X23412.Phospholipids in VLDL,PALM2,Paralemmin-2,24845,0.0491905434846084,0.00255575712868391,0.044181259512388,0.0541998274568289,5.92361908039363e-82
NMR metabolomics,X23412.Phospholipids in VLDL,B4GAT1,"Beta-1,4-glucuronyltransferase 1",29443,0.031484741775085,0.001637050006782,0.0282761237617923,0.0346933597883777,6.2912889826668e-82
NMR metabolomics,X23412.Phospholipids in VLDL,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,24240,0.0623615911491909,0.00324147297657572,0.0560083041151025,0.0687148781832793,7.17518731153447e-82
NMR metabolomics,X23412.Phospholipids in VLDL,TMEM106A,Transmembrane protein 106A,24793,0.0917752366058117,0.00477180594979043,0.0824224969442225,0.101127976267401,7.77317349984282e-82
NMR metabolomics,X23412.Phospholipids in VLDL,APOL1,Apolipoprotein L1,24951,0.0779425448772813,0.00405331173526102,0.0699980538761697,0.0858870358783929,8.23029008325444e-82
NMR metabolomics,X23412.Phospholipids in VLDL,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",24922,0.0954694864630134,0.00496565624328861,0.0857368002261677,0.105202172699859,8.79211520156188e-82
NMR metabolomics,X23412.Phospholipids in VLDL,RP2,Protein XRP2,29349,0.0541592656553032,0.0028207666075322,0.04863056310454,0.0596879682060663,1.17007597877253e-81
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINB1,Leukocyte elastase inhibitor,29354,0.115294213306142,0.00600556636802187,0.103523303224819,0.127065123387465,1.22218478029312e-81
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINB9,Serpin B9,29218,0.0429262008195246,0.00223620230751914,0.0385432442967871,0.0473091573422621,1.27304207490871e-81
NMR metabolomics,X23412.Phospholipids in VLDL,VPS4B,Vacuolar protein sorting-associated protein 4B,24793,0.122245811270368,0.00636907548625659,0.109762423317305,0.134729199223431,1.63463196503347e-81
NMR metabolomics,X23412.Phospholipids in VLDL,CASP10,Caspase-10,28774,0.0923132203963502,0.00481437633044749,0.0828770427886731,0.101749398004027,1.95071206005137e-81
NMR metabolomics,X23412.Phospholipids in VLDL,BPIFB2,BPI fold-containing family B member 2,24852,0.0839748572435493,0.0043806850154056,0.0753887146133543,0.0925609998737442,2.58284853383558e-81
NMR metabolomics,X23412.Phospholipids in VLDL,PGF,Placenta growth factor,29786,0.0338355326474995,0.0017663056673992,0.0303735735393971,0.037297491755602,2.65855854006741e-81
NMR metabolomics,X23412.Phospholipids in VLDL,DTNB,Dystrobrevin beta,24752,0.0561519086464388,0.00293291445787413,0.0504033963090054,0.0619004209838721,4.08352519115484e-81
NMR metabolomics,X23412.Phospholipids in VLDL,HNMT,Histamine N-methyltransferase,29082,0.0606803223073481,0.00317368065932673,0.0544599082150677,0.0669007363996285,5.42898740086735e-81
NMR metabolomics,X23412.Phospholipids in VLDL,TP53I3,Quinone oxidoreductase PIG3,23906,0.0689088832162054,0.00360429593197563,0.0618444631895332,0.0759733032428777,7.11626664723914e-81
NMR metabolomics,X23412.Phospholipids in VLDL,SCGB3A2,Secretoglobin family 3A member 2,29536,-0.105365847424173,0.00551533550880398,-0.116175905021429,-0.0945557898269177,7.18101387691409e-81
NMR metabolomics,X23412.Phospholipids in VLDL,ANGPT1,Angiopoietin-1,29322,0.108165484282501,0.0056645255341356,0.0970630142355951,0.119267954329407,8.57003995705393e-81
NMR metabolomics,X23412.Phospholipids in VLDL,ANKRD54,Ankyrin repeat domain-containing protein 54,28797,0.0735981672697583,0.0038541661790367,0.0660440015588463,0.0811523329806702,8.66462355959907e-81
NMR metabolomics,X23412.Phospholipids in VLDL,ATP6AP2,Renin receptor,28797,0.0521854219653346,0.00273342082015721,0.0468279171578264,0.0575429267728427,9.36770286180901e-81
NMR metabolomics,X23412.Phospholipids in VLDL,SDHB,Succinate dehydrogenase,24805,0.0886655870925729,0.00464403319381305,0.0795632820326993,0.0977678921524465,1.10959582751059e-80
NMR metabolomics,X23412.Phospholipids in VLDL,KCTD5,BTB/POZ domain-containing protein KCTD5,24429,0.0567221199790677,0.00297213478532383,0.050896735799833,0.0625475041583024,1.31007700848902e-80
NMR metabolomics,X23412.Phospholipids in VLDL,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,24240,0.0986776678193941,0.00517042383170723,0.088543637109248,0.10881169852954,1.31424117175819e-80
NMR metabolomics,X23412.Phospholipids in VLDL,MANF,Mesencephalic astrocyte-derived neurotrophic factor,29581,0.153291401927939,0.00803826541075562,0.137536401722858,0.16904640213302,1.36210188123357e-80
NMR metabolomics,X23412.Phospholipids in VLDL,SEPTIN9,Septin-9,29349,0.0365005327098525,0.00191410893280264,0.0327488792015594,0.0402521862181457,1.40041820380484e-80
NMR metabolomics,X23412.Phospholipids in VLDL,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,24381,0.037094156048659,0.00194561908370155,0.033280742644604,0.0409075694527141,1.88485063802923e-80
NMR metabolomics,X23412.Phospholipids in VLDL,C1R,Complement C1r subcomponent,24966,0.0249753956369039,0.00131059610650995,0.0224066272681444,0.0275441640056634,2.16263254105663e-80
NMR metabolomics,X23412.Phospholipids in VLDL,EIF4E,Eukaryotic translation initiation factor 4E,24229,0.116723204899657,0.00612796022113687,0.104712402866229,0.128734006933086,2.65905076661998e-80
NMR metabolomics,X23412.Phospholipids in VLDL,MEP1A,Meprin A subunit alpha,24805,0.0925758359321922,0.00486130766620034,0.0830476729064395,0.102103998957945,2.79178556000247e-80
NMR metabolomics,X23412.Phospholipids in VLDL,PPCDC,Phosphopantothenoylcysteine decarboxylase,29694,0.0598932061759424,0.00314953405744948,0.0537201194233414,0.0660662929285433,3.73405006192782e-80
NMR metabolomics,X23412.Phospholipids in VLDL,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,28797,0.0863011135921386,0.00454652581796361,0.0773899229889299,0.0952123041953473,7.42933705355276e-80
NMR metabolomics,X23412.Phospholipids in VLDL,MSTN,Growth/differentiation factor 8,28916,0.0672743985876918,0.00354486442564668,0.0603264643134243,0.0742223328619593,7.94023536299084e-80
NMR metabolomics,X23412.Phospholipids in VLDL,CASP2,Caspase-2,29434,0.0867329016923538,0.00457122501606034,0.0777733006608755,0.095692502723832,8.44560367400277e-80
NMR metabolomics,X23412.Phospholipids in VLDL,DNAJB14,DnaJ homolog subfamily B member 14,24805,0.0822529017831396,0.0043349239765687,0.0737564507890649,0.0907493527772142,1.01925993388327e-79
NMR metabolomics,X23412.Phospholipids in VLDL,TSC22D1,TSC22 domain family protein 1,24867,0.0852384187994656,0.00449717938790964,0.0764239471991627,0.0940528903997685,1.49827538196114e-79
NMR metabolomics,X23412.Phospholipids in VLDL,DPT,Dermatopontin,29820,0.0336002533147539,0.0017752393660512,0.0301207841572935,0.0370797224722142,1.99381686185315e-79
NMR metabolomics,X23412.Phospholipids in VLDL,TBC1D5,TBC1 domain family member 5,29434,0.0994899912947024,0.00526052734928717,0.0891793576900995,0.109800624899305,2.65916025548351e-79
NMR metabolomics,X23412.Phospholipids in VLDL,PEBP1,Phosphatidylethanolamine-binding protein 1,29443,0.0729841320629412,0.00385948634807235,0.0654195388207194,0.080548725305163,2.77161710448479e-79
NMR metabolomics,X23412.Phospholipids in VLDL,ESM1,Endothelial cell-specific molecule 1,29454,-0.0436187389837924,0.00230669269036797,-0.0481398566569136,-0.0390976213106712,2.80592232205218e-79
NMR metabolomics,X23412.Phospholipids in VLDL,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,24381,0.0771468721377894,0.00407727136440425,0.0691554202635571,0.0851383240120218,2.82641410431644e-79
NMR metabolomics,X23412.Phospholipids in VLDL,DNAJB2,DnaJ homolog subfamily B member 2,24381,0.068442105305842,0.00361776459917467,0.0613512866914597,0.0755329239202244,2.98167218024255e-79
NMR metabolomics,X23412.Phospholipids in VLDL,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",24209,0.101887303176536,0.00538832127380735,0.0913261934798737,0.112448412873199,3.58907139362609e-79
NMR metabolomics,X23412.Phospholipids in VLDL,DTD1,D-aminoacyl-tRNA deacylase 1,24381,0.111253034494681,0.00589364276849992,0.0997014946684212,0.122804574320941,6.47912822259542e-79
NMR metabolomics,X23412.Phospholipids in VLDL,STX8,Syntaxin-8,29434,0.0614229952737584,0.00325617951571668,0.0550408834229537,0.0678051071245631,6.6567565317421e-79
NMR metabolomics,X23412.Phospholipids in VLDL,GZMA,Granzyme A,29786,0.0440082537070043,0.00233443795237006,0.039432755320359,0.0485837520936496,8.18919637897604e-79
NMR metabolomics,X23412.Phospholipids in VLDL,BAG3,BAG family molecular chaperone regulator 3,29169,0.0509322174218219,0.0027019607855432,0.0456363742821572,0.0562280605614866,8.63688907868468e-79
NMR metabolomics,X23412.Phospholipids in VLDL,MATN2,Matrilin-2,29497,0.0377599148407531,0.00200350484273682,0.033833045348989,0.0416867843325173,9.05429622209962e-79
NMR metabolomics,X23412.Phospholipids in VLDL,GMFG,Glia maturation factor gamma,24922,0.0913367761261923,0.00484464140232721,0.081841278977631,0.100832273274754,9.79055834519236e-79
NMR metabolomics,X23412.Phospholipids in VLDL,GGCT,Gamma-glutamylcyclotransferase,24904,0.0609936446354865,0.00323677479510184,0.0546495660370869,0.0673377232338862,1.16317309456018e-78
NMR metabolomics,X23412.Phospholipids in VLDL,MIF,Macrophage migration inhibitory factor,29386,0.08627201561245,0.00458086952383055,0.0772935113457421,0.0952505198791578,1.17662082807893e-78
NMR metabolomics,X23412.Phospholipids in VLDL,GPRC5C,G-protein coupled receptor family C group 5 member C,24793,0.0724747502810766,0.00384639725585016,0.0649358116596103,0.0800136889025429,1.20766032298702e-78
NMR metabolomics,X23412.Phospholipids in VLDL,TREM2,Triggering receptor expressed on myeloid cells 2,29454,0.0658874069009906,0.00350248279263871,0.0590225406274188,0.0727522731745625,1.7521072247846e-78
NMR metabolomics,X23412.Phospholipids in VLDL,FGL1,Fibrinogen-like protein 1,24951,-0.0809946444723914,0.0043072663813407,-0.0894368865798192,-0.0725524023649636,2.43269826231126e-78
NMR metabolomics,X23412.Phospholipids in VLDL,PAEP,Glycodelin,29218,-0.166983014179202,0.00888484455959312,-0.184397309516004,-0.149568718842399,2.44769081401507e-78
NMR metabolomics,X23412.Phospholipids in VLDL,CD5,T-cell surface glycoprotein CD5,29683,0.0435007207449318,0.00231569432920167,0.0389619598596965,0.0480394816301671,2.84492597201608e-78
NMR metabolomics,X23412.Phospholipids in VLDL,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,29536,0.0963125736159067,0.00513769001109298,0.0862427011941644,0.106382446037649,5.8945118497381e-78
NMR metabolomics,X23412.Phospholipids in VLDL,VASH1,Tubulinyl-Tyr carboxypeptidase 1,29434,0.103220673033415,0.00550683531982003,0.0924272758065678,0.114014070260262,6.16012436654925e-78
NMR metabolomics,X23412.Phospholipids in VLDL,AKT2,RAC-beta serine/threonine-protein kinase,24867,0.159925934094651,0.00853556210941461,0.143196232360198,0.176655635829104,8.59200778012075e-78
NMR metabolomics,X23412.Phospholipids in VLDL,HPSE,Heparanase,24688,0.118733276902872,0.00633960034744119,0.106307660221887,0.131158893583856,9.9789413666691e-78
NMR metabolomics,X23412.Phospholipids in VLDL,ITGA2,Integrin alpha-2,24381,0.0434020115957193,0.00231810033584517,0.0388585349374628,0.0479454882539759,1.12694702620907e-77
NMR metabolomics,X23412.Phospholipids in VLDL,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,24381,0.0532192802498408,0.00284626213360754,0.04764060646797,0.0587979540317115,1.79417736235871e-77
NMR metabolomics,X23412.Phospholipids in VLDL,DCTD,Deoxycytidylate deaminase,24381,0.119854906105198,0.00641319080655804,0.107285052124344,0.132424760086052,2.12452609486272e-77
NMR metabolomics,X23412.Phospholipids in VLDL,CRYZL1,Quinone oxidoreductase-like protein 1,24240,0.116167501803281,0.00621675532398665,0.103982661368267,0.128352342238294,2.2457814093748e-77
NMR metabolomics,X23412.Phospholipids in VLDL,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,24867,0.125252334269047,0.00670863851218697,0.11210340278516,0.138401265752933,2.91896053702638e-77
NMR metabolomics,X23412.Phospholipids in VLDL,MYO9B,Unconventional myosin-IXb,28931,0.0830428860787722,0.00445163837404653,0.074317674865641,0.0917680972919034,3.30210702926122e-77
NMR metabolomics,X23412.Phospholipids in VLDL,CHM,Rab proteins geranylgeranyltransferase component A 1,24195,0.0769652920623786,0.00412783492141426,0.0688747356164067,0.0850558485083506,4.77527125068482e-77
NMR metabolomics,X23412.Phospholipids in VLDL,STX4,Syntaxin-4,29349,0.0744706498057339,0.00399760706614277,0.0666353399560941,0.0823059596553737,5.22609306939706e-77
NMR metabolomics,X23412.Phospholipids in VLDL,JPT2,Jupiter microtubule associated homolog 2,24805,0.109979318538624,0.00591924925439744,0.0983775900000047,0.121581047077243,1.54681872471432e-76
NMR metabolomics,X23412.Phospholipids in VLDL,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,29218,0.117804096159067,0.00634586292260353,0.105366204830764,0.13024198748737,1.73601071058677e-76
NMR metabolomics,X23412.Phospholipids in VLDL,AKT3,RAC-gamma serine/threonine-protein kinase,28662,0.0720874118934076,0.00388354206516167,0.0644756694456907,0.0796991543411244,1.82435658539257e-76
NMR metabolomics,X23412.Phospholipids in VLDL,CD1C,T-cell surface glycoprotein CD1c,29566,0.0304035339217986,0.00163822350875468,0.0271926158446394,0.0336144519989577,1.88354301750682e-76
NMR metabolomics,X23412.Phospholipids in VLDL,GP5,Platelet glycoprotein V,24381,0.0453781343249649,0.00244392734126008,0.0405880367360951,0.0501682319138346,1.97693266292973e-76
NMR metabolomics,X23412.Phospholipids in VLDL,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,24793,0.13506895936645,0.00727719408818558,0.120805658953606,0.149332259779293,2.20871643689815e-76
NMR metabolomics,X23412.Phospholipids in VLDL,CRYBB1,Beta-crystallin B1,24922,0.0818616506375635,0.00441088041752117,0.073216325019222,0.090506976255905,2.25879939496627e-76
NMR metabolomics,X23412.Phospholipids in VLDL,PARK7,Parkinson disease protein 7,29443,0.0651973529273022,0.00351627656796001,0.0583054508541006,0.0720892550005038,2.5976597188256e-76
NMR metabolomics,X23412.Phospholipids in VLDL,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,29218,0.0549837777520138,0.0029698420879045,0.049162887259721,0.0608046682443066,4.34140966136563e-76
NMR metabolomics,X23412.Phospholipids in VLDL,MFAP5,Microfibrillar-associated protein 5,29820,0.0509071719264234,0.00275092958678236,0.0455153499363299,0.0562989939165168,4.98215464215328e-76
NMR metabolomics,X23412.Phospholipids in VLDL,ECHS1,"Enoyl-CoA hydratase, mitochondrial",24240,0.121374914232725,0.00656576871089183,0.108506007559377,0.134243820906073,8.89278753277652e-76
NMR metabolomics,X23412.Phospholipids in VLDL,CPPED1,Serine/threonine-protein phosphatase CPPED1,29694,0.081369043374707,0.00440597289525089,0.0727333365000153,0.0900047502493988,9.95669591169536e-76
NMR metabolomics,X23412.Phospholipids in VLDL,DTX3,Probable E3 ubiquitin-protein ligase DTX3,29349,0.0300894329009983,0.00163023883319593,0.0268941647879342,0.0332847010140623,1.22776910616331e-75
NMR metabolomics,X23412.Phospholipids in VLDL,TPK1,Thiamin pyrophosphokinase 1,24922,0.0343322642719682,0.00186022232517849,0.0306862285146183,0.037978300029318,1.48975673570709e-75
NMR metabolomics,X23412.Phospholipids in VLDL,GSR,"Glutathione reductase, mitochondrial",24867,0.0282106110200448,0.00153067936810375,0.0252104794585615,0.0312107425815282,2.39486886057621e-75
NMR metabolomics,X23412.Phospholipids in VLDL,APOE,Apolipoprotein E,24966,0.0905189575083518,0.00491198156411593,0.0808914736426846,0.100146441374019,2.46933153273682e-75
NMR metabolomics,X23412.Phospholipids in VLDL,DYNLT1,Dynein light chain Tctex-type 1,24195,0.0997793171721102,0.00541564944975857,0.0891646442505834,0.110393990093637,2.75141379635583e-75
NMR metabolomics,X23412.Phospholipids in VLDL,CASP3,Caspase-3,29820,0.108971187770078,0.00592554279090936,0.0973571238998952,0.12058525164026,4.11094271638796e-75
NMR metabolomics,X23412.Phospholipids in VLDL,INPP1,Inositol polyphosphate 1-phosphatase,29349,0.0663532277544239,0.00360865333326322,0.059280267221228,0.0734261882876198,4.39457532841396e-75
NMR metabolomics,X23412.Phospholipids in VLDL,PNMA1,Paraneoplastic antigen Ma1,24240,0.0702028474159208,0.00381618288880123,0.0627231289538704,0.0776825658779712,4.58512408037845e-75
NMR metabolomics,X23412.Phospholipids in VLDL,CXCL1,Growth-regulated alpha protein,29420,0.117861797465159,0.00641586016825894,0.105286711535371,0.130436883394946,5.96276298857563e-75
NMR metabolomics,X23412.Phospholipids in VLDL,F2R,Proteinase-activated receptor 1,29536,0.0708697954193182,0.00386057236817558,0.0633030735776941,0.0784365172609424,7.53421031989559e-75
NMR metabolomics,X23412.Phospholipids in VLDL,MICALL2,MICAL-like protein 2,24195,0.0847433451769849,0.00461794695067932,0.0756921691536534,0.0937945212003164,1.04523195851858e-74
NMR metabolomics,X23412.Phospholipids in VLDL,RAB33A,Ras-related protein Rab-33A,24111,0.0819765904878135,0.00449458310510313,0.0731672076018114,0.0907859733738156,7.95129212502636e-74
NMR metabolomics,X23412.Phospholipids in VLDL,JAM3,Junctional adhesion molecule C,24381,0.0623898958797811,0.00342315644770478,0.0556805092422798,0.0690992825172825,9.9519650237751e-74
NMR metabolomics,X23412.Phospholipids in VLDL,ANXA3,Annexin A3,29640,0.0854421370536814,0.00469434746841262,0.0762412160155927,0.0946430580917701,1.27609629153285e-73
NMR metabolomics,X23412.Phospholipids in VLDL,PDAP1,28 kDa heat- and acid-stable phosphoprotein,24922,0.120587482378529,0.00662179288018524,0.107608768333365,0.133566196423692,1.27617908280545e-73
NMR metabolomics,X23412.Phospholipids in VLDL,MARCO,Macrophage receptor MARCO,29478,0.0322848829498798,0.0017739537558707,0.0288079335883732,0.0357618323113864,1.3219050053187e-73
NMR metabolomics,X23412.Phospholipids in VLDL,FOXO3,Forkhead box protein O3,28797,0.118263340370575,0.0064981390723446,0.10552698778878,0.13099969295237,1.34677007267536e-73
NMR metabolomics,X23412.Phospholipids in VLDL,PRSS2,Trypsin-2,29594,0.0655861619968957,0.00360490650135551,0.0585205452542389,0.0726517787395524,1.46280104108881e-73
NMR metabolomics,X23412.Phospholipids in VLDL,SNAP25,Synaptosomal-associated protein 25,24101,0.0582064055381701,0.00319902402848142,0.0519363184423465,0.0644764926339936,1.7557202938823e-73
NMR metabolomics,X23412.Phospholipids in VLDL,AIF1,Allograft inflammatory factor 1,28797,0.0642829986349856,0.00353699048235316,0.0573504972895734,0.0712154999803978,2.11704224171215e-73
NMR metabolomics,X23412.Phospholipids in VLDL,MSR1,Macrophage scavenger receptor types I and II,29694,0.0561712992282571,0.00309475814185167,0.0501055732702278,0.0622370251862864,3.17242036478319e-73
NMR metabolomics,X23412.Phospholipids in VLDL,NT5C3A,Cytosolic 5'-nucleotidase 3A,29373,0.107380453804723,0.00591701101155226,0.0957831122220807,0.118977795387366,3.36431772004209e-73
NMR metabolomics,X23412.Phospholipids in VLDL,NECAP2,Adaptin ear-binding coat-associated protein 2,24111,0.0817644681529098,0.00450358833740683,0.0729374350115924,0.0905915012942272,3.58010260396489e-73
NMR metabolomics,X23412.Phospholipids in VLDL,PLA2G4A,Cytosolic phospholipase A2,29581,0.106917002335935,0.00589468113492601,0.0953634273114798,0.11847057736039,3.99291115182323e-73
NMR metabolomics,X23412.Phospholipids in VLDL,LAP3,Cytosol aminopeptidase,28931,0.0592097836519621,0.00327794179972847,0.0527850177244943,0.0656345495794299,1.56011867769795e-72
NMR metabolomics,X23412.Phospholipids in VLDL,TXNDC9,Thioredoxin domain-containing protein 9,24845,0.0650001988785346,0.00359699957565443,0.0579500797102519,0.0720503180468172,1.58283742369604e-72
NMR metabolomics,X23412.Phospholipids in VLDL,FGFBP2,Fibroblast growth factor-binding protein 2,24938,0.061592261381946,0.00341095109316135,0.0549067972393498,0.0682777255245423,2.00574173440079e-72
NMR metabolomics,X23412.Phospholipids in VLDL,DXO,Decapping and exoribonuclease protein,24845,0.0555192712816518,0.00307753848833988,0.0494872958445056,0.0615512467187979,2.73117328823453e-72
NMR metabolomics,X23412.Phospholipids in VLDL,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,29434,0.146185057700325,0.00810756568364205,0.130294228960387,0.162075886440263,2.74358872007133e-72
NMR metabolomics,X23412.Phospholipids in VLDL,MDH1,"Malate dehydrogenase, cytoplasmic",24852,0.0487954527893201,0.00270537719140607,0.0434929134941642,0.054097992084476,2.91613011193239e-72
NMR metabolomics,X23412.Phospholipids in VLDL,PRDX5,"Peroxiredoxin-5, mitochondrial",29786,0.0824081199389985,0.00457362134805162,0.0734438220968173,0.0913724177811797,3.39879959058011e-72
NMR metabolomics,X23412.Phospholipids in VLDL,CDC37,Hsp90 co-chaperone Cdc37,29566,0.101430175779499,0.0056337402472565,0.0903880448948763,0.112472306664122,4.39962616071739e-72
NMR metabolomics,X23412.Phospholipids in VLDL,RILP,Rab-interacting lysosomal protein,29632,0.0720943653912793,0.00400496619878188,0.0642446316416668,0.0799440991408918,4.61736648139192e-72
NMR metabolomics,X23412.Phospholipids in VLDL,FAS,Tumor necrosis factor receptor superfamily member 6,29736,0.0395835178929508,0.00219906212412034,0.0352733561296749,0.0438936796562267,4.69118310203518e-72
NMR metabolomics,X23412.Phospholipids in VLDL,APP,Amyloid-beta precursor protein,29395,0.080696856564907,0.00448370730091841,0.0719087902551069,0.089484922874707,4.94522167206383e-72
NMR metabolomics,X23412.Phospholipids in VLDL,CCT5,T-complex protein 1 subunit epsilon,28797,0.0548876594682237,0.00305341290784605,0.0489029701688454,0.0608723487676019,7.45275069501927e-72
NMR metabolomics,X23412.Phospholipids in VLDL,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,24229,0.0972769607941535,0.00541495933964063,0.0866636404884579,0.107890281099849,1.08038214598988e-71
NMR metabolomics,X23412.Phospholipids in VLDL,ABRAXAS2,BRISC complex subunit Abraxas 2,24111,0.0809434451112658,0.00450840575255277,0.0721069698362624,0.0897799203862692,1.31099191383166e-71
NMR metabolomics,X23412.Phospholipids in VLDL,LRP11,Low-density lipoprotein receptor-related protein 11,29478,0.0436302316696194,0.00243194680401699,0.0388636159337461,0.0483968474054927,1.37123391476442e-71
NMR metabolomics,X23412.Phospholipids in VLDL,GET3,ATPase GET3,24922,0.0668448230349847,0.00372431821456384,0.0595451593344396,0.0741444867355298,1.40108869582572e-71
NMR metabolomics,X23412.Phospholipids in VLDL,NRGN,Neurogranin,24951,0.110474748203673,0.00616723068035413,0.0983869760701787,0.122562520337167,2.60616061584244e-71
NMR metabolomics,X23412.Phospholipids in VLDL,CD164,Sialomucin core protein 24,29443,0.0322936184040596,0.00180514405874691,0.0287555360489156,0.0358317007592035,3.37938536139115e-71
NMR metabolomics,X23412.Phospholipids in VLDL,REEP4,Receptor expression-enhancing protein 4,24867,0.075054237118108,0.00419766067313486,0.0668268221987637,0.0832816520374523,4.70784960058491e-71
NMR metabolomics,X23412.Phospholipids in VLDL,FMNL1,Formin-like protein 1,28774,0.0738799373613728,0.00413790477580957,0.0657696440007861,0.0819902307219595,6.45211550163254e-71
NMR metabolomics,X23412.Phospholipids in VLDL,WDR46,WD repeat-containing protein 46,24793,0.0434179040422864,0.00243360204376422,0.0386480440365085,0.0481877640480643,9.41510883247737e-71
NMR metabolomics,X23412.Phospholipids in VLDL,MGMT,Methylated-DNA--protein-cysteine methyltransferase,29434,0.145818987994594,0.00817781753064648,0.129790465634527,0.161847510354661,9.57304172951121e-71
NMR metabolomics,X23412.Phospholipids in VLDL,LTBP3,Latent-transforming growth factor beta-binding protein 3,28797,0.0646414119914905,0.00362636927169776,0.0575337282189629,0.0717490957640181,1.07823257304049e-70
NMR metabolomics,X23412.Phospholipids in VLDL,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,24922,0.0482550040707746,0.00270671193149187,0.0429498486850506,0.0535601594564987,1.18042856153382e-70
NMR metabolomics,X23412.Phospholipids in VLDL,TNFSF14,Tumor necrosis factor ligand superfamily member 14,29218,0.0691050890989572,0.00388049843241091,0.0614993121714318,0.0767108660264826,1.4401327679195e-70
NMR metabolomics,X23412.Phospholipids in VLDL,ITGB1BP2,Integrin beta-1-binding protein 2,28916,0.133155053247738,0.00748632366387047,0.118481858866552,0.147828247628924,2.13768512833849e-70
NMR metabolomics,X23412.Phospholipids in VLDL,DBI,Acyl-CoA-binding protein,29329,0.093859202105307,0.00528309294890973,0.0835043399254439,0.10421406428517,3.03132877486734e-70
NMR metabolomics,X23412.Phospholipids in VLDL,ADGRF5,Adhesion G protein-coupled receptor F5,24922,0.0341871326706614,0.00192538972893005,0.0304133688019585,0.0379608965393643,4.19512206588427e-70
NMR metabolomics,X23412.Phospholipids in VLDL,NID1,Nidogen-1,29518,0.0453271261273005,0.00255683189764124,0.0403157356079237,0.0503385166466774,5.89965399323745e-70
NMR metabolomics,X23412.Phospholipids in VLDL,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,28797,0.078065595081981,0.00440508379468672,0.069431630844395,0.0866995593195669,6.71090880936394e-70
NMR metabolomics,X23412.Phospholipids in VLDL,CEMIP2,Cell surface hyaluronidase,24229,0.039661417203273,0.00224090141253432,0.0352692504347058,0.0440535839718403,1.17560810480025e-69
NMR metabolomics,X23412.Phospholipids in VLDL,CFB,Complement factor B,24538,0.0392650199076156,0.00222057164901333,0.0349126994755495,0.0436173403396818,1.54936853063228e-69
NMR metabolomics,X23412.Phospholipids in VLDL,TST,Thiosulfate sulfurtransferase,28706,0.0900649849321424,0.00510065872894499,0.0800676938234102,0.100062276040875,2.07624822816347e-69
NMR metabolomics,X23412.Phospholipids in VLDL,GIPC3,PDZ domain-containing protein GIPC3,24805,0.117190458329991,0.00663637310770275,0.104183167038893,0.130197749621088,2.31649387820432e-69
NMR metabolomics,X23412.Phospholipids in VLDL,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,24805,0.0769511022387654,0.0043676066126062,0.0683905932780573,0.0855116111994736,4.67774918677492e-69
NMR metabolomics,X23412.Phospholipids in VLDL,TTF2,Transcription termination factor 2,24195,0.0584557297700538,0.0033180971705057,0.0519522593158626,0.0649592002242449,4.90708820761043e-69
NMR metabolomics,X23412.Phospholipids in VLDL,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,29434,0.0724465008957583,0.00412022655562114,0.0643708568467408,0.0805221449447757,7.47016792717919e-69
NMR metabolomics,X23412.Phospholipids in VLDL,BMPER,BMP-binding endothelial regulator protein,24381,0.0270913008190756,0.00154415849039355,0.0240647501779042,0.0301178514602469,1.73263341622554e-68
NMR metabolomics,X23412.Phospholipids in VLDL,ABHD14B,Protein ABHD14B,29121,0.067733468469113,0.00386655382570347,0.0601550229707342,0.0753119139674918,2.35263207744554e-68
NMR metabolomics,X23412.Phospholipids in VLDL,CD72,B-cell differentiation antigen CD72,24381,0.0507384646356046,0.00289542813469851,0.0450634254915955,0.0564135037796137,2.48370864010944e-68
NMR metabolomics,X23412.Phospholipids in VLDL,HPGDS,Hematopoietic prostaglandin D synthase,28797,0.0446204766363867,0.00254791740650176,0.0396265585196432,0.0496143947531302,2.60128293584333e-68
NMR metabolomics,X23412.Phospholipids in VLDL,FADD,FAS-associated death domain protein,29478,0.0900032795776492,0.00514246715020689,0.0799240439632437,0.100082515192055,3.06759725158911e-68
NMR metabolomics,X23412.Phospholipids in VLDL,SUOX,"Sulfite oxidase, mitochondrial",24867,0.0739520050873564,0.00422392779672795,0.0656731066057696,0.0822309035689432,3.20528059149853e-68
NMR metabolomics,X23412.Phospholipids in VLDL,DBN1,Drebrin,24229,0.0607109923063934,0.00347283473799348,0.0539042362199262,0.0675177483928606,5.17306306754508e-68
NMR metabolomics,X23412.Phospholipids in VLDL,FSHB,Follitropin subunit beta,24240,0.0764887098536839,0.00437586385980182,0.0679120166884724,0.0850654030188955,5.35303785861984e-68
NMR metabolomics,X23412.Phospholipids in VLDL,RNASEH2A,Ribonuclease H2 subunit A,24867,0.0575379302490078,0.00329249411551598,0.0510846417825965,0.0639912187154191,5.61988216952415e-68
NMR metabolomics,X23412.Phospholipids in VLDL,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,29497,0.035927410218581,0.00205806405938724,0.031893604662182,0.03996121577498,6.70343174455649e-68
NMR metabolomics,X23412.Phospholipids in VLDL,GGACT,Gamma-glutamylaminecyclotransferase,24922,0.0836177716328635,0.00478968643261434,0.0742299862249394,0.0930055570407876,7.60662368911214e-68
NMR metabolomics,X23412.Phospholipids in VLDL,CCL2,C-C motif chemokine 2,29169,0.0617263803394966,0.00353965869639211,0.054788649294568,0.0686641113844251,9.29890080343371e-68
NMR metabolomics,X23412.Phospholipids in VLDL,ARL13B,ADP-ribosylation factor-like protein 13B,24111,0.0816897434513277,0.00468417592817912,0.0725087586320966,0.0908707282705588,1.07791831420226e-67
NMR metabolomics,X23412.Phospholipids in VLDL,CEP170,Centrosomal protein of 170 kDa,24240,0.0909221320083397,0.00521579345814139,0.0806991768303826,0.101145087186297,1.21940358309492e-67
NMR metabolomics,X23412.Phospholipids in VLDL,MMP7,Matrilysin,28870,0.0586294791214867,0.00336911965239826,0.0520260046027862,0.0652329536401873,1.76235940959065e-67
NMR metabolomics,X23412.Phospholipids in VLDL,ROBO2,Roundabout homolog 2,29694,0.0271669826036661,0.00156169610014722,0.0241060582473775,0.0302279069599546,1.91911068482096e-67
NMR metabolomics,X23412.Phospholipids in VLDL,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",29349,0.0389656989066885,0.00224386531552653,0.0345677228882565,0.0433636749251205,3.27162213311866e-67
NMR metabolomics,X23412.Phospholipids in VLDL,DDT,D-dopachrome decarboxylase,24938,0.0479357521176575,0.00275936498258731,0.0425273967517863,0.0533441074835286,3.3464561385852e-67
NMR metabolomics,X23412.Phospholipids in VLDL,SFRP1,Secreted frizzled-related protein 1,29120,0.0507352100484958,0.00292301076443154,0.04500610895021,0.0564643111467816,3.79525337390272e-67
NMR metabolomics,X23412.Phospholipids in VLDL,CTSZ,Cathepsin Z,29487,0.0369482250048025,0.00212896861785161,0.0327754465138133,0.0411210034957916,3.90325787181077e-67
NMR metabolomics,X23412.Phospholipids in VLDL,LARP1,La-related protein 1,24793,0.0736240330447528,0.00424480020345057,0.0653042246459897,0.081943841443516,5.39988589120667e-67
NMR metabolomics,X23412.Phospholipids in VLDL,CFHR5,Complement factor H-related protein 5,24623,0.0490102407043606,0.00282597624042746,0.0434713272731228,0.0545491541355984,5.60045026917019e-67
NMR metabolomics,X23412.Phospholipids in VLDL,SMTN,Smoothelin,24776,0.110666198983659,0.00638717066324979,0.0981473444836896,0.123185053483629,7.38682542489168e-67
NMR metabolomics,X23412.Phospholipids in VLDL,NPDC1,Neural proliferation differentiation and control protein 1,29478,0.0374107303565208,0.00216040845758928,0.0331763297796458,0.0416451309333958,7.57287888678715e-67
NMR metabolomics,X23412.Phospholipids in VLDL,GP6,Platelet glycoprotein VI,29400,0.10265662422586,0.00593070657749353,0.0910324393339729,0.114280809117748,8.58327610364088e-67
NMR metabolomics,X23412.Phospholipids in VLDL,CA13,Carbonic anhydrase 13,29114,0.121617406178992,0.00703140861586618,0.107835845291895,0.13539896706609,1.08182390473273e-66
NMR metabolomics,X23412.Phospholipids in VLDL,DNAJC9,DnaJ homolog subfamily C member 9,24805,0.0891658640956078,0.00515749501023659,0.0790571738755441,0.0992745543156715,1.40966497076154e-66
NMR metabolomics,X23412.Phospholipids in VLDL,BLNK,B-cell linker protein,24229,0.0466507634806419,0.00269935820273957,0.0413600214032723,0.0519415055580114,1.6076055485213e-66
NMR metabolomics,X23412.Phospholipids in VLDL,TBCA,Tubulin-specific chaperone A,24381,0.100094764427819,0.00579286704064449,0.088740745028156,0.111448783827482,1.68855807617295e-66
NMR metabolomics,X23412.Phospholipids in VLDL,CNDP1,Beta-Ala-His dipeptidase,29594,0.0534015816112061,0.00309751876613659,0.0473304448295784,0.0594727183928338,2.80136797900555e-66
NMR metabolomics,X23412.Phospholipids in VLDL,MEP1B,Meprin A subunit beta,29478,0.135637003641568,0.00788007570457442,0.120192055260602,0.151081952022534,4.49502319175881e-66
NMR metabolomics,X23412.Phospholipids in VLDL,CCL26,C-C motif chemokine 26,29434,0.103483961778987,0.00601223500447637,0.0916999811702131,0.11526794238776,4.53274204136747e-66
NMR metabolomics,X23412.Phospholipids in VLDL,SCARF1,Scavenger receptor class F member 1,29820,0.0490864122924154,0.00285697392148657,0.0434867434063018,0.0546860811785291,7.62034646630194e-66
NMR metabolomics,X23412.Phospholipids in VLDL,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,29218,0.0651383567376315,0.00379123323885283,0.05770753958948,0.072569173885783,7.72858626102312e-66
NMR metabolomics,X23412.Phospholipids in VLDL,RAB2B,Ras-related protein Rab-2B,24793,0.0716912741526038,0.00417495414459821,0.0635083640291913,0.0798741842760163,1.03803501705538e-65
NMR metabolomics,X23412.Phospholipids in VLDL,CLEC4A,C-type lectin domain family 4 member A,29434,-0.0404746800571804,0.00235856145722677,-0.0450974605133449,-0.0358518996010159,1.09160631382228e-65
NMR metabolomics,X23412.Phospholipids in VLDL,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",24922,0.0870592774328761,0.0050729560934577,0.077116283489699,0.0970022713760532,1.23146251222489e-65
NMR metabolomics,X23412.Phospholipids in VLDL,CDC26,Anaphase-promoting complex subunit CDC26,24764,0.0814633251708635,0.0047480597327387,0.0721571280946957,0.0907695222470314,1.33150868737311e-65
NMR metabolomics,X23412.Phospholipids in VLDL,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,24190,0.0415790322997524,0.00242796704161206,0.0368202168981928,0.046337847701312,2.34686903918331e-65
NMR metabolomics,X23412.Phospholipids in VLDL,CCS,Copper chaperone for superoxide dismutase,29218,0.0546992866667827,0.00320035988325129,0.0484265812956102,0.0609719920379553,3.55881170263082e-65
NMR metabolomics,X23412.Phospholipids in VLDL,OCLN,Occludin,24867,0.05072763195368,0.00296734024187506,0.0449116450796049,0.0565436188277552,3.79378735443407e-65
NMR metabolomics,X23412.Phospholipids in VLDL,SLMAP,Sarcolemmal membrane-associated protein,24805,0.0959819764096051,0.00562485509316574,0.0849572604270003,0.10700669239221,6.4732052689141e-65
NMR metabolomics,X23412.Phospholipids in VLDL,ATG4A,Cysteine protease ATG4A,28797,0.0677040299747174,0.00397052260127529,0.0599218056762179,0.075486254273217,7.08025512953281e-65
NMR metabolomics,X23412.Phospholipids in VLDL,LAMP1,Lysosome-associated membrane glycoprotein 1,24256,0.0325105673343219,0.00190669865780379,0.0287734379650265,0.0362476967036173,8.24791906189684e-65
NMR metabolomics,X23412.Phospholipids in VLDL,MEGF10,Multiple epidermal growth factor-like domains protein 10,29454,0.0455045926292196,0.00267155106331465,0.0402683525451229,0.0507408327133163,9.55178250162242e-65
NMR metabolomics,X23412.Phospholipids in VLDL,GBP1,Guanylate-binding protein 1,24816,0.0743927583138021,0.00436685635745568,0.065833719853189,0.0829517967744152,1.04125738046301e-64
NMR metabolomics,X23412.Phospholipids in VLDL,CBLN4,Cerebellin-4,29725,0.0364388097702889,0.00214219151837486,0.0322401143942741,0.0406375051463036,1.39943027054705e-64
NMR metabolomics,X23412.Phospholipids in VLDL,CCDC80,Coiled-coil domain-containing protein 80,29478,0.040402852355223,0.00237529697704525,0.0357472702802143,0.0450584344302317,1.41868614819632e-64
NMR metabolomics,X23412.Phospholipids in VLDL,PTX3,Pentraxin-related protein PTX3,29434,-0.0567031206534721,0.00333555257130022,-0.0632408036932205,-0.0501654376137237,1.68110765165808e-64
NMR metabolomics,X23412.Phospholipids in VLDL,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,24229,0.0561781047784739,0.00330843819043655,0.0496935659252183,0.0626626436317296,2.71061457182915e-64
NMR metabolomics,X23412.Phospholipids in VLDL,MRI1,Methylthioribose-1-phosphate isomerase,24195,0.0780589798588495,0.00460417134200923,0.0690348040285114,0.0870831556891876,4.22296577195143e-64
NMR metabolomics,X23412.Phospholipids in VLDL,RAB6A,Ras-related protein Rab-6A,29434,0.0529392693409573,0.00312468118054199,0.046814894227095,0.0590636444548196,4.42018095665917e-64
NMR metabolomics,X23412.Phospholipids in VLDL,PTPRM,Receptor-type tyrosine-protein phosphatase mu,29398,0.0279000206239806,0.00164794482930776,0.0246700487585373,0.0311299924894238,5.42352649936387e-64
NMR metabolomics,X23412.Phospholipids in VLDL,BRSK2,Serine/threonine-protein kinase BRSK2,24867,0.0437471497017368,0.00259251814228024,0.0386658141428676,0.0488284852606061,1.56902659445259e-63
NMR metabolomics,X23412.Phospholipids in VLDL,CALCA,Calcitonin,29163,0.0707057050426776,0.0041926669920085,0.062488077738341,0.0789233323470143,1.65355386700328e-63
NMR metabolomics,X23412.Phospholipids in VLDL,RASSF2,Ras association domain-containing protein 2,28797,0.0635620011491492,0.00376908005826591,0.0561746042349481,0.0709493980633504,1.67016707970383e-63
NMR metabolomics,X23412.Phospholipids in VLDL,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,29655,0.0347939390021522,0.00206428679383819,0.0307479368862293,0.038839941118075,1.89922818698619e-63
NMR metabolomics,X23412.Phospholipids in VLDL,CPA1,Carboxypeptidase A1,29820,0.0690170735960129,0.00409954059872687,0.0609819740225083,0.0770521731695176,2.63894403806811e-63
NMR metabolomics,X23412.Phospholipids in VLDL,SCRN1,Secernin-1,29434,0.0633789838033078,0.00376684033740988,0.0559959767419844,0.0707619908646311,3.13733054394062e-63
NMR metabolomics,X23412.Phospholipids in VLDL,TMSB10,Thymosin beta-10,29443,0.0858074654995868,0.00511593481989846,0.0757802332525858,0.0958346977465878,7.58936553651096e-63
NMR metabolomics,X23412.Phospholipids in VLDL,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,24229,0.0635565426235953,0.00379157292145739,0.0561250596975388,0.0709880255496518,1.03499206350586e-62
NMR metabolomics,X23412.Phospholipids in VLDL,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,24701,0.034422451430527,0.00205484054064319,0.0303949639708663,0.0384499388901876,1.21745830331617e-62
NMR metabolomics,X23412.Phospholipids in VLDL,PTP4A3,Protein tyrosine phosphatase type IVA 3,24229,0.0594193967360282,0.00354790985711813,0.0524654934160767,0.0663733000559798,1.32498855214165e-62
NMR metabolomics,X23412.Phospholipids in VLDL,CDCP1,CUB domain-containing protein 1,29218,0.058728518716025,0.00351275026817336,0.0518435281904052,0.0656135092416448,1.87151776459017e-62
NMR metabolomics,X23412.Phospholipids in VLDL,BAP18,Chromatin complexes subunit BAP18,24845,0.0749425674483788,0.00448362593019619,0.0661546606251942,0.0837304742715633,2.24622521713325e-62
NMR metabolomics,X23412.Phospholipids in VLDL,CYB5R2,NADH-cytochrome b5 reductase 2,24523,0.0630654131860995,0.0037738882213026,0.0556685922723464,0.0704622340998526,2.414243756712e-62
NMR metabolomics,X23412.Phospholipids in VLDL,FXYD5,FXYD domain-containing ion transport regulator 5,28931,0.0739261850710561,0.00442918982319979,0.0652449730175845,0.0826073971245277,2.9985863419065e-62
NMR metabolomics,X23412.Phospholipids in VLDL,PAM,Peptidyl-glycine alpha-amidating monooxygenase,29652,0.0316654987542534,0.00189890412202612,0.0279436466750823,0.0353873508334246,3.78428580185067e-62
NMR metabolomics,X23412.Phospholipids in VLDL,POMC,Pro-opiomelanocortin,24240,0.0797358964501279,0.00478146954443923,0.070364216143027,0.0891075767572287,4.34820787399958e-62
NMR metabolomics,X23412.Phospholipids in VLDL,IFT20,Intraflagellar transport protein 20 homolog,24195,0.0488393615567843,0.00292874935730008,0.0430990128164761,0.0545797102970924,4.36768360898557e-62
NMR metabolomics,X23412.Phospholipids in VLDL,ZNRD2,Protein ZNRD2,24805,0.0774800850825434,0.00464710153523057,0.0683717660734915,0.0865884040915953,4.50615662634754e-62
NMR metabolomics,X23412.Phospholipids in VLDL,MIA,Melanoma-derived growth regulatory protein,29566,0.0415159448402535,0.00249151654003143,0.0366325724217919,0.0463993172587151,4.68341094073594e-62
NMR metabolomics,X23412.Phospholipids in VLDL,RAD23B,UV excision repair protein RAD23 homolog B,28797,0.0526886948605131,0.00316809227813584,0.0464792339953668,0.0588981557256593,8.07504221426936e-62
NMR metabolomics,X23412.Phospholipids in VLDL,ACYP1,Acylphosphatase-1,24297,0.0738547008463617,0.004440447721069,0.0651514233130664,0.0825579783796569,8.9443038944433e-62
NMR metabolomics,X23412.Phospholipids in VLDL,MCEMP1,Mast cell-expressed membrane protein 1,24229,0.101654834717649,0.0061264500426482,0.0896469926340586,0.11366267680124,1.71860540843275e-61
NMR metabolomics,X23412.Phospholipids in VLDL,NPPB,Natriuretic peptides B,28916,-0.149923828493352,0.00904451460672777,-0.167651077122538,-0.132196579864165,1.99078194945947e-61
NMR metabolomics,X23412.Phospholipids in VLDL,FRMD4B,FERM domain-containing protein 4B,24111,0.0788742743624357,0.00475687580184881,0.069550797790812,0.0881977509340594,2.09050374104605e-61
NMR metabolomics,X23412.Phospholipids in VLDL,CEBPB,CCAAT/enhancer-binding protein beta,28916,0.0421381639322996,0.00254260033706866,0.037154667271645,0.0471216605929542,2.10391353017853e-61
NMR metabolomics,X23412.Phospholipids in VLDL,SWAP70,Switch-associated protein 70,24805,0.0401437669149318,0.00242312873937479,0.0353944345857572,0.0448930992441064,2.58347107781777e-61
NMR metabolomics,X23412.Phospholipids in VLDL,AGXT,Serine--pyruvate aminotransferase,29478,0.0860567121135323,0.00519922726990104,0.0758662266645263,0.0962471975625384,2.93830461536624e-61
NMR metabolomics,X23412.Phospholipids in VLDL,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,24240,0.0592867408984627,0.00358169557828004,0.0522666175650339,0.0663068642318916,3.32103586553539e-61
NMR metabolomics,X23412.Phospholipids in VLDL,ICAM1,Intercellular adhesion molecule 1,29391,0.0321754720579898,0.00194508061686782,0.0283631140489289,0.0359878300670507,3.46197634927317e-61
NMR metabolomics,X23412.Phospholipids in VLDL,LRRN1,Leucine-rich repeat neuronal protein 1,28931,0.0440690980939177,0.00266628671215749,0.038843176138089,0.0492950200497463,4.38092001177292e-61
NMR metabolomics,X23412.Phospholipids in VLDL,CTSL,Cathepsin L1,29478,0.0271375586684195,0.00164209927820313,0.0239190440831413,0.0303560732536976,4.48318711780237e-61
NMR metabolomics,X23412.Phospholipids in VLDL,BTC,Probetacellulin,28797,0.0826403290984191,0.00501963189860851,0.0728018505771465,0.0924788076196918,1.27270363914449e-60
NMR metabolomics,X23412.Phospholipids in VLDL,BDNF,Brain-derived neurotrophic factor,24938,0.0925073096372684,0.00562140629864063,0.0814893532919328,0.103525265982604,1.57847635143202e-60
NMR metabolomics,X23412.Phospholipids in VLDL,MCFD2,Multiple coagulation factor deficiency protein 2,29327,0.0489801801313401,0.00297815273560608,0.0431430007695522,0.054817359493128,1.65974165170328e-60
NMR metabolomics,X23412.Phospholipids in VLDL,MZT1,Mitotic-spindle organizing protein 1,28797,0.0583198048114267,0.00354783357249308,0.0513660510093403,0.0652735586135132,1.92443685000945e-60
NMR metabolomics,X23412.Phospholipids in VLDL,CD40LG,CD40 ligand,29786,0.0859230613534034,0.00524154589422148,0.0756496314007293,0.0961964913060775,3.95822825093173e-60
NMR metabolomics,X23412.Phospholipids in VLDL,BMP6,Bone morphogenetic protein 6,28884,0.0454847119618573,0.00278474905322606,0.0400266038175343,0.0509428201061804,1.05680901934716e-59
NMR metabolomics,X23412.Phospholipids in VLDL,OXT,Oxytocin-neurophysin 1,29694,0.15295982606478,0.00937616354526002,0.13458254551607,0.17133710661349,1.43372350971824e-59
NMR metabolomics,X23412.Phospholipids in VLDL,SLAMF6,SLAM family member 6,28797,0.0420846976373818,0.00258179851492695,0.037024372548125,0.0471450227266387,1.80783381305168e-59
NMR metabolomics,X23412.Phospholipids in VLDL,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,29694,-0.0503885583883781,0.00309169107902542,-0.056448272903268,-0.0443288438734883,1.84755015625677e-59
NMR metabolomics,X23412.Phospholipids in VLDL,CD274,Programmed cell death 1 ligand 1,29218,0.0376267153284898,0.00231191067678369,0.0330953704019938,0.0421580602549859,2.70325277628457e-59
NMR metabolomics,X23412.Phospholipids in VLDL,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,29561,-0.0343254624525985,0.00211098426942924,-0.0384629916206799,-0.0301879332845172,3.40851209385552e-59
NMR metabolomics,X23412.Phospholipids in VLDL,IGF1R,Insulin-like growth factor 1 receptor,29349,0.0238823392735934,0.0014690709145203,0.0210029602811337,0.0267617182660532,3.63077026489743e-59
NMR metabolomics,X23412.Phospholipids in VLDL,RGS10,Regulator of G-protein signaling 10,24867,0.0655559829679029,0.00403464001275099,0.057648088542911,0.0734638773928949,4.63234735451878e-59
NMR metabolomics,X23412.Phospholipids in VLDL,MTIF3,"Translation initiation factor IF-3, mitochondrial",24805,0.0958178296439376,0.00593068262764497,0.0841936916937534,0.107441967594122,2.03951761790721e-58
NMR metabolomics,X23412.Phospholipids in VLDL,ARFIP1,Arfaptin-1,24867,0.0751951000130679,0.00465547152960508,0.0660703758150419,0.0843198242110938,2.18172905319229e-58
NMR metabolomics,X23412.Phospholipids in VLDL,RAB10,Ras-related protein Rab-10,24922,0.05846034008194,0.00362033421055336,0.0513644850292554,0.0655561951346245,2.3306465719861e-58
NMR metabolomics,X23412.Phospholipids in VLDL,PCYT2,Ethanolamine-phosphate cytidylyltransferase,24805,0.0834090220552535,0.00516569004948186,0.0732842695582691,0.093533774552238,2.37747186575591e-58
NMR metabolomics,X23412.Phospholipids in VLDL,AK2,"Adenylate kinase 2, mitochondrial",24845,0.115836352337795,0.0071747302825942,0.10177388098391,0.129898823691679,2.44002074258442e-58
NMR metabolomics,X23412.Phospholipids in VLDL,CPB1,Carboxypeptidase B,29820,0.0642271971964251,0.00398178973427517,0.0564228893172458,0.0720315050756045,2.7629206461436e-58
NMR metabolomics,X23412.Phospholipids in VLDL,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,28774,0.0696969841084008,0.00432444450646697,0.0612210728757255,0.078172895341076,3.48840328535959e-58
NMR metabolomics,X23412.Phospholipids in VLDL,CTSS,Cathepsin S,23389,0.026636425344494,0.00165280557221825,0.0233969264229462,0.0298759242660418,4.06049451278091e-58
NMR metabolomics,X23412.Phospholipids in VLDL,STXBP3,Syntaxin-binding protein 3,28797,0.0476179905581692,0.00295681224582111,0.0418226385563598,0.0534133425599786,4.25866980175984e-58
NMR metabolomics,X23412.Phospholipids in VLDL,GRPEL1,"GrpE protein homolog 1, mitochondrial",29349,0.0657985322855292,0.00408602456037602,0.0577899241471922,0.0738071404238662,4.29336844950969e-58
NMR metabolomics,X23412.Phospholipids in VLDL,SRC,Proto-oncogene tyrosine-protein kinase Src,29525,0.129776955272201,0.00805956178141557,0.113980214180627,0.145573696363776,4.35334915526826e-58
NMR metabolomics,X23412.Phospholipids in VLDL,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",29434,0.0893758563482383,0.00556559965739611,0.0784672810197419,0.100284431676735,8.76338264731212e-58
NMR metabolomics,X23412.Phospholipids in VLDL,TSNAX,Translin-associated protein X,24111,0.0428338401393234,0.00266629138425399,0.0376079090261856,0.0480597712524613,8.96915030541112e-58
NMR metabolomics,X23412.Phospholipids in VLDL,PRSS8,Prostasin,29347,0.044431660674423,0.00276716839363931,0.0390080106228899,0.049855310725956,9.04812218178967e-58
NMR metabolomics,X23412.Phospholipids in VLDL,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,24111,0.0439274542320068,0.00274315832558813,0.0385508639138541,0.0493040445501596,2.03708090706125e-57
NMR metabolomics,X23412.Phospholipids in VLDL,EGFL7,Epidermal growth factor-like protein 7,28797,0.0427611225850302,0.00267368992900369,0.0375206903241829,0.0480015548458774,2.51444653477759e-57
NMR metabolomics,X23412.Phospholipids in VLDL,ITGA6,Integrin alpha-6,29434,0.0561868236417315,0.00351669151086235,0.0492941082804413,0.0630795390030217,3.20973789624695e-57
NMR metabolomics,X23412.Phospholipids in VLDL,ITGAL,Integrin alpha-L,24229,0.0470992107608369,0.00295389963969439,0.0413095674670359,0.0528888540546379,6.04232662377801e-57
NMR metabolomics,X23412.Phospholipids in VLDL,LONP1,"Lon protease homolog, mitochondrial",24240,0.0939344605937686,0.00589172856364474,0.0823866726090249,0.105482248578512,6.16714584108667e-57
NMR metabolomics,X23412.Phospholipids in VLDL,AKR1B1,Aldo-keto reductase family 1 member B1,28797,0.0812287980786869,0.00509830442746134,0.0712361214008627,0.0912214747565111,6.60360586370725e-57
NMR metabolomics,X23412.Phospholipids in VLDL,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,28797,0.0470236700392902,0.00295779076937784,0.0412264001313096,0.0528209399472708,1.13636401594272e-56
NMR metabolomics,X23412.Phospholipids in VLDL,PKN3,Serine/threonine-protein kinase N3,24445,0.0811881085193105,0.00510585000521144,0.0711806425090961,0.091195574529525,1.2003957732754e-56
NMR metabolomics,X23412.Phospholipids in VLDL,CXCL11,C-X-C motif chemokine 11,29694,0.0842072955994734,0.00531435553843696,0.073791158744137,0.0946234324548098,2.58151665788793e-56
NMR metabolomics,X23412.Phospholipids in VLDL,CTRB1,Chymotrypsinogen B,29443,0.0594896949592916,0.0037554919367716,0.0521289307632192,0.0668504591553639,2.78528289870111e-56
NMR metabolomics,X23412.Phospholipids in VLDL,XPNPEP2,Xaa-Pro aminopeptidase 2,29566,0.105141481529668,0.0066420454596433,0.092123072428767,0.118159890630569,3.30718020858231e-56
NMR metabolomics,X23412.Phospholipids in VLDL,ACAN,Aggrecan core protein,29192,0.0302396489168113,0.00191039617460648,0.0264952724145826,0.03398402541904,3.36612116216254e-56
NMR metabolomics,X23412.Phospholipids in VLDL,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,24805,0.0504824243077265,0.00318913677185052,0.0442317162348994,0.0567331323805535,3.67163759378189e-56
NMR metabolomics,X23412.Phospholipids in VLDL,NBN,Nibrin,28931,0.0560548129286138,0.00354244994586749,0.0491116110347135,0.0629980148225141,3.67418374920545e-56
NMR metabolomics,X23412.Phospholipids in VLDL,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,24966,0.0277399514615206,0.00175274834180874,0.0243045647115755,0.0311753382114658,3.83042608246463e-56
NMR metabolomics,X23412.Phospholipids in VLDL,LGALS3,Galectin-3,29544,0.0317571242004794,0.00201157252535587,0.0278144420507819,0.0356998063501769,6.45528629866993e-56
NMR metabolomics,X23412.Phospholipids in VLDL,SFTPA2,Pulmonary surfactant-associated protein A2,28797,0.0539356711547665,0.00342007457984864,0.0472323249782631,0.0606390173312698,8.53196181387895e-56
NMR metabolomics,X23412.Phospholipids in VLDL,DNER,Delta and Notch-like epidermal growth factor-related receptor,29382,0.0271476316298426,0.00172176658549874,0.0237729691222651,0.0305222941374201,8.84959810210893e-56
NMR metabolomics,X23412.Phospholipids in VLDL,BOLA2_BOLA2B,BolA-like protein 2,24240,0.0582507867221755,0.00369614888447347,0.0510063349086075,0.0654952385357435,1.11151695799727e-55
NMR metabolomics,X23412.Phospholipids in VLDL,PCDH7,Protocadherin-7,24805,0.0370821385019755,0.00235665947539346,0.0324630859302044,0.0417011910737467,1.61569621062923e-55
NMR metabolomics,X23412.Phospholipids in VLDL,GRK5,G protein-coupled receptor kinase 5,28916,0.0552381722637274,0.00351241721903255,0.0483538345144236,0.0621225100130312,1.69106164706206e-55
NMR metabolomics,X23412.Phospholipids in VLDL,NFAT5,Nuclear factor of activated T-cells 5,24229,0.0920204904312616,0.00585165720084824,0.0805512423175991,0.103489738544924,1.90199645552499e-55
NMR metabolomics,X23412.Phospholipids in VLDL,ENO2,Gamma-enolase,29694,0.069356128112656,0.0044194688845213,0.0606939690989942,0.0780182871263177,2.80454598559612e-55
NMR metabolomics,X23412.Phospholipids in VLDL,ACRBP,Acrosin-binding protein,24793,0.041150977564297,0.00262272757014223,0.0360104315268182,0.0462915236017758,3.25882560284857e-55
NMR metabolomics,X23412.Phospholipids in VLDL,SOD1,Superoxide dismutase [Cu-Zn],28826,0.0510219302856606,0.00325697554754835,0.0446382582124659,0.0574056023588554,4.40110516071608e-55
NMR metabolomics,X23412.Phospholipids in VLDL,KLF4,Krueppel-like factor 4,24101,0.0421702982029535,0.00269105957072322,0.036895821444336,0.047444774961571,4.50291035441406e-55
NMR metabolomics,X23412.Phospholipids in VLDL,PECAM1,Platelet endothelial cell adhesion molecule,29443,0.0317798801932004,0.0020307608069178,0.0277995890116415,0.0357601713747593,5.60274235546125e-55
NMR metabolomics,X23412.Phospholipids in VLDL,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,23721,0.0524699985423594,0.0033525759775558,0.04589894962635,0.0590410474583687,6.19588174490264e-55
NMR metabolomics,X23412.Phospholipids in VLDL,MOG,Myelin-oligodendrocyte glycoprotein,29725,0.0345268598344052,0.0022210154780077,0.0301736694975101,0.0388800501713003,2.79269773485341e-54
NMR metabolomics,X23412.Phospholipids in VLDL,PARD3,Partitioning defective 3 homolog,24445,0.0779660709646673,0.00501542928542948,0.0681358295652255,0.087796312364109,3.11808993946776e-54
NMR metabolomics,X23412.Phospholipids in VLDL,ASS1,Argininosuccinate synthase,24111,0.0834536324900287,0.00537347441882445,0.0729216226291328,0.0939856423509247,3.93793772577033e-54
NMR metabolomics,X23412.Phospholipids in VLDL,PRDX6,Peroxiredoxin-6,29725,-0.0625618530007729,0.00403856530609936,-0.0704774410007276,-0.0546462650008182,6.47649375331969e-54
NMR metabolomics,X23412.Phospholipids in VLDL,PQBP1,Polyglutamine-binding protein 1,28797,0.0582214920882502,0.00376227057891526,0.0508474417535763,0.0655955424229241,8.42058081974084e-54
NMR metabolomics,X23412.Phospholipids in VLDL,DYNLT3,Dynein light chain Tctex-type 3,24793,0.0456045132745982,0.00295141579425617,0.0398197383178561,0.0513892882313403,1.30662044503929e-53
NMR metabolomics,X23412.Phospholipids in VLDL,AMOT,Angiomotin,24381,0.0421488002514096,0.00272789052967147,0.0368021348132535,0.0474954656895657,1.33321346985168e-53
NMR metabolomics,X23412.Phospholipids in VLDL,SNX9,Sorting nexin-9,29478,0.0710734131412525,0.00460874886473235,0.0620402653663771,0.0801065609161279,1.9015521592523e-53
NMR metabolomics,X23412.Phospholipids in VLDL,DNM1,Dynamin-1,24805,0.119365832133589,0.0077386116670334,0.104198153266203,0.134533511000974,1.97831415201646e-53
NMR metabolomics,X23412.Phospholipids in VLDL,KLRD1,Natural killer cells antigen CD94,29786,0.0482310727618011,0.00313093707187322,0.0420944361009296,0.0543677094226726,2.44655766342316e-53
NMR metabolomics,X23412.Phospholipids in VLDL,CORO1A,Coronin-1A,28847,0.092813983287444,0.00603304866257333,0.0809892079088003,0.104638758666088,3.39771813021486e-53
NMR metabolomics,X23412.Phospholipids in VLDL,CPXM1,Probable carboxypeptidase X1,29566,0.0712679425767289,0.00463381212488639,0.0621856708119516,0.0803502143415062,3.58540160079819e-53
NMR metabolomics,X23412.Phospholipids in VLDL,CCDC134,Coiled-coil domain-containing protein 134,24793,0.0507041582266774,0.00329577737630274,0.044244434569124,0.0571638818842308,3.65959103431671e-53
NMR metabolomics,X23412.Phospholipids in VLDL,IMPA1,Inositol monophosphatase 1,29218,0.0633027463791484,0.00411817294198637,0.0552311274128551,0.0713743653454417,4.10194972317296e-53
NMR metabolomics,X23412.Phospholipids in VLDL,PAGR1,PAXIP1-associated glutamate-rich protein 1,24240,0.045221916453511,0.00295001154106661,0.0394398938330204,0.0510039390740015,8.61013077014258e-53
NMR metabolomics,X23412.Phospholipids in VLDL,FGF2,Fibroblast growth factor 2,29434,0.069765108917973,0.00455476978734839,0.0608377601347701,0.0786924577011758,9.42170261610964e-53
NMR metabolomics,X23412.Phospholipids in VLDL,OPLAH,5-oxoprolinase,24240,0.0711730669484503,0.00464544440501483,0.0620679959146213,0.0802781379822794,9.77984196335019e-53
NMR metabolomics,X23412.Phospholipids in VLDL,IL6R,Interleukin-6 receptor subunit alpha,29361,0.0349955311524221,0.00228875309725147,0.0305095750818092,0.0394814872230349,1.41756756551918e-52
NMR metabolomics,X23412.Phospholipids in VLDL,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",24805,0.106823051650555,0.00699543767375933,0.0931119938099862,0.120534109491123,2.08690684126036e-52
NMR metabolomics,X23412.Phospholipids in VLDL,ITPA,Inosine triphosphate pyrophosphatase,24111,0.0698360678829833,0.00457329317103523,0.0608724132677543,0.0787997224982124,2.11925553595035e-52
NMR metabolomics,X23412.Phospholipids in VLDL,PPM1F,Protein phosphatase 1F,24922,0.0544308363171729,0.00356847519908595,0.0474366249269644,0.0614250477073813,2.70039301038667e-52
NMR metabolomics,X23412.Phospholipids in VLDL,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",24867,0.094312002485234,0.00619231627650472,0.0821750625832847,0.106448942387183,3.81805546076962e-52
NMR metabolomics,X23412.Phospholipids in VLDL,SH3BP1,SH3 domain-binding protein 1,24805,0.0493631776228036,0.00324345135499163,0.04300601296702,0.0557203422785872,4.52684905689482e-52
NMR metabolomics,X23412.Phospholipids in VLDL,KLB,Beta-klotho,28774,-0.0758760729228455,0.00500373608707698,-0.0856833956535164,-0.0660687501921746,9.72674349583231e-52
NMR metabolomics,X23412.Phospholipids in VLDL,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,28797,0.061172458606029,0.00403508595701856,0.0532636901302726,0.0690812270817854,1.02893098230549e-51
NMR metabolomics,X23412.Phospholipids in VLDL,DNAJC21,DnaJ homolog subfamily C member 21,24845,0.039399716870654,0.00259821507424098,0.0343072153251417,0.0444922184161663,1.04168150602447e-51
NMR metabolomics,X23412.Phospholipids in VLDL,BST2,Bone marrow stromal antigen 2,29694,0.0536642140472938,0.00354422253510452,0.046717537878489,0.0606108902160987,1.34822216907799e-51
NMR metabolomics,X23412.Phospholipids in VLDL,FUT8,"Alpha-(1,6)-fucosyltransferase",29218,0.0595308770930676,0.00393452691916809,0.0518192043314981,0.067242549854637,1.6017012716158e-51
NMR metabolomics,X23412.Phospholipids in VLDL,IFNAR1,Interferon alpha/beta receptor 1,24805,0.0262259423175197,0.00173545169108174,0.0228244570029995,0.0296274276320399,2.29108255497135e-51
NMR metabolomics,X23412.Phospholipids in VLDL,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",24381,0.0910048408546926,0.00602375871980716,0.0791982737638706,0.102811407945515,2.4639671199473e-51
NMR metabolomics,X23412.Phospholipids in VLDL,CFHR4,Complement factor H-related protein 4,24892,0.074949583373565,0.00496194438495962,0.0652241723790441,0.0846749943680858,2.54074418299107e-51
NMR metabolomics,X23412.Phospholipids in VLDL,PTPRR,Receptor-type tyrosine-protein phosphatase R,24845,0.0375417860829527,0.00248551774411858,0.0326701713044803,0.0424134008614252,2.56900127371544e-51
NMR metabolomics,X23412.Phospholipids in VLDL,TCL1A,T-cell leukemia/lymphoma protein 1A,29194,0.0999823685633673,0.00662457520029949,0.0869982011707803,0.112966535955954,2.8282018288428e-51
NMR metabolomics,X23412.Phospholipids in VLDL,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,28931,0.0433206038511912,0.00287076058324578,0.0376939131080295,0.048947294594353,2.94214769957539e-51
NMR metabolomics,X23412.Phospholipids in VLDL,SPINT2,Kunitz-type protease inhibitor 2,29581,0.0414946258409081,0.0027533134954977,0.0360981313897326,0.0468911202920836,3.90507882209882e-51
NMR metabolomics,X23412.Phospholipids in VLDL,SPINK2,Serine protease inhibitor Kazal-type 2,24381,0.037834822673213,0.00250947708640751,0.0329162475838543,0.0427533977625718,3.9174346937178e-51
NMR metabolomics,X23412.Phospholipids in VLDL,EPPK1,Epiplakin,24240,0.0749455049868388,0.00499299064353962,0.0651592433255011,0.0847317666481765,1.0654296664021e-50
NMR metabolomics,X23412.Phospholipids in VLDL,FXN,"Frataxin, mitochondrial",29725,0.0742127659784781,0.00494979628981632,0.0645111652504381,0.0839143667065181,1.24838094431343e-50
NMR metabolomics,X23412.Phospholipids in VLDL,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",28916,0.0891613568701578,0.0059591296346211,0.0774814627863004,0.100841250954015,2.00524201816119e-50
NMR metabolomics,X23412.Phospholipids in VLDL,DSCAM,Down syndrome cell adhesion molecule,24867,0.0361881514102779,0.00241866992657929,0.0314475583541825,0.0409287444663733,2.15611141075661e-50
NMR metabolomics,X23412.Phospholipids in VLDL,GGH,Gamma-glutamyl hydrolase,28984,0.0343787973826441,0.00230209297627508,0.0298666951491449,0.0388908996161432,3.05978286272472e-50
NMR metabolomics,X23412.Phospholipids in VLDL,ING1,Inhibitor of growth protein 1,28719,0.0463193377329054,0.00310634160976656,0.040230908177763,0.0524077672880479,4.29257485975874e-50
NMR metabolomics,X23412.Phospholipids in VLDL,UNC79,Protein unc-79 homolog,24016,0.0567266481186609,0.00380483627597678,0.0492691690177464,0.0641841272195754,4.8193075860401e-50
NMR metabolomics,X23412.Phospholipids in VLDL,C1RL,Complement C1r subcomponent-like protein,24925,0.0196909931184414,0.00132145609385579,0.0171009391744841,0.0222810470623988,5.33471874455632e-50
NMR metabolomics,X23412.Phospholipids in VLDL,CRIM1,Cysteine-rich motor neuron 1 protein,29581,-0.0205906441810344,0.00138244266373704,-0.023300231801959,-0.0178810565601097,5.44302729717692e-50
NMR metabolomics,X23412.Phospholipids in VLDL,DCTN6,Dynactin subunit 6,28774,0.0717324363898352,0.00481748243809657,0.062290170811166,0.0811747019685045,5.87572387976596e-50
NMR metabolomics,X23412.Phospholipids in VLDL,AMIGO2,Amphoterin-induced protein 2,29349,0.0230922031706691,0.00155091471077829,0.0200524103375437,0.0261319960037946,5.88035777223762e-50
NMR metabolomics,X23412.Phospholipids in VLDL,CD84,SLAM family member 5,29434,0.0313520296003307,0.00211066606206967,0.0272151241186741,0.0354889350819872,9.91487856896798e-50
NMR metabolomics,X23412.Phospholipids in VLDL,DARS1,"Aspartate--tRNA ligase, cytoplasmic",29163,0.0734395941356205,0.00494422056015528,0.0637489218377162,0.0831302664335249,1.00223594202172e-49
NMR metabolomics,X23412.Phospholipids in VLDL,COL15A1,Collagen alpha-1(XV) chain,24938,0.0266111053754769,0.00179274684918262,0.023097321551079,0.0301248891998749,1.24445626614132e-49
NMR metabolomics,X23412.Phospholipids in VLDL,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",28931,0.0721031492504091,0.00486566060363397,0.0625664544672865,0.0816398440335317,1.68363327345686e-49
NMR metabolomics,X23412.Phospholipids in VLDL,ASAH1,Acid ceramidase,24732,0.0466565202102356,0.00315415141211376,0.0404743834424926,0.0528386569779786,2.67767748400135e-49
NMR metabolomics,X23412.Phospholipids in VLDL,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,29478,0.0632433167484914,0.00427848856123158,0.0548574791684775,0.0716291543285053,2.88774283267626e-49
NMR metabolomics,X23412.Phospholipids in VLDL,ENAH,Protein enabled homolog,28931,0.0475535599917568,0.00322082065327998,0.041240751511328,0.0538663684721856,3.75292917698826e-49
NMR metabolomics,X23412.Phospholipids in VLDL,GNAS,Neuroendocrine secretory protein 55,24867,0.0882351664580581,0.00598625042216158,0.0765021156306214,0.0999682172854948,5.77597913631539e-49
NMR metabolomics,X23412.Phospholipids in VLDL,TREML2,Trem-like transcript 2 protein,29443,0.033744158523152,0.00229094355234163,0.0292539091605624,0.0382344078857416,6.23918619880877e-49
NMR metabolomics,X23412.Phospholipids in VLDL,FRZB,Secreted frizzled-related protein 3,29123,0.0256315427958818,0.00174062500258701,0.0222199177908113,0.0290431678009524,6.63497212093682e-49
NMR metabolomics,X23412.Phospholipids in VLDL,PRG2,Bone marrow proteoglycan,24938,-0.0516678851753465,0.00351005148387736,-0.0585475860837461,-0.0447881842669469,7.6963414321022e-49
NMR metabolomics,X23412.Phospholipids in VLDL,CPXM2,Inactive carboxypeptidase-like protein X2,24922,0.0252048717294664,0.0017128136132729,0.0218477570474516,0.0285619864114813,8.22369121184164e-49
NMR metabolomics,X23412.Phospholipids in VLDL,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,24922,0.0325273146346407,0.00221706913841845,0.0281818591233405,0.0368727701459408,1.5694954701094e-48
NMR metabolomics,X23412.Phospholipids in VLDL,ANXA4,Annexin A4,29341,0.0712358309852897,0.00486283818220909,0.0617046681481599,0.0807669938224195,2.02721059320262e-48
NMR metabolomics,X23412.Phospholipids in VLDL,LAMA4,Laminin subunit alpha-4,29581,0.0330267217775077,0.00225675250392051,0.0286034868698235,0.0374499566851919,2.49372460501366e-48
NMR metabolomics,X23412.Phospholipids in VLDL,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,24111,0.0277536579360133,0.00189890163681398,0.0240318107278579,0.0314755051441687,3.59013209086493e-48
NMR metabolomics,X23412.Phospholipids in VLDL,ARHGAP1,Rho GTPase-activating protein 1,28797,0.0455435080425521,0.00311872682364841,0.0394308034682012,0.051656212616903,3.98241781763448e-48
NMR metabolomics,X23412.Phospholipids in VLDL,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",29349,0.0682902577550314,0.00468488118859657,0.0591078906253822,0.0774726248846807,5.81343946227366e-48
NMR metabolomics,X23412.Phospholipids in VLDL,SCG2,Secretogranin-2,29559,0.0320783681808574,0.00220226155187954,0.0277619355391735,0.0363948008225413,6.7661592189731e-48
NMR metabolomics,X23412.Phospholipids in VLDL,TLR3,Toll-like receptor 3,29786,0.0601036827226883,0.00412649917557313,0.052015744338565,0.0681916211068117,6.82607579283195e-48
NMR metabolomics,X23412.Phospholipids in VLDL,IL10RB,Interleukin-10 receptor subunit beta,29581,0.0285322107697278,0.00196057241697082,0.024689488832465,0.0323749327069906,8.18207393546235e-48
NMR metabolomics,X23412.Phospholipids in VLDL,KLK7,Kallikrein-7,23801,0.0386065425895464,0.00265228960228137,0.0334080549690749,0.0438050302100179,8.59790870840044e-48
NMR metabolomics,X23412.Phospholipids in VLDL,SLC27A4,Long-chain fatty acid transport protein 4,28774,0.0659955623470424,0.00454042616085206,0.0570963270717724,0.0748947976223124,1.07208573121158e-47
NMR metabolomics,X23412.Phospholipids in VLDL,IMMT,MICOS complex subunit MIC60,24793,0.0437732877116367,0.00301166845857556,0.0378704175328286,0.0496761578904448,1.14990398758173e-47
NMR metabolomics,X23412.Phospholipids in VLDL,PTPRC,Receptor-type tyrosine-protein phosphatase C,24938,0.0223807479801987,0.00154381509420823,0.0193548703955506,0.0254066255648468,1.97336052595812e-47
NMR metabolomics,X23412.Phospholipids in VLDL,CALB2,Calretinin,28774,0.0299002850618136,0.00206340173796349,0.0258560176554052,0.0339445524682221,2.03663804871616e-47
NMR metabolomics,X23412.Phospholipids in VLDL,PDZD2,PDZ domain-containing protein 2,24111,0.0591324148439055,0.00408073435114864,0.0511341755156541,0.0671306541721568,2.19773654057951e-47
NMR metabolomics,X23412.Phospholipids in VLDL,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",24938,0.061212720333686,0.00422735112670272,0.0529271121253487,0.0694983285420234,2.51782996358197e-47
NMR metabolomics,X23412.Phospholipids in VLDL,TNF,Tumor necrosis factor,28868,0.0373578805265787,0.00258412658949498,0.0322929924111685,0.0424227686419888,3.32781562606406e-47
NMR metabolomics,X23412.Phospholipids in VLDL,TIMP1,Metalloproteinase inhibitor 1,29173,0.027719665711525,0.00191819228310631,0.0239600088366366,0.0314793225864134,3.60089680946788e-47
NMR metabolomics,X23412.Phospholipids in VLDL,CLTA,Clathrin light chain A,28916,0.0459394787709819,0.00317991318407249,0.0397068489301998,0.052172108611764,3.83615986336315e-47
NMR metabolomics,X23412.Phospholipids in VLDL,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,24381,0.0670792035641775,0.00464333703852795,0.0579782629686627,0.0761801441596922,4.14045930810559e-47
NMR metabolomics,X23412.Phospholipids in VLDL,RELT,Tumor necrosis factor receptor superfamily member 19L,29443,0.0279882482870277,0.00193817295839639,0.0241894292885707,0.0317870672854846,4.16883581478021e-47
NMR metabolomics,X23412.Phospholipids in VLDL,LGALS3BP,Galectin-3-binding protein,24966,0.0296949629742477,0.00205674979684397,0.0256637333724336,0.0337261925760619,4.63218287823139e-47
NMR metabolomics,X23412.Phospholipids in VLDL,SCARB2,Lysosome membrane protein 2,28762,0.0310027776029839,0.00214904084184726,0.0267906575529633,0.0352148976530046,5.15943186781824e-47
NMR metabolomics,X23412.Phospholipids in VLDL,PNLIPRP1,Inactive pancreatic lipase-related protein 1,24845,0.0778132928480945,0.0053928737812169,0.0672432602369094,0.0883833254592797,5.27582519209916e-47
NMR metabolomics,X23412.Phospholipids in VLDL,GIP,Gastric inhibitory polypeptide,24240,0.0499579420960648,0.00346489519843303,0.0431667475071361,0.0567491366849935,6.2108266776918e-47
NMR metabolomics,X23412.Phospholipids in VLDL,PRSS27,Serine protease 27,29395,0.0391676441118924,0.00272011621958306,0.0338362163215096,0.0444990719022752,7.55414302981317e-47
NMR metabolomics,X23412.Phospholipids in VLDL,C5,Complement C5,24966,0.0147867081904764,0.00102713994065888,0.012773513906785,0.0167999024741678,8.44561398415934e-47
NMR metabolomics,X23412.Phospholipids in VLDL,NTRK2,BDNF/NT-3 growth factors receptor,29478,0.025006308800335,0.00173888343834413,0.0215980972611805,0.0284145203394895,9.85414305439857e-47
NMR metabolomics,X23412.Phospholipids in VLDL,HRG,Histidine-rich glycoprotein,24833,0.0305648447476912,0.00212678908023413,0.0263963381504323,0.0347333513449501,1.20514451189785e-46
NMR metabolomics,X23412.Phospholipids in VLDL,LGMN,Legumain,29581,0.0347032138860761,0.00241983234059944,0.0299603424985012,0.039446085273651,1.73351539619083e-46
NMR metabolomics,X23412.Phospholipids in VLDL,CLSTN3,Calsyntenin-3,24845,0.0296505682132888,0.00206728594112806,0.0255986877686778,0.0337024486578998,1.81422516193706e-46
NMR metabolomics,X23412.Phospholipids in VLDL,ARAF,Serine/threonine-protein kinase A-Raf,24445,0.0656129590229749,0.00458198839565778,0.0566322617674857,0.0745936562784642,2.53703260345078e-46
NMR metabolomics,X23412.Phospholipids in VLDL,AMOTL2,Angiomotin-like protein 2,24711,0.0468996370314475,0.00327547175311597,0.0404797123953402,0.0533195616675548,2.57331347517255e-46
NMR metabolomics,X23412.Phospholipids in VLDL,TCOF1,Treacle protein,24922,0.0303009094918818,0.00211946779501118,0.0261467526136598,0.0344550663701037,3.50722717158564e-46
NMR metabolomics,X23412.Phospholipids in VLDL,SF3B4,Splicing factor 3B subunit 4,29349,0.0702392683250393,0.00492415260556317,0.0605879292181355,0.0798906074319431,5.21196476344652e-46
NMR metabolomics,X23412.Phospholipids in VLDL,SNRPB2,U2 small nuclear ribonucleoprotein B'',24845,0.0402969635106915,0.00282419172134109,0.0347615477368629,0.04583237928452,5.22976715015976e-46
NMR metabolomics,X23412.Phospholipids in VLDL,TREH,Trehalase,24938,0.0722425036275984,0.00507384936527017,0.0622977588716689,0.082187248383528,8.0296658971801e-46
NMR metabolomics,X23412.Phospholipids in VLDL,CD83,CD83 antigen,29434,0.0326921788480544,0.00229746867694908,0.0281891402412342,0.0371952174548746,8.51348496555139e-46
NMR metabolomics,X23412.Phospholipids in VLDL,FCRL1,Fc receptor-like protein 1,29478,0.0436167456805449,0.00306853310499077,0.037602420794763,0.0496310705663269,1.05956279158118e-45
NMR metabolomics,X23412.Phospholipids in VLDL,PSMG3,Proteasome assembly chaperone 3,29434,0.0483618001008345,0.00340334079726817,0.0416912521381889,0.0550323480634801,1.12366558184331e-45
NMR metabolomics,X23412.Phospholipids in VLDL,ASGR2,Asialoglycoprotein receptor 2,24951,0.0250588966284759,0.00176638198389697,0.0215967879400379,0.028521005316914,1.66846115680664e-45
NMR metabolomics,X23412.Phospholipids in VLDL,VCAM1,Vascular cell adhesion protein 1,29545,-0.0260521422584875,0.00184583575192922,-0.0296699803322688,-0.0224343041847063,4.36482984627595e-45
NMR metabolomics,X23412.Phospholipids in VLDL,NOTCH1,Neurogenic locus notch homolog protein 1,29820,0.0151172878770975,0.00107115701580468,0.0130178201261203,0.0172167556280747,4.41076506341911e-45
NMR metabolomics,X23412.Phospholipids in VLDL,CASP8,Caspase-8,29632,0.0586350801467119,0.00415726796677901,0.0504868349318251,0.0667833253615988,5.00415054593696e-45
NMR metabolomics,X23412.Phospholipids in VLDL,GDNF,Glial cell line-derived neurotrophic factor,28774,0.0364438245751072,0.00258777242168623,0.0313717906286022,0.0415158585216122,6.8053523958765e-45
NMR metabolomics,X23412.Phospholipids in VLDL,COX6B1,Cytochrome c oxidase subunit 6B1,24922,0.030831069904601,0.00218955046826806,0.0265395509867956,0.0351225888224064,7.38787523308058e-45
NMR metabolomics,X23412.Phospholipids in VLDL,ZHX2,Zinc fingers and homeoboxes protein 2,24845,0.0303270432499666,0.0021537917457559,0.026105611428285,0.0345484750716482,7.42144576201949e-45
NMR metabolomics,X23412.Phospholipids in VLDL,PALM,Paralemmin-1,24657,0.028497264740742,0.00202531547628045,0.0245276464072323,0.0324668830742517,8.59391150206679e-45
NMR metabolomics,X23412.Phospholipids in VLDL,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,24229,0.0426290625827383,0.0030299899277805,0.0366902823242885,0.0485678428411881,8.83686744580495e-45
NMR metabolomics,X23412.Phospholipids in VLDL,WAS,Wiskott-Aldrich syndrome protein,28931,0.0636163835285678,0.00452509078053221,0.0547472055987247,0.072485561458411,9.58264430171038e-45
NMR metabolomics,X23412.Phospholipids in VLDL,CR1,Complement receptor type 1,24903,0.0341477387411547,0.00243483073756058,0.029375470495536,0.0389200069867735,1.62691307615711e-44
NMR metabolomics,X23412.Phospholipids in VLDL,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,24229,0.0423208978818456,0.00302688357053726,0.0363882060835926,0.0482535896800987,2.99815519967525e-44
NMR metabolomics,X23412.Phospholipids in VLDL,IL17RB,Interleukin-17 receptor B,29034,-0.0506018833380221,0.00362669789526597,-0.0577102112127434,-0.0434935554633008,4.21221096759488e-44
NMR metabolomics,X23412.Phospholipids in VLDL,STX16,Syntaxin-16,28797,0.0547436695520469,0.00392459021830158,0.0470514727241758,0.062435866379918,4.44797103380114e-44
NMR metabolomics,X23412.Phospholipids in VLDL,ERMAP,Erythroid membrane-associated protein,24229,0.0422733699121929,0.00302966063357777,0.0363352350703805,0.0482115047540054,4.45906837019519e-44
NMR metabolomics,X23412.Phospholipids in VLDL,ARSA,Arylsulfatase A,29443,0.042145789862398,0.00302504015135781,0.0362167111657367,0.0480748685590593,5.56231816230359e-44
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINA9,Serpin A9,29227,0.0679583100878767,0.00488947778325672,0.0583749336326935,0.0775416865430599,8.87040788561852e-44
NMR metabolomics,X23412.Phospholipids in VLDL,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,29349,-0.0185591517402809,0.00133554670939196,-0.0211768232906892,-0.0159414801898727,9.18328284464067e-44
NMR metabolomics,X23412.Phospholipids in VLDL,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,29536,0.0476888794903329,0.00344692783540242,0.0409329009329442,0.0544448580477217,2.13613193509878e-43
NMR metabolomics,X23412.Phospholipids in VLDL,CD46,Membrane cofactor protein,29331,0.0267094021730062,0.00193576052661005,0.0229153115408505,0.0305034928051619,3.58163986459077e-43
NMR metabolomics,X23412.Phospholipids in VLDL,NID2,Nidogen-2,29443,0.068321024551047,0.00495231491368535,0.0586144873202237,0.0780275617818702,3.68296450981469e-43
NMR metabolomics,X23412.Phospholipids in VLDL,LAMB1,Laminin subunit beta-1,24240,0.0284191552029306,0.00206173287211643,0.0243781587735824,0.0324601516322788,4.6195378447338e-43
NMR metabolomics,X23412.Phospholipids in VLDL,ADA,Adenosine deaminase,29786,0.032382891226376,0.00235120484749975,0.0277745297252765,0.0369912527274756,5.02902882692019e-43
NMR metabolomics,X23412.Phospholipids in VLDL,VGF,Neurosecretory protein VGF,24867,0.0282511133513809,0.0020559269971136,0.0242214964370382,0.0322807302657235,8.23724902126014e-43
NMR metabolomics,X23412.Phospholipids in VLDL,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,24445,0.0809809115217673,0.00589714662414978,0.0694225041384337,0.0925393189051008,9.38693579298442e-43
NMR metabolomics,X23412.Phospholipids in VLDL,TPMT,Thiopurine S-methyltransferase,28797,0.0674121216174307,0.00491958625820439,0.0577697325513501,0.0770545106835113,1.329313863485e-42
NMR metabolomics,X23412.Phospholipids in VLDL,THBD,Thrombomodulin,29478,0.0265009729001879,0.00193634823097693,0.0227057303674732,0.0302962154329027,1.65971515397707e-42
NMR metabolomics,X23412.Phospholipids in VLDL,DMD,Dystrophin,24240,0.0479412398768458,0.00350254978275076,0.0410762423026543,0.0548062374510372,1.73506347247756e-42
NMR metabolomics,X23412.Phospholipids in VLDL,C7orf50,Uncharacterized protein C7orf50,24845,0.0206304955252042,0.00151130255483937,0.017668342517719,0.0235926485326893,2.83786794908265e-42
NMR metabolomics,X23412.Phospholipids in VLDL,C1QA,Complement C1q subcomponent subunit A,29646,-0.0209249786292055,0.0015341095255189,-0.0239318332992226,-0.0179181239591885,3.11446563601307e-42
NMR metabolomics,X23412.Phospholipids in VLDL,STK4,Serine/threonine-protein kinase 4,29478,0.079722146828324,0.00584514626779308,0.0682656601434496,0.0911786335131985,3.15329612301327e-42
NMR metabolomics,X23412.Phospholipids in VLDL,PPL,Periplakin,24229,0.0302581153067195,0.00221899766097083,0.0259088798912167,0.0346073507222223,3.50537348856796e-42
NMR metabolomics,X23412.Phospholipids in VLDL,TSPYL1,Testis-specific Y-encoded-like protein 1,24229,0.037375820763286,0.00274804948630658,0.0319896437701251,0.0427619977564469,5.64620247408253e-42
NMR metabolomics,X23412.Phospholipids in VLDL,ERI1,3'-5' exoribonuclease 1,24445,0.0312342005537068,0.00229855797721285,0.0267290269183696,0.035739374189044,6.64586073907612e-42
NMR metabolomics,X23412.Phospholipids in VLDL,LY75,Lymphocyte antigen 75,29434,0.035678381797324,0.00262658337922266,0.0305302783740476,0.0408264852206005,6.70658618059352e-42
NMR metabolomics,X23412.Phospholipids in VLDL,ESAM,Endothelial cell-selective adhesion molecule,29820,0.0292241867238572,0.00215164551804412,0.0250069615084907,0.0334414119392237,6.80233644004868e-42
NMR metabolomics,X23412.Phospholipids in VLDL,NGRN,Neugrin,24845,0.0203875050086146,0.00150164111813857,0.017444288417063,0.0233307216001662,7.75387754567126e-42
NMR metabolomics,X23412.Phospholipids in VLDL,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,29594,0.0385965375774415,0.00284396958120954,0.0330223571982708,0.0441707179566122,7.90235545848968e-42
NMR metabolomics,X23412.Phospholipids in VLDL,CHAD,Chondroadherin,24381,0.0476959922791111,0.0035140540908457,0.0408084462610535,0.0545835382971686,8.2269663215753e-42
NMR metabolomics,X23412.Phospholipids in VLDL,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,24867,0.0616051830214068,0.00454262871575607,0.0527016307385249,0.0705087353042887,9.52890260350261e-42
NMR metabolomics,X23412.Phospholipids in VLDL,LRG1,Leucine-rich alpha-2-glycoprotein,24966,-0.0238223946800422,0.00176534379856413,-0.0272824685252279,-0.0203623208348565,2.35439099246078e-41
NMR metabolomics,X23412.Phospholipids in VLDL,MAGED1,Melanoma-associated antigen D1,28797,0.0440929606450401,0.0032690690301545,0.0376855853459373,0.0505003359441429,2.46036273393737e-41
NMR metabolomics,X23412.Phospholipids in VLDL,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",24922,0.0274455114445735,0.00204058833842118,0.023445958301268,0.031445064587879,4.29585544943921e-41
NMR metabolomics,X23412.Phospholipids in VLDL,ENTR1,Endosome-associated-trafficking regulator 1,24240,0.054028781594153,0.00401847397624218,0.0461525726007183,0.0619049905875877,4.61835130237466e-41
NMR metabolomics,X23412.Phospholipids in VLDL,CCN4,CCN family member 4,29725,0.0363907181523396,0.00270862568792035,0.0310818118040157,0.0416996245006635,4.96129105678421e-41
NMR metabolomics,X23412.Phospholipids in VLDL,TPP1,Tripeptidyl-peptidase 1,29286,0.0416405128349672,0.00310020318271753,0.0355641145968409,0.0477169110730936,5.22701499059116e-41
NMR metabolomics,X23412.Phospholipids in VLDL,IL12A_IL12B,Interleukin-12,29349,0.0703460341460943,0.00524786623111556,0.0600602163331078,0.0806318519590808,7.48794016690269e-41
NMR metabolomics,X23412.Phospholipids in VLDL,CTSE,Cathepsin E,24381,0.0474030745971852,0.00354176314075407,0.0404612188413072,0.0543449303530632,1.04408597290079e-40
NMR metabolomics,X23412.Phospholipids in VLDL,PTN,Pleiotrophin,28916,0.0452589717123199,0.00338256454488722,0.038629145204341,0.0518887982202989,1.04528394880725e-40
NMR metabolomics,X23412.Phospholipids in VLDL,DKK4,Dickkopf-related protein 4,29169,0.0414094038272764,0.00310223222049902,0.0353290286750983,0.0474897789794545,1.59491254812538e-40
NMR metabolomics,X23412.Phospholipids in VLDL,CARHSP1,Calcium-regulated heat-stable protein 1,28774,0.0462761646472202,0.00346770879116849,0.03947945541653,0.0530728738779105,1.67469572786935e-40
NMR metabolomics,X23412.Phospholipids in VLDL,ITGB6,Integrin beta-6,28931,0.0274255695131278,0.00205610768567081,0.023395598449213,0.0314555405770426,1.81861966230773e-40
NMR metabolomics,X23412.Phospholipids in VLDL,GLRX,Glutaredoxin-1,29291,0.0505239273049285,0.00379015295405343,0.0430952275149837,0.0579526270948732,2.02375953484698e-40
NMR metabolomics,X23412.Phospholipids in VLDL,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",24845,0.0361308177967356,0.00271192343708066,0.0308154478600575,0.0414461877334137,2.34278524302261e-40
NMR metabolomics,X23412.Phospholipids in VLDL,BPIFA2,BPI fold-containing family A member 2,23405,-0.100087272121201,0.00751723068064103,-0.114821044255257,-0.0853534999871445,2.67723879645934e-40
NMR metabolomics,X23412.Phospholipids in VLDL,FCN1,Ficolin-1,24919,0.0504897367565954,0.00379604577994362,0.0430494870279059,0.0579299864852849,3.14959187148641e-40
NMR metabolomics,X23412.Phospholipids in VLDL,SCRIB,Protein scribble homolog,24240,0.0813811231080634,0.00613217926306044,0.069362051752465,0.0934001944636619,4.6962782384594e-40
NMR metabolomics,X23412.Phospholipids in VLDL,IL17D,Interleukin-17D,28931,0.0306261778313923,0.002309925160443,0.026098724516924,0.0351536311458606,5.27169005719282e-40
NMR metabolomics,X23412.Phospholipids in VLDL,REN,Renin,29478,-0.0680919821989954,0.00513952480663028,-0.0781654508199907,-0.058018513578,5.97462855753183e-40
NMR metabolomics,X23412.Phospholipids in VLDL,XCL1,Lymphotactin,29725,0.0496188324175861,0.00374826638565004,0.042272230301712,0.0569654345334602,6.88564935725938e-40
NMR metabolomics,X23412.Phospholipids in VLDL,ANXA2,Annexin A2,23907,0.0637065814435481,0.00481284021854484,0.0542734146152002,0.073139748271896,7.432833407642e-40
NMR metabolomics,X23412.Phospholipids in VLDL,HPCAL1,Hippocalcin-like protein 1,29786,0.0655523997050044,0.0049572566328442,0.0558361767046297,0.075268622705379,8.31335934270744e-40
NMR metabolomics,X23412.Phospholipids in VLDL,NADK,NAD kinase,29478,0.0482897292905281,0.00365252373685994,0.0411307827662826,0.0554486758147736,8.62748808825849e-40
NMR metabolomics,X23412.Phospholipids in VLDL,IDO1,"Indoleamine 2,3-dioxygenase 1",24240,0.0573432305519831,0.00433904859562939,0.0488386953045495,0.0658477657994167,9.78723567062096e-40
NMR metabolomics,X23412.Phospholipids in VLDL,CLU,Clusterin,24966,0.0283477949765886,0.0021528976013133,0.0241281156780145,0.0325674742751627,1.83359463366305e-39
NMR metabolomics,X23412.Phospholipids in VLDL,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,24178,0.0246924010889147,0.00188228121402875,0.0210031299094184,0.028381672268411,3.51972124664712e-39
NMR metabolomics,X23412.Phospholipids in VLDL,ROBO1,Roundabout homolog 1,29497,0.0213386613828413,0.00162810344000991,0.0181475786404219,0.0245297441252607,3.89139828611527e-39
NMR metabolomics,X23412.Phospholipids in VLDL,SLIT2,Slit homolog 2 protein,28774,0.0461101370669767,0.00351892362160703,0.039213046768627,0.0530072273653265,4.07172537689917e-39
NMR metabolomics,X23412.Phospholipids in VLDL,TREML1,Trem-like transcript 1 protein,24951,0.0468163495802507,0.00357664907800051,0.0398061173873697,0.0538265817731317,5.0888669910029e-39
NMR metabolomics,X23412.Phospholipids in VLDL,SPAG1,Sperm-associated antigen 1,24867,0.051259158654089,0.0039218617280069,0.0435723096671955,0.0589460076409825,6.55798899690237e-39
NMR metabolomics,X23412.Phospholipids in VLDL,EFCAB2,Dynein regulatory complex protein 8,24445,0.0309782125834469,0.00237044798637657,0.0263321345301488,0.035624290636745,6.73079168416232e-39
NMR metabolomics,X23412.Phospholipids in VLDL,CD74,HLA class II histocompatibility antigen gamma chain,29694,0.0305349110920711,0.00234332444995998,0.0259419951701496,0.0351278270139927,1.0469775324916e-38
NMR metabolomics,X23412.Phospholipids in VLDL,BOLA1,BolA-like protein 1,24101,0.0482250715926123,0.0037038940177466,0.040965439317829,0.0554847038673957,1.26998578960905e-38
NMR metabolomics,X23412.Phospholipids in VLDL,LAMP3,Lysosome-associated membrane glycoprotein 3,29760,0.0451465519093695,0.00347073712999868,0.0383439071345721,0.0519491966841669,1.40854671509442e-38
NMR metabolomics,X23412.Phospholipids in VLDL,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,24195,0.0474310394366626,0.00364667627758308,0.0402835539325997,0.0545785249407254,1.51086685446971e-38
NMR metabolomics,X23412.Phospholipids in VLDL,ECE1,Endothelin-converting enzyme 1,28774,0.0310037045547853,0.0023861867978953,0.0263267784309105,0.0356806306786601,1.72110934953257e-38
NMR metabolomics,X23412.Phospholipids in VLDL,DENR,Density-regulated protein,24229,0.0505944849086737,0.00389813794441889,0.0429541345376127,0.0582348352797348,2.15819789850756e-38
NMR metabolomics,X23412.Phospholipids in VLDL,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,24845,0.0419252735539661,0.00323565768304098,0.0355833844952057,0.0482671626127264,2.84464307542456e-38
NMR metabolomics,X23412.Phospholipids in VLDL,ACP6,Lysophosphatidic acid phosphatase type 6,29674,0.058389763975004,0.0045160851382064,0.0495382371041195,0.0672412908458886,3.901160551821e-38
NMR metabolomics,X23412.Phospholipids in VLDL,KIF22,Kinesin-like protein KIF22,24111,0.107739622350593,0.00834055890379888,0.0913921268991477,0.124087117802039,4.79381272306996e-38
NMR metabolomics,X23412.Phospholipids in VLDL,MENT,Protein MENT,24381,-0.019829105316456,0.00153756289546033,-0.0228427285915583,-0.0168154820413538,6.27294104691136e-38
NMR metabolomics,X23412.Phospholipids in VLDL,CCL19,C-C motif chemokine 19,29694,0.10708172064545,0.00830729329522108,0.0907994257868168,0.123364015504083,6.47119835479194e-38
NMR metabolomics,X23412.Phospholipids in VLDL,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,24230,0.03399233384836,0.00263815837695732,0.0288215434295236,0.0391631242671963,7.29469781068061e-38
NMR metabolomics,X23412.Phospholipids in VLDL,WARS,"Tryptophan--tRNA ligase, cytoplasmic",29443,0.0332762393850107,0.00258641461052377,0.0282068667483841,0.0383456120216373,8.86816944594434e-38
NMR metabolomics,X23412.Phospholipids in VLDL,FGA,Fibrinogen alpha chain,24407,0.0269561201496237,0.00209712953937624,0.0228457462524463,0.0310664940468011,1.08526240486169e-37
NMR metabolomics,X23412.Phospholipids in VLDL,GLO1,Lactoylglutathione lyase,28916,0.0502974694606523,0.00391557980354667,0.0426229330457008,0.0579720058756037,1.15636391650745e-37
NMR metabolomics,X23412.Phospholipids in VLDL,CCL25,C-C motif chemokine 25,29786,0.0426647565920523,0.0033223007554789,0.0361530471113136,0.0491764660727909,1.20185296980509e-37
NMR metabolomics,X23412.Phospholipids in VLDL,MDK,Midkine,29455,0.0440417440673956,0.0034367330007516,0.0373057473859225,0.0507777407488688,1.70238170061962e-37
NMR metabolomics,X23412.Phospholipids in VLDL,FEN1,Flap endonuclease 1,28797,0.054514625864694,0.00425688684847267,0.0461711276416876,0.0628581240877005,1.91525608446489e-37
NMR metabolomics,X23412.Phospholipids in VLDL,DCTN2,Dynactin subunit 2,29349,0.0815165927776826,0.00637589727482978,0.0690198341190162,0.0940133514363489,2.49820577174448e-37
NMR metabolomics,X23412.Phospholipids in VLDL,ABCA2,ATP-binding cassette sub-family A member 2,24111,0.0316430566325171,0.00247632701872535,0.0267894556758154,0.0364966575892188,2.86718063220249e-37
NMR metabolomics,X23412.Phospholipids in VLDL,PSAP,Prosaposin,24761,0.0246374825078682,0.00192830010043771,0.0208580143110102,0.0284169507047261,2.89894898372257e-37
NMR metabolomics,X23412.Phospholipids in VLDL,PTGES2,Prostaglandin E synthase 2,24037,0.0474967871388972,0.00373744251095857,0.0401713998174184,0.054822174460376,6.98513020374702e-37
NMR metabolomics,X23412.Phospholipids in VLDL,LRRC37A2,Leucine-rich repeat-containing protein 37A2,24805,0.036849376132311,0.00290397495391555,0.0311575852226365,0.0425411670419855,8.82434764388015e-37
NMR metabolomics,X23412.Phospholipids in VLDL,PMM2,Phosphomannomutase 2,24111,0.0517238644167489,0.0040807816202121,0.0437255324411332,0.0597221963923646,1.06580714771265e-36
NMR metabolomics,X23412.Phospholipids in VLDL,MAN2B2,Epididymis-specific alpha-mannosidase,24922,0.051096669453159,0.00403265086904889,0.0431926737498231,0.0590006651564948,1.11496599671082e-36
NMR metabolomics,X23412.Phospholipids in VLDL,AK1,Adenylate kinase isoenzyme 1,29478,0.0536760808079412,0.00424961563802422,0.0453468341574137,0.0620053274584687,1.77566572660857e-36
NMR metabolomics,X23412.Phospholipids in VLDL,FAM3C,Protein FAM3C,29433,0.0256050249172738,0.00202782914306981,0.021630479796857,0.0295795700376907,1.86818738294324e-36
NMR metabolomics,X23412.Phospholipids in VLDL,ACOT13,Acyl-coenzyme A thioesterase 13,24805,0.0973465497527785,0.00770923305335741,0.082236452968198,0.112456646537359,1.93435431901141e-36
NMR metabolomics,X23412.Phospholipids in VLDL,C7,Complement component C7,24374,-0.0278379556232073,0.00220468321636953,-0.0321591347272916,-0.023516776519123,1.95623856100126e-36
NMR metabolomics,X23412.Phospholipids in VLDL,SFRP4,Secreted frizzled-related protein 4,24381,0.0354054667743933,0.00280582260624518,0.0299060544661527,0.0409048790826338,2.16845590158998e-36
NMR metabolomics,X23412.Phospholipids in VLDL,CGA,Glycoprotein hormones alpha chain,29443,0.0684107458635306,0.00542378618994281,0.0577801249312427,0.0790413667958185,2.2214277305941e-36
NMR metabolomics,X23412.Phospholipids in VLDL,ASPN,Asporin,24922,0.0235538252963109,0.00186734937053778,0.0198938205300568,0.0272138300625649,2.2983481091038e-36
NMR metabolomics,X23412.Phospholipids in VLDL,XRCC4,DNA repair protein XRCC4,28774,0.0315668591197235,0.00250459167701006,0.0266578594327838,0.0364758588066633,2.51701695888137e-36
NMR metabolomics,X23412.Phospholipids in VLDL,NEK7,Serine/threonine-protein kinase Nek7,24445,0.0640026836731139,0.00508454638035409,0.0540369727676199,0.0739683945786079,3.19766629071878e-36
NMR metabolomics,X23412.Phospholipids in VLDL,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,24867,0.0501304940279741,0.00398319818520416,0.042323425584974,0.0579375624709743,3.27306007480847e-36
NMR metabolomics,X23412.Phospholipids in VLDL,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",29163,0.0815906216454552,0.00649800037547266,0.0688545409095288,0.0943267023813817,4.55400611353308e-36
NMR metabolomics,X23412.Phospholipids in VLDL,RGMB,RGM domain family member B,29694,0.0228506558748632,0.00182100700651602,0.0192814821420918,0.0264198296076346,5.01020208043592e-36
NMR metabolomics,X23412.Phospholipids in VLDL,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,29820,0.0196394246908606,0.00156538612113392,0.0165712678934381,0.0227075814882831,5.15276757543875e-36
NMR metabolomics,X23412.Phospholipids in VLDL,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",24240,0.0777290298258487,0.00620619058689832,0.065564896275528,0.0898931633761694,7.089553743609e-36
NMR metabolomics,X23412.Phospholipids in VLDL,PVR,Poliovirus receptor,29694,0.0313220252347402,0.00250312927803511,0.0264158918497913,0.036228158619689,7.79270025585994e-36
NMR metabolomics,X23412.Phospholipids in VLDL,ATP6V1F,V-type proton ATPase subunit F,28719,0.0560328744661041,0.00448369794601646,0.0472448264919118,0.0648209224402963,9.60280341203629e-36
NMR metabolomics,X23412.Phospholipids in VLDL,DDX58,Antiviral innate immune response receptor RIG-I,28797,0.0480244488226462,0.00384803148415529,0.0404823071137018,0.0555665905315906,1.18337795002995e-35
NMR metabolomics,X23412.Phospholipids in VLDL,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,28797,0.0399889221130838,0.00320590952820966,0.0337053394377929,0.0462725047883747,1.28763569884663e-35
NMR metabolomics,X23412.Phospholipids in VLDL,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,29478,0.0412405012347111,0.00331291212531558,0.0347471934690926,0.0477338090003296,1.75223812629057e-35
NMR metabolomics,X23412.Phospholipids in VLDL,ANGPTL1,Angiopoietin-related protein 1,29030,0.0245559831564524,0.00197322144165157,0.0206884691308153,0.0284234971820895,1.84296669669759e-35
NMR metabolomics,X23412.Phospholipids in VLDL,SLITRK2,SLIT and NTRK-like protein 2,29725,0.0328989948623579,0.00264594612725158,0.0277129404529448,0.038085049271771,2.10016222144221e-35
NMR metabolomics,X23412.Phospholipids in VLDL,CELA3A,Chymotrypsin-like elastase family member 3A,29789,0.0483732440152119,0.00389195322294281,0.040745015698244,0.0560014723321798,2.22558122610735e-35
NMR metabolomics,X23412.Phospholipids in VLDL,NAA10,N-alpha-acetyltransferase 10,24111,0.0428737456535614,0.00345709172408489,0.0360978458743551,0.0496496454327678,3.27778113701406e-35
NMR metabolomics,X23412.Phospholipids in VLDL,CCL20,C-C motif chemokine 20,29786,0.0734238006029773,0.00593171086749562,0.0617976473026859,0.0850499539032687,4.18557071082605e-35
NMR metabolomics,X23412.Phospholipids in VLDL,IL5RA,Interleukin-5 receptor subunit alpha,29434,-0.0469733696915689,0.00379778123499868,-0.0544170209121663,-0.0395297184709715,4.72231951836775e-35
NMR metabolomics,X23412.Phospholipids in VLDL,VIT,Vitrin,24922,0.0315832846521769,0.00255312210164211,0.0265791653329583,0.0365874039713954,4.78740952238086e-35
NMR metabolomics,X23412.Phospholipids in VLDL,PER3,Period circadian protein homolog 3,24229,0.100756666805357,0.00814704316474829,0.0847884622024499,0.116724871408263,5.01374984395318e-35
NMR metabolomics,X23412.Phospholipids in VLDL,CSTB,Cystatin-B,29030,0.0354289036838463,0.00287708200512562,0.0297898229538,0.0410679844138925,9.28099679013532e-35
NMR metabolomics,X23412.Phospholipids in VLDL,BRDT,Bromodomain testis-specific protein,24111,0.0307611745751522,0.00250209477275658,0.0258570688205493,0.0356652803297551,1.23654582640437e-34
NMR metabolomics,X23412.Phospholipids in VLDL,TEK,Angiopoietin-1 receptor,29566,0.018156636313966,0.00147745161939658,0.0152608311399487,0.0210524414879832,1.25860248005306e-34
NMR metabolomics,X23412.Phospholipids in VLDL,HDGF,Hepatoma-derived growth factor,29688,0.0776846343319715,0.006321542554003,0.0652944109261256,0.0900748577378174,1.2620142024601e-34
NMR metabolomics,X23412.Phospholipids in VLDL,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,24805,0.0981973360346146,0.00799163520257404,0.0825337310375695,0.11386094103166,1.33304863651664e-34
NMR metabolomics,X23412.Phospholipids in VLDL,ALCAM,CD166 antigen,29820,0.0162301966619511,0.00132330478549385,0.0136365192823832,0.0188238740415191,1.69324001004427e-34
NMR metabolomics,X23412.Phospholipids in VLDL,NAP1L4,Nucleosome assembly protein 1-like 4,24764,0.0340459882341999,0.00278029664988478,0.0285966068004257,0.0394953696679741,2.23460562416041e-34
NMR metabolomics,X23412.Phospholipids in VLDL,CHRDL1,Chordin-like protein 1,29536,0.026068972545845,0.00212990124231652,0.0218943661109047,0.0302435789807854,2.31600426312253e-34
NMR metabolomics,X23412.Phospholipids in VLDL,EPCAM,Epithelial cell adhesion molecule,29457,-0.080021188965382,0.00655256622622648,-0.0928642187687859,-0.0671781591619781,3.2381695777974e-34
NMR metabolomics,X23412.Phospholipids in VLDL,ANPEP,Aminopeptidase N,29531,0.0231531800285055,0.00189795073531959,0.0194331965872791,0.0268731634697319,3.80104971225695e-34
NMR metabolomics,X23412.Phospholipids in VLDL,HSPB6,Heat shock protein beta-6,29725,0.0316919136392295,0.00259865387193227,0.0265985520502422,0.0367852752282167,3.9636677710088e-34
NMR metabolomics,X23412.Phospholipids in VLDL,PDIA3,Protein disulfide-isomerase A3,24381,0.0207486074560706,0.00170108945271233,0.0174144721287544,0.0240827427833867,4.04331349954577e-34
NMR metabolomics,X23412.Phospholipids in VLDL,RPE,Ribulose-phosphate 3-epimerase,24445,0.0583754340335276,0.00478735296314676,0.04899222222576,0.0677586458412953,4.22080905094993e-34
NMR metabolomics,X23412.Phospholipids in VLDL,PTGR1,Prostaglandin reductase 1,24922,0.0674598077656878,0.00553397245300148,0.0566132217578049,0.0783063937735707,4.38864131329235e-34
NMR metabolomics,X23412.Phospholipids in VLDL,POSTN,Periostin,24938,-0.0313217465769963,0.00257052370705392,-0.036359973042822,-0.0262835201111706,4.67282855255299e-34
NMR metabolomics,X23412.Phospholipids in VLDL,MCAM,Cell surface glycoprotein MUC18,29594,-0.0272808287317214,0.0022475146677579,-0.0316859574805269,-0.0228756999829159,7.97415598080797e-34
NMR metabolomics,X23412.Phospholipids in VLDL,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,24867,0.0544830252703905,0.00448843018204396,0.0456857021135844,0.0632803484271967,8.22633601235893e-34
NMR metabolomics,X23412.Phospholipids in VLDL,CD34,Hematopoietic progenitor cell antigen CD34,29593,0.0198905520020574,0.00164169396598281,0.0166728318287311,0.0231082721753838,1.04616593396907e-33
NMR metabolomics,X23412.Phospholipids in VLDL,NPHS1,Nephrin,24229,0.0280206070631525,0.00231435528437691,0.0234844707057737,0.0325567434205312,1.20868325227747e-33
NMR metabolomics,X23412.Phospholipids in VLDL,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,29725,0.0211869087421281,0.00175113319524479,0.0177546876794483,0.0246191298048079,1.28313108755436e-33
NMR metabolomics,X23412.Phospholipids in VLDL,SGSH,N-sulphoglucosamine sulphohydrolase,24571,0.0459968454213287,0.00380077814616264,0.0385473202548499,0.0534463705878075,1.2856254548925e-33
NMR metabolomics,X23412.Phospholipids in VLDL,LBP,Lipopolysaccharide-binding protein,29594,-0.0475794657374153,0.00394622408182218,-0.0553140649377867,-0.0398448665370438,2.13492902087418e-33
NMR metabolomics,X23412.Phospholipids in VLDL,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,29218,0.0289167447975719,0.00240638408831909,0.0242002319844665,0.0336332576106773,3.47813863609137e-33
NMR metabolomics,X23412.Phospholipids in VLDL,LTBP2,Latent-transforming growth factor beta-binding protein 2,29820,-0.0258601096204931,0.00215207774987442,-0.030078182010247,-0.0216420372307392,3.4794721476556e-33
NMR metabolomics,X23412.Phospholipids in VLDL,NPC2,NPC intracellular cholesterol transporter 2,24609,0.0259749166936382,0.00216329674492353,0.0217348550735881,0.0302149783136883,4.03642053896707e-33
NMR metabolomics,X23412.Phospholipids in VLDL,CD200R1,Cell surface glycoprotein CD200 receptor 1,29341,0.028295129709675,0.00235966273718225,0.0236701907447978,0.0329200686745522,4.72314100810722e-33
NMR metabolomics,X23412.Phospholipids in VLDL,DHPS,Deoxyhypusine synthase,24793,0.0331020108585867,0.00276284070427777,0.0276868430782022,0.0385171786389711,5.50316951181256e-33
NMR metabolomics,X23412.Phospholipids in VLDL,CDA,Cytidine deaminase,24890,0.0379331676124296,0.00316735345191704,0.0317251548466722,0.044141180378187,5.82818881682585e-33
NMR metabolomics,X23412.Phospholipids in VLDL,MTUS1,Microtubule-associated tumor suppressor 1,24445,0.0455729408027675,0.00380842059059083,0.0381084364452095,0.0530374451603256,6.59000268749193e-33
NMR metabolomics,X23412.Phospholipids in VLDL,CD302,CD302 antigen,29349,0.0246733765236228,0.00206519105944742,0.0206256020471058,0.0287211510001397,7.99721972288487e-33
NMR metabolomics,X23412.Phospholipids in VLDL,CSNK1D,Casein kinase I isoform delta,24229,0.0517943189211426,0.00433796643909079,0.0432919047005247,0.0602967331417605,9.07588828261442e-33
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINI1,Neuroserpin,24329,0.0247927692615006,0.00207670116823325,0.0207224349717634,0.0288631035512378,9.2028021445278e-33
NMR metabolomics,X23412.Phospholipids in VLDL,FBP1,"Fructose-1,6-bisphosphatase 1",29478,0.0590304885751703,0.00494909772357124,0.0493302570369707,0.0687307201133699,1.0118938094981e-32
NMR metabolomics,X23412.Phospholipids in VLDL,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,24845,0.0698556069227801,0.00585737667995932,0.0583751486300598,0.0813360652155003,1.06312898667208e-32
NMR metabolomics,X23412.Phospholipids in VLDL,CD14,Monocyte differentiation antigen CD14,28954,0.0334017122852738,0.00280160600634478,0.027910564512838,0.0388928600577095,1.07989156390619e-32
NMR metabolomics,X23412.Phospholipids in VLDL,PSG1,Pregnancy-specific beta-1-glycoprotein 1,29218,-0.0925788342750654,0.0077661482460686,-0.10780048483736,-0.0773571837127709,1.09802902723476e-32
NMR metabolomics,X23412.Phospholipids in VLDL,STX6,Syntaxin-6,28797,0.0541397741328405,0.0045504989194641,0.0452207962506909,0.0630587520149902,1.45318083736108e-32
NMR metabolomics,X23412.Phospholipids in VLDL,FAM3B,Protein FAM3B,29349,0.0286895186984732,0.00241153657337163,0.0239629070146648,0.0334161303822816,1.46170712241256e-32
NMR metabolomics,X23412.Phospholipids in VLDL,S100P,Protein S100-P,28916,0.043075207699797,0.00362357922243644,0.0359729924238216,0.0501774229757725,1.63731810594938e-32
NMR metabolomics,X23412.Phospholipids in VLDL,TXN,Thioredoxin,24647,0.0352964909667214,0.00297019481364974,0.0294749091319679,0.0411180728014749,1.76788421893685e-32
NMR metabolomics,X23412.Phospholipids in VLDL,COL2A1,Collagen alpha-1(II) chain,24240,0.065082946270709,0.005477155451534,0.0543477215857024,0.0758181709557156,1.79395431915489e-32
NMR metabolomics,X23412.Phospholipids in VLDL,DAPK2,Death-associated protein kinase 2,24229,0.0432171997195796,0.00364340295328089,0.0360761299311491,0.0503582695080102,2.29870165510012e-32
NMR metabolomics,X23412.Phospholipids in VLDL,CXCL8,Interleukin-8,29218,0.0543348647859339,0.00458612180482888,0.0453460660484693,0.0633236635233985,2.62388478970643e-32
NMR metabolomics,X23412.Phospholipids in VLDL,ADM,Pro-adrenomedullin,29725,0.021284206969272,0.00179657914208569,0.017762911850784,0.0248055020877599,2.6348984895012e-32
NMR metabolomics,X23412.Phospholipids in VLDL,APRT,Adenine phosphoribosyltransferase,29192,0.0382635908814062,0.00323121577363667,0.0319304079650784,0.0445967737977341,2.81186253115278e-32
NMR metabolomics,X23412.Phospholipids in VLDL,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,29218,0.0569617531779603,0.00481335668996802,0.047527574065623,0.0663959322902976,3.08234437706941e-32
NMR metabolomics,X23412.Phospholipids in VLDL,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",24867,0.0380581173953155,0.00321986377691121,0.0317471843925695,0.0443690503980615,3.76138620480846e-32
NMR metabolomics,X23412.Phospholipids in VLDL,CASP9,Caspase-9,24229,0.0503791494325602,0.00427667765342316,0.0419968612318508,0.0587614376332695,6.05243464077705e-32
NMR metabolomics,X23412.Phospholipids in VLDL,EFNA4,Ephrin-A4,29169,0.0245054284301502,0.00208082420820964,0.0204270129820593,0.0285838438782411,6.07461873683315e-32
NMR metabolomics,X23412.Phospholipids in VLDL,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,28719,0.0381400601260377,0.00324416472456586,0.0317814972658886,0.0444986229861868,7.73590951403608e-32
NMR metabolomics,X23412.Phospholipids in VLDL,ADAMTSL4,ADAMTS-like protein 4,24240,0.0191349021039406,0.00162999964268928,0.0159401028042696,0.0223297014036116,9.78110723018504e-32
NMR metabolomics,X23412.Phospholipids in VLDL,MMP3,Stromelysin-1,29443,-0.0389316305645035,0.00331772880934276,-0.0454343790308153,-0.0324288820981917,9.99247257061022e-32
NMR metabolomics,X23412.Phospholipids in VLDL,RANBP1,Ran-specific GTPase-activating protein,24240,0.0416157036498741,0.00355556783256373,0.0346467906980492,0.048584616601699,1.47218681080393e-31
NMR metabolomics,X23412.Phospholipids in VLDL,ECI2,Enoyl-CoA delta isomerase 2,24111,0.0490845001116018,0.00419393988405468,0.0408643779388546,0.0573046222843489,1.48592639624837e-31
NMR metabolomics,X23412.Phospholipids in VLDL,FABP6,Gastrotropin,28872,0.0445334153943069,0.00380684999065675,0.0370719894126197,0.0519948413759942,1.53341347319069e-31
NMR metabolomics,X23412.Phospholipids in VLDL,TFPI2,Tissue factor pathway inhibitor 2,29473,0.0308418590156645,0.00264114926840471,0.0256652064495913,0.0360185115817378,1.94996861966584e-31
NMR metabolomics,X23412.Phospholipids in VLDL,HEPH,Hephaestin,24922,0.0209283620028187,0.00179229847855671,0.0174154569848476,0.0244412670207899,2.02184575921987e-31
NMR metabolomics,X23412.Phospholipids in VLDL,SMS,Spermine synthase,24101,0.0506581495518525,0.00434130621633268,0.0421491893678405,0.0591671097358646,2.23318632632171e-31
NMR metabolomics,X23412.Phospholipids in VLDL,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,24229,0.0284433928600619,0.00243758718968326,0.0236657219682827,0.0332210637518411,2.23627307470361e-31
NMR metabolomics,X23412.Phospholipids in VLDL,FASLG,Tumor necrosis factor ligand superfamily member 6,29786,0.0289674868263822,0.00248463140222224,0.0240976092780266,0.0338373643747377,2.42484635851005e-31
NMR metabolomics,X23412.Phospholipids in VLDL,CD276,CD276 antigen,29454,-0.0283253228448972,0.00243146005643387,-0.0330909845555076,-0.0235596611342868,2.70335151003621e-31
NMR metabolomics,X23412.Phospholipids in VLDL,FGF23,Fibroblast growth factor 23,29693,0.0447463775473909,0.00384113527931181,0.0372177523999397,0.052275002694842,2.70792501600521e-31
NMR metabolomics,X23412.Phospholipids in VLDL,PKD1,Polycystin-1,24922,0.0209945560712875,0.00180267669119235,0.0174613097565505,0.0245278023860245,2.88746604643456e-31
NMR metabolomics,X23412.Phospholipids in VLDL,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,24240,0.0333396985026002,0.00286474284204669,0.0277248025321887,0.0389545944730117,3.20082594712519e-31
NMR metabolomics,X23412.Phospholipids in VLDL,TPR,Nucleoprotein TPR,24111,0.0377166532435523,0.0032413810242341,0.0313635464360534,0.0440697600510511,3.27794762139682e-31
NMR metabolomics,X23412.Phospholipids in VLDL,DGKZ,Diacylglycerol kinase zeta,28931,0.0278540729334582,0.00240245144497114,0.0231452681013148,0.0325628777656017,5.1754748916493e-31
NMR metabolomics,X23412.Phospholipids in VLDL,KLK6,Kallikrein-6,29519,0.0239803056616458,0.00207173203211857,0.0199197108786934,0.0280409004445982,6.4347553334869e-31
NMR metabolomics,X23412.Phospholipids in VLDL,ELOB,Elongin-B,24111,0.0310941432225914,0.00269220494651009,0.0258174215274316,0.0363708649177512,8.92891466453937e-31
NMR metabolomics,X23412.Phospholipids in VLDL,HIP1R,Huntingtin-interacting protein 1-related protein,24788,0.0337606115061811,0.00292784865505395,0.0280220281422754,0.0394991948700869,1.1045287239028e-30
NMR metabolomics,X23412.Phospholipids in VLDL,CD101,Immunoglobulin superfamily member 2,24805,0.0334580631655952,0.00290591993858313,0.0277624600859723,0.0391536662452181,1.3454555614611e-30
NMR metabolomics,X23412.Phospholipids in VLDL,LTA,Lymphotoxin-alpha,29434,0.0312075683663144,0.00271250106219764,0.025891066284407,0.0365240704482218,1.44583578850171e-30
NMR metabolomics,X23412.Phospholipids in VLDL,FLT3LG,Fms-related tyrosine kinase 3 ligand,29786,0.0264038715124747,0.00229670415448781,0.0219023313696786,0.0309054116552708,1.59510523607678e-30
NMR metabolomics,X23412.Phospholipids in VLDL,ITGB1,Integrin beta-1,29474,0.01686492998715,0.00146963173285337,0.0139844517907574,0.0197454081835426,2.03022986607562e-30
NMR metabolomics,X23412.Phospholipids in VLDL,INSR,Insulin receptor,24229,0.0132331916970183,0.00115334199456124,0.0109726413876783,0.0154937420063583,2.14130862792871e-30
NMR metabolomics,X23412.Phospholipids in VLDL,DEFB103A_DEFB103B,Beta-defensin 103,24109,0.0321862910560797,0.00280518872967783,0.0266881211459112,0.0376844609662483,2.14170294804757e-30
NMR metabolomics,X23412.Phospholipids in VLDL,LGALS7_LGALS7B,Galectin-7,29320,0.0325565222790401,0.00283972389529924,0.0269906634442536,0.0381223811138266,2.30426090276107e-30
NMR metabolomics,X23412.Phospholipids in VLDL,FGR,Tyrosine-protein kinase Fgr,28774,0.0440379503319183,0.00384228918878615,0.0365070635218974,0.0515688371419392,2.39999362439549e-30
NMR metabolomics,X23412.Phospholipids in VLDL,FOLR2,Folate receptor beta,29694,-0.0226994075307928,0.00198120763302655,-0.0265825744915248,-0.0188162405700607,2.50185459238929e-30
NMR metabolomics,X23412.Phospholipids in VLDL,EDF1,Endothelial differentiation-related factor 1,24867,0.0528399968120067,0.00461376279434419,0.0437970217350921,0.0618829718889213,2.71574960717864e-30
NMR metabolomics,X23412.Phospholipids in VLDL,SPINK6,Serine protease inhibitor Kazal-type 6,29725,0.041680103384956,0.00364207910742182,0.0345416283344093,0.0488185784355028,2.91494449183661e-30
NMR metabolomics,X23412.Phospholipids in VLDL,MMP1,Interstitial collagenase,28424,0.0708378150118551,0.00619029628717941,0.0587048342889834,0.0829707957347267,2.95734021225857e-30
NMR metabolomics,X23412.Phospholipids in VLDL,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,29443,0.0277887784953556,0.00243295019527507,0.0230201961126164,0.0325573608780947,3.7652106200536e-30
NMR metabolomics,X23412.Phospholipids in VLDL,TSHB,Thyrotropin subunit beta,29478,0.0593695612961806,0.00520345655608739,0.0491707864462493,0.0695683361461119,4.32926575287616e-30
NMR metabolomics,X23412.Phospholipids in VLDL,PODXL,Podocalyxin,29349,0.0117012145761456,0.00102595517703674,0.00969034242915357,0.0137120867231376,4.55824482398105e-30
NMR metabolomics,X23412.Phospholipids in VLDL,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,24805,-0.0264621730286232,0.00232300844797635,-0.0310152695866568,-0.0219090764705895,5.4842174687645e-30
NMR metabolomics,X23412.Phospholipids in VLDL,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],29349,0.0437880769239787,0.00384633927138032,0.0362492519520733,0.0513269018958842,5.7843050745258e-30
NMR metabolomics,X23412.Phospholipids in VLDL,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",24240,0.038194471627288,0.00336333206617123,0.0316023407775923,0.0447866024769836,8.22429847496891e-30
NMR metabolomics,X23412.Phospholipids in VLDL,NFASC,Neurofascin,29786,0.0217473408425702,0.00191647538620187,0.0179910490856146,0.0255036325995259,8.77963309326362e-30
NMR metabolomics,X23412.Phospholipids in VLDL,PTGDS,Prostaglandin-H2 D-isomerase,29291,0.0233945514086698,0.0020622577750157,0.019352526169639,0.0274365766477006,9.1505058560269e-30
NMR metabolomics,X23412.Phospholipids in VLDL,CHCHD6,MICOS complex subunit MIC25,24793,0.0223168295547654,0.0019671901098691,0.018461136939422,0.0261725221701088,9.35056706957321e-30
NMR metabolomics,X23412.Phospholipids in VLDL,IL32,Interleukin-32,29434,-0.0334106399431532,0.00294617959900503,-0.039185151957203,-0.0276361279291033,9.55020719458101e-30
NMR metabolomics,X23412.Phospholipids in VLDL,AKR7L,Aflatoxin B1 aldehyde reductase member 4,24229,0.0535280529010577,0.00473171184674005,0.0442538976814472,0.0628022081206682,1.34855808050205e-29
NMR metabolomics,X23412.Phospholipids in VLDL,SMARCA2,Probable global transcription activator SNF2L2,28774,0.0559668524215265,0.00495718179066934,0.0462507761118146,0.0656829287312384,1.69538845241319e-29
NMR metabolomics,X23412.Phospholipids in VLDL,PEPD,Xaa-Pro dipeptidase,24951,0.0200587881712528,0.0017765862563244,0.0165766791088569,0.0235408972336486,1.7214801322024e-29
NMR metabolomics,X23412.Phospholipids in VLDL,BSG,Basigin,29760,0.0156646567502176,0.00138932984092874,0.0129415702619973,0.018387743238438,2.00155567561549e-29
NMR metabolomics,X23412.Phospholipids in VLDL,ACVRL1,Serine/threonine-protein kinase receptor R3,29169,0.0189841303658896,0.0016852236563843,0.0156810919993764,0.0222871687324029,2.24545323142476e-29
NMR metabolomics,X23412.Phospholipids in VLDL,SORCS2,VPS10 domain-containing receptor SorCS2,28797,0.0272661231312599,0.00242217004863185,0.0225186698359414,0.0320135764265783,2.46654374778632e-29
NMR metabolomics,X23412.Phospholipids in VLDL,GRN,Progranulin,29313,0.0187639957208204,0.00166924730178171,0.0154922710093282,0.0220357204323126,2.94435015701267e-29
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINB8,Serpin B8,29786,0.0427253305775442,0.00380790936601987,0.0352618282201453,0.0501888329349431,3.71565354738266e-29
NMR metabolomics,X23412.Phospholipids in VLDL,C8B,Complement component C8 beta chain,24966,0.0231534498541287,0.00206398055336114,0.0191080479695408,0.0271988517387165,3.91295633042663e-29
NMR metabolomics,X23412.Phospholipids in VLDL,SPRR3,Small proline-rich protein 3,24845,0.0515194406527461,0.00460856251650871,0.0424866581203891,0.0605522231851032,6.05391391297787e-29
NMR metabolomics,X23412.Phospholipids in VLDL,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,24111,0.0502147458036312,0.00449810541367753,0.0413984591928232,0.0590310324144392,7.23966509337603e-29
NMR metabolomics,X23412.Phospholipids in VLDL,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,24229,0.045192932446635,0.0040491632878785,0.0372565724023932,0.0531292924908769,7.43737038939684e-29
NMR metabolomics,X23412.Phospholipids in VLDL,RBP2,Retinol-binding protein 2,29349,-0.0579087304212133,0.00520089066063488,-0.0681024761160577,-0.047714984726369,9.74404445282806e-29
NMR metabolomics,X23412.Phospholipids in VLDL,S100A13,Protein S100-A13,24229,0.0266010838703774,0.00238905140814116,0.0219185431104207,0.0312836246303341,9.99885792661308e-29
NMR metabolomics,X23412.Phospholipids in VLDL,SV2A,Synaptic vesicle glycoprotein 2A,24195,0.0467671032431859,0.0042031037753605,0.0385290198434793,0.0550051866428925,1.09081866158452e-28
NMR metabolomics,X23412.Phospholipids in VLDL,PVALB,Parvalbumin alpha,29599,0.0844133843725192,0.00759406793490986,0.0695290112200959,0.0992977575249426,1.19916354359034e-28
NMR metabolomics,X23412.Phospholipids in VLDL,STX7,Syntaxin-7,24229,0.037468612930334,0.00337387183643884,0.0308558241309139,0.0440814017297542,1.38252620632305e-28
NMR metabolomics,X23412.Phospholipids in VLDL,IL12B,Interleukin-12 subunit beta,29786,0.0408216975973947,0.00368245956520653,0.0336040768495899,0.0480393183451995,1.67860315122856e-28
NMR metabolomics,X23412.Phospholipids in VLDL,C2orf69,UPF0565 protein C2orf69,24195,0.0448371892582875,0.00404451127701254,0.0369099471553429,0.0527644313612321,1.71963380883679e-28
NMR metabolomics,X23412.Phospholipids in VLDL,IL31RA,Interleukin-31 receptor subunit alpha,24134,0.0297660106641384,0.00268761233333034,0.0244982904908109,0.0350337308374659,1.93695707407712e-28
NMR metabolomics,X23412.Phospholipids in VLDL,PLA2G15,Phospholipase A2 group XV,29566,0.0198622745858517,0.00179485604269719,0.0163443567421652,0.0233801924295382,2.08055938752802e-28
NMR metabolomics,X23412.Phospholipids in VLDL,INSL3,Insulin-like 3,24845,0.0566587659873907,0.00512215298916864,0.0466193461286201,0.0666981858461612,2.24622242814898e-28
NMR metabolomics,X23412.Phospholipids in VLDL,IFNGR2,Interferon gamma receptor 2,29218,0.0389401055132014,0.00352534783507335,0.0320304237564577,0.0458497872699452,2.6153183949371e-28
NMR metabolomics,X23412.Phospholipids in VLDL,AHCY,Adenosylhomocysteinase,29478,0.0503976547335674,0.00456805072033081,0.041444275321719,0.0593510341454158,3.02083945783351e-28
NMR metabolomics,X23412.Phospholipids in VLDL,CRYM,Ketimine reductase mu-crystallin,24101,0.0571452088029446,0.00517956090435967,0.0469932694303996,0.0672971481754895,3.10118194994446e-28
NMR metabolomics,X23412.Phospholipids in VLDL,XG,Glycoprotein Xg,29693,0.0239320004347572,0.0021788709815536,0.0196614133109121,0.0282025875586022,5.18535212750093e-28
NMR metabolomics,X23412.Phospholipids in VLDL,RPL14,60S ribosomal protein L14,24240,0.0299304711481326,0.00273295854149783,0.0245738724067968,0.0352870698894683,7.58192892928305e-28
NMR metabolomics,X23412.Phospholipids in VLDL,MANSC1,MANSC domain-containing protein 1,29566,-0.0203798425502711,0.00186583560460544,-0.0240368803352977,-0.0167228047652444,1.01517817207609e-27
NMR metabolomics,X23412.Phospholipids in VLDL,WFDC1,WAP four-disulfide core domain protein 1,24326,0.0401737609597303,0.00368435952457556,0.0329524162915622,0.0473951056278984,1.27995115642999e-27
NMR metabolomics,X23412.Phospholipids in VLDL,CD28,T-cell-specific surface glycoprotein CD28,28797,0.0268810570756793,0.00247082017951763,0.0220382495238248,0.0317238646275339,1.63477839772988e-27
NMR metabolomics,X23412.Phospholipids in VLDL,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",24240,0.0243864386083555,0.00224109772519523,0.0199938870669729,0.0287789901497382,1.63576377757222e-27
NMR metabolomics,X23412.Phospholipids in VLDL,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,24793,0.039934565578887,0.00368109670734316,0.0327196160324944,0.0471495151252795,2.33447533621974e-27
NMR metabolomics,X23412.Phospholipids in VLDL,SCT,Secretin,24195,0.0344671516531161,0.00318447595982529,0.0282255787718586,0.0407087245343737,3.07641767234619e-27
NMR metabolomics,X23412.Phospholipids in VLDL,MCTS1,Malignant T-cell-amplified sequence 1,24805,0.0191289307689901,0.00176770963487662,0.015664219884632,0.0225936416533483,3.13918575619714e-27
NMR metabolomics,X23412.Phospholipids in VLDL,CCL14,C-C motif chemokine 14,29435,0.0289736066360838,0.00267914308445169,0.0237224861905585,0.0342247270816092,3.30646121285944e-27
NMR metabolomics,X23412.Phospholipids in VLDL,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",24922,0.0391080125515012,0.00362169854593823,0.0320094834014623,0.0462065417015401,4.02879211829414e-27
NMR metabolomics,X23412.Phospholipids in VLDL,ITGAV,Integrin alpha-V,29725,0.0121198228985316,0.00112347528458005,0.00991781134075467,0.0143218344563085,4.41279055274922e-27
NMR metabolomics,X23412.Phospholipids in VLDL,STAM,Signal transducing adapter molecule 1,24793,0.0268865808235387,0.00250073931757484,0.021985131761092,0.0317880298859854,6.68813802347579e-27
NMR metabolomics,X23412.Phospholipids in VLDL,RARRES1,Retinoic acid receptor responder protein 1,28797,0.0243449889593611,0.00226561385478395,0.0199043858039845,0.0287855921147376,7.00359434742424e-27
NMR metabolomics,X23412.Phospholipids in VLDL,COLEC12,Collectin-12,29454,0.0191343505080415,0.00178298347307649,0.0156397029008116,0.0226289981152714,8.10483329227391e-27
NMR metabolomics,X23412.Phospholipids in VLDL,CD300LF,CMRF35-like molecule 1,29725,0.0436963753893347,0.00408229335606662,0.0356950804114442,0.0516976703672253,1.09181595731229e-26
NMR metabolomics,X23412.Phospholipids in VLDL,BGN,Biglycan,28750,-0.0866221999530068,0.00810568681679084,-0.102509346113917,-0.0707350537920968,1.31960781509807e-26
NMR metabolomics,X23412.Phospholipids in VLDL,TAFA5,Chemokine-like protein TAFA-5,29349,0.0261859443022205,0.00245278845407307,0.0213784789322372,0.0309934096722037,1.47522635267527e-26
NMR metabolomics,X23412.Phospholipids in VLDL,CD86,T-lymphocyte activation antigen CD86,24805,0.0216729805432091,0.00203246768693982,0.0176893438768071,0.0256566172096112,1.72357062873144e-26
NMR metabolomics,X23412.Phospholipids in VLDL,LEPR,Leptin receptor,29478,-0.0223536092443279,0.00210104611418384,-0.0264716596281283,-0.0182355588605276,2.18469051043146e-26
NMR metabolomics,X23412.Phospholipids in VLDL,FES,Tyrosine-protein kinase Fes/Fps,28797,0.0341653338880415,0.00321128487852197,0.0278712155261384,0.0404594522499446,2.19339196979931e-26
NMR metabolomics,X23412.Phospholipids in VLDL,HGFAC,Hepatocyte growth factor activator,24720,0.0201043912114745,0.00190545788915694,0.0163696937487269,0.0238390886742222,5.7110666784568e-26
NMR metabolomics,X23412.Phospholipids in VLDL,GPR15L,Protein GPR15L,24805,0.043791143638459,0.00415058798156507,0.0356559911945914,0.0519262960823265,5.73053312411835e-26
NMR metabolomics,X23412.Phospholipids in VLDL,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,24445,0.0272490223499785,0.0025850291250492,0.0221823652648821,0.0323156794350749,6.34884091173644e-26
NMR metabolomics,X23412.Phospholipids in VLDL,SNX5,Sorting nexin-5,24240,0.0213486756862083,0.00202661777855906,0.0173765048402325,0.025320846532184,6.84070265138114e-26
NMR metabolomics,X23412.Phospholipids in VLDL,IDS,Iduronate 2-sulfatase,29786,0.00632903477724766,0.000601630599488939,0.00514983880224934,0.00750823075224598,7.77285335145834e-26
NMR metabolomics,X23412.Phospholipids in VLDL,CXADR,Coxsackievirus and adenovirus receptor,29434,0.0364897319761226,0.00347020875922064,0.0296881228080502,0.0432913411441951,8.17567381189163e-26
NMR metabolomics,X23412.Phospholipids in VLDL,IL6ST,Interleukin-6 receptor subunit beta,29478,0.0125332127368126,0.00119280894543635,0.0101953072037574,0.0148711182698679,8.87944747225909e-26
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINA6,Corticosteroid-binding globulin,24966,0.0120008559966113,0.00114409086745408,0.00975843789640134,0.0142432740968213,1.09273416729217e-25
NMR metabolomics,X23412.Phospholipids in VLDL,CBS,Cystathionine beta-synthase,24240,0.036399922046391,0.00347776778726908,0.0295834971833436,0.0432163469094384,1.39659606506581e-25
NMR metabolomics,X23412.Phospholipids in VLDL,DNAJB8,DnaJ homolog subfamily B member 8,28916,0.0407208572952356,0.00389490217268879,0.0330868490367655,0.0483548655537056,1.54526377117031e-25
NMR metabolomics,X23412.Phospholipids in VLDL,LETM1,Mitochondrial proton/calcium exchanger protein,24867,0.0373163368295074,0.00357242641920829,0.0303143810478591,0.0443182926111556,1.73223523362707e-25
NMR metabolomics,X23412.Phospholipids in VLDL,AARSD1,Alanyl-tRNA editing protein Aarsd1,29349,0.0386436787973808,0.00370662993068798,0.0313786841332324,0.0459086734615292,2.09958922456762e-25
NMR metabolomics,X23412.Phospholipids in VLDL,IGFBP4,Insulin-like growth factor-binding protein 4,28967,0.0309476691710004,0.0029686363909988,0.0251291418446427,0.036766196497358,2.1174371630627e-25
NMR metabolomics,X23412.Phospholipids in VLDL,PRDX1,Peroxiredoxin-1,28669,-0.0635775197205891,0.00610859873952527,-0.0755503732500586,-0.0516046661911196,2.5328130651681e-25
NMR metabolomics,X23412.Phospholipids in VLDL,GC,Vitamin D-binding protein,24966,0.0182730206833295,0.00175725894097091,0.0148287931590265,0.0217172482076325,2.8340755946548e-25
NMR metabolomics,X23412.Phospholipids in VLDL,LACRT,Extracellular glycoprotein lacritin,24732,0.035114950016437,0.00337939184234094,0.0284913420054488,0.0417385580274253,3.07436325539428e-25
NMR metabolomics,X23412.Phospholipids in VLDL,CA12,Carbonic anhydrase 12,29349,-0.0229277244250286,0.00220771630598325,-0.0272548483847558,-0.0186006004653015,3.20018990235306e-25
NMR metabolomics,X23412.Phospholipids in VLDL,CRYGD,Gamma-crystallin D,24845,0.0681375608670059,0.0065669930045801,0.0552662545780289,0.0810088671559829,3.59865802032236e-25
NMR metabolomics,X23412.Phospholipids in VLDL,CD163,Scavenger receptor cysteine-rich type 1 protein M130,29594,0.0301125555527121,0.00290420763603094,0.0244203085860915,0.0358048025193328,3.80502385748338e-25
NMR metabolomics,X23412.Phospholipids in VLDL,CPQ,Carboxypeptidase Q,24920,0.025939851847019,0.0025032374932611,0.0210335063602272,0.0308461973338107,4.12953741945449e-25
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINA12,Serpin A12,28628,0.078375047937206,0.00757090621609809,0.0635360717536537,0.0932140241207582,4.53178995109906e-25
NMR metabolomics,X23412.Phospholipids in VLDL,VAMP5,Vesicle-associated membrane protein 5,28916,0.0378217488170413,0.00366219877932962,0.0306438392095552,0.0449996584245273,5.84224612331889e-25
NMR metabolomics,X23412.Phospholipids in VLDL,APOB,Apolipoprotein B-100,24951,0.0157759186122974,0.00152791091324933,0.0127812132223287,0.0187706240022661,6.08849472051507e-25
NMR metabolomics,X23412.Phospholipids in VLDL,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",28931,0.0417038070388275,0.00404167863437259,0.0337821169154572,0.0496254971621978,6.42529704467273e-25
NMR metabolomics,X23412.Phospholipids in VLDL,S100A12,Protein S100-A12,29023,0.0523788995997511,0.00507853025938838,0.0424249802913499,0.0623328189081524,6.74043042253715e-25
NMR metabolomics,X23412.Phospholipids in VLDL,CST5,Cystatin-D,28890,0.0387543244178973,0.0037630221215135,0.0313788010597309,0.0461298477760638,7.88316506949982e-25
NMR metabolomics,X23412.Phospholipids in VLDL,GRSF1,G-rich sequence factor 1,23862,0.0565130174047142,0.00548773491639931,0.0457570569685716,0.0672689778408569,8.10445830941233e-25
NMR metabolomics,X23412.Phospholipids in VLDL,ZBTB17,Zinc finger and BTB domain-containing protein 17,28916,0.0287994853292781,0.00279719814329682,0.0233169769684164,0.0342819936901399,8.12194400185871e-25
NMR metabolomics,X23412.Phospholipids in VLDL,HLA_E,,29434,0.0201972978293533,0.00196363105450906,0.0163485809625156,0.0240460146961911,9.00534189647583e-25
NMR metabolomics,X23412.Phospholipids in VLDL,AGER,Advanced glycosylation end product-specific receptor,29378,0.0283439603639135,0.00275566731183653,0.0229428524327139,0.0337450682951131,9.00618287508316e-25
NMR metabolomics,X23412.Phospholipids in VLDL,ADGRG2,Adhesion G-protein coupled receptor G2,29478,0.0188535408267257,0.00183527176285593,0.0152564081715281,0.0224506734819233,1.02780140137831e-24
NMR metabolomics,X23412.Phospholipids in VLDL,KLRB1,Killer cell lectin-like receptor subfamily B member 1,29786,0.0263910110087077,0.00256917609174269,0.021355425868892,0.0314265961485233,1.03443609049824e-24
NMR metabolomics,X23412.Phospholipids in VLDL,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",24805,0.0716128578117032,0.00697157568287752,0.0579485694732633,0.0852771461501432,1.05486101053928e-24
NMR metabolomics,X23412.Phospholipids in VLDL,AMFR,E3 ubiquitin-protein ligase AMFR,28774,0.0443484836298713,0.00432229725541384,0.0358767810092601,0.0528201862504824,1.17202454077553e-24
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINI2,Serpin I2,24805,0.0394481882069183,0.00385362710349735,0.0318950790840635,0.0470012973297731,1.52057381681915e-24
NMR metabolomics,X23412.Phospholipids in VLDL,FCRL2,Fc receptor-like protein 2,29645,0.0340812699748497,0.00333583077999417,0.0275430416460611,0.0406194983036383,1.83230997600856e-24
NMR metabolomics,X23412.Phospholipids in VLDL,SLITRK6,SLIT and NTRK-like protein 6,28916,-0.0237236182324236,0.00232244552602306,-0.0282756114634288,-0.0191716250014184,1.87083841791287e-24
NMR metabolomics,X23412.Phospholipids in VLDL,KLK4,Kallikrein-4,29725,-0.0434602934665338,0.00425922976012533,-0.0518083837963795,-0.0351122031366882,2.09210069788053e-24
NMR metabolomics,X23412.Phospholipids in VLDL,CD80,T-lymphocyte activation antigen CD80,24922,0.0236824812480473,0.00232139146817857,0.0191325539704173,0.0282324085256773,2.17264602656051e-24
NMR metabolomics,X23412.Phospholipids in VLDL,CSDE1,Cold shock domain-containing protein E1,24111,0.0819954651818938,0.00804521327489605,0.0662268471630976,0.0977640832006901,2.41644022467552e-24
NMR metabolomics,X23412.Phospholipids in VLDL,BRK1,Protein BRICK1,28774,0.0308035748074506,0.00302999592589558,0.0248647827926953,0.0367423668222059,3.0840125136725e-24
NMR metabolomics,X23412.Phospholipids in VLDL,AFAP1,Actin filament-associated protein 1,24381,0.0579995894234279,0.0057119124852551,0.0468042409523279,0.0691949378945279,3.54815501853508e-24
NMR metabolomics,X23412.Phospholipids in VLDL,IGHMBP2,DNA-binding protein SMUBP-2,24111,0.0384290106016532,0.00378662005488219,0.0310072352940841,0.0458507859092223,3.75817858676779e-24
NMR metabolomics,X23412.Phospholipids in VLDL,CLEC5A,C-type lectin domain family 5 member A,29395,-0.0200662177084449,0.00197820958122738,-0.0239435084876506,-0.0161889269292393,3.87658307430676e-24
NMR metabolomics,X23412.Phospholipids in VLDL,NXPH3,Neurexophilin-3,24229,0.0208091591664849,0.00205705887464803,0.0167773237721748,0.024840994560795,5.23837549780812e-24
NMR metabolomics,X23412.Phospholipids in VLDL,CD300A,CMRF35-like molecule 8,24381,0.0205922312928777,0.00203634875333529,0.0166009877363406,0.0245834748494149,5.43252067773911e-24
NMR metabolomics,X23412.Phospholipids in VLDL,PNLIP,Pancreatic triacylglycerol lipase,24951,0.0433008300008256,0.00428572866191822,0.0349008018234659,0.0517008581781853,5.92827224676134e-24
NMR metabolomics,X23412.Phospholipids in VLDL,COL24A1,Collagen alpha-1(XXIV) chain,24805,0.0380675787154851,0.00377170713129927,0.0306750327381386,0.0454601246928317,6.60352241598352e-24
NMR metabolomics,X23412.Phospholipids in VLDL,GIMAP8,GTPase IMAP family member 8,24016,0.0349257269232216,0.00346499989571532,0.0281343271276196,0.0417171267188236,7.58766129024752e-24
NMR metabolomics,X23412.Phospholipids in VLDL,WASF3,Wiskott-Aldrich syndrome protein family member 3,28774,0.057330171774139,0.00570187861122134,0.0461544896961452,0.0685058538521329,9.59592980190659e-24
NMR metabolomics,X23412.Phospholipids in VLDL,CILP,Cartilage intermediate layer protein 1,24938,0.0371575467943889,0.00369680617130924,0.0299118066986228,0.044403286890155,1.00656198064423e-23
NMR metabolomics,X23412.Phospholipids in VLDL,TF,Serotransferrin,24966,0.014745917465382,0.00146733570262276,0.0118699394882414,0.0176218954425226,1.02498394195942e-23
NMR metabolomics,X23412.Phospholipids in VLDL,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,24240,-0.0239846458853099,0.00238910206903196,-0.0286672859406126,-0.0193020058300073,1.14045630218443e-23
NMR metabolomics,X23412.Phospholipids in VLDL,CTSC,Dipeptidyl peptidase 1,29446,0.029414824510351,0.00293459611508326,0.0236630161247878,0.0351666328959142,1.31170422170807e-23
NMR metabolomics,X23412.Phospholipids in VLDL,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",28797,0.0538181764384136,0.00537103003447894,0.0432909575708349,0.0643453953059924,1.35986825769157e-23
NMR metabolomics,X23412.Phospholipids in VLDL,SCGB3A1,Secretoglobin family 3A member 1,24381,-0.0173432924791798,0.0017343792147144,-0.0207426757400201,-0.0139439092183396,1.69650906811553e-23
NMR metabolomics,X23412.Phospholipids in VLDL,SIGLEC9,Sialic acid-binding Ig-like lectin 9,29683,0.0202471415277975,0.00202796282165151,0.0162723343973605,0.0242219486582344,1.95065216974088e-23
NMR metabolomics,X23412.Phospholipids in VLDL,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,29434,0.0253415832140365,0.00254306627123387,0.0203571733224181,0.0303259931056548,2.36248028351564e-23
NMR metabolomics,X23412.Phospholipids in VLDL,CFHR2,Complement factor H-related protein 2,24789,0.0384723732628767,0.00387434060580188,0.030878665675505,0.0460660808502484,3.40466784219322e-23
NMR metabolomics,X23412.Phospholipids in VLDL,LCP1,Plastin-2,24938,0.031938975354037,0.00322043924767896,0.0256269144285862,0.0382510362794877,3.85337105634002e-23
NMR metabolomics,X23412.Phospholipids in VLDL,CWC15,Spliceosome-associated protein CWC15 homolog,24681,0.0406730613884208,0.00410512184559767,0.0326270225710493,0.0487191002057922,4.2491597596833e-23
NMR metabolomics,X23412.Phospholipids in VLDL,GOT1,"Aspartate aminotransferase, cytoplasmic",24938,0.0281229121001106,0.00283941450036412,0.0225576596793969,0.0336881645208242,4.39137281649197e-23
NMR metabolomics,X23412.Phospholipids in VLDL,THBS4,Thrombospondin-4,29518,0.0303108923550989,0.00306089035697579,0.0243115472554263,0.0363102374547714,4.40499024589006e-23
NMR metabolomics,X23412.Phospholipids in VLDL,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",24793,0.0249240793856803,0.00251741391554713,0.019989948111208,0.0298582106601527,4.56376888757551e-23
NMR metabolomics,X23412.Phospholipids in VLDL,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,28916,0.0383431288625459,0.00387477055439557,0.0307485785759306,0.0459376791491612,4.73381721440419e-23
NMR metabolomics,X23412.Phospholipids in VLDL,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",24240,0.0469136667511715,0.00474086157758134,0.0376215780591121,0.0562057554432309,4.81079707692858e-23
NMR metabolomics,X23412.Phospholipids in VLDL,PRTG,Protogenin,29725,0.0166859995487876,0.00168718518421669,0.0133791165877229,0.0199928825098523,5.00093136638332e-23
NMR metabolomics,X23412.Phospholipids in VLDL,COPB2,Coatomer subunit beta',24111,0.0289296457878612,0.00292483931795545,0.0231969607246685,0.0346623308510539,5.03779562281904e-23
NMR metabolomics,X23412.Phospholipids in VLDL,CAPG,Macrophage-capping protein,29174,0.038990339813938,0.00394859908826656,0.0312510856009356,0.0467295940269405,5.83618041687687e-23
NMR metabolomics,X23412.Phospholipids in VLDL,CIT,Citron Rho-interacting kinase,24195,0.0303119560562308,0.00307756751478278,0.0242799237272566,0.0363439883852051,7.61907941610481e-23
NMR metabolomics,X23412.Phospholipids in VLDL,FABP2,"Fatty acid-binding protein, intestinal",29478,-0.0521783965176139,0.00531028827174021,-0.0625865615302247,-0.0417702315050031,9.43918667814191e-23
NMR metabolomics,X23412.Phospholipids in VLDL,SNX2,Sorting nexin-2,24793,0.0542133107004092,0.0055203298674781,0.0433934641601521,0.0650331572406663,1.00932837547476e-22
NMR metabolomics,X23412.Phospholipids in VLDL,PPM1A,Protein phosphatase 1A,28797,0.0206818585237367,0.00210865670444776,0.0165488913830191,0.0248148256644543,1.12800497685947e-22
NMR metabolomics,X23412.Phospholipids in VLDL,MDM1,Nuclear protein MDM1,24195,0.0208410709491807,0.00212655269035552,0.0166730276760839,0.0250091142222775,1.2357310321146e-22
NMR metabolomics,X23412.Phospholipids in VLDL,EPHB4,Ephrin type-B receptor 4,29820,-0.0165284674429887,0.00168899522534982,-0.0198388980846744,-0.0132180368013031,1.39882785250559e-22
NMR metabolomics,X23412.Phospholipids in VLDL,PCDH1,Protocadherin-1,29713,0.0140609099890414,0.00143713743357019,0.0112441206192438,0.016877699358839,1.42715533133557e-22
NMR metabolomics,X23412.Phospholipids in VLDL,CPA2,Carboxypeptidase A2,29577,0.0431211240694273,0.00441508292741577,0.0344675615316924,0.0517746866071623,1.69097564435082e-22
NMR metabolomics,X23412.Phospholipids in VLDL,ADAMTSL2,ADAMTS-like protein 2,24938,0.0217932601243674,0.00223175772499175,0.0174190149833835,0.0261675052653512,1.74484734935411e-22
NMR metabolomics,X23412.Phospholipids in VLDL,REPS1,RalBP1-associated Eps domain-containing protein 1,24229,0.025583011762077,0.00262264676873851,0.0204426240953495,0.0307233994288045,1.93796072856406e-22
NMR metabolomics,X23412.Phospholipids in VLDL,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,24805,0.0543617892668674,0.00558216480163734,0.0434207462556582,0.0653028322780766,2.26620963510613e-22
NMR metabolomics,X23412.Phospholipids in VLDL,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,24922,0.0222494925559613,0.00229081916023721,0.0177594870018963,0.0267394981100262,2.92225122789294e-22
NMR metabolomics,X23412.Phospholipids in VLDL,GCLM,Glutamate--cysteine ligase regulatory subunit,24111,0.0295853116345194,0.00305182441552671,0.023603735780087,0.0355668874889517,3.49992857635099e-22
NMR metabolomics,X23412.Phospholipids in VLDL,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",28797,0.0331170382747666,0.00342481350760065,0.0264044037998693,0.0398296727496638,4.38048643228949e-22
NMR metabolomics,X23412.Phospholipids in VLDL,CD8A,T-cell surface glycoprotein CD8 alpha chain,29694,0.0323394337982842,0.00334531757609118,0.0257826113491454,0.0388962562474229,4.48498713870447e-22
NMR metabolomics,X23412.Phospholipids in VLDL,LRRC25,Leucine-rich repeat-containing protein 25,29349,0.0255434530996554,0.00264275214982248,0.0203636588860033,0.0307232473133074,4.55941497958322e-22
NMR metabolomics,X23412.Phospholipids in VLDL,C2CD2L,Phospholipid transfer protein C2CD2L,28719,0.0277336118020287,0.00287073653050301,0.0221069682022428,0.0333602554018146,4.77955755470886e-22
NMR metabolomics,X23412.Phospholipids in VLDL,TDP1,Tyrosyl-DNA phosphodiesterase 1,24793,0.0448406326667363,0.00464121149436715,0.0357438581377767,0.053937407195696,4.80985028511155e-22
NMR metabolomics,X23412.Phospholipids in VLDL,ZBP1,Z-DNA-binding protein 1,24229,0.0267107932790111,0.00276593418060364,0.021289562285028,0.0321320242729942,5.02793182750783e-22
NMR metabolomics,X23412.Phospholipids in VLDL,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",24240,0.0506326797612709,0.00524463699493574,0.0403531912511968,0.0609121682713449,5.17037065398711e-22
NMR metabolomics,X23412.Phospholipids in VLDL,MNDA,Myeloid cell nuclear differentiation antigen,29426,0.0632200062328753,0.00658636245622824,0.050310735818668,0.0761292766470827,8.72043603225945e-22
NMR metabolomics,X23412.Phospholipids in VLDL,PPME1,Protein phosphatase methylesterase 1,29349,0.0386932543999366,0.00404779831784279,0.0307595696969647,0.0466269391029084,1.27740853043506e-21
NMR metabolomics,X23412.Phospholipids in VLDL,DSC2,Desmocollin-2,29135,-0.0222137726162338,0.00232765324608141,-0.0267759729785533,-0.0176515722539142,1.48606841656413e-21
NMR metabolomics,X23412.Phospholipids in VLDL,VWC2,Brorin,29114,0.0257772631335967,0.00270190775089662,0.0204815239418393,0.0310730023253541,1.53002597519538e-21
NMR metabolomics,X23412.Phospholipids in VLDL,FCRL3,Fc receptor-like protein 3,28931,0.0349719692058666,0.00366744361548551,0.0277837797195151,0.0421601586922182,1.59998252630992e-21
NMR metabolomics,X23412.Phospholipids in VLDL,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,29462,0.0374781268239855,0.00393397622121061,0.0297675334304127,0.0451887202175583,1.74230086210872e-21
NMR metabolomics,X23412.Phospholipids in VLDL,GAS2,Growth arrest-specific protein 2,24445,0.0341649798449227,0.00358846689442228,0.0271315847318551,0.0411983749579904,1.87278768794161e-21
NMR metabolomics,X23412.Phospholipids in VLDL,RABEPK,Rab9 effector protein with kelch motifs,28797,0.037959861569839,0.00399171804557253,0.0301360942005168,0.0457836289391612,2.05668726085895e-21
NMR metabolomics,X23412.Phospholipids in VLDL,CABP2,Calcium-binding protein 2,24195,0.0420214156788026,0.00443560288166323,0.0333276340307427,0.0507151973268626,2.94139818568754e-21
NMR metabolomics,X23412.Phospholipids in VLDL,ENSA,Alpha-endosulfine,24793,0.0339409702764359,0.00358515093259503,0.0269140744485496,0.0409678661043221,3.12519767872673e-21
NMR metabolomics,X23412.Phospholipids in VLDL,PRSS22,Brain-specific serine protease 4,24229,0.0224998105774276,0.00237882472478417,0.0178373141168506,0.0271623070380045,3.40268827350558e-21
NMR metabolomics,X23412.Phospholipids in VLDL,CAT,Catalase,24587,0.0343406510181872,0.00363400209666665,0.0272180069087205,0.0414632951276538,3.68704674338662e-21
NMR metabolomics,X23412.Phospholipids in VLDL,NXPH1,Neurexophilin-1,28774,0.0244250808317477,0.00258778893207181,0.019353014524887,0.0294971471386085,4.05378008218208e-21
NMR metabolomics,X23412.Phospholipids in VLDL,TGFA,Protransforming growth factor alpha,29434,0.0298069731162632,0.00316317725455491,0.0236071456973355,0.0360068005351908,4.68897955229805e-21
NMR metabolomics,X23412.Phospholipids in VLDL,LTB,Lymphotoxin-beta,24793,0.0223372650507178,0.00237117224105305,0.0176897674582539,0.0269847626431818,4.87555042592031e-21
NMR metabolomics,X23412.Phospholipids in VLDL,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,24195,0.0348138708623585,0.00369998767073215,0.0275618950277235,0.0420658466969935,5.43079212495663e-21
NMR metabolomics,X23412.Phospholipids in VLDL,IGSF21,Immunoglobulin superfamily member 21,24240,0.0253650431101243,0.00269871130670381,0.0200755689489848,0.0306545172712638,5.98306487927987e-21
NMR metabolomics,X23412.Phospholipids in VLDL,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",24229,0.0284829064497455,0.0030324652529679,0.0225392745539284,0.0344265383455625,6.35029508306889e-21
NMR metabolomics,X23412.Phospholipids in VLDL,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",29378,0.0414995544809344,0.00442269718294996,0.0328310680023525,0.0501680409595164,6.83859591551018e-21
NMR metabolomics,X23412.Phospholipids in VLDL,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",29434,0.0274524313986966,0.00293522512315529,0.0216993901573122,0.033205472640081,9.1256663685542e-21
NMR metabolomics,X23412.Phospholipids in VLDL,COMP,Cartilage oligomeric matrix protein,29214,0.0212878580156358,0.00227877308365062,0.0168214627716805,0.025754253259591,1.01221912018851e-20
NMR metabolomics,X23412.Phospholipids in VLDL,NFIC,Nuclear factor 1 C-type,24867,0.0282240941093869,0.00302181719188566,0.0223013324132911,0.0341468558054828,1.04056683879243e-20
NMR metabolomics,X23412.Phospholipids in VLDL,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",28719,0.0296786181840723,0.00318072494799078,0.0234443972860104,0.0359128390821342,1.12429837582005e-20
NMR metabolomics,X23412.Phospholipids in VLDL,APOD,Apolipoprotein D,23787,-0.027617282210162,0.00295937917760843,-0.0334176653982745,-0.0218168990220495,1.12572502895243e-20
NMR metabolomics,X23412.Phospholipids in VLDL,ICOSLG,ICOS ligand,29349,0.0120601476933944,0.00129401839150235,0.00952387164604985,0.014596423740739,1.24327295203493e-20
NMR metabolomics,X23412.Phospholipids in VLDL,PDCD1,Programmed cell death protein 1,29661,0.0270515722636876,0.00290460848879932,0.021358539625641,0.0327446049017343,1.32178117325566e-20
NMR metabolomics,X23412.Phospholipids in VLDL,CA2,Carbonic anhydrase 2,29368,0.0432719360759473,0.00464726030266574,0.0341633058827224,0.0523805662691722,1.34833351782861e-20
NMR metabolomics,X23412.Phospholipids in VLDL,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",24240,0.0235441533897352,0.00252851006526801,0.0185882736618099,0.0285000331176605,1.36458223408035e-20
NMR metabolomics,X23412.Phospholipids in VLDL,SFTPD,Pulmonary surfactant-associated protein D,29478,0.0421191479802202,0.00452666881129299,0.033246877110086,0.0509914188503545,1.43429838032964e-20
NMR metabolomics,X23412.Phospholipids in VLDL,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",29566,-0.0219460028144021,0.00236083016512931,-0.0265732299380556,-0.0173187756907487,1.55714833271868e-20
NMR metabolomics,X23412.Phospholipids in VLDL,PSMD9,26S proteasome non-ATPase regulatory subunit 9,29349,0.0340789867277372,0.00366801524722969,0.026889676843167,0.0412682966123074,1.63310860923493e-20
NMR metabolomics,X23412.Phospholipids in VLDL,PRL,Prolactin,29694,-0.0475705430985514,0.00513118464198876,-0.0576276649968493,-0.0375134212002534,1.96747461204741e-20
NMR metabolomics,X23412.Phospholipids in VLDL,RCOR1,REST corepressor 1,28916,0.028022291973581,0.00302512882518139,0.0220930394762255,0.0339515444709365,2.1178021533504e-20
NMR metabolomics,X23412.Phospholipids in VLDL,CBLIF,Cobalamin binding intrinsic factor,29433,0.0465104664107218,0.00504131836021173,0.0366294824247068,0.0563914503967368,2.99568525356729e-20
NMR metabolomics,X23412.Phospholipids in VLDL,S100A11,Protein S100-A11,29208,0.0284224489128377,0.0030812074425153,0.0223832823255077,0.0344616155001677,3.03649326715225e-20
NMR metabolomics,X23412.Phospholipids in VLDL,NCAN,Neurocan core protein,29694,0.0233310307556019,0.00253045795826949,0.0183713331573937,0.0282907283538101,3.15917020243559e-20
NMR metabolomics,X23412.Phospholipids in VLDL,PECR,Peroxisomal trans-2-enoyl-CoA reductase,24240,0.0175670405388938,0.00191069580928807,0.0138220767526892,0.0213120043250984,4.07894291390977e-20
NMR metabolomics,X23412.Phospholipids in VLDL,CTSH,Pro-cathepsin H,28852,0.0456390531578217,0.00496513392040825,0.0359073906738216,0.0553707156418219,4.11121800040129e-20
NMR metabolomics,X23412.Phospholipids in VLDL,YAP1,Transcriptional coactivator YAP1,24845,0.0168535637689637,0.00183576276413248,0.013255468751264,0.0204516587866633,4.60809536772465e-20
NMR metabolomics,X23412.Phospholipids in VLDL,FCER2,Low affinity immunoglobulin epsilon Fc receptor,29443,0.0314897474995984,0.00343460076019597,0.0247579300096142,0.0382215649895825,5.10520773213392e-20
NMR metabolomics,X23412.Phospholipids in VLDL,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,24445,0.0450610025433546,0.00491487693251898,0.0354278437556174,0.0546941613310919,5.1742745177675e-20
NMR metabolomics,X23412.Phospholipids in VLDL,CA4,Carbonic anhydrase 4,29820,-0.0147500223842241,0.00160981880955196,-0.017905267250946,-0.0115947775175023,5.38482011552794e-20
NMR metabolomics,X23412.Phospholipids in VLDL,ADGRG1,Adhesion G-protein coupled receptor G1,29349,-0.0428320212814945,0.00467714441868431,-0.0519992243421157,-0.0336648182208732,5.63483439168505e-20
NMR metabolomics,X23412.Phospholipids in VLDL,NPTX1,Neuronal pentraxin-1,29443,0.0252117274400518,0.00275383700333164,0.0198142069135217,0.0306092479665818,5.7707809336622e-20
NMR metabolomics,X23412.Phospholipids in VLDL,PLXNB2,Plexin-B2,29701,0.0147873719815501,0.00161590600479378,0.0116201962121543,0.0179545477509459,5.9843713171908e-20
NMR metabolomics,X23412.Phospholipids in VLDL,IL1B,Interleukin-1 beta,28745,0.0348941916735479,0.0038139797931915,0.0274187912788925,0.0423695920682032,6.11430328704974e-20
NMR metabolomics,X23412.Phospholipids in VLDL,RNASE3,Eosinophil cationic protein,29343,0.0672258199081389,0.007352826074477,0.052814280802164,0.0816373590141138,6.46421963445496e-20
NMR metabolomics,X23412.Phospholipids in VLDL,PRELP,Prolargin,29454,0.0143731828894553,0.00157449947651871,0.0112871639154786,0.017459201863432,7.36118902999396e-20
NMR metabolomics,X23412.Phospholipids in VLDL,LIPF,Gastric triacylglycerol lipase,24240,0.0378302556248745,0.00414847537225289,0.0296992438952589,0.0459612673544902,8.14986695354335e-20
NMR metabolomics,X23412.Phospholipids in VLDL,CRH,Corticoliberin,28751,0.0536324567010723,0.00588236285422775,0.0421030255067859,0.0651618878953587,8.17467969799644e-20
NMR metabolomics,X23412.Phospholipids in VLDL,PRSS53,Serine protease 53,24845,0.0231315127059828,0.00253681324220279,0.0181593587512654,0.0281036666607003,8.19094471532602e-20
NMR metabolomics,X23412.Phospholipids in VLDL,GNLY,Granulysin,29443,0.0321625182104057,0.00353389421123886,0.0252360855563776,0.0390889508644339,9.48625765338656e-20
NMR metabolomics,X23412.Phospholipids in VLDL,AREG,Amphiregulin,29349,-0.0280472225247235,0.00309416796420914,-0.0341117917345734,-0.0219826533148736,1.32706794022979e-19
NMR metabolomics,X23412.Phospholipids in VLDL,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,29497,0.0207624248501012,0.00229296423850111,0.016268214942639,0.0252566347575634,1.44975173277134e-19
NMR metabolomics,X23412.Phospholipids in VLDL,APLP1,Amyloid-like protein 1,29478,-0.031517194289949,0.00348214558081257,-0.0383421996283417,-0.0246921889515564,1.50041117683123e-19
NMR metabolomics,X23412.Phospholipids in VLDL,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,29218,0.042813226500683,0.00473238634063924,0.03353774927303,0.0520887037283359,1.56026008033494e-19
NMR metabolomics,X23412.Phospholipids in VLDL,SORBS1,Sorbin and SH3 domain-containing protein 1,24867,0.0241595642766844,0.00267355835030361,0.0189193899100893,0.0293997386432795,1.73275201000231e-19
NMR metabolomics,X23412.Phospholipids in VLDL,ECM1,Extracellular matrix protein 1,24349,0.0225198387321127,0.00249945992689119,0.017620897275406,0.0274187801888195,2.21059607048511e-19
NMR metabolomics,X23412.Phospholipids in VLDL,NAGA,Alpha-N-acetylgalactosaminidase,24177,0.0358238467433753,0.00397684925493409,0.0280292222037045,0.0436184712830461,2.24783197100386e-19
NMR metabolomics,X23412.Phospholipids in VLDL,LUZP2,Leucine zipper protein 2,24793,0.0273577633802026,0.0030409421164626,0.0213975168319359,0.0333180099284693,2.49371761645929e-19
NMR metabolomics,X23412.Phospholipids in VLDL,DSG4,Desmoglein-4,29242,0.0301856797914142,0.00335944197303397,0.0236011735242676,0.0367701860585608,2.73107142553799e-19
NMR metabolomics,X23412.Phospholipids in VLDL,CD59,CD59 glycoprotein,28277,0.0140030711909975,0.0015616573297973,0.0109422228245948,0.0170639195574002,3.23635527756949e-19
NMR metabolomics,X23412.Phospholipids in VLDL,NCF2,Neutrophil cytosol factor 2,29395,0.0503322798346001,0.00561965000721844,0.0393177658204519,0.0613467938487482,3.54521072114056e-19
NMR metabolomics,X23412.Phospholipids in VLDL,MMP12,Macrophage metalloelastase,29466,0.0321163672736224,0.00359516018110261,0.0250698533186613,0.0391628812285835,4.37303506639206e-19
NMR metabolomics,X23412.Phospholipids in VLDL,EBI3_IL27,Interleukin-27,29674,-0.0187050724439833,0.00209446083664225,-0.0228102156838021,-0.0145999292041645,4.47055852138408e-19
NMR metabolomics,X23412.Phospholipids in VLDL,GPNMB,Transmembrane glycoprotein NMB,28733,0.0173175159463431,0.00194178492779882,0.0135116174878574,0.0211234144048288,5.00722243695028e-19
NMR metabolomics,X23412.Phospholipids in VLDL,TOR1AIP1,Torsin-1A-interacting protein 1,24240,0.0309629505299264,0.00348033915605134,0.0241414857840658,0.0377844152757871,6.15575226377917e-19
NMR metabolomics,X23412.Phospholipids in VLDL,TINAGL1,Tubulointerstitial nephritis antigen-like,29425,0.0134164665942852,0.00150844947343584,0.0104599056263509,0.0163730275622195,6.21277224786576e-19
NMR metabolomics,X23412.Phospholipids in VLDL,KLRF1,Killer cell lectin-like receptor subfamily F member 1,24229,0.0262781910729681,0.00296636840626504,0.0204641089966886,0.0320922731492475,8.63881856526306e-19
NMR metabolomics,X23412.Phospholipids in VLDL,SCN4B,Sodium channel subunit beta-4,24240,0.0256834733335588,0.00290074779675537,0.0199980076519182,0.0313689390151993,9.00280276088549e-19
NMR metabolomics,X23412.Phospholipids in VLDL,MYOM3,Myomesin-3,24381,-0.0561722596226188,0.00634547079815905,-0.0686093823870105,-0.043735136858227,9.14107170058183e-19
NMR metabolomics,X23412.Phospholipids in VLDL,CTSF,Cathepsin F,29566,0.0240252036704212,0.00271509279049156,0.0187036218010577,0.0293467855397846,9.33225604165001e-19
NMR metabolomics,X23412.Phospholipids in VLDL,DMP1,Dentin matrix acidic phosphoprotein 1,24240,-0.0365388561046395,0.00413398826944041,-0.0446414731127427,-0.0284362390965363,1.03335576542683e-18
NMR metabolomics,X23412.Phospholipids in VLDL,GFAP,Glial fibrillary acidic protein,28753,0.0276116063772308,0.00313231975151387,0.0214722596642636,0.033750953090198,1.26222350569944e-18
NMR metabolomics,X23412.Phospholipids in VLDL,CYTL1,Cytokine-like protein 1,24938,0.0144129136113593,0.00164012636064464,0.0111982659444958,0.0176275612782227,1.62313965397298e-18
NMR metabolomics,X23412.Phospholipids in VLDL,PTPRH,Receptor-type tyrosine-protein phosphatase H,24805,0.0292286647394311,0.00332832939836923,0.0227051391186274,0.0357521903602348,1.71092436710879e-18
NMR metabolomics,X23412.Phospholipids in VLDL,ITGB1BP1,Integrin beta-1-binding protein 1,28797,0.024214777067309,0.00276715732178481,0.0187911487166108,0.0296384054180072,2.2323438831099e-18
NMR metabolomics,X23412.Phospholipids in VLDL,GALNT7,N-acetylgalactosaminyltransferase 7,29349,0.0124112623979954,0.00142079989243655,0.00962649460881973,0.015196030187171,2.55444246326174e-18
NMR metabolomics,X23412.Phospholipids in VLDL,CSF3R,Granulocyte colony-stimulating factor receptor,24229,0.0181409328283555,0.00209585790654723,0.0140330513315229,0.022248814325188,5.20260249353436e-18
NMR metabolomics,X23412.Phospholipids in VLDL,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,29725,0.0188552817305601,0.00218228621180791,0.0145780007554166,0.0231325627057036,5.89029475475753e-18
NMR metabolomics,X23412.Phospholipids in VLDL,PZP,Pregnancy zone protein,24966,0.0312163263823913,0.00362463668997548,0.0241120384700394,0.0383206142947433,7.57945577098177e-18
NMR metabolomics,X23412.Phospholipids in VLDL,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,28916,-0.0179246146260305,0.00208831955987064,-0.022017720963377,-0.013831508288684,9.67591482234377e-18
NMR metabolomics,X23412.Phospholipids in VLDL,JAM2,Junctional adhesion molecule B,29694,0.0155208000735239,0.00180876286301803,0.0119756248620085,0.0190659752850392,9.86524076934766e-18
NMR metabolomics,X23412.Phospholipids in VLDL,TACSTD2,Tumor-associated calcium signal transducer 2,25976,-0.0181629555307288,0.00211739337015629,-0.0223130465362351,-0.0140128645252225,1.01855415923087e-17
NMR metabolomics,X23412.Phospholipids in VLDL,IL1R1,Interleukin-1 receptor type 1,29390,-0.0133717216101752,0.001559074348507,-0.016427507333249,-0.0103159358871015,1.02349346621801e-17
NMR metabolomics,X23412.Phospholipids in VLDL,SAA4,Serum amyloid A-4 protein,24966,0.0190597234047794,0.00222470056881921,0.0146993102898938,0.023420136519665,1.1194647434741e-17
NMR metabolomics,X23412.Phospholipids in VLDL,CCL15,C-C motif chemokine 15,29820,0.0255016967750273,0.00297985470118949,0.0196611815606959,0.0313422119893587,1.20229976977504e-17
NMR metabolomics,X23412.Phospholipids in VLDL,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,29218,0.0172139289412888,0.00201649024267975,0.0132616080656364,0.0211662498169411,1.44852234016713e-17
NMR metabolomics,X23412.Phospholipids in VLDL,SLAMF7,SLAM family member 7,29434,-0.0337102740764512,0.00396914153500946,-0.0414897914850697,-0.0259307566678326,2.10552334251846e-17
NMR metabolomics,X23412.Phospholipids in VLDL,NECTIN2,Nectin-2,29433,0.0171227840774185,0.0020176152367249,0.0131682582134377,0.0210773099413993,2.22527971338458e-17
NMR metabolomics,X23412.Phospholipids in VLDL,UMOD,Uromodulin,29750,-0.0309037699657134,0.00365357122948422,-0.0380647695755024,-0.0237427703559243,2.830421616481e-17
NMR metabolomics,X23412.Phospholipids in VLDL,COL28A1,Collagen alpha-1(XXVIII) chain,24195,0.0442496064703713,0.00523134372587018,0.0339961727676658,0.0545030401730769,2.8581439602162e-17
NMR metabolomics,X23412.Phospholipids in VLDL,PBK,Lymphokine-activated killer T-cell-originated protein kinase,24016,-0.0175886258085632,0.0020817606875466,-0.0216688767561545,-0.0135083748609718,3.10466121932194e-17
NMR metabolomics,X23412.Phospholipids in VLDL,IL12RB1,Interleukin-12 receptor subunit beta-1,28931,0.0216154473329602,0.00256262825899593,0.0165926959453282,0.0266381987205922,3.46789183524067e-17
NMR metabolomics,X23412.Phospholipids in VLDL,VSIG10,V-set and immunoglobulin domain-containing protein 10,24793,0.0201184903367693,0.00238816755296922,0.0154376819329496,0.0247992987405889,3.82541236081029e-17
NMR metabolomics,X23412.Phospholipids in VLDL,VIPR1,Vasoactive intestinal polypeptide receptor 1,24240,-0.0142781694895668,0.00169519983369883,-0.0176007611636165,-0.0109555778155171,3.88022804468962e-17
NMR metabolomics,X23412.Phospholipids in VLDL,BAX,Apoptosis regulator BAX,28722,0.051300876927065,0.00611702545923549,0.0393115070269634,0.0632902468271666,5.231540073554e-17
NMR metabolomics,X23412.Phospholipids in VLDL,TPM3,Tropomyosin alpha-3 chain,24111,-0.0251560385560934,0.00300327861465677,-0.0310424646408207,-0.0192696124713661,5.76095045187571e-17
NMR metabolomics,X23412.Phospholipids in VLDL,GSTT2B,Glutathione S-transferase theta-2B,24845,0.135666862686746,0.016262193712946,0.103792963009372,0.167540762364121,7.64899302693337e-17
NMR metabolomics,X23412.Phospholipids in VLDL,ICAM5,Intercellular adhesion molecule 5,29478,0.0253572384678752,0.00304648977124669,0.0193861185162317,0.0313283584195187,8.91053339649611e-17
NMR metabolomics,X23412.Phospholipids in VLDL,IGFBP6,Insulin-like growth factor-binding protein 6,29394,0.0169139620234019,0.00203379961747511,0.0129277147731507,0.0209002092736531,9.45189897695328e-17
NMR metabolomics,X23412.Phospholipids in VLDL,KIF1C,Kinesin-like protein KIF1C,24111,0.0205316528652128,0.00247023456227603,0.0156899931231517,0.0253733126072738,9.93273680262494e-17
NMR metabolomics,X23412.Phospholipids in VLDL,PRKD2,Serine/threonine-protein kinase D2,24111,0.0257619899178843,0.00310929377318791,0.019667774122436,0.0318562057133326,1.23691785122994e-16
NMR metabolomics,X23412.Phospholipids in VLDL,CHGA,Chromogranin-A,24938,-0.049410454681061,0.00596544001458111,-0.06110271710964,-0.037718192252482,1.26306211977944e-16
NMR metabolomics,X23412.Phospholipids in VLDL,PIGR,Polymeric immunoglobulin receptor,29115,0.0202777112620083,0.00245026711520102,0.0154751877162143,0.0250802348078023,1.330847279425e-16
NMR metabolomics,X23412.Phospholipids in VLDL,CA9,Carbonic anhydrase 9,29725,-0.0255512988376783,0.00309758440115092,-0.0316225642639341,-0.0194800334114225,1.66552868178116e-16
NMR metabolomics,X23412.Phospholipids in VLDL,LYPD3,Ly6/PLAUR domain-containing protein 3,29340,0.0191390998354498,0.00232868239997245,0.0145748823315038,0.0237033173393958,2.13838526880781e-16
NMR metabolomics,X23412.Phospholipids in VLDL,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,24240,0.0206059890723898,0.00250803705948753,0.0156902364357942,0.0255217417089854,2.20850833815059e-16
NMR metabolomics,X23412.Phospholipids in VLDL,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,29536,0.0495159691307366,0.00603029416961759,0.0376965925582861,0.061335345703187,2.27822567874329e-16
NMR metabolomics,X23412.Phospholipids in VLDL,LMNB2,Lamin-B2,24845,0.0155799227020061,0.00190149640758988,0.0118529897431299,0.0193068556608822,2.65837012608169e-16
NMR metabolomics,X23412.Phospholipids in VLDL,COL9A1,Collagen alpha-1(IX) chain,29434,0.0258864881391053,0.00317235671717431,0.0196686689734436,0.0321043073047669,3.48206641095995e-16
NMR metabolomics,X23412.Phospholipids in VLDL,BCL2,Apoptosis regulator Bcl-2,24805,0.0297316654221207,0.00364678609274082,0.0225839646803487,0.0368793661638927,3.72134984957557e-16
NMR metabolomics,X23412.Phospholipids in VLDL,EFHD1,EF-hand domain-containing protein D1,24867,0.0194955683251182,0.00239493688809679,0.0148014920244485,0.0241896446257879,4.12528823671745e-16
NMR metabolomics,X23412.Phospholipids in VLDL,NFYA,Nuclear transcription factor Y subunit alpha,24111,0.0212226601916065,0.00261297616977081,0.0161012268988557,0.0263440934843573,4.80250462561057e-16
NMR metabolomics,X23412.Phospholipids in VLDL,SART1,U4/U6.U5 tri-snRNP-associated protein 1,24111,0.0201256469079959,0.00248351333163933,0.0152579607779828,0.024993333038009,5.58228030770241e-16
NMR metabolomics,X23412.Phospholipids in VLDL,CA7,Carbonic anhydrase 7,24445,-0.0189241757341579,0.00233691237721834,-0.0235045239935058,-0.0143438274748099,5.8485603871467e-16
NMR metabolomics,X23412.Phospholipids in VLDL,DSG3,Desmoglein-3,29589,0.0187060728274885,0.00231682257593917,0.0141651005786477,0.0232470450763293,7.05818288899365e-16
NMR metabolomics,X23412.Phospholipids in VLDL,MEPE,Matrix extracellular phosphoglycoprotein,29454,0.0136768851712797,0.00170638858728476,0.0103323635402015,0.0170214068023578,1.14084722775365e-15
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINA7,Thyroxine-binding globulin,24966,0.0100751090454947,0.00125862445136622,0.00760820512081693,0.0125420129701725,1.24778393217378e-15
NMR metabolomics,X23412.Phospholipids in VLDL,IL22RA1,Interleukin-22 receptor subunit alpha-1,28931,0.0234040513704697,0.00292440606250018,0.0176722154879693,0.02913588725297,1.25928837686054e-15
NMR metabolomics,X23412.Phospholipids in VLDL,AGT,Angiotensinogen,24951,0.0125492417466097,0.00156923211789568,0.00947354679553418,0.0156249366976853,1.32919359118613e-15
NMR metabolomics,X23412.Phospholipids in VLDL,TMPRSS11D,Transmembrane protease serine 11D,24801,0.0208507424044012,0.00261020008075181,0.0157347502461276,0.0259667345626747,1.42861338747326e-15
NMR metabolomics,X23412.Phospholipids in VLDL,CD300E,CMRF35-like molecule 2,29642,0.0219963960726619,0.00275906502389276,0.0165886286258321,0.0274041635194917,1.611696166801e-15
NMR metabolomics,X23412.Phospholipids in VLDL,MTPN,Myotrophin,28916,0.0176825570562548,0.00222205549705081,0.0133273282820352,0.0220377858304743,1.81570989168997e-15
NMR metabolomics,X23412.Phospholipids in VLDL,CD300C,CMRF35-like molecule 6,29694,0.0186254478246237,0.00234192584976016,0.0140352731590938,0.0232156224901537,1.88405265809718e-15
NMR metabolomics,X23412.Phospholipids in VLDL,DGCR6,Protein DGCR6,24101,0.0236759111257621,0.0029767488139454,0.0178414834504291,0.0295103388010951,1.89062668744896e-15
NMR metabolomics,X23412.Phospholipids in VLDL,BCAN,Brevican core protein,29218,0.0183186426293947,0.00230476546916186,0.0138013023098374,0.0228359829489519,1.96083090367064e-15
NMR metabolomics,X23412.Phospholipids in VLDL,DDR1,Epithelial discoidin domain-containing receptor 1,29694,0.012454410960788,0.00157906929983309,0.00935943513311518,0.0155493867884609,3.19638522632892e-15
NMR metabolomics,X23412.Phospholipids in VLDL,PCSK7,Proprotein convertase subtilisin/kexin type 7,24793,0.0240292084325359,0.00305667298360912,0.018038129384662,0.0300202874804097,3.95787085708688e-15
NMR metabolomics,X23412.Phospholipids in VLDL,ATP6V1G2,V-type proton ATPase subunit G 2,24111,0.0530574028091983,0.00676532077145576,0.039797374097145,0.0663174315212516,4.59690516889809e-15
NMR metabolomics,X23412.Phospholipids in VLDL,C1QL2,Complement C1q-like protein 2,24229,0.0229081784652136,0.00292226509763168,0.0171805388738555,0.0286358180565717,4.72070124325758e-15
NMR metabolomics,X23412.Phospholipids in VLDL,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,28931,0.0193374441585689,0.00246871281925459,0.0144987670328299,0.0241761212843079,4.92592210906513e-15
NMR metabolomics,X23412.Phospholipids in VLDL,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,29786,0.0185602083305611,0.00236971305891892,0.01391557073508,0.0232048459260422,4.95045755338931e-15
NMR metabolomics,X23412.Phospholipids in VLDL,RNF149,E3 ubiquitin-protein ligase RNF149,24240,0.0164228726341505,0.00209690639180242,0.0123129361062177,0.0205328091620832,4.99960544709671e-15
NMR metabolomics,X23412.Phospholipids in VLDL,SFTPA1,Pulmonary surfactant-associated protein A1,28797,0.0306327197658464,0.00391476669440309,0.0229597770448163,0.0383056624868764,5.25340555339127e-15
NMR metabolomics,X23412.Phospholipids in VLDL,CCN5,CCN family member 5,29443,0.0205621014707357,0.00263525108547229,0.01539700934321,0.0257271935982614,6.25911409442278e-15
NMR metabolomics,X23412.Phospholipids in VLDL,CDH5,Cadherin-5,29820,-0.0160389593734366,0.00205705075480736,-0.0200707788528591,-0.0120071398940142,6.54217871226947e-15
NMR metabolomics,X23412.Phospholipids in VLDL,COL6A3,Collagen alpha-3(VI) chain,29820,0.0184617432779207,0.00236969029224298,0.0138171503051245,0.023106336250717,6.87515379552515e-15
NMR metabolomics,X23412.Phospholipids in VLDL,ARID4B,AT-rich interactive domain-containing protein 4B,28774,0.0217143281815301,0.00278988292690512,0.016246157644796,0.0271824987182641,7.30547713397958e-15
NMR metabolomics,X23412.Phospholipids in VLDL,LAMTOR5,Ragulator complex protein LAMTOR5,24793,0.0215970574030364,0.0027747423530174,0.0161585623911222,0.0270355524149505,7.33219916629759e-15
NMR metabolomics,X23412.Phospholipids in VLDL,SPTLC1,Serine palmitoyltransferase 1,24845,0.0196138194313783,0.00252073123595897,0.0146731862088988,0.0245544526538579,7.47421188940924e-15
NMR metabolomics,X23412.Phospholipids in VLDL,HSPA2,Heat shock-related 70 kDa protein 2,24793,0.0179970606440148,0.00231385601139872,0.0134619028616734,0.0225322184263563,7.65686643270192e-15
NMR metabolomics,X23412.Phospholipids in VLDL,INSL5,Insulin-like peptide INSL5,24805,0.0514958952379231,0.00663779265594311,0.0384858216322746,0.0645059688435716,8.96022820483137e-15
NMR metabolomics,X23412.Phospholipids in VLDL,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,24016,0.0351629990897997,0.00454284777613008,0.0262590174485847,0.0440669807310146,1.03082922466059e-14
NMR metabolomics,X23412.Phospholipids in VLDL,ODAM,Odontogenic ameloblast-associated protein,28722,0.0280132868329098,0.00363565485689166,0.0208874033134022,0.0351391703524175,1.34889859646509e-14
NMR metabolomics,X23412.Phospholipids in VLDL,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",28774,0.0157522759834966,0.00204714928124297,0.0117398633922603,0.0197646885747328,1.4631554217426e-14
NMR metabolomics,X23412.Phospholipids in VLDL,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,24805,0.0207267661496413,0.0026969781005991,0.0154406890724671,0.0260128432268156,1.58428460827749e-14
NMR metabolomics,X23412.Phospholipids in VLDL,NPTXR,Neuronal pentraxin receptor,29478,0.0176954600954656,0.00230637452586758,0.0131749660247652,0.0222159541661661,1.73991051644056e-14
NMR metabolomics,X23412.Phospholipids in VLDL,TDO2,"Tryptophan 2,3-dioxygenase",24195,0.0203292407768802,0.00264988825919348,0.015135459788861,0.0255230217648994,1.76074248516149e-14
NMR metabolomics,X23412.Phospholipids in VLDL,GZMB,Granzyme B,29434,0.0338022728788845,0.00441852166990733,0.0251419704058662,0.0424625753519029,2.06898941712392e-14
NMR metabolomics,X23412.Phospholipids in VLDL,UBAC1,Ubiquitin-associated domain-containing protein 1,29349,0.0177556702331139,0.00233031988023864,0.0131882432678462,0.0223230971983816,2.62504666463965e-14
NMR metabolomics,X23412.Phospholipids in VLDL,CGREF1,Cell growth regulator with EF hand domain protein 1,29478,0.0219515522986806,0.00288372531778356,0.0162994506758249,0.0276036539215364,2.77473307645528e-14
NMR metabolomics,X23412.Phospholipids in VLDL,BRD1,Bromodomain-containing protein 1,24445,-0.0158510773495233,0.00208637154396415,-0.0199403655756931,-0.0117617891233536,3.12876938704575e-14
NMR metabolomics,X23412.Phospholipids in VLDL,FGF16,Fibroblast growth factor 16,24229,0.0247548295290226,0.00325877515734926,0.0183676302206181,0.0311420288374272,3.15584295548599e-14
NMR metabolomics,X23412.Phospholipids in VLDL,ANGPTL4,Angiopoietin-related protein 4,29536,-0.0231580304912766,0.00305796459376145,-0.0291516410950491,-0.0171644198875042,3.75289805333426e-14
NMR metabolomics,X23412.Phospholipids in VLDL,MZB1,Marginal zone B- and B1-cell-specific protein,29542,-0.0262935614388218,0.00347429838592126,-0.0331031862752275,-0.0194839366024161,3.89987499881577e-14
NMR metabolomics,X23412.Phospholipids in VLDL,GPC1,Glypican-1,29725,0.0150534532741282,0.00199514941425034,0.0111429604221975,0.0189639461260588,4.65124835175812e-14
NMR metabolomics,X23412.Phospholipids in VLDL,NEO1,Neogenin,24867,0.0111774202460397,0.00148977639390473,0.00825745851398647,0.014097381978093,6.45858952423713e-14
NMR metabolomics,X23412.Phospholipids in VLDL,PRUNE2,Protein prune homolog 2,24445,0.0148878140709852,0.00198697591095763,0.0109933412855083,0.0187822868564622,6.9758566839103e-14
NMR metabolomics,X23412.Phospholipids in VLDL,VSIG4,V-set and immunoglobulin domain-containing protein 4,29396,-0.0208190138789419,0.00277918152468264,-0.0262662096673199,-0.0153718180905639,7.02392347479402e-14
NMR metabolomics,X23412.Phospholipids in VLDL,CA1,Carbonic anhydrase 1,28867,0.0302826086826417,0.00404537098399203,0.0223536815540173,0.038211535811266,7.31733698808949e-14
NMR metabolomics,X23412.Phospholipids in VLDL,CSF1R,Macrophage colony-stimulating factor 1 receptor,24951,0.0203557231280822,0.00272266520098954,0.0150192993341427,0.0256921469220217,7.89030666234582e-14
NMR metabolomics,X23412.Phospholipids in VLDL,DUSP3,Dual specificity protein phosphatase 3,28774,0.0430877115312859,0.00577233611122715,0.0317739327532807,0.0544014903092911,8.59710588184373e-14
NMR metabolomics,X23412.Phospholipids in VLDL,PSPN,Persephin,29434,0.0474683259390889,0.00636737198069158,0.0349882768569334,0.0599483750212444,9.23886918059413e-14
NMR metabolomics,X23412.Phospholipids in VLDL,CLPS,Colipase,29400,0.0357496477071665,0.00480539389503748,0.026331075672893,0.0451682197414399,1.03842096321035e-13
NMR metabolomics,X23412.Phospholipids in VLDL,CD93,Complement component C1q receptor,28353,-0.0158604053782252,0.00213321750763185,-0.0200415116931837,-0.0116792990632668,1.07550743452571e-13
NMR metabolomics,X23412.Phospholipids in VLDL,FCRL5,Fc receptor-like protein 5,29443,-0.0289021683050106,0.0038968433065453,-0.0365399811858394,-0.0212643554241818,1.23203833947453e-13
NMR metabolomics,X23412.Phospholipids in VLDL,BTN2A1,Butyrophilin subfamily 2 member A1,29581,0.0132489294870736,0.00179109598603498,0.00973838135444506,0.0167594776197022,1.4287784272181e-13
NMR metabolomics,X23412.Phospholipids in VLDL,MST1,Hepatocyte growth factor-like protein,24615,0.0322654559237044,0.00436258367746319,0.0237147919158765,0.0408161199315322,1.4488718974491e-13
NMR metabolomics,X23412.Phospholipids in VLDL,MILR1,Allergin-1,28931,-0.0252714643757773,0.00342026782176352,-0.0319751893064338,-0.0185677394451208,1.52234909593432e-13
NMR metabolomics,X23412.Phospholipids in VLDL,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,29218,0.0194808929121915,0.00263707976340034,0.0143122165759268,0.0246495692484562,1.53849763669098e-13
NMR metabolomics,X23412.Phospholipids in VLDL,CR2,Complement receptor type 2,29594,0.0232795093725039,0.00315460047007641,0.0170964924511541,0.0294625262938536,1.63008999123776e-13
NMR metabolomics,X23412.Phospholipids in VLDL,HSD17B3,Testosterone 17-beta-dehydrogenase 3,24111,0.0242381168205819,0.00328796652699472,0.0177937024276722,0.0306825312134915,1.73808460210044e-13
NMR metabolomics,X23412.Phospholipids in VLDL,MYOM2,Myomesin-2,24111,-0.0255428379149012,0.00347284664763207,-0.0323496173442601,-0.0187360584855423,1.97001174304612e-13
NMR metabolomics,X23412.Phospholipids in VLDL,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,29640,0.0144336330544869,0.00196424515178167,0.0105837125569948,0.018283553551979,2.06103545234488e-13
NMR metabolomics,X23412.Phospholipids in VLDL,CENPF,Centromere protein F,24445,0.027069379824173,0.00368629673653711,0.0198442382205602,0.0342945214277857,2.14998375009337e-13
NMR metabolomics,X23412.Phospholipids in VLDL,DPP7,Dipeptidyl peptidase 2,29279,0.0296797210492341,0.0040764885454406,0.0216898035001705,0.0376696385982977,3.4043690404372e-13
NMR metabolomics,X23412.Phospholipids in VLDL,SEL1L,Protein sel-1 homolog 1,24240,0.0158053346094559,0.00217138678118173,0.0115494165183397,0.0200612527005721,3.46773520323198e-13
NMR metabolomics,X23412.Phospholipids in VLDL,DIPK2B,Divergent protein kinase domain 2B,24381,0.0139433165457686,0.00191595530395222,0.0101880441500222,0.0176985889415149,3.50419246751929e-13
NMR metabolomics,X23412.Phospholipids in VLDL,CRTAC1,Cartilage acidic protein 1,29820,0.0147813563809738,0.00203771732537484,0.0107874304232391,0.0187752823387085,4.1486654459452e-13
NMR metabolomics,X23412.Phospholipids in VLDL,NME3,Nucleoside diphosphate kinase 3,29497,0.0117297543310515,0.00161876810914296,0.00855696883713128,0.0149025398249717,4.39466853119035e-13
NMR metabolomics,X23412.Phospholipids in VLDL,DCTPP1,dCTP pyrophosphatase 1,29478,0.0155744713124175,0.00215247483094948,0.0113556206437565,0.0197933219810784,4.74745755804205e-13
NMR metabolomics,X23412.Phospholipids in VLDL,LYZL2,Lysozyme-like protein 2,24016,0.017745587602823,0.00245265952432405,0.0129383749351478,0.0225528002704981,4.78648503515781e-13
NMR metabolomics,X23412.Phospholipids in VLDL,IL34,Interleukin-34,28722,0.017711861415804,0.00244969317953203,0.0129104627839212,0.0225132600476868,4.94196549029081e-13
NMR metabolomics,X23412.Phospholipids in VLDL,EGFLAM,Pikachurin,24805,0.0150899841110992,0.00209357789492022,0.0109865714370555,0.0191933967851428,5.85123133947382e-13
NMR metabolomics,X23412.Phospholipids in VLDL,RALY,RNA-binding protein Raly,24793,0.0235605290239758,0.00326926560988957,0.0171527684285923,0.0299682896193594,5.89760801318766e-13
NMR metabolomics,X23412.Phospholipids in VLDL,LYAR,Cell growth-regulating nucleolar protein,28797,0.0258053896803639,0.0035815526481011,0.0187855464900857,0.032825232870642,5.9433101232608e-13
NMR metabolomics,X23412.Phospholipids in VLDL,FABP9,Fatty acid-binding protein 9,29434,0.0272838613098847,0.00379536833685859,0.0198449393696419,0.0347227832501276,6.69564558264122e-13
NMR metabolomics,X23412.Phospholipids in VLDL,CEBPA,CCAAT/enhancer-binding protein alpha,24229,0.0182072921370404,0.00254867668874255,0.013211885827105,0.0232026984469758,9.33387776232849e-13
NMR metabolomics,X23412.Phospholipids in VLDL,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,24845,0.0305283702446826,0.00427734414000712,0.0221447757302687,0.0389119647590966,9.78501291959855e-13
NMR metabolomics,X23412.Phospholipids in VLDL,MPO,Myeloperoxidase,29443,0.0221734250840318,0.00310978195322055,0.0160782524557195,0.028268597712344,1.02519410492953e-12
NMR metabolomics,X23412.Phospholipids in VLDL,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,24867,-0.0183333322579534,0.00257104686553677,-0.0233725841144055,-0.0132940804015014,1.02600289727262e-12
NMR metabolomics,X23412.Phospholipids in VLDL,PDGFRA,Platelet-derived growth factor receptor alpha,29478,-0.0137569140578785,0.00192978369929651,-0.0175392901084997,-0.00997453800725733,1.03626583963991e-12
NMR metabolomics,X23412.Phospholipids in VLDL,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,29786,0.0187316309109072,0.00262866830455438,0.0135794410339806,0.0238838207878337,1.05751728478392e-12
NMR metabolomics,X23412.Phospholipids in VLDL,GBP4,Guanylate-binding protein 4,28774,0.0236359793695536,0.0033285760284606,0.0171119703537708,0.0301599883853364,1.26797825847455e-12
NMR metabolomics,X23412.Phospholipids in VLDL,APOA1,Apolipoprotein A-I,24966,-0.0132350271280948,0.00186779162348769,-0.0168958987101307,-0.00957415554605895,1.41790555182518e-12
NMR metabolomics,X23412.Phospholipids in VLDL,UXS1,UDP-glucuronic acid decarboxylase 1,28797,0.025224285389019,0.00356423067852059,0.0182383932591186,0.0322101775189193,1.50610744349367e-12
NMR metabolomics,X23412.Phospholipids in VLDL,CRLF1,Cytokine receptor-like factor 1,29581,0.0123572508866767,0.00174751991877765,0.00893211184587253,0.0157823899274809,1.56887434381811e-12
NMR metabolomics,X23412.Phospholipids in VLDL,LHB,Lutropin subunit beta,28797,0.0416437405510263,0.00589369968036257,0.0300920891775157,0.053195391924537,1.63316988037899e-12
NMR metabolomics,X23412.Phospholipids in VLDL,SCGB1A1,Uteroglobin,29523,0.0264547985386217,0.00374478186388985,0.0191150260853976,0.0337945709918458,1.64834339357039e-12
NMR metabolomics,X23412.Phospholipids in VLDL,TNFSF13,Tumor necrosis factor ligand superfamily member 13,29581,0.0128665020246262,0.0018240366605508,0.00929139016994661,0.0164416138793057,1.77844776698308e-12
NMR metabolomics,X23412.Phospholipids in VLDL,MRC1,Macrophage mannose receptor 1,24951,0.0135672638830646,0.00192470085244752,0.0097948502122675,0.0173396775538618,1.84867785194939e-12
NMR metabolomics,X23412.Phospholipids in VLDL,CNTN2,Contactin-2,29725,0.0212623333892196,0.00302397385516039,0.0153353446331052,0.027189322145334,2.09103629309631e-12
NMR metabolomics,X23412.Phospholipids in VLDL,PFDN2,Prefoldin subunit 2,28774,0.0265076894572301,0.00377006595894763,0.0191183601776927,0.0338970187367675,2.09492991044334e-12
NMR metabolomics,X23412.Phospholipids in VLDL,GLYR1,Putative oxidoreductase GLYR1,24793,0.0280965716787592,0.00403075690840465,0.0201962881382861,0.0359968552192324,3.23630210068308e-12
NMR metabolomics,X23412.Phospholipids in VLDL,NELL2,Protein kinase C-binding protein NELL2,29581,0.013475433686886,0.00193515843326564,0.00968252315768539,0.0172683442160867,3.38906135558268e-12
NMR metabolomics,X23412.Phospholipids in VLDL,RHOC,Rho-related GTP-binding protein RhoC,29089,0.054973660433905,0.00789948079721557,0.0394906780713625,0.0704566427964475,3.49589783876082e-12
NMR metabolomics,X23412.Phospholipids in VLDL,VEGFB,Vascular endothelial growth factor B,24229,0.013680113923541,0.0019686278410981,0.00982160335498876,0.0175386244920933,3.77047237103127e-12
NMR metabolomics,X23412.Phospholipids in VLDL,ANGPT2,Angiopoietin-2,29725,-0.0179456570964024,0.00258324835729662,-0.0230088238767038,-0.012882490316101,3.80995182458969e-12
NMR metabolomics,X23412.Phospholipids in VLDL,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,29114,0.0156517019873802,0.00225723710155943,0.0112275172683237,0.0200758867064367,4.17617123362572e-12
NMR metabolomics,X23412.Phospholipids in VLDL,CCN3,CCN family member 3,29795,0.0158304296084528,0.00229341954274787,0.0113353273046669,0.0203255319122386,5.21022573031228e-12
NMR metabolomics,X23412.Phospholipids in VLDL,ATXN2,Ataxin-2,24101,0.0519992687710004,0.00754311450589215,0.0372147643394518,0.0667837732025491,5.57378099131525e-12
NMR metabolomics,X23412.Phospholipids in VLDL,TYRO3,Tyrosine-protein kinase receptor TYRO3,29478,0.0132417836215772,0.00192142043139557,0.0094757995760419,0.0170077676671125,5.62529202697672e-12
NMR metabolomics,X23412.Phospholipids in VLDL,NECTIN1,Nectin-1,24229,0.0151654229952293,0.00220299687053068,0.0108475491289892,0.0194832968614694,5.96172632673972e-12
NMR metabolomics,X23412.Phospholipids in VLDL,GM2A,Ganglioside GM2 activator,24421,0.0179552089579619,0.00261056351188944,0.0128385044746586,0.0230719134412652,6.22051114943911e-12
NMR metabolomics,X23412.Phospholipids in VLDL,AHSP,Alpha-hemoglobin-stabilizing protein,29400,0.039336023187447,0.00572121464215379,0.0281224424888256,0.0505496038860685,6.30218240329939e-12
NMR metabolomics,X23412.Phospholipids in VLDL,CD55,Complement decay-accelerating factor,28490,0.0122455969853598,0.00178151975139681,0.0087538182726221,0.0157373756980976,6.38557382047901e-12
NMR metabolomics,X23412.Phospholipids in VLDL,MRPL46,"39S ribosomal protein L46, mitochondrial",28774,0.01286081844697,0.00187341971746519,0.00918891580073824,0.0165327210932018,6.78937281784087e-12
NMR metabolomics,X23412.Phospholipids in VLDL,USP47,Ubiquitin carboxyl-terminal hydrolase 47,24111,0.0399082974242887,0.00582490507907743,0.028491483469297,0.0513251113792805,7.49327983201761e-12
NMR metabolomics,X23412.Phospholipids in VLDL,DKK3,Dickkopf-related protein 3,29820,-0.013634409890902,0.00199428646251689,-0.0175432113574351,-0.00972560842436889,8.2578687986693e-12
NMR metabolomics,X23412.Phospholipids in VLDL,SYT1,Synaptotagmin-1,24845,0.0183319175445512,0.00268629337193728,0.0130667825355541,0.0235970525535483,9.04231435091556e-12
NMR metabolomics,X23412.Phospholipids in VLDL,CST1,Cystatin-SN,21656,0.0486111254680569,0.00715845705317285,0.0345805496438381,0.0626417012922757,1.14461347178119e-11
NMR metabolomics,X23412.Phospholipids in VLDL,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,24195,0.0478077353664386,0.00704321799904012,0.03400302808832,0.0616124426445572,1.16514498192325e-11
NMR metabolomics,X23412.Phospholipids in VLDL,PCDHB15,Protocadherin beta-15,24793,-0.0184590668455082,0.00272070719571514,-0.0237916529491098,-0.0131264807419065,1.18982695659668e-11
NMR metabolomics,X23412.Phospholipids in VLDL,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,29786,0.0126269170830697,0.00186490971601707,0.00897169403967625,0.0162821401264631,1.30456086205926e-11
NMR metabolomics,X23412.Phospholipids in VLDL,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,29349,0.0205949219727686,0.00304498950628536,0.0146267425404493,0.0265631014050879,1.37182321811645e-11
NMR metabolomics,X23412.Phospholipids in VLDL,CA6,Carbonic anhydrase 6,29372,-0.028868733799256,0.00428115299253475,-0.0372597936646241,-0.0204776739338879,1.57789873920235e-11
NMR metabolomics,X23412.Phospholipids in VLDL,LY9,T-lymphocyte surface antigen Ly-9,29116,0.013419758848986,0.00199480579290465,0.00950993949489286,0.0173295782030791,1.75978725644563e-11
NMR metabolomics,X23412.Phospholipids in VLDL,MYL3,Myosin light chain 3,24240,-0.0333721855148248,0.00497230472829998,-0.0431179027822928,-0.0236264682473568,1.96733375542052e-11
NMR metabolomics,X23412.Phospholipids in VLDL,PDGFRB,Platelet-derived growth factor receptor beta,29820,0.0157494776959722,0.00235574929767595,0.0111322090725273,0.0203667463194171,2.34117563085987e-11
NMR metabolomics,X23412.Phospholipids in VLDL,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,24922,0.0124683301250378,0.00187070870826023,0.00880174105684771,0.0161349191932278,2.7013606455817e-11
NMR metabolomics,X23412.Phospholipids in VLDL,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,24229,0.0152911418427708,0.00229570975788017,0.0107915507173257,0.019790732968216,2.78277467478716e-11
NMR metabolomics,X23412.Phospholipids in VLDL,RAB37,Ras-related protein Rab-37,28931,0.0371203803794035,0.00557540548314567,0.026192585632438,0.048048175126369,2.82774599774928e-11
NMR metabolomics,X23412.Phospholipids in VLDL,REG4,Regenerating islet-derived protein 4,29497,0.0223829811493625,0.00336600993893764,0.0157856016690447,0.0289803606296803,2.98802690970269e-11
NMR metabolomics,X23412.Phospholipids in VLDL,PDIA5,Protein disulfide-isomerase A5,24016,0.0277359405636816,0.00417858356028706,0.019545916785519,0.0359259643418443,3.25538975128983e-11
NMR metabolomics,X23412.Phospholipids in VLDL,RLN1,Prorelaxin H1,24867,-0.0310373802702711,0.00468131454472412,-0.0402127567779304,-0.0218620037626119,3.42435988490236e-11
NMR metabolomics,X23412.Phospholipids in VLDL,PSME2,Proteasome activator complex subunit 2,29081,0.0162471655847457,0.0024546009482217,0.0114361477262311,0.0210581834432602,3.67760842124745e-11
NMR metabolomics,X23412.Phospholipids in VLDL,CRISP3,Cysteine-rich secretory protein 3,24738,-0.0121913468687875,0.00184313896831866,-0.0158038992466921,-0.00857879449088293,3.80553674918653e-11
NMR metabolomics,X23412.Phospholipids in VLDL,SOD2,"Superoxide dismutase [Mn], mitochondrial",29443,0.0168535576248468,0.00254961629657318,0.0118563096835634,0.0218508055661303,3.90270451926258e-11
NMR metabolomics,X23412.Phospholipids in VLDL,IFNGR1,Interferon gamma receptor 1,29581,0.00939425581362865,0.0014250654972152,0.00660112743908685,0.0121873841881704,4.40771962481991e-11
NMR metabolomics,X23412.Phospholipids in VLDL,SPON1,Spondin-1,29497,0.0146466050558503,0.00222434103577527,0.0102868966257308,0.0190063134859698,4.63477517980745e-11
NMR metabolomics,X23412.Phospholipids in VLDL,L1CAM,Neural cell adhesion molecule L1,29566,0.0128965457181128,0.00196223814889018,0.00905055894628801,0.0167425324899375,5.03457413135126e-11
NMR metabolomics,X23412.Phospholipids in VLDL,CRTAP,Cartilage-associated protein,24195,0.0217890314706624,0.0033158073253692,0.0152900491129388,0.0282880138283861,5.090622592606e-11
NMR metabolomics,X23412.Phospholipids in VLDL,ACTN2,Alpha-actinin-2,24111,-0.0264993869418077,0.00403344818177522,-0.0344049453780871,-0.0185938285055282,5.13730022827566e-11
NMR metabolomics,X23412.Phospholipids in VLDL,TPPP3,Tubulin polymerization-promoting protein family member 3,28774,0.0174541300131958,0.00265738341434944,0.0122456585210709,0.0226626015053207,5.18078312261374e-11
NMR metabolomics,X23412.Phospholipids in VLDL,NRCAM,Neuronal cell adhesion molecule,29478,0.0125863248334754,0.00191964101381199,0.00882382844640385,0.0163488212205468,5.5956651897458e-11
NMR metabolomics,X23412.Phospholipids in VLDL,GFRA2,GDNF family receptor alpha-2,29349,0.00935416579173971,0.0014268095563158,0.00655761906136075,0.0121507125221187,5.61865152003513e-11
NMR metabolomics,X23412.Phospholipids in VLDL,GZMH,Granzyme H,28916,0.0338426951598358,0.00518221301030368,0.0236855576596406,0.043999832660031,6.6615817023858e-11
NMR metabolomics,X23412.Phospholipids in VLDL,SBSN,Suprabasin,24905,-0.0153025156170837,0.002343315409146,-0.0198954138190098,-0.0107096174151575,6.69103301795561e-11
NMR metabolomics,X23412.Phospholipids in VLDL,CFC1,Cryptic protein,28797,0.0208185219461395,0.00318889710337851,0.0145682836235177,0.0270687602687614,6.75637220109197e-11
NMR metabolomics,X23412.Phospholipids in VLDL,LXN,Latexin,29117,-0.0297224848746646,0.00455981691455246,-0.0386597260271875,-0.0207852437221418,7.22467731106053e-11
NMR metabolomics,X23412.Phospholipids in VLDL,SIGLEC6,Sialic acid-binding Ig-like lectin 6,29725,0.0148230952433892,0.00227833853524206,0.0103575517143148,0.0192886387724637,7.83533117374051e-11
NMR metabolomics,X23412.Phospholipids in VLDL,CXCL9,C-X-C motif chemokine 9,29581,0.0292477320937196,0.0045008025099395,0.0204261591742382,0.038069305013201,8.25035311631562e-11
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINA3,Alpha-1-antichymotrypsin,24883,0.00654448675569193,0.00100773974144085,0.00456931686246787,0.00851965664891599,8.50383627426421e-11
NMR metabolomics,X23412.Phospholipids in VLDL,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,29274,0.0114950805543002,0.00177055364402867,0.00802479541200398,0.0149653656965964,8.58516203626744e-11
NMR metabolomics,X23412.Phospholipids in VLDL,CLC,Galectin-10,29426,-0.0291412809669773,0.00449314121102794,-0.037947837740592,-0.0203347241933625,8.97060748150478e-11
NMR metabolomics,X23412.Phospholipids in VLDL,SDC1,Syndecan-1,29478,0.0176636786891139,0.00272394816508185,0.0123247402855535,0.0230026170926743,9.03826609182268e-11
NMR metabolomics,X23412.Phospholipids in VLDL,GART,Trifunctional purine biosynthetic protein adenosine-3,24867,0.0118591776889285,0.00183158125715474,0.00826927842490517,0.0154490769529518,9.6690372325625e-11
NMR metabolomics,X23412.Phospholipids in VLDL,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,29454,0.0129437330651087,0.00200144586770811,0.00902089916440084,0.0168665669658166,1.01405298682218e-10
NMR metabolomics,X23412.Phospholipids in VLDL,EDA2R,Tumor necrosis factor receptor superfamily member 27,29725,-0.0167899611694684,0.00260143496289945,-0.0218887736967513,-0.0116911486421854,1.10529011099988e-10
NMR metabolomics,X23412.Phospholipids in VLDL,LMNB1,Lamin-B1,24756,0.0257288821985103,0.00399754860553867,0.0178936869316545,0.0335640774653661,1.24773755432359e-10
NMR metabolomics,X23412.Phospholipids in VLDL,FOSB,Protein fosB,28774,0.0168744549436895,0.00262680592032211,0.0117259153398582,0.0220229945475208,1.34861882334505e-10
NMR metabolomics,X23412.Phospholipids in VLDL,ANXA1,Annexin A1,24281,0.0186386514244995,0.00290923661205741,0.012936547664867,0.024340755184132,1.51414732611312e-10
NMR metabolomics,X23412.Phospholipids in VLDL,CNPY2,Protein canopy homolog 2,28916,0.0263925150928817,0.00413008462073502,0.0182975492362411,0.0344874809495224,1.68071763078814e-10
NMR metabolomics,X23412.Phospholipids in VLDL,LEO1,RNA polymerase-associated protein LEO1,24867,0.0130665763506009,0.00204564492022269,0.00905711230696447,0.0170760403942374,1.71592386085703e-10
NMR metabolomics,X23412.Phospholipids in VLDL,CSF2,Granulocyte-macrophage colony-stimulating factor,24111,0.0155428630580341,0.00243959609360104,0.0107612547145761,0.0203244714014922,1.9109256860862e-10
NMR metabolomics,X23412.Phospholipids in VLDL,MUC16,Mucin-16,29349,0.0814706662706969,0.0128126085303933,0.0563579535511259,0.106583378990268,2.06551917514374e-10
NMR metabolomics,X23412.Phospholipids in VLDL,FLT1,Vascular endothelial growth factor receptor 1,29288,0.00967667876680501,0.00152434175311832,0.00668896893069309,0.0126643886029169,2.21177759089088e-10
NMR metabolomics,X23412.Phospholipids in VLDL,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,24229,0.0134776850338554,0.00212445783706121,0.00931374767321545,0.0176416223944954,2.27746474569163e-10
NMR metabolomics,X23412.Phospholipids in VLDL,CX3CL1,Fractalkine,29218,-0.0145197070274995,0.00229044179049062,-0.0190089729368611,-0.0100304411181379,2.34240907988871e-10
NMR metabolomics,X23412.Phospholipids in VLDL,SDK2,Protein sidekick-2,24381,0.0166920834080898,0.00263568298062418,0.0115261447660664,0.0218580220501132,2.44453114323698e-10
NMR metabolomics,X23412.Phospholipids in VLDL,CREBZF,CREB/ATF bZIP transcription factor,24016,-0.0112761102153688,0.00178512296244579,-0.0147749512217626,-0.00777726920897509,2.71870297021808e-10
NMR metabolomics,X23412.Phospholipids in VLDL,SLC16A1,Monocarboxylate transporter 1,28774,0.0245284417524575,0.00391644705752876,0.0168522055197011,0.0322046779852138,3.83145618681005e-10
NMR metabolomics,X23412.Phospholipids in VLDL,SSH3,Protein phosphatase Slingshot homolog 3,24016,0.0124893800629983,0.00199841510519854,0.00857248645680918,0.0164062736691875,4.18311352557453e-10
NMR metabolomics,X23412.Phospholipids in VLDL,IL17C,Interleukin-17C,28931,-0.0298018678234223,0.0047757627006338,-0.0391623627166645,-0.02044137293018,4.42977202542602e-10
NMR metabolomics,X23412.Phospholipids in VLDL,ULBP2,UL16-binding protein 2,29218,0.016148535504333,0.00258877262497833,0.0110745411593755,0.0212225298492906,4.49526340497594e-10
NMR metabolomics,X23412.Phospholipids in VLDL,CLGN,Calmegin,24195,0.0190384737143261,0.00305557124910857,0.0130495540660733,0.0250273933625789,4.71890248396068e-10
NMR metabolomics,X23412.Phospholipids in VLDL,CLASP1,CLIP-associating protein 1,24016,0.0309639442604724,0.00497039613210615,0.0212219678415444,0.0407059206794005,4.75170607285626e-10
NMR metabolomics,X23412.Phospholipids in VLDL,MUC2,Mucin-2,24938,0.0387309265433256,0.00622086875443568,0.0265380237846316,0.0509238293020195,4.86227023330185e-10
NMR metabolomics,X23412.Phospholipids in VLDL,SEPTIN8,Septin-8,24801,0.0135771772040806,0.00218613445425826,0.00929235367373438,0.0178620007344267,5.36256565278025e-10
NMR metabolomics,X23412.Phospholipids in VLDL,GDF15,Growth/differentiation factor 15,29820,-0.0186634226939669,0.00300984786452859,-0.0245627245084429,-0.0127641208794908,5.69185121356738e-10
NMR metabolomics,X23412.Phospholipids in VLDL,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,24111,0.0216736700506846,0.00350010749378307,0.0148134593628698,0.0285338807384994,6.0255308211361e-10
NMR metabolomics,X23412.Phospholipids in VLDL,NINJ1,Ninjurin-1,28797,0.0231986793877347,0.00375216504730778,0.0158444358950114,0.0305529228804579,6.38422864522298e-10
NMR metabolomics,X23412.Phospholipids in VLDL,LAG3,Lymphocyte activation gene 3 protein,29349,-0.0170758796331871,0.00276996886750417,-0.0225050186134953,-0.0116467406528789,7.15605110610476e-10
NMR metabolomics,X23412.Phospholipids in VLDL,DLL4,Delta-like protein 4,24240,0.0360032781760849,0.00584529712247496,0.024546495816034,0.0474600605361359,7.418956747889e-10
NMR metabolomics,X23412.Phospholipids in VLDL,TGFBR2,TGF-beta receptor type-2,29566,0.0136425768352898,0.00222016926183377,0.00929104508209561,0.017994108588484,8.10676373279805e-10
NMR metabolomics,X23412.Phospholipids in VLDL,GBA,Lysosomal acid glucosylceramidase,24195,0.022533559024622,0.00366756914362658,0.0153451235031139,0.0297219945461301,8.17228869121616e-10
NMR metabolomics,X23412.Phospholipids in VLDL,DPP10,Inactive dipeptidyl peptidase 10,29434,0.0146827655682662,0.0023906788127368,0.00999703509530203,0.0193684960412303,8.27020472732953e-10
NMR metabolomics,X23412.Phospholipids in VLDL,RPA2,Replication protein A 32 kDa subunit,24229,0.0133008351900776,0.00216619872288868,0.00905508569321576,0.0175465846869394,8.37133020113387e-10
NMR metabolomics,X23412.Phospholipids in VLDL,TGFB2,Transforming growth factor beta-2 proprotein,24793,0.0218760533495994,0.00356355740252771,0.0148914808406451,0.0288606258585537,8.43963040236389e-10
NMR metabolomics,X23412.Phospholipids in VLDL,KLK8,Kallikrein-8,28443,0.0149800476371751,0.00244097487239821,0.0101957368872746,0.0197643583870756,8.52519783882124e-10
NMR metabolomics,X23412.Phospholipids in VLDL,EXTL1,Exostosin-like 1,24111,0.0198885564788368,0.00324093236777527,0.0135363290379973,0.0262407839196763,8.55789857809838e-10
NMR metabolomics,X23412.Phospholipids in VLDL,ACP1,Low molecular weight phosphotyrosine protein phosphatase,24229,0.0183604335667854,0.00299389477936658,0.0124923997992269,0.0242284673343439,8.77783842601631e-10
NMR metabolomics,X23412.Phospholipids in VLDL,TRAF3,"TNF receptor-associated factor 3, Isoform 2",24229,0.0150713508027596,0.00245916395825897,0.0102513894445721,0.0198913121609472,8.9996779752716e-10
NMR metabolomics,X23412.Phospholipids in VLDL,PLAU,Urokinase-type plasminogen activator,29443,0.0120485586687747,0.00197165116855544,0.00818412237840608,0.0159129949591434,1.00314740878124e-09
NMR metabolomics,X23412.Phospholipids in VLDL,B4GALT1,"Beta-1,4-galactosyltransferase 1",29581,0.0113966078927337,0.00186799032899725,0.00773534684789905,0.0150578689375683,1.06714710116577e-09
NMR metabolomics,X23412.Phospholipids in VLDL,DDC,Aromatic-L-amino-acid decarboxylase,29433,-0.019934955203058,0.003273004004074,-0.0263500430510431,-0.013519867355073,1.13795083837689e-09
NMR metabolomics,X23412.Phospholipids in VLDL,SATB1,DNA-binding protein SATB1,24867,0.0122601792033506,0.00201794593263937,0.00830500517537748,0.0162153532313238,1.25340445173754e-09
NMR metabolomics,X23412.Phospholipids in VLDL,SEZ6L,Seizure 6-like protein,29566,0.0113123410035876,0.00186361692111489,0.00765965183820242,0.0149650301689728,1.29385727926415e-09
NMR metabolomics,X23412.Phospholipids in VLDL,FAM171B,Protein FAM171B,24793,0.0111682714550076,0.00184562003677544,0.00755085618292771,0.0147856867270874,1.45806226246929e-09
NMR metabolomics,X23412.Phospholipids in VLDL,ICAM4,Intercellular adhesion molecule 4,29434,-0.0215564764775984,0.00356600625788728,-0.0285458487430575,-0.0145671042121393,1.51214601130557e-09
NMR metabolomics,X23412.Phospholipids in VLDL,IL18BP,Interleukin-18-binding protein,29594,0.0126036491804137,0.00209165136573247,0.00850401250357809,0.0167032858572494,1.70374874266688e-09
NMR metabolomics,X23412.Phospholipids in VLDL,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,29581,0.0173795187428812,0.00288546508283527,0.011724007180524,0.0230350303052383,1.73098284201153e-09
NMR metabolomics,X23412.Phospholipids in VLDL,SAT2,Thialysine N-epsilon-acetyltransferase,24445,0.0284757859123194,0.00473160741494204,0.019201835379033,0.0377497364456058,1.78873109476945e-09
NMR metabolomics,X23412.Phospholipids in VLDL,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,28916,0.0144070000665828,0.002394084345349,0.00971459474969874,0.0190994053834668,1.78985197290139e-09
NMR metabolomics,X23412.Phospholipids in VLDL,MELTF,Melanotransferrin,24922,0.0121192489260106,0.00201393016540889,0.00817194580180919,0.016066552050212,1.79371356657695e-09
NMR metabolomics,X23412.Phospholipids in VLDL,KLRK1,NKG2-D type II integral membrane protein,24845,0.0189463069114677,0.00315866178124962,0.0127553298202184,0.0251372840027169,2.02267520281941e-09
NMR metabolomics,X23412.Phospholipids in VLDL,GGT5,Glutathione hydrolase 5 proenzyme,29218,0.00947274820976035,0.00158030817065458,0.00637534419527737,0.0125701522242433,2.06833609396884e-09
NMR metabolomics,X23412.Phospholipids in VLDL,PREB,Prolactin regulatory element-binding protein,28931,0.0117901345380114,0.0019674528271626,0.00793392699677272,0.0156463420792501,2.08969134047724e-09
NMR metabolomics,X23412.Phospholipids in VLDL,HSBP1,Heat shock factor-binding protein 1,24240,0.0389163380458309,0.00650617127668816,0.0261642423435221,0.0516684337481397,2.24261372384709e-09
NMR metabolomics,X23412.Phospholipids in VLDL,AHNAK2,Protein AHNAK2,24240,0.0120896763423887,0.00202338624697785,0.00812383929831209,0.0160555133864653,2.33343081237875e-09
NMR metabolomics,X23412.Phospholipids in VLDL,TSPAN8,Tetraspanin-8,24805,0.0405968606398992,0.00680818382765135,0.0272528203377025,0.0539409009420958,2.51077349795832e-09
NMR metabolomics,X23412.Phospholipids in VLDL,HMOX1,Heme oxygenase 1,29165,-0.0193687011564164,0.00325602876144405,-0.0257505175288467,-0.012986884783986,2.73584235366273e-09
NMR metabolomics,X23412.Phospholipids in VLDL,NAMPT,Nicotinamide phosphoribosyltransferase,28797,0.0207734960402564,0.00349983371826862,0.0139138219524499,0.0276331701280629,2.9618292948309e-09
NMR metabolomics,X23412.Phospholipids in VLDL,SIL1,Nucleotide exchange factor SIL1,24240,0.0130049169635956,0.00219765500811058,0.00869751314769882,0.0173123207794923,3.3099820315347e-09
NMR metabolomics,X23412.Phospholipids in VLDL,IFNG,Interferon gamma,28931,0.0455625627657002,0.00771245723063388,0.0304461465936578,0.0606789789377426,3.508841706816e-09
NMR metabolomics,X23412.Phospholipids in VLDL,TBC1D17,TBC1 domain family member 17,28774,0.0178250129350194,0.00302460711139342,0.0118967829966883,0.0237532428733505,3.82700085124823e-09
NMR metabolomics,X23412.Phospholipids in VLDL,REG3A,Regenerating islet-derived protein 3-alpha,29820,-0.0246836456181559,0.00419668933948279,-0.0329091567235421,-0.0164581345127696,4.10415590294582e-09
NMR metabolomics,X23412.Phospholipids in VLDL,SCARF2,Scavenger receptor class F member 2,29694,-0.0115747248041551,0.00197668384944957,-0.0154490251490763,-0.00770042445923396,4.80211211407945e-09
NMR metabolomics,X23412.Phospholipids in VLDL,CD27,CD27 antigen,29566,-0.0165057490699934,0.00281961246409679,-0.0220321894996231,-0.0109793086403637,4.8522509538399e-09
NMR metabolomics,X23412.Phospholipids in VLDL,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,24240,0.0249830573792509,0.00426830276005213,0.0166171839695487,0.033348930788953,4.88533661059181e-09
NMR metabolomics,X23412.Phospholipids in VLDL,RSPO3,R-spondin-3,29725,0.0112276939249869,0.00192192262508802,0.00746072557981434,0.0149946622701594,5.21439294967398e-09
NMR metabolomics,X23412.Phospholipids in VLDL,MFAP4,Microfibril-associated glycoprotein 4,24381,-0.0127906927218692,0.00219046740627928,-0.0170840088381766,-0.0084973766055618,5.31007630484114e-09
NMR metabolomics,X23412.Phospholipids in VLDL,FSTL1,Follistatin-related protein 1,24240,-0.00906456102894694,0.00155382291575746,-0.0121100539438316,-0.00601906811406231,5.4895683330805e-09
NMR metabolomics,X23412.Phospholipids in VLDL,BAMBI,BMP and activin membrane-bound inhibitor homolog,28797,0.0118532963265146,0.00203415330780426,0.00786635584321827,0.015840236809811,5.69855110694962e-09
NMR metabolomics,X23412.Phospholipids in VLDL,VWF,von Willebrand factor,29820,-0.0285911078539887,0.00491594850846989,-0.0382263669305897,-0.0189558487773878,6.0890950275702e-09
NMR metabolomics,X23412.Phospholipids in VLDL,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,28931,0.0167808799747593,0.00288802702673384,0.011120347002361,0.0224414129471576,6.29393061130487e-09
NMR metabolomics,X23412.Phospholipids in VLDL,SRPX,Sushi repeat-containing protein SRPX,24922,-0.0139988642345047,0.00241093381063513,-0.0187242945033495,-0.00927343396565984,6.46023370800739e-09
NMR metabolomics,X23412.Phospholipids in VLDL,SLITRK1,SLIT and NTRK-like protein 1,24229,0.0127769628843018,0.00220580317922471,0.00845358865302138,0.0171003371155822,7.02330811243805e-09
NMR metabolomics,X23412.Phospholipids in VLDL,AZU1,Azurocidin,28534,0.0300220620967919,0.00518808619691714,0.0198534131508343,0.0401907110427495,7.25195211727057e-09
NMR metabolomics,X23412.Phospholipids in VLDL,EPHX2,Bifunctional epoxide hydrolase 2,28916,0.0241964658978313,0.00419059671240147,0.0159828963415244,0.0324100354541381,7.82076034808421e-09
NMR metabolomics,X23412.Phospholipids in VLDL,PMS1,PMS1 protein homolog 1,24195,0.0198399914042889,0.00345326037689231,0.01307160106558,0.0266083817429978,9.28632506551119e-09
NMR metabolomics,X23412.Phospholipids in VLDL,HMBS,Porphobilinogen deaminase,29725,0.0167509998730133,0.00291940290252393,0.0110289701840664,0.0224730295619602,9.68355895386497e-09
NMR metabolomics,X23412.Phospholipids in VLDL,CNTN5,Contactin-5,29511,0.0144053788925025,0.0025125671275824,0.00948074732244101,0.019330010462564,9.94371926734428e-09
NMR metabolomics,X23412.Phospholipids in VLDL,TNFSF8,Tumor necrosis factor ligand superfamily member 8,24938,0.0141227997363842,0.00246425815863839,0.00929285374545294,0.0189527457273154,1.00958281285123e-08
NMR metabolomics,X23412.Phospholipids in VLDL,AKR1C4,Aldo-keto reductase family 1 member C4,28916,0.0207186797891362,0.00361613147318639,0.0136310621016908,0.0278062974765815,1.01717661994943e-08
NMR metabolomics,X23412.Phospholipids in VLDL,SNU13,NHP2-like protein 1,24111,0.0243918411318781,0.00425919798996697,0.0160438130715429,0.0327398691922134,1.03521571797252e-08
NMR metabolomics,X23412.Phospholipids in VLDL,FUCA1,Tissue alpha-L-fucosidase,29623,0.0318343303083464,0.00557208736438296,0.0209130390741558,0.042755621542537,1.11947321969884e-08
NMR metabolomics,X23412.Phospholipids in VLDL,GBP2,Guanylate-binding protein 2,28931,0.0231512661976131,0.0040651396119512,0.0151835925581887,0.0311189398370375,1.24513979749585e-08
NMR metabolomics,X23412.Phospholipids in VLDL,DNPEP,Aspartyl aminopeptidase,24845,0.022512733776174,0.0039614245915826,0.0147483415766721,0.0302771259756758,1.3384248841266e-08
NMR metabolomics,X23412.Phospholipids in VLDL,OBP2B,Odorant-binding protein 2b,29137,-0.0241313855530564,0.00424698637108873,-0.0324554788403903,-0.0158072922657225,1.34396155780649e-08
NMR metabolomics,X23412.Phospholipids in VLDL,LPCAT2,Lysophosphatidylcholine acyltransferase 2,29349,0.0149815800601636,0.00263689532400922,0.00981326522510558,0.0201498948952217,1.34764020922992e-08
NMR metabolomics,X23412.Phospholipids in VLDL,REG1A,Lithostathine-1-alpha,29353,-0.0189454067520791,0.00333580151959766,-0.0254835777304905,-0.0124072357736677,1.36431557829899e-08
NMR metabolomics,X23412.Phospholipids in VLDL,COL9A2,Collagen alpha-2(IX) chain,24445,0.0175624489935455,0.00309526557359158,0.011495728469306,0.023629169517785,1.41102329975148e-08
NMR metabolomics,X23412.Phospholipids in VLDL,CTRC,Chymotrypsin-C,29456,0.0245389453821937,0.00432676595087503,0.0160584841184787,0.0330194066459088,1.42937057680006e-08
NMR metabolomics,X23412.Phospholipids in VLDL,ITM2A,Integral membrane protein 2A,29434,-0.0231909502850402,0.00409252778163136,-0.0312123047370377,-0.0151695958330427,1.46970261815857e-08
NMR metabolomics,X23412.Phospholipids in VLDL,UROS,Uroporphyrinogen-III synthase,24195,0.0262899782317825,0.00464200667381702,0.0171916451511011,0.0353883113124638,1.50003917011176e-08
NMR metabolomics,X23412.Phospholipids in VLDL,SEMA7A,Semaphorin-7A,29736,0.0106087709720955,0.00187383642503311,0.00693605157903057,0.0142814903651603,1.51415793527719e-08
NMR metabolomics,X23412.Phospholipids in VLDL,LIF,Leukemia inhibitory factor,28774,0.0196095725295876,0.00348482137395696,0.0127793226366319,0.0264398224225432,1.84926764078467e-08
NMR metabolomics,X23412.Phospholipids in VLDL,NTF3,Neurotrophin-3,29434,0.0132178160498504,0.00235316081526012,0.00860562085194055,0.0178300112477602,1.96000709038904e-08
NMR metabolomics,X23412.Phospholipids in VLDL,GAST,Gastrin,24845,0.049711504644128,0.0088511941250626,0.0323631641590053,0.0670598451292507,1.97105888817207e-08
NMR metabolomics,X23412.Phospholipids in VLDL,MAEA,E3 ubiquitin-protein transferase MAEA,28797,0.0151659850879371,0.00270125391124437,0.00987152742189814,0.0204604427539761,1.99033640114498e-08
NMR metabolomics,X23412.Phospholipids in VLDL,BCAM,Basal cell adhesion molecule,29443,-0.00915316395271091,0.00163175023032715,-0.0123513944041521,-0.0059549335012697,2.04833356100122e-08
NMR metabolomics,X23412.Phospholipids in VLDL,DDX25,ATP-dependent RNA helicase DDX25,24195,-0.0143546910647433,0.0025630349994103,-0.0193782396635875,-0.00933114246589915,2.15854990463084e-08
NMR metabolomics,X23412.Phospholipids in VLDL,IGFBPL1,Insulin-like growth factor-binding protein-like 1,29478,0.0128540418450596,0.00229738870180908,0.00835115998951378,0.0173569237006054,2.22494360028401e-08
NMR metabolomics,X23412.Phospholipids in VLDL,LTA4H,Leukotriene A-4 hydrolase,29725,0.0221863296347665,0.00397373631953789,0.0143978064484722,0.0299748528210607,2.38136605761627e-08
NMR metabolomics,X23412.Phospholipids in VLDL,CALCB,Calcitonin gene-related peptide 2,24845,0.0152005188786948,0.00273058750378965,0.00984856737126704,0.0205524703861225,2.62203544611049e-08
NMR metabolomics,X23412.Phospholipids in VLDL,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",29349,0.0130411443164252,0.00234388270470625,0.00844713421520098,0.0176351544176495,2.66101576536789e-08
NMR metabolomics,X23412.Phospholipids in VLDL,SELL,L-selectin,24966,0.00877815106297429,0.00157832529654605,0.00568463348174403,0.0118716686442046,2.69915896483568e-08
NMR metabolomics,X23412.Phospholipids in VLDL,TK1,"Thymidine kinase, cytosolic",24445,0.0172926142183766,0.00311401010541858,0.0111891544117562,0.023396074024997,2.83459268385675e-08
NMR metabolomics,X23412.Phospholipids in VLDL,ERC2,ERC protein 2,24195,0.028466590312807,0.00512846503107605,0.0184147988518979,0.038518381773716,2.87506176724005e-08
NMR metabolomics,X23412.Phospholipids in VLDL,REG3G,Regenerating islet-derived protein 3-gamma,24793,0.0150667705021121,0.00271765260432333,0.00974017139763841,0.0203933696065859,2.98584915617509e-08
NMR metabolomics,X23412.Phospholipids in VLDL,PCDH12,Protocadherin-12,24867,0.00959522409113315,0.00173673733152027,0.00619121892135343,0.0129992292609129,3.33059728635392e-08
NMR metabolomics,X23412.Phospholipids in VLDL,LGALS4,Galectin-4,29454,-0.0203925124559221,0.00369418720609768,-0.0276331193798736,-0.0131519055319707,3.41540574728985e-08
NMR metabolomics,X23412.Phospholipids in VLDL,PROCR,Endothelial protein C receptor,24111,-0.0134701060113083,0.002441192806448,-0.0182548439119464,-0.0086853681106702,3.4672563953621e-08
NMR metabolomics,X23412.Phospholipids in VLDL,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,24793,0.0250418964871469,0.00454531993251462,0.0161330694194183,0.0339507235548756,3.63678743019127e-08
NMR metabolomics,X23412.Phospholipids in VLDL,CDH17,Cadherin-17,29478,-0.0253291399097905,0.00460488132911955,-0.0343547073148649,-0.0163035725047162,3.81864665575489e-08
NMR metabolomics,X23412.Phospholipids in VLDL,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,29594,-0.0162374609709381,0.00296020543563953,-0.0220394636247915,-0.0104354583170846,4.1626755587502e-08
NMR metabolomics,X23412.Phospholipids in VLDL,CPA4,Carboxypeptidase A4,23902,0.0163175912025982,0.00298542892013006,0.0104661505191432,0.0221690318860531,4.65577468813978e-08
NMR metabolomics,X23412.Phospholipids in VLDL,PEAR1,Platelet endothelial aggregation receptor 1,29820,0.00839787209464992,0.00154117520632967,0.00537716869024377,0.0114185754990561,5.10530184073701e-08
NMR metabolomics,X23412.Phospholipids in VLDL,AMPD3,AMP deaminase 3,24845,0.0262105238774059,0.00481676165003401,0.0167696710433392,0.0356513767114725,5.33260420723976e-08
NMR metabolomics,X23412.Phospholipids in VLDL,RNASE6,Ribonuclease K6,24828,0.0113436839291835,0.00208844326103712,0.00725033513755071,0.0154370327208162,5.63611342248327e-08
NMR metabolomics,X23412.Phospholipids in VLDL,LRRC38,Leucine-rich repeat-containing protein 38,24195,0.017845770781392,0.00328708774484677,0.0114030788014923,0.0242884627612917,5.71992243705533e-08
NMR metabolomics,X23412.Phospholipids in VLDL,KIAA0319,Dyslexia-associated protein KIAA0319,24845,0.0113028753930865,0.00209454967823583,0.00719755802374426,0.0154081927624287,6.86412824336046e-08
NMR metabolomics,X23412.Phospholipids in VLDL,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,29820,0.0099885638818452,0.00185975296780681,0.00634344806494385,0.0136336796987465,7.89267433993169e-08
NMR metabolomics,X23412.Phospholipids in VLDL,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,29434,-0.0142244177195366,0.00265191161136076,-0.0194221644778037,-0.0090266709612695,8.20873812327456e-08
NMR metabolomics,X23412.Phospholipids in VLDL,SCGB2A2,Mammaglobin-A,24111,-0.0115319114155937,0.00215073044059499,-0.0157473430791599,-0.00731647975202754,8.31279148230338e-08
NMR metabolomics,X23412.Phospholipids in VLDL,RCC1,Regulator of chromosome condensation,24793,0.018729291094656,0.00350039874007862,0.0118685095641019,0.0255900726252101,8.84327653688425e-08
NMR metabolomics,X23412.Phospholipids in VLDL,SLURP1,Secreted Ly-6/uPAR-related protein 1,24801,0.0135719320050993,0.00253932476956926,0.00859485545674358,0.0185490085534551,9.13661158321273e-08
NMR metabolomics,X23412.Phospholipids in VLDL,FGFR4,Fibroblast growth factor receptor 4,24381,0.0192392986363261,0.00360159144436846,0.0121801794053639,0.0262984178672882,9.28080485243622e-08
NMR metabolomics,X23412.Phospholipids in VLDL,EDN1,Endothelin-1,24240,0.0105880743197488,0.00198558312792338,0.00669633138901897,0.0144798172504786,9.77502570629588e-08
NMR metabolomics,X23412.Phospholipids in VLDL,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",29365,-0.0241218555978048,0.00452579680498759,-0.0329924173355805,-0.0152512938600291,9.90141418503228e-08
NMR metabolomics,X23412.Phospholipids in VLDL,SELENOP,Selenoprotein P,24966,0.00820151201808665,0.0015392630629733,0.00518455641465899,0.0112184676215143,1.00046803077935e-07
NMR metabolomics,X23412.Phospholipids in VLDL,CLEC14A,C-type lectin domain family 14 member A,29443,-0.0114170326660388,0.0021519760746651,-0.0156349057723824,-0.00719915955969515,1.13255929344387e-07
NMR metabolomics,X23412.Phospholipids in VLDL,S100A14,Protein S100-A14,24867,0.0190418917169893,0.00359437292185259,0.0119969207901582,0.0260868626438203,1.18271578979475e-07
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINA1,Alpha-1-antitrypsin,24548,-0.00292648527575182,0.000553670981283752,-0.00401168039906798,-0.00184129015243567,1.26361591256028e-07
NMR metabolomics,X23412.Phospholipids in VLDL,LPA,Apolipoprotein(a),24484,-0.0641098769811595,0.0121476750032247,-0.0879193199874798,-0.0403004339748392,1.32042550121155e-07
NMR metabolomics,X23412.Phospholipids in VLDL,CXCL12,Stromal cell-derived factor 1,28931,0.0143321786605552,0.00271620144500756,0.00900842382834043,0.0196559334927701,1.32584526614495e-07
NMR metabolomics,X23412.Phospholipids in VLDL,TPSAB1,Tryptase alpha/beta-1,29753,0.0187102067130717,0.00354842866405741,0.0117552865315192,0.0256651268946242,1.35284819440057e-07
NMR metabolomics,X23412.Phospholipids in VLDL,NCAM2,Neural cell adhesion molecule 2,29443,-0.00963093760176956,0.00182670805156791,-0.0132112853828427,-0.00605058982069645,1.35680600533896e-07
NMR metabolomics,X23412.Phospholipids in VLDL,NELL1,Protein kinase C-binding protein NELL1,29566,0.0150844715302151,0.00286648745926848,0.00946615611004893,0.0207027869503814,1.43213849042815e-07
NMR metabolomics,X23412.Phospholipids in VLDL,CCND2,G1/S-specific cyclin-D2,24445,0.0131899899229843,0.00250758955257758,0.0082751143999322,0.0181048654460363,1.45246760826801e-07
NMR metabolomics,X23412.Phospholipids in VLDL,FOLH1,Glutamate carboxypeptidase 2,24229,0.0379535950055591,0.00722446760315125,0.0237936385033827,0.0521135515077355,1.50513956932814e-07
NMR metabolomics,X23412.Phospholipids in VLDL,LSM1,U6 snRNA-associated Sm-like protein LSm1,28797,0.0197626512063848,0.00376851084242773,0.0123763699552264,0.0271489324575431,1.58109537918305e-07
NMR metabolomics,X23412.Phospholipids in VLDL,STX3,Syntaxin-3,24845,0.0136633553901468,0.00260899261820982,0.0085497298584556,0.0187769809218381,1.64516149518152e-07
NMR metabolomics,X23412.Phospholipids in VLDL,ARG1,Arginase-1,29216,0.0183735557318579,0.00351209605388471,0.0114898474662438,0.0252572639974719,1.6929262113349e-07
NMR metabolomics,X23412.Phospholipids in VLDL,BRD3,Bromodomain-containing protein 3,24111,0.0170655277364332,0.00326190579882027,0.0106721923707454,0.0234588631021209,1.69302065910387e-07
NMR metabolomics,X23412.Phospholipids in VLDL,EFNA1,Ephrin-A1,29390,0.0100097739978075,0.00191568172075806,0.0062550378251217,0.0137645101704933,1.75176388806233e-07
NMR metabolomics,X23412.Phospholipids in VLDL,EIF5,Eukaryotic translation initiation factor 5,24111,0.0156661263123039,0.00300088510478395,0.00978439150692737,0.0215478611176805,1.79918430123062e-07
NMR metabolomics,X23412.Phospholipids in VLDL,KIAA1549L,UPF0606 protein KIAA1549L,24445,-0.0100160603173026,0.00192141429748157,-0.0137820323403665,-0.00625008829423875,1.87465076975471e-07
NMR metabolomics,X23412.Phospholipids in VLDL,GLP1R,Glucagon-like peptide 1 receptor,24101,-0.0134374702676846,0.00258096195008799,-0.0184961556898571,-0.00837878484551216,1.94140053514432e-07
NMR metabolomics,X23412.Phospholipids in VLDL,VASN,Vasorin,29065,0.00969593748709409,0.00186464016344573,0.00604124276674047,0.0133506322074477,2.00748321593813e-07
NMR metabolomics,X23412.Phospholipids in VLDL,QPCT,Glutaminyl-peptide cyclotransferase,29517,0.00946770138016222,0.00182350409405532,0.0058936333558138,0.0130417694045106,2.09383501380762e-07
NMR metabolomics,X23412.Phospholipids in VLDL,RNASET2,Ribonuclease T2,29697,0.00932702343609581,0.00179937889062116,0.00580024081047833,0.0128538060617133,2.19222465135458e-07
NMR metabolomics,X23412.Phospholipids in VLDL,NEDD9,Enhancer of filamentation 1,24229,0.0117653573845224,0.00227059096575532,0.00731499909164192,0.0162157156774028,2.21720732923628e-07
NMR metabolomics,X23412.Phospholipids in VLDL,CALB1,Calbindin,29349,0.0152975825010273,0.00296110160170973,0.00949382336167618,0.0211013416403783,2.40489015043381e-07
NMR metabolomics,X23412.Phospholipids in VLDL,CKAP4,Cytoskeleton-associated protein 4,29678,0.00951099844786497,0.00184199373629017,0.00590069072473623,0.0131213061709937,2.44034409006135e-07
NMR metabolomics,X23412.Phospholipids in VLDL,NCAM1,Neural cell adhesion molecule 1,29594,0.0105576335845949,0.00204719114978211,0.00654513893102195,0.0145701282381678,2.52376404807967e-07
NMR metabolomics,X23412.Phospholipids in VLDL,B2M,Beta-2-microglobulin,24966,0.0108668459196335,0.00211528217025608,0.00672089286593156,0.0150127989733354,2.80805740754771e-07
NMR metabolomics,X23412.Phospholipids in VLDL,ROBO4,Roundabout homolog 4,24240,-0.00628450956465909,0.00122496933664068,-0.00868544946447483,-0.00388356966484335,2.91448241089905e-07
NMR metabolomics,X23412.Phospholipids in VLDL,RBPMS,RNA-binding protein with multiple splicing,24229,0.0224027137452791,0.00438808064740502,0.0138020756763652,0.0310033518141929,3.32670926360623e-07
NMR metabolomics,X23412.Phospholipids in VLDL,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",24867,0.0247463390766148,0.00484749222448301,0.0152452543166281,0.0342474238366015,3.33272142537144e-07
NMR metabolomics,X23412.Phospholipids in VLDL,EP300,Histone acetyltransferase p300,24229,0.010490686124415,0.00205698211238165,0.00645900118414698,0.014522371064683,3.42145433483043e-07
NMR metabolomics,X23412.Phospholipids in VLDL,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,28393,0.0220495627918597,0.00433331959488753,0.0135562563858802,0.0305428691978393,3.63442305867049e-07
NMR metabolomics,X23412.Phospholipids in VLDL,ATXN10,Ataxin-10,28774,0.0250661905427563,0.00493178109151559,0.0153998996033857,0.0347324814821268,3.74665509631471e-07
NMR metabolomics,X23412.Phospholipids in VLDL,SMPD1,Sphingomyelin phosphodiesterase,29530,-0.016905177847389,0.00333913556772813,-0.0234498835601361,-0.0103604721346419,4.15754029890497e-07
NMR metabolomics,X23412.Phospholipids in VLDL,LMOD1,Leiomodin-1,24867,-0.0121946107736213,0.00241241175383324,-0.0169229378111344,-0.00746628373610812,4.33567242887468e-07
NMR metabolomics,X23412.Phospholipids in VLDL,CASP1,Caspase-1,28774,0.0232676968579229,0.0046050011536381,0.0142418945967923,0.0322934991190536,4.38269096355605e-07
NMR metabolomics,X23412.Phospholipids in VLDL,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,24938,-0.0136395805287267,0.00270005539709981,-0.0189316891070424,-0.00834747195041109,4.41232490364055e-07
NMR metabolomics,X23412.Phospholipids in VLDL,BCL7B,B-cell CLL/lymphoma 7 protein family member B,24793,0.015427836904914,0.00305444991576823,0.00944111507000825,0.0214145587398197,4.42764830129567e-07
NMR metabolomics,X23412.Phospholipids in VLDL,CSPG4,Chondroitin sulfate proteoglycan 4,24938,-0.0113250100140016,0.00224584922258673,-0.0157268744902716,-0.00692314553773163,4.62369349847311e-07
NMR metabolomics,X23412.Phospholipids in VLDL,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,29820,0.0239138268492837,0.00474626537188324,0.0146111467203925,0.0332165069781748,4.72053971316271e-07
NMR metabolomics,X23412.Phospholipids in VLDL,ITGAM,Integrin alpha-M,29443,-0.0107990203460659,0.00214459526192903,-0.0150024270594468,-0.006595613632685,4.7951907649901e-07
NMR metabolomics,X23412.Phospholipids in VLDL,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,29517,-0.0167707515789257,0.00333378986006467,-0.0233049797046524,-0.0102365234531989,4.91976874053533e-07
NMR metabolomics,X23412.Phospholipids in VLDL,CELA2A,Chymotrypsin-like elastase family member 2A,24938,0.0209743390209139,0.00417091218345263,0.0127993511413467,0.029149326900481,4.97194759948753e-07
NMR metabolomics,X23412.Phospholipids in VLDL,GSN,Gelsolin,24845,0.00651651326862682,0.00129612361317023,0.00397611098681317,0.00905691555044048,4.99864491355381e-07
NMR metabolomics,X23412.Phospholipids in VLDL,CSF3,Granulocyte colony-stimulating factor,28931,0.0164992172555185,0.00328371949423609,0.0100631270468158,0.0229353074642213,5.07615481127396e-07
NMR metabolomics,X23412.Phospholipids in VLDL,FABP3,"Fatty acid-binding protein, heart",24922,0.0172988706441765,0.0034445070833354,0.0105476367608391,0.0240501045275139,5.14459009533443e-07
NMR metabolomics,X23412.Phospholipids in VLDL,PADI4,Protein-arginine deiminase type-4,28722,0.0241746495286582,0.00481660943391264,0.0147340950381894,0.0336152040191269,5.22464693253317e-07
NMR metabolomics,X23412.Phospholipids in VLDL,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",24867,0.0143929959392281,0.0028720753905791,0.00876372817369311,0.0200222637047632,5.44182693244247e-07
NMR metabolomics,X23412.Phospholipids in VLDL,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,29694,0.024106987096004,0.00482323016243491,0.0146534559776315,0.0335605182143764,5.82270218824074e-07
NMR metabolomics,X23412.Phospholipids in VLDL,SCGN,Secretagogin,28931,-0.0149354604010255,0.00299174610891806,-0.0207992827745049,-0.00907163802754614,6.00352857368883e-07
NMR metabolomics,X23412.Phospholipids in VLDL,TDGF1,Teratocarcinoma-derived growth factor 1,28774,0.0489503657296478,0.00983857427873108,0.0296667601433349,0.0682339713159607,6.55047172138205e-07
NMR metabolomics,X23412.Phospholipids in VLDL,QSOX1,Sulfhydryl oxidase 1,24502,0.0144042151321957,0.00290182153442118,0.0087166449247302,0.0200917853396612,6.95721336626137e-07
NMR metabolomics,X23412.Phospholipids in VLDL,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,24111,-0.0106497363774829,0.0021475215590966,-0.0148588786333123,-0.00644059412165358,7.13082249521629e-07
NMR metabolomics,X23412.Phospholipids in VLDL,RPS10,40S ribosomal protein S10,24111,-0.0141552900225854,0.00285728453712198,-0.0197555677153445,-0.00855501232982633,7.31555203863057e-07
NMR metabolomics,X23412.Phospholipids in VLDL,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,24445,0.0218602336371567,0.00441272457320658,0.0132112934736718,0.0305091738006416,7.32229797965692e-07
NMR metabolomics,X23412.Phospholipids in VLDL,NPR1,Atrial natriuretic peptide receptor 1,24111,-0.0139339905187191,0.00281320280149444,-0.0194478680096482,-0.00842011302779,7.35457645205259e-07
NMR metabolomics,X23412.Phospholipids in VLDL,TRIM26,Tripartite motif-containing protein 26,24016,0.0188518943202229,0.00381631542492293,0.0113719160873739,0.0263318725530718,7.87220272913117e-07
NMR metabolomics,X23412.Phospholipids in VLDL,CCL21,C-C motif chemokine 21,29581,0.0135538992481348,0.00275045945740839,0.00816299871161438,0.0189447997846553,8.35811330345623e-07
NMR metabolomics,X23412.Phospholipids in VLDL,SLC13A1,Solute carrier family 13 member 1,24793,0.0204122256391306,0.00415245656918725,0.0122734107635236,0.0285510405147376,8.90314096947469e-07
NMR metabolomics,X23412.Phospholipids in VLDL,CRNN,Cornulin,28580,0.0222485678483121,0.00453531982656612,0.0133593409882425,0.0311377947083817,9.36431655952992e-07
NMR metabolomics,X23412.Phospholipids in VLDL,MSLN,Mesothelin,29293,0.0185239291170088,0.00379678682244396,0.0110822269450186,0.0259656312889989,1.0726974183862e-06
NMR metabolomics,X23412.Phospholipids in VLDL,NTF4,Neurotrophin-4,28797,0.0130503611243013,0.00267624230650583,0.00780492620354989,0.0182957960450527,1.086289254185e-06
NMR metabolomics,X23412.Phospholipids in VLDL,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,24951,0.0142945861407855,0.00293447493035521,0.00854301527728926,0.0200461570042817,1.11569158204587e-06
NMR metabolomics,X23412.Phospholipids in VLDL,EPHB6,Ephrin type-B receptor 6,29163,0.010538872860603,0.00216401703524028,0.00629739947153206,0.014780346249674,1.12153726173585e-06
NMR metabolomics,X23412.Phospholipids in VLDL,OMG,Oligodendrocyte-myelin glycoprotein,29349,0.0216833706189096,0.00445495427107087,0.0129516602476107,0.0304150809902085,1.1374998413505e-06
NMR metabolomics,X23412.Phospholipids in VLDL,MNAT1,CDK-activating kinase assembly factor MAT1,24445,0.0145332188824793,0.0029861657434459,0.00868033402532535,0.0203861037396333,1.14098217523382e-06
NMR metabolomics,X23412.Phospholipids in VLDL,STX5,Syntaxin-5,24229,0.0135373757642264,0.00278258871737796,0.00808350187816555,0.0189912496502872,1.15158538553567e-06
NMR metabolomics,X23412.Phospholipids in VLDL,DDI2,Protein DDI1 homolog 2,24381,0.025350746408399,0.00521369734350982,0.0151318996151197,0.0355695932016782,1.1673115849199e-06
NMR metabolomics,X23412.Phospholipids in VLDL,SUSD2,Sushi domain-containing protein 2,29443,-0.00937228577235665,0.00193630097421564,-0.0131674356818193,-0.00557713586289398,1.30297120907853e-06
NMR metabolomics,X23412.Phospholipids in VLDL,PGA4,Pepsin A-4,24951,0.0233433254496407,0.00483605873387096,0.0138646503312536,0.0328220005680278,1.39472856853462e-06
NMR metabolomics,X23412.Phospholipids in VLDL,ARHGAP5,Rho GTPase-activating protein 5,24016,0.0251098091107587,0.00522122958608292,0.0148761991220362,0.0353434190994812,1.52472583238072e-06
NMR metabolomics,X23412.Phospholipids in VLDL,RANBP2,E3 SUMO-protein ligase RanBP2,24101,-0.0108650166543288,0.00225927364212693,-0.0152931929928976,-0.00643684031576002,1.52545795567762e-06
NMR metabolomics,X23412.Phospholipids in VLDL,IL17RA,Interleukin-17 receptor A,29443,0.01432277688721,0.00298733627783431,0.00846759778265477,0.0201779559917653,1.63879202376927e-06
NMR metabolomics,X23412.Phospholipids in VLDL,ALPP,"Alkaline phosphatase, placental type",29349,0.0336377593386022,0.00701831988070958,0.0198818523724115,0.047393666304793,1.6523233275227e-06
NMR metabolomics,X23412.Phospholipids in VLDL,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,28498,-0.02770291797829,0.00579973282778972,-0.0390703943207578,-0.0163354416358221,1.7918363649059e-06
NMR metabolomics,X23412.Phospholipids in VLDL,SAFB2,Scaffold attachment factor B2,24867,0.00890617081065307,0.00186561837487156,0.00524955879590482,0.0125627828254013,1.81770632131925e-06
NMR metabolomics,X23412.Phospholipids in VLDL,SIGLEC10,Sialic acid-binding Ig-like lectin 10,29434,0.0109942968822738,0.00230370165795285,0.00647904163268621,0.0155095521318614,1.82873158755226e-06
NMR metabolomics,X23412.Phospholipids in VLDL,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,29345,0.0599400729257419,0.0125634249801211,0.0353157599647046,0.0845643858867792,1.84196750678836e-06
NMR metabolomics,X23412.Phospholipids in VLDL,SIRT1,NAD-dependent protein deacetylase sirtuin-1,24229,0.028241026595195,0.00592291351690501,0.0166321161020612,0.0398499370883288,1.87054936893848e-06
NMR metabolomics,X23412.Phospholipids in VLDL,ATP6V1D,V-type proton ATPase subunit D,29349,0.00841670447521667,0.0017699514552982,0.0049475996228322,0.0118858093276011,1.99062109042444e-06
NMR metabolomics,X23412.Phospholipids in VLDL,INHBB,Inhibin beta B chain,24381,0.0167438952032752,0.00352858463475964,0.00982786931914628,0.0236599210874041,2.09465028965811e-06
NMR metabolomics,X23412.Phospholipids in VLDL,APOBR,Apolipoprotein B receptor,24240,-0.0137457703838131,0.00289736595869514,-0.0194246076628556,-0.00806693310477063,2.10493472264586e-06
NMR metabolomics,X23412.Phospholipids in VLDL,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",24845,0.0176944572067363,0.00373301168702635,0.0103777543001647,0.0250111601133079,2.14907237973124e-06
NMR metabolomics,X23412.Phospholipids in VLDL,ITGB7,Integrin beta-7,29725,0.0146710004452681,0.00310743577603,0.00858042632424933,0.0207615745662869,2.35460780282712e-06
NMR metabolomics,X23412.Phospholipids in VLDL,SLC28A1,Sodium/nucleoside cotransporter 1,24016,0.0190961186751525,0.00404483997672608,0.0111682323207694,0.0270240050295356,2.3588933706014e-06
NMR metabolomics,X23412.Phospholipids in VLDL,AGR2,Anterior gradient protein 2 homolog,28553,0.0322464181202243,0.00683758779021417,0.0188447460514045,0.0456480901890441,2.41601511476294e-06
NMR metabolomics,X23412.Phospholipids in VLDL,ERBB4,Receptor tyrosine-protein kinase erbB-4,29566,-0.00765324538539364,0.00162295584586904,-0.010834238843297,-0.00447225192749033,2.42073285228133e-06
NMR metabolomics,X23412.Phospholipids in VLDL,CDH1,Cadherin-1,28477,0.0128111940542268,0.00272100304951612,0.00747802807717523,0.0181443600312784,2.51014593137568e-06
NMR metabolomics,X23412.Phospholipids in VLDL,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",24111,-0.0130551079232069,0.00277988946312777,-0.0185036912709373,-0.00760652457547647,2.66416409962379e-06
NMR metabolomics,X23412.Phospholipids in VLDL,RAB44,Ras-related protein Rab-44,24793,0.0133710152879893,0.00286389502831374,0.00775778103249435,0.0189842495434842,3.04518585794004e-06
NMR metabolomics,X23412.Phospholipids in VLDL,CD7,T-cell antigen CD7,24177,0.0138053909729318,0.00297359404381806,0.00797714664704842,0.0196336352988152,3.45757192438634e-06
NMR metabolomics,X23412.Phospholipids in VLDL,NDRG1,Protein NDRG1,28774,0.0212279755550229,0.00457434673575883,0.0122622559529356,0.0301936951571103,3.48833309724247e-06
NMR metabolomics,X23412.Phospholipids in VLDL,PDRG1,p53 and DNA damage-regulated protein 1,24195,0.016465915327922,0.00355676109950713,0.00949466357288807,0.023437167082956,3.68509070976398e-06
NMR metabolomics,X23412.Phospholipids in VLDL,CEP152,Centrosomal protein of 152 kDa,24016,0.0131394303750425,0.00284221815825848,0.00756868278485589,0.0187101779652291,3.80291633549523e-06
NMR metabolomics,X23412.Phospholipids in VLDL,ARTN,Artemin,28931,0.0140356140069818,0.00303716290459404,0.00808277471397746,0.0199884532999861,3.83004084317065e-06
NMR metabolomics,X23412.Phospholipids in VLDL,CLSTN1,Calsyntenin-1,28774,0.0161833028450788,0.00350390704361317,0.00931564503959694,0.0230509606505606,3.8792544470009e-06
NMR metabolomics,X23412.Phospholipids in VLDL,CAPS,Calcyphosin,24845,0.0295726385316237,0.00644394724655088,0.016942501928384,0.0422027751348635,4.47099377747769e-06
NMR metabolomics,X23412.Phospholipids in VLDL,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,24805,0.0158052831832682,0.00344636038748053,0.00905041682380637,0.0225601495427301,4.53853555483776e-06
NMR metabolomics,X23412.Phospholipids in VLDL,ACE,Angiotensin-converting enzyme,24951,-0.00815714397708269,0.00178124960814594,-0.0116483932090487,-0.00466589474511665,4.68452015926658e-06
NMR metabolomics,X23412.Phospholipids in VLDL,CPTP,Ceramide-1-phosphate transfer protein,24111,-0.012417516550668,0.00271322572573678,-0.0177354389731121,-0.0070995941282239,4.74811110170236e-06
NMR metabolomics,X23412.Phospholipids in VLDL,CTRL,Chymotrypsin-like protease CTRL-1,24845,-0.0211289781680954,0.00462875376512524,-0.0302013355477408,-0.0120566207884499,5.02551546030337e-06
NMR metabolomics,X23412.Phospholipids in VLDL,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,24101,0.0191430010746775,0.00420366366782964,0.0109038202857314,0.0273821818636236,5.29219792121875e-06
NMR metabolomics,X23412.Phospholipids in VLDL,SEMA4C,Semaphorin-4C,29349,0.00866106439031744,0.00190910981329041,0.00491920915626823,0.0124029196243666,5.73667836954942e-06
NMR metabolomics,X23412.Phospholipids in VLDL,RNF43,E3 ubiquitin-protein ligase RNF43,24445,0.0179527577294096,0.00396118136885916,0.0101888422464456,0.0257166732123735,5.8656780659665e-06
NMR metabolomics,X23412.Phospholipids in VLDL,VIM,Vimentin,28916,0.0357898102243032,0.00790955886418251,0.0202870748505055,0.051292545598101,6.06701062128057e-06
NMR metabolomics,X23412.Phospholipids in VLDL,CDHR1,Cadherin-related family member 1,28774,0.0131023253414599,0.00290071951488109,0.00741691509229291,0.0187877355906268,6.29941303045716e-06
NMR metabolomics,X23412.Phospholipids in VLDL,RAB39B,Ras-related protein Rab-39B,24111,0.0276842866771419,0.0061537000722076,0.015623034535615,0.0397455388186688,6.86562024543112e-06
NMR metabolomics,X23412.Phospholipids in VLDL,CTSV,Cathepsin L2,29618,0.0126115422501921,0.00280975590819328,0.00710442067013325,0.0181186638302509,7.20023057051891e-06
NMR metabolomics,X23412.Phospholipids in VLDL,NEFL,Neurofilament light polypeptide,28674,0.0136326106789248,0.0030396038545936,0.00767498712392133,0.0195902342339283,7.31982614144189e-06
NMR metabolomics,X23412.Phospholipids in VLDL,BMP10,Bone morphogenetic protein 10,24381,0.00870632086017256,0.00194152774325296,0.00490092648339676,0.0125117152369484,7.35001791769841e-06
NMR metabolomics,X23412.Phospholipids in VLDL,SOX9,Transcription factor SOX-9,24195,0.00832362212781265,0.00185929464273355,0.0046794046280549,0.0119678396275704,7.61293184577966e-06
NMR metabolomics,X23412.Phospholipids in VLDL,PSMD1,26S proteasome non-ATPase regulatory subunit 1,24867,0.0148377724281205,0.0033182533951498,0.00833399577362688,0.0213415490826141,7.79942470829563e-06
NMR metabolomics,X23412.Phospholipids in VLDL,RBFOX3,RNA binding protein fox-1 homolog 3,24867,0.0116902084332057,0.00261674461801127,0.00656138898190363,0.0168190278845078,7.95018407768294e-06
NMR metabolomics,X23412.Phospholipids in VLDL,TMOD4,Tropomodulin-4,24016,-0.0124754111338627,0.00279356837522744,-0.0179508051493085,-0.00700001711841694,8.01480171326863e-06
NMR metabolomics,X23412.Phospholipids in VLDL,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,24966,-0.00589580346828053,0.00132272856604442,-0.0084883514577276,-0.00330325547883347,8.33581084136056e-06
NMR metabolomics,X23412.Phospholipids in VLDL,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,29218,0.0126269195208804,0.00283405735870261,0.00707216709782324,0.0181816719439375,8.40394344993497e-06
NMR metabolomics,X23412.Phospholipids in VLDL,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,29218,0.0316018092477566,0.00709341084988913,0.0176987239819739,0.0455048945135393,8.416781830885e-06
NMR metabolomics,X23412.Phospholipids in VLDL,NFKB2,Nuclear factor NF-kappa-B p100 subunit,24445,0.0168569391159104,0.00379397791268541,0.00942074240704695,0.0242931358247738,8.90705506715272e-06
NMR metabolomics,X23412.Phospholipids in VLDL,CENPJ,Centromere protein J,24445,0.0217115189043905,0.00488735991231459,0.0121322934762539,0.031290744332527,8.9359000764798e-06
NMR metabolomics,X23412.Phospholipids in VLDL,VEGFD,Vascular endothelial growth factor D,29732,-0.0107174131618792,0.00242605833164804,-0.0154724874919093,-0.00596233883184901,1.00144254022943e-05
NMR metabolomics,X23412.Phospholipids in VLDL,NAPRT,Nicotinate phosphoribosyltransferase,24845,0.00998341711769285,0.00226035454048087,0.00555312221835035,0.0144137120170354,1.00619996344584e-05
NMR metabolomics,X23412.Phospholipids in VLDL,VSIG2,V-set and immunoglobulin domain-containing protein 2,24793,0.0178367628140592,0.00404463291352423,0.00990928230355172,0.0257642433245667,1.03813699144253e-05
NMR metabolomics,X23412.Phospholipids in VLDL,CHRM1,Muscarinic acetylcholine receptor M1,24195,-0.0110827618233628,0.00251323164160859,-0.0160086958409157,-0.00615682780581,1.03928839628788e-05
NMR metabolomics,X23412.Phospholipids in VLDL,FMR1,Synaptic functional regulator FMR1,28797,0.0106046510368442,0.0024096959984998,0.0058816468797846,0.0153276551939038,1.08227422665185e-05
NMR metabolomics,X23412.Phospholipids in VLDL,AXL,Tyrosine-protein kinase receptor UFO,29594,0.00818957036342221,0.00187154030961079,0.00452135135658507,0.0118577893702593,1.21376738904264e-05
NMR metabolomics,X23412.Phospholipids in VLDL,TLR4,Toll-like receptor 4,24229,0.00844989029434518,0.00193197883449525,0.00466321177873449,0.0122365688099559,1.22669503549519e-05
NMR metabolomics,X23412.Phospholipids in VLDL,JCHAIN,Immunoglobulin J chain,28931,-0.0182164393250904,0.00417915860117427,-0.0264075901833919,-0.0100252884667888,1.31182160648085e-05
NMR metabolomics,X23412.Phospholipids in VLDL,SNX18,Sorting nexin-18,24805,0.0132241018013273,0.00303473400164905,0.00727602315809514,0.0191721804445594,1.32035724650931e-05
NMR metabolomics,X23412.Phospholipids in VLDL,MANSC4,MANSC domain-containing protein 4,24111,0.0197696055529168,0.0045369337782117,0.0108772153476219,0.0286619957582117,1.32111384430803e-05
NMR metabolomics,X23412.Phospholipids in VLDL,GSAP,Gamma-secretase-activating protein,28797,0.0256227260078266,0.00589538581720024,0.0140677698061141,0.0371776822095391,1.38969296181205e-05
NMR metabolomics,X23412.Phospholipids in VLDL,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,24966,0.00551652246412603,0.00127081977826544,0.00302571569872577,0.0080073292295263,1.42447878976722e-05
NMR metabolomics,X23412.Phospholipids in VLDL,CLIC5,Chloride intracellular channel protein 5,24195,-0.00941345860232013,0.0021688740907071,-0.013664451820106,-0.00516246538453423,1.42897291009297e-05
NMR metabolomics,X23412.Phospholipids in VLDL,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,29218,0.00964472054777101,0.00222603743719252,0.00528168717087367,0.0140077539246684,1.47792768471895e-05
NMR metabolomics,X23412.Phospholipids in VLDL,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,29218,-0.0083640601400649,0.00193849511933107,-0.0121635105739538,-0.00456460970617599,1.60331399050359e-05
NMR metabolomics,X23412.Phospholipids in VLDL,TIE1,Tyrosine-protein kinase receptor Tie-1,29820,0.0120251887937263,0.00278795357535874,0.00656079978602315,0.0174895778014294,1.61376365786545e-05
NMR metabolomics,X23412.Phospholipids in VLDL,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,29760,0.0111199506797844,0.0025805460994767,0.00606208032481006,0.0161778210347587,1.64411675299424e-05
NMR metabolomics,X23412.Phospholipids in VLDL,KLK11,Kallikrein-11,29296,0.00901325097963284,0.00209183438681745,0.00491325558147063,0.013113246377795,1.64693487776265e-05
NMR metabolomics,X23412.Phospholipids in VLDL,NMRK2,Nicotinamide riboside kinase 2,24016,-0.0121771877704338,0.00283155249803065,-0.0177270306665739,-0.00662734487429371,1.71059476524194e-05
NMR metabolomics,X23412.Phospholipids in VLDL,OLFM4,Olfactomedin-4,23498,0.0360429068898417,0.00838802724218841,0.0196023734951524,0.052483440284531,1.73863018074858e-05
NMR metabolomics,X23412.Phospholipids in VLDL,KIAA1549,UPF0606 protein KIAA1549,24445,0.0203258323723229,0.00473973225242073,0.0110359571575783,0.0296157075870675,1.80661132055209e-05
NMR metabolomics,X23412.Phospholipids in VLDL,IL10RA,Interleukin-10 receptor subunit alpha,28931,0.016938378655957,0.00395133738012941,0.00919375739090336,0.0246829999210107,1.8189617051826e-05
NMR metabolomics,X23412.Phospholipids in VLDL,BLVRB,Flavin reductase,29443,0.018907739602999,0.00441243952525311,0.0102593581335029,0.0275561210724951,1.83237712039365e-05
NMR metabolomics,X23412.Phospholipids in VLDL,TSC1,Hamartin,24229,0.0218679218285075,0.00511417716142417,0.0118441345921161,0.0318917090648989,1.91059714353647e-05
NMR metabolomics,X23412.Phospholipids in VLDL,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,24805,0.00620085322887263,0.00145869969063502,0.003341801835228,0.00905990462251726,2.13647875025001e-05
NMR metabolomics,X23412.Phospholipids in VLDL,IL4R,Interleukin-4 receptor subunit alpha,29434,-0.0106000710094569,0.00249497099238072,-0.0154902141545231,-0.00570992786439068,2.15795894663904e-05
NMR metabolomics,X23412.Phospholipids in VLDL,GPR158,Probable G-protein coupled receptor 158,24867,0.0103104884956993,0.0024390461521061,0.00552995803757136,0.0150910189538273,2.37395941812538e-05
NMR metabolomics,X23412.Phospholipids in VLDL,PRKCQ,Protein kinase C theta type,28931,0.012482818700927,0.00295630941441635,0.00668845224867095,0.0182771851531831,2.42417225024961e-05
NMR metabolomics,X23412.Phospholipids in VLDL,WIF1,Wnt inhibitory factor 1,29725,0.00972988485181918,0.00230924801349897,0.0052037587453612,0.0142560109582772,2.52248584675754e-05
NMR metabolomics,X23412.Phospholipids in VLDL,SULT1A1,Sulfotransferase 1A1,29694,-0.0365645527938182,0.00870106961552803,-0.0536186492402531,-0.0195104563473832,2.64982159810321e-05
NMR metabolomics,X23412.Phospholipids in VLDL,KEL,Kell blood group glycoprotein,28774,0.0101480781055034,0.00243440532481876,0.00537664366885862,0.0149195125421481,3.07363607265013e-05
NMR metabolomics,X23412.Phospholipids in VLDL,NAAA,N-acylethanolamine-hydrolyzing acid amidase,29087,0.0167858475397074,0.00403214406945983,0.00888284516356617,0.0246888499158487,3.14986444803817e-05
NMR metabolomics,X23412.Phospholipids in VLDL,IL7R,Interleukin-7 receptor subunit alpha,29443,-0.0147680137743329,0.00355469878395817,-0.0217352233908909,-0.0078008041577749,3.26912186663415e-05
NMR metabolomics,X23412.Phospholipids in VLDL,TNC,Tenascin,29594,-0.0133863065520367,0.00323306510255944,-0.0197231141530532,-0.00704949895102017,3.47603303493933e-05
NMR metabolomics,X23412.Phospholipids in VLDL,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,29566,0.012692064157635,0.00306836975076736,0.00667805944613099,0.018706068869139,3.53741927895039e-05
NMR metabolomics,X23412.Phospholipids in VLDL,DRAXIN,Draxin,29218,0.012024120997733,0.00291079255919035,0.00631896758171994,0.0177292744137461,3.62389958745907e-05
NMR metabolomics,X23412.Phospholipids in VLDL,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",24381,-0.0179847628520889,0.00436063132265077,-0.0265316002444844,-0.00943792545969341,3.73018142991901e-05
NMR metabolomics,X23412.Phospholipids in VLDL,VTCN1,V-set domain-containing T-cell activation inhibitor 1,28797,-0.00895692049192136,0.00218166292495117,-0.0132329798248256,-0.00468086115901707,4.04470825980021e-05
NMR metabolomics,X23412.Phospholipids in VLDL,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,28301,0.0104952424260886,0.00256063807367493,0.00547639180168573,0.0155140930504915,4.16667015890984e-05
NMR metabolomics,X23412.Phospholipids in VLDL,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,24240,-0.00726213689055976,0.00177933846356648,-0.0107496402791501,-0.00377463350196947,4.49146511933146e-05
NMR metabolomics,X23412.Phospholipids in VLDL,ADAMTSL5,ADAMTS-like protein 5,24922,-0.0109399466799879,0.00268104052332356,-0.0161947861057021,-0.00568510725427375,4.50816853248528e-05
NMR metabolomics,X23412.Phospholipids in VLDL,PDCD6,Programmed cell death protein 6,29478,-0.0192679850546064,0.00474793302683546,-0.0285739337872039,-0.00996203632200892,4.95833043048383e-05
NMR metabolomics,X23412.Phospholipids in VLDL,BABAM1,BRISC and BRCA1-A complex member 1,24229,0.00813265979807921,0.00200441802018405,0.00420400047851846,0.0120613191176399,4.97845949038937e-05
NMR metabolomics,X23412.Phospholipids in VLDL,CPVL,Probable serine carboxypeptidase CPVL,29662,0.0111770313234675,0.00276169168370404,0.0057641156234076,0.0165899470235274,5.19723740588809e-05
NMR metabolomics,X23412.Phospholipids in VLDL,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,29372,0.0162733823909515,0.00403211587300014,0.0083704352798712,0.0241763295020317,5.45216262853809e-05
NMR metabolomics,X23412.Phospholipids in VLDL,AOC1,Amiloride-sensitive amine oxidase [copper-containing],28931,0.0151985896046727,0.00377791434559319,0.00779387748731,0.0226033017220353,5.76049045460977e-05
NMR metabolomics,X23412.Phospholipids in VLDL,MYOM1,Myomesin-1,24101,0.0129974813941844,0.00324895090414867,0.006629537622053,0.0193654251663158,6.33931932497706e-05
NMR metabolomics,X23412.Phospholipids in VLDL,CDH15,Cadherin-15,29639,0.0156763591423434,0.00391904518731325,0.00799503057520941,0.0233576877094773,6.34840046047739e-05
NMR metabolomics,X23412.Phospholipids in VLDL,SEPTIN3,Neuronal-specific septin-3,24867,-0.0205971239184338,0.00514981742729866,-0.0306907660759392,-0.0105034817609285,6.36376278172636e-05
NMR metabolomics,X23412.Phospholipids in VLDL,CD48,CD48 antigen,29536,0.0080991832569045,0.00203023516139503,0.00411992234057024,0.0120784441732388,6.6432996475352e-05
NMR metabolomics,X23412.Phospholipids in VLDL,CSF1,Macrophage colony-stimulating factor 1,29581,0.00728715306036977,0.00183014639216869,0.00370006613171914,0.0108742399890204,6.85783044655882e-05
NMR metabolomics,X23412.Phospholipids in VLDL,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,29673,0.00932836691565051,0.00234391792233596,0.00473428778787202,0.013922446043429,6.91320408074644e-05
NMR metabolomics,X23412.Phospholipids in VLDL,ITGB5,Integrin beta-5,29566,0.0101385656202717,0.00255528733306838,0.0051302024474577,0.0151469287930857,7.2746542070442e-05
NMR metabolomics,X23412.Phospholipids in VLDL,AIF1L,Allograft inflammatory factor 1-like,24240,0.0154143774926429,0.00390010911422666,0.00777016362875867,0.0230585913565272,7.76251460845765e-05
NMR metabolomics,X23412.Phospholipids in VLDL,IL15RA,Interleukin-15 receptor subunit alpha,28931,0.00940655538905429,0.00238648500270265,0.0047290447837571,0.0140840659943515,8.11321940781883e-05
NMR metabolomics,X23412.Phospholipids in VLDL,CLEC10A,C-type lectin domain family 10 member A,29218,-0.00966741140739668,0.00245685371489848,-0.0144828446885977,-0.00485197812619565,8.34327122010257e-05
NMR metabolomics,X23412.Phospholipids in VLDL,TERF1,Telomeric repeat-binding factor 1,24229,-0.00786417187482889,0.00200057181720548,-0.0117852926365516,-0.00394305111310615,8.4841858406146e-05
NMR metabolomics,X23412.Phospholipids in VLDL,M6PR,Cation-dependent mannose-6-phosphate receptor,24240,0.0108542684726668,0.00276725005142929,0.00543045837186536,0.0162780785734682,8.7912015626963e-05
NMR metabolomics,X23412.Phospholipids in VLDL,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,29443,-0.00967322110879938,0.00247736548389741,-0.0145288574572383,-0.00481758476036046,9.45760615635621e-05
NMR metabolomics,X23412.Phospholipids in VLDL,CDKL5,Cyclin-dependent kinase-like 5,24101,-0.0141380635474286,0.0036278460994788,-0.021248641902407,-0.00702748519245011,9.76164925215685e-05
NMR metabolomics,X23412.Phospholipids in VLDL,SEMA6C,Semaphorin-6C,24229,0.00694155416841527,0.00178484080314054,0.00344326619425981,0.0104398421425707,0.000100855095355692
NMR metabolomics,X23412.Phospholipids in VLDL,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",24229,0.016398229216656,0.0042203178158757,0.00812640629753967,0.0246700521357724,0.000102372799033001
NMR metabolomics,X23412.Phospholipids in VLDL,NRTN,Neurturin,28931,0.0130273634607052,0.00335479912396756,0.00645195717772878,0.0196027697436816,0.000103318894452452
NMR metabolomics,X23412.Phospholipids in VLDL,ADGRE1,Adhesion G protein-coupled receptor E1,24805,0.01447379534624,0.00372872938466604,0.00716548575229458,0.0217821049401855,0.000103998914090206
NMR metabolomics,X23412.Phospholipids in VLDL,NOTCH2,Neurogenic locus notch homolog protein 2,24938,0.00565111778757322,0.00146578074535191,0.00277818752668348,0.00852404804846297,0.000115847779491227
NMR metabolomics,X23412.Phospholipids in VLDL,UBE2B,Ubiquitin-conjugating enzyme E2 B,24793,0.00749607296653677,0.00194637990205576,0.00368116835850748,0.011310977574566,0.000117792845074801
NMR metabolomics,X23412.Phospholipids in VLDL,CLEC4D,C-type lectin domain family 4 member D,29434,0.0160414211451627,0.00416766383620581,0.00787280002619929,0.0242100422641261,0.000118841941545345
NMR metabolomics,X23412.Phospholipids in VLDL,PDCD1LG2,Programmed cell death 1 ligand 2,29349,0.00816465883138077,0.002122024331302,0.00400549114202884,0.0123238265207327,0.000119542656203245
NMR metabolomics,X23412.Phospholipids in VLDL,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",28774,0.0140628973222513,0.00365727071579927,0.00689464671928475,0.0212311479252179,0.000120718925628941
NMR metabolomics,X23412.Phospholipids in VLDL,CCL28,C-C motif chemokine 28,29327,0.0154075529980467,0.00401806794673659,0.00753213982244301,0.0232829661736504,0.000126048389437804
NMR metabolomics,X23412.Phospholipids in VLDL,TIMP2,Metalloproteinase inhibitor 2,24922,-0.00690094461269644,0.00180812442491085,-0.0104448684855217,-0.00335702073987117,0.00013561308194876
NMR metabolomics,X23412.Phospholipids in VLDL,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,29433,0.00823432670169047,0.0021737960270827,0.00397368648860839,0.0124949669147726,0.000152170546059891
NMR metabolomics,X23412.Phospholipids in VLDL,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,24805,-0.00776433992355339,0.00205351720253275,-0.0117892336405176,-0.0037394462065892,0.000156568570887406
NMR metabolomics,X23412.Phospholipids in VLDL,RNF31,E3 ubiquitin-protein ligase RNF31,24229,0.00941692984507008,0.00249188770885878,0.00453282993570687,0.0143010297544333,0.000157814765922451
NMR metabolomics,X23412.Phospholipids in VLDL,ITGBL1,Integrin beta-like protein 1,24938,0.00954397065401909,0.00253350303533499,0.00457830470476252,0.0145096366032757,0.000165531769524657
NMR metabolomics,X23412.Phospholipids in VLDL,CFD,Complement factor D,24966,0.00499226659628769,0.00133083189457636,0.00238383608291803,0.00760069710965735,0.000176361793178253
NMR metabolomics,X23412.Phospholipids in VLDL,NME1,Nucleoside diphosphate kinase A,24229,-0.00558437069525395,0.0014923111790247,-0.00850930060614236,-0.00265944078436554,0.000182913624268755
NMR metabolomics,X23412.Phospholipids in VLDL,NUP50,Nuclear pore complex protein Nup50,24111,-0.0086035441219348,0.00230288455821372,-0.0131171978560337,-0.00408989038783591,0.000187412373835611
NMR metabolomics,X23412.Phospholipids in VLDL,MERTK,Tyrosine-protein kinase Mer,29786,0.00644163535475506,0.00172566263299151,0.0030593365940917,0.00982393411541842,0.00018967948170706
NMR metabolomics,X23412.Phospholipids in VLDL,GUCA2A,Guanylin,29333,-0.00866106223129704,0.0023225494448139,-0.0132132591431323,-0.0041088653194618,0.000192512365884353
NMR metabolomics,X23412.Phospholipids in VLDL,IGLC2,Immunoglobulin lambda constant 2,24915,-0.00630313323172405,0.0016916921923555,-0.00961884992874084,-0.00298741653470726,0.000195023290753768
NMR metabolomics,X23412.Phospholipids in VLDL,ENO1,Alpha-enolase,29392,0.019922777065563,0.0053472237456156,0.00944221852415646,0.0304033356069696,0.000195048067146821
NMR metabolomics,X23412.Phospholipids in VLDL,DEFB104A_DEFB104B,Beta-defensin 104,24101,0.014259514415682,0.00383304897116248,0.00674673843220354,0.0217722903991605,0.000199557109163767
NMR metabolomics,X23412.Phospholipids in VLDL,KLK15,Kallikrein-15,24754,0.013090420079432,0.00351995686434193,0.00619130462532183,0.0199895355335422,0.000200522153468273
NMR metabolomics,X23412.Phospholipids in VLDL,GSTP1,Glutathione S-transferase P,28604,-0.0175595023410233,0.0047313341595239,-0.0268329172936902,-0.00828608738835647,0.000206570850433152
NMR metabolomics,X23412.Phospholipids in VLDL,CCDC28A,Coiled-coil domain-containing protein 28A,24195,0.00750455298187828,0.00202351322276233,0.00353846706526411,0.0114706388984924,0.000208812373248755
NMR metabolomics,X23412.Phospholipids in VLDL,CLSTN2,Calsyntenin-2,29786,-0.00993955398556061,0.00268369649387424,-0.0151995991135541,-0.0046795088575671,0.000212877804887103
NMR metabolomics,X23412.Phospholipids in VLDL,MYO6,Unconventional myosin-VI,24867,0.00940547380613436,0.00254137531939714,0.00442437818011596,0.0143865694321527,0.00021526707575477
NMR metabolomics,X23412.Phospholipids in VLDL,DCC,Netrin receptor DCC,24195,0.00571507945283416,0.0015568564163839,0.00266364087672172,0.0087665180289466,0.000242208567939353
NMR metabolomics,X23412.Phospholipids in VLDL,LIFR,Leukemia inhibitory factor receptor,29434,-0.00604983593834515,0.00164827132481651,-0.00928044773498551,-0.00281922414170479,0.000242587103852111
NMR metabolomics,X23412.Phospholipids in VLDL,NMI,N-myc-interactor,24706,0.0179734979704756,0.00490080784077588,0.00836791460255492,0.0275790813383964,0.000245489785002487
NMR metabolomics,X23412.Phospholipids in VLDL,APOF,Apolipoprotein F,24951,-0.00618937018567008,0.00170017286086265,-0.00952170899296087,-0.0028570313783793,0.000272727214782896
NMR metabolomics,X23412.Phospholipids in VLDL,METAP1,Methionine aminopeptidase 1,28774,0.00738372127699248,0.00202896730236951,0.00340694536434825,0.0113604971896367,0.000274015695647891
NMR metabolomics,X23412.Phospholipids in VLDL,NBL1,Neuroblastoma suppressor of tumorigenicity 1,29566,0.00662777647835307,0.00182738365041783,0.00304610452353413,0.010209448433172,0.000287303286312688
NMR metabolomics,X23412.Phospholipids in VLDL,FDX2,"Ferredoxin-2, mitochondrial",24111,0.0139271166256107,0.00384191687668914,0.00639695954729996,0.0214572737039214,0.000289507530912012
NMR metabolomics,X23412.Phospholipids in VLDL,SPESP1,Sperm equatorial segment protein 1,24922,0.00747391206420593,0.00206572320383773,0.00342509458468397,0.0115227295437279,0.000297405785788548
NMR metabolomics,X23412.Phospholipids in VLDL,FCRLB,Fc receptor-like B,28797,0.0150015987860659,0.00415292315708508,0.0068618693981791,0.0231413281739526,0.000304011040422944
NMR metabolomics,X23412.Phospholipids in VLDL,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",28774,0.0122478883541021,0.0033976693518114,0.0055884564245518,0.0189073202836525,0.000312931841928738
NMR metabolomics,X23412.Phospholipids in VLDL,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",24445,0.0172851874655505,0.00479510094029511,0.00788678962257213,0.026683585308529,0.000313063076468979
NMR metabolomics,X23412.Phospholipids in VLDL,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,28774,0.0115943453491036,0.00322245150051819,0.00527834040808795,0.0179103502901192,0.000321225010289781
NMR metabolomics,X23412.Phospholipids in VLDL,NPTX2,Neuronal pentraxin-2,24938,-0.00814789783603524,0.00226834637723718,-0.0125938567354201,-0.00370193893665037,0.000328782445940705
NMR metabolomics,X23412.Phospholipids in VLDL,GIMAP7,GTPase IMAP family member 7,24381,-0.00789307968252627,0.00219923999329564,-0.0122035900693857,-0.00358256929566681,0.000332595746236532
NMR metabolomics,X23412.Phospholipids in VLDL,LY96,Lymphocyte antigen 96,29218,-0.00864314888232269,0.00241328673270537,-0.0133731908784252,-0.00391310688622016,0.000342202248089489
NMR metabolomics,X23412.Phospholipids in VLDL,NGF,Beta-nerve growth factor,29218,0.00295503576239444,0.000825352784323417,0.00133734430512054,0.00457272721966834,0.00034371640749696
NMR metabolomics,X23412.Phospholipids in VLDL,MATN3,Matrilin-3,29169,-0.00780962438052469,0.00218139038756258,-0.0120851495401473,-0.00353409922090204,0.000344003291577003
NMR metabolomics,X23412.Phospholipids in VLDL,CEP290,Centrosomal protein of 290 kDa,24445,0.0129327360095971,0.00361301608741235,0.00585122447826892,0.0200142475409253,0.000344939237621964
NMR metabolomics,X23412.Phospholipids in VLDL,AMBN,Ameloblastin,28931,-0.00694379116592966,0.00194008338471594,-0.0107463545999729,-0.00314122773188642,0.000345317166555185
NMR metabolomics,X23412.Phospholipids in VLDL,SCN2B,Sodium channel subunit beta-2,24195,-0.00705308483728242,0.00197146677691849,-0.0109171597200427,-0.00318900995452219,0.000347464298694685
NMR metabolomics,X23412.Phospholipids in VLDL,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,24445,0.0127272502946012,0.00355830861813793,0.00575296540305085,0.0197015351861515,0.000348538408976271
NMR metabolomics,X23412.Phospholipids in VLDL,LEG1,Protein LEG1 homolog,23603,-0.0170495968486589,0.00476871598288489,-0.0263962801751132,-0.00770291352220446,0.000350523476087014
NMR metabolomics,X23412.Phospholipids in VLDL,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",24845,-0.00622087202643941,0.00174805260183739,-0.00964705512604068,-0.00279468892683813,0.000373327196406432
NMR metabolomics,X23412.Phospholipids in VLDL,BCL2L15,Bcl-2-like protein 15,24229,0.0136521179918534,0.0038423592612812,0.00612109383974226,0.0211831421439646,0.000381507132246993
NMR metabolomics,X23412.Phospholipids in VLDL,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,28916,0.00655596818820975,0.00185060262011104,0.00292878705279212,0.0101831493236274,0.000396808269320987
NMR metabolomics,X23412.Phospholipids in VLDL,KIRREL2,Kin of IRRE-like protein 2,28774,0.00957836839878013,0.00271163875189496,0.004263556445066,0.0148931803524943,0.000412579814907859
NMR metabolomics,X23412.Phospholipids in VLDL,NRP2,Neuropilin-2,29443,-0.00685084635751476,0.00194292255875678,-0.010658974572678,-0.00304271814235147,0.000422445002654359
NMR metabolomics,X23412.Phospholipids in VLDL,MRPL52,"39S ribosomal protein L52, mitochondrial",23975,0.00619674474446255,0.00176053015859813,0.00274610563361021,0.00964738385531489,0.000432644955920942
NMR metabolomics,X23412.Phospholipids in VLDL,MRPS16,"28S ribosomal protein S16, mitochondrial",24229,0.00698612659620459,0.00198623280283965,0.00309311030263888,0.0108791428897703,0.000436800221536941
NMR metabolomics,X23412.Phospholipids in VLDL,CEP164,Centrosomal protein of 164 kDa,28931,0.0149655877864261,0.00427998189472054,0.00657682327277381,0.0233543523000783,0.000471850467346037
NMR metabolomics,X23412.Phospholipids in VLDL,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,29694,0.00650499914536207,0.00187142034889114,0.00283701526153544,0.0101729830291887,0.000509738408473407
NMR metabolomics,X23412.Phospholipids in VLDL,SCP2,Non-specific lipid-transfer protein,28797,0.017862329687458,0.00516755973801762,0.00773391260094345,0.0279907467739725,0.00054776950003755
NMR metabolomics,X23412.Phospholipids in VLDL,MYOC,Myocilin,29443,0.0106375407926189,0.00309711301468431,0.00456719928383761,0.0167078823014001,0.000594107950409644
NMR metabolomics,X23412.Phospholipids in VLDL,RAD51,DNA repair protein RAD51 homolog 1,24445,0.0124339837542064,0.00363577371781476,0.00530786726728946,0.0195601002411233,0.000627464438772396
NMR metabolomics,X23412.Phospholipids in VLDL,SEMA3G,Semaphorin-3G,24381,0.010292730805818,0.00301148949562036,0.00439021139440212,0.0161952502172339,0.000632278867815016
NMR metabolomics,X23412.Phospholipids in VLDL,GPR101,Probable G-protein coupled receptor 101,24101,-0.0143451469607589,0.00419818468793618,-0.0225735889491138,-0.00611670497240396,0.000634226652807631
NMR metabolomics,X23412.Phospholipids in VLDL,PRR4,Proline-rich protein 4,24203,-0.016150911100659,0.0047473098790788,-0.0254556384636535,-0.00684618373766455,0.00066973855100885
NMR metabolomics,X23412.Phospholipids in VLDL,DDA1,DET1- and DDB1-associated protein 1,24111,0.00922920564251997,0.00272266700610326,0.00389277831055757,0.0145656329744824,0.000700642937101501
NMR metabolomics,X23412.Phospholipids in VLDL,PODXL2,Podocalyxin-like protein 2,29566,0.00641105492334894,0.00189218525537213,0.00270237182281957,0.0101197380238783,0.000704511383411657
NMR metabolomics,X23412.Phospholipids in VLDL,FGF9,Fibroblast growth factor 9,23970,0.00940966964634554,0.00278229502702919,0.00395637139336832,0.0148629678993228,0.000720801088911393
NMR metabolomics,X23412.Phospholipids in VLDL,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",24016,0.0117470720948287,0.00348290595316036,0.00492057642663438,0.018573567763023,0.000745311973590757
NMR metabolomics,X23412.Phospholipids in VLDL,ITGB2,Integrin beta-2,29274,0.00657201344828525,0.00194934166081122,0.00275130379309527,0.0103927231034752,0.000748835218476272
NMR metabolomics,X23412.Phospholipids in VLDL,RBM19,Probable RNA-binding protein 19,24111,-0.0109689059479174,0.00326104602405021,-0.0173605561550558,-0.00457725574077895,0.000770483770856848
NMR metabolomics,X23412.Phospholipids in VLDL,GABARAP,Gamma-aminobutyric acid receptor-associated protein,24793,0.0112807632434135,0.0033575595811942,0.00469994646427284,0.0178615800225541,0.000781136549365037
NMR metabolomics,X23412.Phospholipids in VLDL,CDK1,Cyclin-dependent kinase 1,24016,0.00833853107285163,0.00248681609879358,0.00346437151921622,0.013212690626487,0.000800367411394125
NMR metabolomics,X23412.Phospholipids in VLDL,SHISA5,Protein shisa-5,24938,0.00576322069641769,0.00172200183001729,0.0023880971095838,0.00913834428325157,0.000818667258322192
NMR metabolomics,X23412.Phospholipids in VLDL,TNN,Tenascin-N,24938,0.00988917918295517,0.00295835308974661,0.00409080712705181,0.0156875512388585,0.000830600592350523
NMR metabolomics,X23412.Phospholipids in VLDL,CLSPN,Claspin,28719,0.0078737750339476,0.00235684959669968,0.00325434982441623,0.012493200243479,0.000836423529833684
NMR metabolomics,X23412.Phospholipids in VLDL,TMEM25,Transmembrane protein 25,24867,-0.0102668062768093,0.00307398574637712,-0.0162918183397085,-0.00424179421391018,0.000839317231865118
NMR metabolomics,X23412.Phospholipids in VLDL,CST7,Cystatin-F,29498,0.020979406636566,0.00630321838475174,0.00862509860245255,0.0333337146706794,0.000874645072074382
NMR metabolomics,X23412.Phospholipids in VLDL,CD3D,T-cell surface glycoprotein CD3 delta chain,24101,-0.00777264082959585,0.00233663978565595,-0.0123524548094815,-0.00319282684971018,0.000881014121337646
NMR metabolomics,X23412.Phospholipids in VLDL,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",29349,-0.00951567739154264,0.00286368905277322,-0.0151285079349781,-0.00390284684810712,0.000892041525617051
NMR metabolomics,X23412.Phospholipids in VLDL,IL1RL1,Interleukin-1 receptor-like 1,29736,-0.0104199210862833,0.00315226471150526,-0.0165983599208336,-0.00424148225173304,0.000949075026311541
NMR metabolomics,X23412.Phospholipids in VLDL,TTN,Titin,24111,-0.0151127215858582,0.00457674037789917,-0.0240831327265406,-0.00614231044517581,0.000961133756788974
NMR metabolomics,X23412.Phospholipids in VLDL,UNG,Uracil-DNA glycosylase,24793,0.00773402726371025,0.00234219319411177,0.00314332860325119,0.0123247259241693,0.000961184395457804
NMR metabolomics,X23412.Phospholipids in VLDL,ACHE,Acetylcholinesterase,24381,0.00740693295917165,0.00224857309733437,0.00299972968839629,0.011814136229947,0.000988924601743358
NMR metabolomics,X23412.Phospholipids in VLDL,TEF,Thyrotroph embryonic factor,24111,0.00961390108027368,0.00292051987867778,0.00388968211806522,0.0153381200424821,0.0009967528937691
NMR metabolomics,X23412.Phospholipids in VLDL,PLB1,"Phospholipase B1, membrane-associated",24845,0.0134200800356788,0.00407965785368149,0.00542395064246307,0.0214162094288945,0.00100501252978743
NMR metabolomics,X23412.Phospholipids in VLDL,MKI67,Proliferation marker protein Ki-67,24229,0.00874529462435415,0.00265869919849039,0.00353424419531299,0.0139563450533953,0.00100575462904738
NMR metabolomics,X23412.Phospholipids in VLDL,SAG,S-arrestin,24101,-0.0118220276152108,0.00359635981018964,-0.0188708928431825,-0.00477316238723908,0.00101326376955987
NMR metabolomics,X23412.Phospholipids in VLDL,MYH7B,Myosin-7B,24016,-0.00994035128369727,0.00302459775611684,-0.0158685628856863,-0.00401213968170826,0.00101585053706766
NMR metabolomics,X23412.Phospholipids in VLDL,TYMP,Thymidine phosphorylase,29301,0.0147879055564537,0.00450852540128537,0.00595119576993438,0.023624615342973,0.00103932981575751
NMR metabolomics,X23412.Phospholipids in VLDL,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,24922,0.0164006518179505,0.0050258225485829,0.00655003962272799,0.026251264013173,0.00110280105977697
NMR metabolomics,X23412.Phospholipids in VLDL,CUZD1,CUB and zona pellucida-like domain-containing protein 1,24195,0.00843052722958585,0.00258972339172811,0.00335466938179876,0.0135063850773729,0.0011339745707647
NMR metabolomics,X23412.Phospholipids in VLDL,TCN1,Transcobalamin-1,24546,0.00757082457499483,0.00232603852323117,0.00301178906946174,0.0121298600805279,0.00113620031090022
NMR metabolomics,X23412.Phospholipids in VLDL,HAVCR2,Hepatitis A virus cellular receptor 2,29443,-0.00774979895857595,0.00238505900149344,-0.0124245146015031,-0.0030750833156488,0.0011581463843091
NMR metabolomics,X23412.Phospholipids in VLDL,GIPC2,PDZ domain-containing protein GIPC2,24845,0.00656882556845913,0.00202462578798252,0.00260055902401339,0.0105370921129049,0.00117827500563346
NMR metabolomics,X23412.Phospholipids in VLDL,APOA4,Apolipoprotein A-IV,24966,0.00787851711875703,0.00243269607994136,0.00311043280207197,0.0126466014354421,0.00120277092547503
NMR metabolomics,X23412.Phospholipids in VLDL,MYL4,Myosin light chain 4,24240,-0.0114025664882111,0.0035421235230932,-0.0183451285934737,-0.00446000438294841,0.00128748192166756
NMR metabolomics,X23412.Phospholipids in VLDL,CLMP,CXADR-like membrane protein,29725,0.00462019232025682,0.00143597964838768,0.00180567220941697,0.00743471243109668,0.00129474297714458
NMR metabolomics,X23412.Phospholipids in VLDL,CLEC4M,C-type lectin domain family 4 member M,24888,0.0107139094890243,0.00333083794705395,0.00418546711279851,0.01724235186525,0.00129893888554654
NMR metabolomics,X23412.Phospholipids in VLDL,IL6,Interleukin-6,29349,0.0160080271625674,0.00500144496120625,0.00620519503860313,0.0258108592865316,0.00137249457419485
NMR metabolomics,X23412.Phospholipids in VLDL,UNC5D,Netrin receptor UNC5D,24229,0.00575750349284504,0.00179945922377471,0.0022305634142466,0.00928444357144348,0.00137808007689355
NMR metabolomics,X23412.Phospholipids in VLDL,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,24111,-0.00873658736229204,0.00273566098422412,-0.0140984828913713,-0.00337469183321277,0.00140694794949916
NMR metabolomics,X23412.Phospholipids in VLDL,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,24195,-0.00688231480528667,0.00215996467935981,-0.0111158455768319,-0.00264878403374143,0.00144283695588819
NMR metabolomics,X23412.Phospholipids in VLDL,ACSL1,Long-chain-fatty-acid--CoA ligase 1,24111,-0.0081054829909525,0.0025659242665656,-0.0131346945534211,-0.00307627142848393,0.00158564613255334
NMR metabolomics,X23412.Phospholipids in VLDL,THBS2,Thrombospondin-2,29443,-0.00801186026120117,0.00253685591797669,-0.0129840978604355,-0.00303962266196685,0.00158915177406739
NMR metabolomics,X23412.Phospholipids in VLDL,TFF3,Trefoil factor 3,29426,-0.00991995289511362,0.00314168075959241,-0.0160776471839147,-0.00376225860631249,0.0015927230034448
NMR metabolomics,X23412.Phospholipids in VLDL,SPINT1,Kunitz-type protease inhibitor 1,29333,0.00556391222176133,0.00176967753224803,0.00209534425855519,0.00903248018496747,0.00166806838310754
NMR metabolomics,X23412.Phospholipids in VLDL,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,24867,0.00559498877382416,0.00178231989680534,0.0021016417760857,0.00908833577156263,0.00169630691917414
NMR metabolomics,X23412.Phospholipids in VLDL,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,24381,0.00802517718771132,0.00256196416017298,0.00300372743377227,0.0130466269416504,0.00173570164414804
NMR metabolomics,X23412.Phospholipids in VLDL,IL2RA,Interleukin-2 receptor subunit alpha,29223,-0.0085887210530648,0.00274319353652733,-0.0139653803846584,-0.00321206172147123,0.00174431105899593
NMR metabolomics,X23412.Phospholipids in VLDL,SPP1,Osteopontin,29757,-0.00977254731456912,0.00312579683600049,-0.0158991091131301,-0.00364598551600816,0.00177120310997639
NMR metabolomics,X23412.Phospholipids in VLDL,SUMF1,Formylglycine-generating enzyme,24229,0.0141473632180056,0.00453067862138855,0.00526723312008403,0.0230274933159271,0.00179490339893036
NMR metabolomics,X23412.Phospholipids in VLDL,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,28916,0.0102802031759361,0.00330078458815561,0.0038106653831511,0.0167497409687211,0.00184454170810358
NMR metabolomics,X23412.Phospholipids in VLDL,GUK1,Guanylate kinase,24111,-0.00848337633782638,0.00273346946579782,-0.0138409764907901,-0.00312577618486264,0.00191454808792287
NMR metabolomics,X23412.Phospholipids in VLDL,PPM1B,Protein phosphatase 1B,24229,0.0132166187523971,0.00425942735514934,0.00486814113630435,0.0215650963684898,0.00191848578518579
NMR metabolomics,X23412.Phospholipids in VLDL,LTO1,Protein LTO1 homolog,28931,0.00864135387100156,0.00279316039249201,0.00316675950171723,0.0141159482402859,0.00197829034504515
NMR metabolomics,X23412.Phospholipids in VLDL,PLXDC2,Plexin domain-containing protein 2,24845,0.005690826393695,0.00184038392618405,0.00208367389837426,0.00929797888901575,0.00198902289957483
NMR metabolomics,X23412.Phospholipids in VLDL,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,24173,0.00809613197138632,0.00262303537191565,0.00295498264243165,0.013237281300341,0.00202722412185536
NMR metabolomics,X23412.Phospholipids in VLDL,STX1B,Syntaxin-1B,24195,0.00871301157923502,0.00283501900471442,0.00315637432999476,0.0142696488284753,0.00211904103101135
NMR metabolomics,X23412.Phospholipids in VLDL,YY1,Transcriptional repressor protein YY1,24229,0.00583852087440948,0.00190407854039218,0.00210652693524082,0.00957051481357815,0.00216947443589924
NMR metabolomics,X23412.Phospholipids in VLDL,FRMD7,FERM domain-containing protein 7,24195,0.00699193706749741,0.00228377529793486,0.00251573748354509,0.0114681366514497,0.00220421344292811
NMR metabolomics,X23412.Phospholipids in VLDL,EPHA4,Ephrin type-A receptor 4,24381,0.00595534148191957,0.00194808324406771,0.00213709832354685,0.00977358464029229,0.00223786809342085
NMR metabolomics,X23412.Phospholipids in VLDL,KIF20B,Kinesin-like protein KIF20B,24101,0.0158921512450339,0.00521038456456467,0.00567979749848718,0.0261045049915807,0.00229019952858891
NMR metabolomics,X23412.Phospholipids in VLDL,NLGN2,Neuroligin-2,24101,-0.00983458565424412,0.00323701917832364,-0.0161791432437585,-0.00349002806472979,0.00238281589453264
NMR metabolomics,X23412.Phospholipids in VLDL,BMP4,Bone morphogenetic protein 4,29169,-0.00952358543175567,0.00313781485165345,-0.0156737025409964,-0.00337346832251492,0.00240666981859344
NMR metabolomics,X23412.Phospholipids in VLDL,SH3GL3,Endophilin-A3,24307,0.0172997110381188,0.00570333687588379,0.00612117076138653,0.028478251314851,0.00242181382537609
NMR metabolomics,X23412.Phospholipids in VLDL,DEFA1_DEFA1B,Neutrophil defensin 1,28862,0.0107898857115138,0.00355773752004451,0.00381672017222654,0.017763051250801,0.00242516029103608
NMR metabolomics,X23412.Phospholipids in VLDL,ATF2,Cyclic AMP-dependent transcription factor ATF-2,28774,0.0139922370483912,0.00461591124334352,0.00494505101143789,0.0230394230853445,0.00243715340573117
NMR metabolomics,X23412.Phospholipids in VLDL,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,29218,0.0125106078316782,0.00413556224372244,0.00440490583398217,0.0206163098293741,0.00248743464509404
NMR metabolomics,X23412.Phospholipids in VLDL,LYPD8,Ly6/PLAUR domain-containing protein 8,28797,0.0106079119423751,0.00350728141566544,0.00373364036767087,0.0174821835170794,0.0024923128235994
NMR metabolomics,X23412.Phospholipids in VLDL,IL11,Interleukin-11,28931,0.0127983642673193,0.0042362570164407,0.00449530051509552,0.0211014280195431,0.00252037337375913
NMR metabolomics,X23412.Phospholipids in VLDL,LY6D,Lymphocyte antigen 6D,29283,0.00786810880954101,0.00260476215249701,0.00276277499064687,0.0129734426284351,0.00252439484244978
NMR metabolomics,X23412.Phospholipids in VLDL,MAPK13,Mitogen-activated protein kinase 13,24016,0.0086836361850989,0.00288129938228106,0.00303628939582802,0.0143309829743698,0.00258274101880416
NMR metabolomics,X23412.Phospholipids in VLDL,WASL,Neural Wiskott-Aldrich syndrome protein,24229,-0.0124743752644341,0.0041392467159613,-0.0205872988277183,-0.00436145170115,0.00258364701162804
NMR metabolomics,X23412.Phospholipids in VLDL,RALB,Ras-related protein Ral-B,24229,0.00606975139438948,0.0020146302887911,0.00212107602835891,0.01001842676042,0.00259085824250937
NMR metabolomics,X23412.Phospholipids in VLDL,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",24867,0.0139504154321398,0.00463764372838646,0.00486063372450231,0.0230401971397772,0.00263164778156128
NMR metabolomics,X23412.Phospholipids in VLDL,CHI3L1,Chitinase-3-like protein 1,28935,0.0160314998638246,0.00533611434483489,0.00557271574794826,0.026490283979701,0.00266385877793794
NMR metabolomics,X23412.Phospholipids in VLDL,OSBPL2,Oxysterol-binding protein-related protein 2,24845,0.00797134769842508,0.00266305833882904,0.00275175335432016,0.01319094204253,0.00276244684603689
NMR metabolomics,X23412.Phospholipids in VLDL,ATP1B4,Protein ATP1B4,24016,-0.00856614295041009,0.00286651557932714,-0.0141845134858913,-0.00294777241492889,0.00280774758256901
NMR metabolomics,X23412.Phospholipids in VLDL,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,29694,-0.00920512475770618,0.00308652188362747,-0.015254707649616,-0.00315554186579634,0.00286266116469467
NMR metabolomics,X23412.Phospholipids in VLDL,CLEC12A,C-type lectin domain family 12 member A,24229,0.00412979615663946,0.00138935270490051,0.00140666485503446,0.00685292745824446,0.00295713681011791
NMR metabolomics,X23412.Phospholipids in VLDL,NPTN,Neuroplastin,28797,0.0164332332917439,0.00553820862854255,0.00557834437980053,0.0272881222036873,0.00300726421124702
NMR metabolomics,X23412.Phospholipids in VLDL,PILRA,Paired immunoglobulin-like type 2 receptor alpha,29443,0.00849246633179222,0.0028669921613886,0.00287316169547057,0.0141117709681139,0.0030574110937102
NMR metabolomics,X23412.Phospholipids in VLDL,NRXN3,Neurexin-3,24195,0.0071158786054813,0.00240261818634354,0.00240674696024797,0.0118250102507146,0.00306224741687684
NMR metabolomics,X23412.Phospholipids in VLDL,ELAVL4,ELAV-like protein 4,24101,0.0170627411136067,0.00576636503318476,0.00576066564856455,0.0283648165786488,0.00308927610774362
NMR metabolomics,X23412.Phospholipids in VLDL,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",24101,0.006473060022055,0.00218803461603079,0.00218451217463465,0.0107616078694753,0.00309550975802839
NMR metabolomics,X23412.Phospholipids in VLDL,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,24111,0.011317587667594,0.00382669728855688,0.00381726098202255,0.0188179143531655,0.00310411372377737
NMR metabolomics,X23412.Phospholipids in VLDL,CD109,CD109 antigen,29443,-0.00676627828190818,0.00228838399773242,-0.0112515109174637,-0.00228104564635264,0.00311103260320424
NMR metabolomics,X23412.Phospholipids in VLDL,DPEP2,Dipeptidase 2,29349,0.00586693168313049,0.00198759182737542,0.00197125170147467,0.00976261166478632,0.00316199084635987
NMR metabolomics,X23412.Phospholipids in VLDL,PTPRS,Receptor-type tyrosine-protein phosphatase S,29820,-0.00490898444725414,0.00166958587752049,-0.0081813727671943,-0.00163659612731398,0.003282091386465
NMR metabolomics,X23412.Phospholipids in VLDL,CD33,Myeloid cell surface antigen CD33,29566,0.0158030266242264,0.00537595580726696,0.0052661532419832,0.0263399000064697,0.00328916785843961
NMR metabolomics,X23412.Phospholipids in VLDL,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",28931,0.0234601192795714,0.00800707905790431,0.0077662443260789,0.0391539942330638,0.00339311739453292
NMR metabolomics,X23412.Phospholipids in VLDL,FSTL3,Follistatin-related protein 3,29351,0.00632559117906268,0.00216162346718906,0.00208880918337211,0.0105623731747532,0.00343266453779112
NMR metabolomics,X23412.Phospholipids in VLDL,C1GALT1C1,C1GALT1-specific chaperone 1,24111,0.00650221158964715,0.00222537988431242,0.0021404670163948,0.0108639561628995,0.00348289470515225
NMR metabolomics,X23412.Phospholipids in VLDL,SHPK,Sedoheptulokinase,24445,-0.00823298948841444,0.00282566294059835,-0.0137712888519872,-0.00269469012484167,0.00357555320147851
NMR metabolomics,X23412.Phospholipids in VLDL,SIRPB1,Signal-regulatory protein beta-1,29409,0.00911033468513676,0.00312835284922223,0.00297876310066119,0.0152419062696123,0.00359182652268103
NMR metabolomics,X23412.Phospholipids in VLDL,PTTG1,Securin,24445,0.00820179692546903,0.00281718758034315,0.00268010926799646,0.0137234845829416,0.00360204964637954
NMR metabolomics,X23412.Phospholipids in VLDL,GGA1,ADP-ribosylation factor-binding protein GGA1,28774,0.0134480262838922,0.00461968598054792,0.00439344176201825,0.0225026108057661,0.00360520431778903
NMR metabolomics,X23412.Phospholipids in VLDL,SLAMF8,SLAM family member 8,28797,0.0105733384793129,0.00363480179586543,0.00344912695941664,0.0176975499992091,0.0036295995874557
NMR metabolomics,X23412.Phospholipids in VLDL,HEPACAM2,HEPACAM family member 2,24845,-0.00827793951706466,0.00285737656222158,-0.013878397579019,-0.00267748145511037,0.00377028526392397
NMR metabolomics,X23412.Phospholipids in VLDL,ALDH2,"Aldehyde dehydrogenase, mitochondrial",24793,0.0102257896686985,0.0035308893377169,0.00330524656677339,0.0171463327706236,0.00378168773950965
NMR metabolomics,X23412.Phospholipids in VLDL,DDX39A,ATP-dependent RNA helicase DDX39A,24229,0.00458941598769247,0.0015904529131444,0.00147212827792945,0.00770670369745549,0.00391009313058006
NMR metabolomics,X23412.Phospholipids in VLDL,DCN,Decorin,28916,-0.00447970904291968,0.00155301181090875,-0.00752361219230084,-0.00143580589353853,0.00392288082236833
NMR metabolomics,X23412.Phospholipids in VLDL,ID4,DNA-binding protein inhibitor ID-4,24445,-0.00861294329372126,0.00298727303439797,-0.0144679984411413,-0.00275788814630124,0.00393985105967575
NMR metabolomics,X23412.Phospholipids in VLDL,MYBPC1,"Myosin-binding protein C, slow-type",24922,-0.0136658883021687,0.00475139779094494,-0.0229786279724208,-0.0043531486319166,0.0040285804537727
NMR metabolomics,X23412.Phospholipids in VLDL,CTHRC1,Collagen triple helix repeat-containing protein 1,24938,0.00548547572359322,0.00191014181108134,0.00174159777387378,0.00922935367331265,0.00408532293708491
NMR metabolomics,X23412.Phospholipids in VLDL,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,28916,-0.00417281355045847,0.00145504792385782,-0.0070247074812198,-0.00132091961969714,0.00413611349228813
NMR metabolomics,X23412.Phospholipids in VLDL,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",24229,0.00689051824407833,0.00240931695191609,0.00216825701832279,0.0116127794698339,0.00424074312051327
NMR metabolomics,X23412.Phospholipids in VLDL,SLC12A2,Solute carrier family 12 member 2,24111,-0.00536013253180135,0.00187901664589054,-0.00904300515774682,-0.00167725990585589,0.00433964634594008
NMR metabolomics,X23412.Phospholipids in VLDL,CEP112,Centrosomal protein of 112 kDa,24111,0.00890288118675911,0.00312538285303785,0.00277713079480493,0.0150286315787133,0.00439529615948022
NMR metabolomics,X23412.Phospholipids in VLDL,CD248,Endosialin,24938,-0.00776342178649434,0.00273591619927109,-0.0131258175370657,-0.00240102603592301,0.00454915285476639
NMR metabolomics,X23412.Phospholipids in VLDL,LAYN,Layilin,29163,-0.00673087194405063,0.00237242290169122,-0.0113808208313654,-0.00208092305673583,0.00455524886443833
NMR metabolomics,X23412.Phospholipids in VLDL,WFDC2,WAP four-disulfide core domain protein 2,27939,0.00769766632204387,0.00271423586865622,0.00237776401947768,0.0130175686246101,0.00457103683090666
NMR metabolomics,X23412.Phospholipids in VLDL,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,24111,0.00884184913642003,0.00312200582441043,0.00272271772057558,0.0149609805522645,0.00462809631672438
NMR metabolomics,X23412.Phospholipids in VLDL,VWC2L,von Willebrand factor C domain-containing protein 2-like,24867,0.00897161946517802,0.00317022778416149,0.0027579730082215,0.0151852659221345,0.00465910705493743
NMR metabolomics,X23412.Phospholipids in VLDL,EIF5A,Eukaryotic translation initiation factor 5A-1,28931,0.00572706533322914,0.00203356447225499,0.00174127896760937,0.00971285169884892,0.00486178059042423
NMR metabolomics,X23412.Phospholipids in VLDL,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,24111,-0.0112538195431952,0.0039962843279047,-0.0190865368258884,-0.00342110226050197,0.00486544432610905
NMR metabolomics,X23412.Phospholipids in VLDL,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",24016,0.0109627166506071,0.00390774101936408,0.00330354425265349,0.0186218890485607,0.00502969920190027
NMR metabolomics,X23412.Phospholipids in VLDL,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",24111,0.00951205755993827,0.00339995850623861,0.0028481388877106,0.0161759762321659,0.00515090200404288
NMR metabolomics,X23412.Phospholipids in VLDL,CCAR2,Cell cycle and apoptosis regulator protein 2,24845,0.0106230983623593,0.00380887987496381,0.00315769380743022,0.0180885029172884,0.00529056369487448
NMR metabolomics,X23412.Phospholipids in VLDL,CYB5A,Cytochrome b5,24016,0.0137414466271659,0.00492718490729761,0.00408416420886262,0.0233987290454692,0.00529283544546453
NMR metabolomics,X23412.Phospholipids in VLDL,IL2RG,Cytokine receptor common subunit gamma,24793,0.00704863034924453,0.00253250124007666,0.00208492791869427,0.0120123327797948,0.00538550380927794
NMR metabolomics,X23412.Phospholipids in VLDL,PNLIPRP2,Pancreatic lipase-related protein 2,29454,0.0556672497341358,0.0200097930187207,0.0164480554174432,0.0948864440508285,0.00540593683488213
NMR metabolomics,X23412.Phospholipids in VLDL,LCN2,Neutrophil gelatinase-associated lipocalin,28586,-0.00722401762140731,0.00260461310891054,-0.012329059314872,-0.00211897592794264,0.00554847371155725
NMR metabolomics,X23412.Phospholipids in VLDL,VSTM1,V-set and transmembrane domain-containing protein 1,28774,0.00927451832292568,0.00334533822529393,0.00271765540134958,0.0158313812445018,0.0055685385222746
NMR metabolomics,X23412.Phospholipids in VLDL,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,28916,0.00597355603608904,0.00215750415229837,0.00174484789758424,0.0102022641745938,0.00563103335862702
NMR metabolomics,X23412.Phospholipids in VLDL,JUN,Transcription factor AP-1,28931,0.00940692067703806,0.00340278033556336,0.00273747121933387,0.0160763701347423,0.00570495751305039
NMR metabolomics,X23412.Phospholipids in VLDL,MB,Myoglobin,29820,-0.0098343290885227,0.00355775450335237,-0.0168075279150934,-0.00286113026195205,0.00570983758460185
NMR metabolomics,X23412.Phospholipids in VLDL,TXNL1,Thioredoxin-like protein 1,24069,0.0184249644646328,0.00668243090280935,0.00532739989512647,0.0315225290341391,0.00583382092747777
NMR metabolomics,X23412.Phospholipids in VLDL,ATP5PO,"ATP synthase subunit O, mitochondrial",28774,0.00791708767602171,0.00287645946414738,0.00227922712629284,0.0135549482257506,0.00592022735709107
NMR metabolomics,X23412.Phospholipids in VLDL,IL20RA,Interleukin-20 receptor subunit alpha,28931,0.00841721014483407,0.00307447025241596,0.00239124845009879,0.0144431718395694,0.00618940596167311
NMR metabolomics,X23412.Phospholipids in VLDL,ART3,Ecto-ADP-ribosyltransferase 3,29594,-0.00638545218723885,0.00233343400847039,-0.0109589828438408,-0.00181192153063689,0.00621328411597124
NMR metabolomics,X23412.Phospholipids in VLDL,MET,Hepatocyte growth factor receptor,29507,0.00366443970365597,0.00134063054029483,0.00103680384467811,0.00629207556263383,0.00627271753920064
NMR metabolomics,X23412.Phospholipids in VLDL,COL1A1,Collagen alpha-1(I) chain,29820,-0.00463192414044214,0.00169546299399035,-0.00795503160866322,-0.00130881667222106,0.00629973081204085
NMR metabolomics,X23412.Phospholipids in VLDL,GKN1,Gastrokine-1,28114,0.00520359692568811,0.0019072313132412,0.00146542355173536,0.00894177029964086,0.00636913516921252
NMR metabolomics,X23412.Phospholipids in VLDL,IGFBP7,Insulin-like growth factor-binding protein 7,29820,0.00559847769600912,0.00205824724046444,0.00156431310469882,0.00963264228731942,0.00653154111404023
NMR metabolomics,X23412.Phospholipids in VLDL,AGBL2,Cytosolic carboxypeptidase 2,24101,0.0168948774284171,0.0062176980216704,0.00470818930594315,0.0290815655508911,0.00658791013810794
NMR metabolomics,X23412.Phospholipids in VLDL,REG1B,Lithostathine-1-beta,29820,-0.0103811629718967,0.00382126666875152,-0.0178708456426497,-0.00289148030114371,0.00659781532791789
NMR metabolomics,X23412.Phospholipids in VLDL,ADA2,Adenosine deaminase 2,29328,-0.00784298374577854,0.00290201193418109,-0.0135309271367735,-0.0021550403547836,0.00688386535240538
NMR metabolomics,X23412.Phospholipids in VLDL,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,24101,0.010632950072324,0.00393806762529295,0.00291433752674981,0.0183515626178982,0.00693790353611349
NMR metabolomics,X23412.Phospholipids in VLDL,CD58,Lymphocyte function-associated antigen 3,29409,0.00322579119993654,0.00119568704931263,0.000882244583283789,0.00556933781658928,0.00698274938007656
NMR metabolomics,X23412.Phospholipids in VLDL,PRDX2,Peroxiredoxin-2,24556,0.0113012712551431,0.00419219998106899,0.00308455929224792,0.0195179832180384,0.00702707691845811
NMR metabolomics,X23412.Phospholipids in VLDL,CD5L,CD5 antigen-like,24833,0.00867039296274511,0.0032176926878113,0.00236371529463496,0.0149770706308553,0.00705207160062491
NMR metabolomics,X23412.Phospholipids in VLDL,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,24101,-0.0111970062416671,0.00418110506230175,-0.0193919721637785,-0.00300204031955567,0.00741130852449118
NMR metabolomics,X23412.Phospholipids in VLDL,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,29478,0.00575358618344241,0.00215932156400054,0.00152131591800134,0.00998585644888347,0.00771370038979914
NMR metabolomics,X23412.Phospholipids in VLDL,CTSB,Cathepsin B,29480,-0.0094586791789066,0.00355593723260264,-0.0164283161548078,-0.00248904220300542,0.00781903708893872
NMR metabolomics,X23412.Phospholipids in VLDL,KRT19,"Keratin, type I cytoskeletal 19",29378,-0.0122118107036732,0.00459812093300812,-0.0212241277323691,-0.00319949367497728,0.00791570666710662
NMR metabolomics,X23412.Phospholipids in VLDL,CRHR1,Corticotropin-releasing factor receptor 1,28916,0.0110036246848859,0.00414467717806602,0.00288005741587647,0.0191271919538953,0.00793798638590178
NMR metabolomics,X23412.Phospholipids in VLDL,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",24229,0.00508091234543869,0.00191417371986389,0.00132913185450547,0.00883269283637191,0.00795101747979365
NMR metabolomics,X23412.Phospholipids in VLDL,IL1RAP,Interleukin-1 receptor accessory protein,29443,-0.00785920512125688,0.00297248474462036,-0.0136852752207128,-0.00203313502180097,0.00819797339559107
NMR metabolomics,X23412.Phospholipids in VLDL,PNMA2,Paraneoplastic antigen Ma2,24101,0.00789237791287393,0.00298646702660177,0.00203890254073446,0.0137458532850134,0.00822976951620727
NMR metabolomics,X23412.Phospholipids in VLDL,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,24867,-0.00532635492078405,0.00201722757024665,-0.0092801209584675,-0.00137258888310061,0.00828518260187504
NMR metabolomics,X23412.Phospholipids in VLDL,SLC4A1,Band 3 anion transport protein,24938,-0.00839778315991182,0.00318227963945251,-0.0146350512532387,-0.0021605150665849,0.00832221910107106
NMR metabolomics,X23412.Phospholipids in VLDL,NECTIN4,Nectin-4,29566,-0.00571261693508493,0.0021677033054747,-0.00996131541381533,-0.00146391845635452,0.00840990044984197
NMR metabolomics,X23412.Phospholipids in VLDL,SAT1,Diamine acetyltransferase 1,24111,-0.00905277181564867,0.00343664316898625,-0.0157885924268617,-0.00231695120443563,0.0084392127571693
NMR metabolomics,X23412.Phospholipids in VLDL,EPN1,Epsin-1,24445,0.00782491480653642,0.00297559964534523,0.00199273950165978,0.0136570901114131,0.00855154474011834
NMR metabolomics,X23412.Phospholipids in VLDL,CDH23,Cadherin-23,24845,-0.00474180076494811,0.00180481907086303,-0.00827924614383966,-0.00120435538605657,0.00861183560928595
NMR metabolomics,X23412.Phospholipids in VLDL,ENG,Endoglin,29820,0.00306083365427398,0.00116717841425843,0.000773163962327458,0.00534850334622049,0.00873517998489955
NMR metabolomics,X23412.Phospholipids in VLDL,VCPKMT,Protein-lysine methyltransferase METTL21D,24016,0.0154283933514702,0.00589671272805319,0.00387083640448598,0.0269859502984545,0.00889077077702149
NMR metabolomics,X23412.Phospholipids in VLDL,PLA2G1B,Phospholipase A2,29787,-0.00762010613376151,0.00292211144242266,-0.0133474445609099,-0.0018927677066131,0.00911877012792733
NMR metabolomics,X23412.Phospholipids in VLDL,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,24805,-0.0124456043908295,0.00479508412852899,-0.0218439692827463,-0.00304723949891268,0.00945111575873882
NMR metabolomics,X23412.Phospholipids in VLDL,RNASE10,Inactive ribonuclease-like protein 10,24240,-0.00849208601323428,0.00327308205186883,-0.0149073268348972,-0.00207684519157136,0.00947793783989462
NMR metabolomics,X23412.Phospholipids in VLDL,PI3,Elafin,29014,0.00967132590276746,0.00373515186218948,0.00235042825287608,0.0169922235526588,0.00962269993301095
NMR metabolomics,X23412.Phospholipids in VLDL,CDH6,Cadherin-6,29478,-0.00670801559154107,0.00260122444921498,-0.0118064155120024,-0.0016096156710797,0.00991946445212383
NMR metabolomics,X23412.Phospholipids in VLDL,INSL4,Early placenta insulin-like peptide,24793,-0.00901183281864065,0.00349817018709335,-0.0158682463853436,-0.00215541925193768,0.00999628620186008
NMR metabolomics,X23412.Phospholipids in VLDL,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,29443,0.00520843992368029,0.00202406436229477,0.00124127377358254,0.00917560607377804,0.0100794566094251
NMR metabolomics,X23412.Phospholipids in VLDL,SIGLEC1,Sialoadhesin,29581,0.00736950820477913,0.00287813880980891,0.00172835613755367,0.0130106602720046,0.0104567345818756
NMR metabolomics,X23412.Phospholipids in VLDL,GBP6,Guanylate-binding protein 6,24111,-0.00804860429314174,0.00314509514077449,-0.0142129907690597,-0.00188421781722375,0.0105004895324672
NMR metabolomics,X23412.Phospholipids in VLDL,RNASE1,Ribonuclease pancreatic,24951,0.00422285032883559,0.00165838025115538,0.000972425036571039,0.00747327562110014,0.0108909219486742
NMR metabolomics,X23412.Phospholipids in VLDL,PAPPA,Pappalysin-1,28931,0.00814688808515506,0.00320035467644134,0.00187419291933004,0.0144195832509801,0.0109135187304604
NMR metabolomics,X23412.Phospholipids in VLDL,MTR,Methionine synthase,24111,0.0112984357008006,0.00444744466821721,0.0025814441510949,0.0200154272505064,0.0110777473778505
NMR metabolomics,X23412.Phospholipids in VLDL,SPINK5,Serine protease inhibitor Kazal-type 5,29443,-0.00583567071851646,0.0022993741162691,-0.0103424439864039,-0.00132889745062903,0.0111558611289909
NMR metabolomics,X23412.Phospholipids in VLDL,PRRT3,Proline-rich transmembrane protein 3,24240,0.00655682087422933,0.00258925292535406,0.00148188514053538,0.0116317566079233,0.0113372653033422
NMR metabolomics,X23412.Phospholipids in VLDL,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",24101,-0.00935782058096155,0.00370164924609337,-0.0166130531033046,-0.00210258805861855,0.0114773191904339
NMR metabolomics,X23412.Phospholipids in VLDL,HTR1B,5-hydroxytryptamine receptor 1B,24101,-0.00738935930192813,0.0029284238319524,-0.0131290700125548,-0.00164964859130142,0.0116315354541096
NMR metabolomics,X23412.Phospholipids in VLDL,COL3A1,Collagen alpha-1(III) chain,24938,-0.00398519089834612,0.00158539802140263,-0.00709257102029528,-0.000877810776396969,0.0119539679634885
NMR metabolomics,X23412.Phospholipids in VLDL,RGMA,Repulsive guidance molecule A,29694,-0.00532322880917578,0.00213390350504528,-0.00950567967906453,-0.00114077793928703,0.0126154267893472
NMR metabolomics,X23412.Phospholipids in VLDL,STOML2,"Stomatin-like protein 2, mitochondrial",24016,0.015665612639696,0.00630875170007511,0.00330045930754878,0.0280307659718432,0.0130291926667505
NMR metabolomics,X23412.Phospholipids in VLDL,PI16,Peptidase inhibitor 16,24951,0.00414488959903359,0.00166953920314276,0.000872592760873783,0.00741718643719339,0.0130472645678918
NMR metabolomics,X23412.Phospholipids in VLDL,CSPG5,Chondroitin sulfate proteoglycan 5,24101,-0.00845410350294621,0.00340555167571316,-0.015128984787344,-0.00177922221854843,0.0130550859912343
NMR metabolomics,X23412.Phospholipids in VLDL,AIDA,"Axin interactor, dorsalization-associated protein",24195,0.0141977322662511,0.0057459410944133,0.00293568772120099,0.0254597768113011,0.0134836242366583
NMR metabolomics,X23412.Phospholipids in VLDL,CST6,Cystatin-M,28830,0.0081764871231568,0.00331048424289393,0.00168793800708469,0.0146650362392289,0.0135217205087268
NMR metabolomics,X23412.Phospholipids in VLDL,BATF,Basic leucine zipper transcriptional factor ATF-like,24195,0.0140825747294415,0.00571735350786488,0.00287656185402638,0.0252885876048567,0.0137799795249051
NMR metabolomics,X23412.Phospholipids in VLDL,CLEC4C,C-type lectin domain family 4 member C,29434,0.00775496013622309,0.00318006445640283,0.00152203380167354,0.0139878864707726,0.014749446627109
NMR metabolomics,X23412.Phospholipids in VLDL,RBP7,Retinoid-binding protein 7,24805,0.00997033480926633,0.00409519468473299,0.00194375322718967,0.017996916391343,0.0149135177041333
NMR metabolomics,X23412.Phospholipids in VLDL,GNPDA1,Glucosamine-6-phosphate isomerase 1,24240,0.00541265383642642,0.0022568182724493,0.000989290022425802,0.00983601765042704,0.0164763616903363
NMR metabolomics,X23412.Phospholipids in VLDL,ENOPH1,Enolase-phosphatase E1,24793,0.00903494136662377,0.00377159887786402,0.00164260756601029,0.0164272751672372,0.0166041726687655
NMR metabolomics,X23412.Phospholipids in VLDL,PLA2G2A,"Phospholipase A2, membrane associated",29402,-0.00900913101293924,0.0037748711485067,-0.0164078784640124,-0.00161038356186611,0.0170109811869721
NMR metabolomics,X23412.Phospholipids in VLDL,PGLYRP4,Peptidoglycan recognition protein 4,24111,0.00991063054282945,0.00415685805122482,0.0017631887624288,0.0180580723232301,0.017125672254991
NMR metabolomics,X23412.Phospholipids in VLDL,SEZ6L2,Seizure 6-like protein 2,29349,-0.00387815898033628,0.0016266690773515,-0.00706643037194523,-0.000689887588727339,0.0171267750033153
NMR metabolomics,X23412.Phospholipids in VLDL,MRPL24,"39S ribosomal protein L24, mitochondrial",24111,0.00635167549509268,0.00268477134602718,0.0010895236568794,0.011613827333306,0.0179982426832369
NMR metabolomics,X23412.Phospholipids in VLDL,TXNDC15,Thioredoxin domain-containing protein 15,29566,0.00436167557450874,0.00185413563539382,0.000727569729136858,0.00799578141988062,0.0186590391204631
NMR metabolomics,X23412.Phospholipids in VLDL,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,24111,-0.00765646024053856,0.00326363391331993,-0.0140531827106456,-0.00125973777043149,0.0189845560133826
NMR metabolomics,X23412.Phospholipids in VLDL,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",24195,-0.00781304657462181,0.00333648677152001,-0.014352560646801,-0.00127353250244258,0.0192042803767779
NMR metabolomics,X23412.Phospholipids in VLDL,PRND,Prion-like protein doppel,24845,-0.00806933619795243,0.00350620887972323,-0.01494150560221,-0.00119716679369489,0.0213749020145618
NMR metabolomics,X23412.Phospholipids in VLDL,SCARB1,Scavenger receptor class B member 1,28774,0.00894305315649886,0.00390215300026032,0.00129483327598864,0.0165912730370091,0.0219229143548791
NMR metabolomics,X23412.Phospholipids in VLDL,ABO,Histo-blood group ABO system transferase,24951,0.0224720601995139,0.00981653513699849,0.00323165133099683,0.0417124690680309,0.0220757686841074
NMR metabolomics,X23412.Phospholipids in VLDL,AMIGO1,Amphoterin-induced protein 1,24195,0.00778572722339186,0.00341870569797393,0.00108506405536296,0.0144863903914208,0.0227716194942608
NMR metabolomics,X23412.Phospholipids in VLDL,DOCK9,Dedicator of cytokinesis protein 9,24101,0.0183611566704663,0.00806422344102261,0.00255527872606201,0.0341670346148707,0.0228029551820604
NMR metabolomics,X23412.Phospholipids in VLDL,IL22,Interleukin-22,24793,-0.0104564992432659,0.00460155175468406,-0.0194755406824466,-0.00143745780408511,0.0230717680416722
NMR metabolomics,X23412.Phospholipids in VLDL,NOP56,Nucleolar protein 56,24111,0.0171653744157857,0.00756680458357656,0.00233443743197563,0.0319963113995957,0.0233069264113733
NMR metabolomics,X23412.Phospholipids in VLDL,MYBPC2,"Myosin-binding protein C, fast-type",24240,-0.0131039134276622,0.00578545595386565,-0.0244434070972388,-0.00176441975808551,0.0235230037609421
NMR metabolomics,X23412.Phospholipids in VLDL,DDX53,Probable ATP-dependent RNA helicase DDX53,24195,0.00547782889948483,0.00242947364708003,0.000716060551207977,0.0102395972477617,0.0241586258502326
NMR metabolomics,X23412.Phospholipids in VLDL,CD3E,T-cell surface glycoprotein CD3 epsilon chain,24445,0.00541757358095039,0.00241251235899889,0.00068904935731257,0.0101460978045882,0.0247375908025553
NMR metabolomics,X23412.Phospholipids in VLDL,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,23970,-0.00802023732448807,0.0035716477896957,-0.0150206669922916,-0.0010198076566845,0.0247432969210744
NMR metabolomics,X23412.Phospholipids in VLDL,LPO,Lactoperoxidase,28452,-0.00918320703876014,0.0040896333291612,-0.0171988883639161,-0.00116752571360419,0.024744714208061
NMR metabolomics,X23412.Phospholipids in VLDL,CRISP2,Cysteine-rich secretory protein 2,29725,0.00876043576042614,0.00390524996304293,0.00110614583286199,0.0164147256879903,0.0248883039119488
NMR metabolomics,X23412.Phospholipids in VLDL,DEFB118,Beta-defensin 118,24101,0.00879002939512932,0.00392338647790533,0.00110019189843488,0.0164798668918238,0.0250728165490265
NMR metabolomics,X23412.Phospholipids in VLDL,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,24938,-0.00403122120368126,0.00180005879244655,-0.0075593364368765,-0.00050310597048602,0.0251325617466603
NMR metabolomics,X23412.Phospholipids in VLDL,CD79B,B-cell antigen receptor complex-associated protein beta chain,29786,-0.00678311987021527,0.0030354646590209,-0.0127326306018962,-0.000833609138534303,0.0254494838040439
NMR metabolomics,X23412.Phospholipids in VLDL,THAP12,52 kDa repressor of the inhibitor of the protein kinase,23970,0.0133367307805635,0.00598165041847908,0.00161269596034451,0.0250607656007825,0.0257827642487534
NMR metabolomics,X23412.Phospholipids in VLDL,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,24016,0.00402851309214346,0.00180855934936448,0.000483736767389077,0.00757328941689785,0.0259250618125958
NMR metabolomics,X23412.Phospholipids in VLDL,NOS1,"Nitric oxide synthase, brain",28774,-0.0081798199466723,0.00367338080694159,-0.0153796463282778,-0.000979993565066783,0.0259695286675542
NMR metabolomics,X23412.Phospholipids in VLDL,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,28797,0.0188609524225011,0.00848550565627734,0.00222936133619753,0.0354925435088047,0.0262420329271097
NMR metabolomics,X23412.Phospholipids in VLDL,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,28797,0.0185790729159332,0.0083689167365326,0.00217599611232929,0.0349821497195371,0.0264258968431948
NMR metabolomics,X23412.Phospholipids in VLDL,TNXB,Tenascin-X,29443,0.00386918614864467,0.0017509156233806,0.000437391526818694,0.00730098077047065,0.0271262064590061
NMR metabolomics,X23412.Phospholipids in VLDL,TMEM132A,Transmembrane protein 132A,24240,0.00941989926721302,0.00426676461222888,0.00105704062724441,0.0177827579071816,0.0272718624793432
NMR metabolomics,X23412.Phospholipids in VLDL,OSM,Oncostatin-M,29293,0.0105699771098052,0.00481724620643671,0.00112817454518928,0.0200117796744212,0.028229228689195
NMR metabolomics,X23412.Phospholipids in VLDL,HLA_DRA,,29322,-0.00534637001133109,0.00245117598780368,-0.0101506749474263,-0.000542065075235878,0.0291806212551908
NMR metabolomics,X23412.Phospholipids in VLDL,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,23494,0.00739651002311248,0.00340355073537553,0.000725550581776442,0.0140674694644485,0.0297771410552567
NMR metabolomics,X23412.Phospholipids in VLDL,PILRB,Paired immunoglobulin-like type 2 receptor beta,29478,0.00843197322684235,0.00389764590210077,0.000792587258724847,0.0160713591949599,0.0305222645058683
NMR metabolomics,X23412.Phospholipids in VLDL,GRIK2,"Glutamate receptor ionotropic, kainate 2",24867,0.00614848535143872,0.0028518745817669,0.000558811171175591,0.0117381595317019,0.0310975095826753
NMR metabolomics,X23412.Phospholipids in VLDL,MYH4,Myosin-4,24111,-0.00685219186503239,0.00318282932818688,-0.0130905373482787,-0.000613846381786109,0.0313394312572841
NMR metabolomics,X23412.Phospholipids in VLDL,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,24793,0.00691327543950097,0.00322677581529726,0.000588794841518328,0.0132377560374836,0.0321652684333269
NMR metabolomics,X23412.Phospholipids in VLDL,IL17A,Interleukin-17A,28879,-0.00620744365414087,0.00289927461002903,-0.0118900218897978,-0.000524865418483975,0.0322796980427615
NMR metabolomics,X23412.Phospholipids in VLDL,NCR1,Natural cytotoxicity triggering receptor 1,29375,0.00537200689856106,0.00251193587112876,0.000448612591148691,0.0102954012059734,0.0324769226960089
NMR metabolomics,X23412.Phospholipids in VLDL,KLK3,Prostate-specific antigen,24938,-0.0128721912586072,0.00605061970323587,-0.0247314058769495,-0.00101297664026492,0.0333952394753912
NMR metabolomics,X23412.Phospholipids in VLDL,SSB,Lupus La protein,28774,0.00859729294196653,0.00404521516315179,0.000668671222189025,0.016525914661744,0.0335701462863976
NMR metabolomics,X23412.Phospholipids in VLDL,SPINT3,Kunitz-type protease inhibitor 3,24805,0.0212906234958553,0.0100232210104192,0.00164511031543361,0.0409361366762771,0.0336691528042778
NMR metabolomics,X23412.Phospholipids in VLDL,RYR1,Ryanodine receptor 1,24111,-0.00493473599033317,0.00232562293377589,-0.0094929569405339,-0.00037651504013243,0.0338564307036665
NMR metabolomics,X23412.Phospholipids in VLDL,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,24793,-0.0125239949645028,0.00591189850337942,-0.0241113160311265,-0.000936673897879135,0.034147850381712
NMR metabolomics,X23412.Phospholipids in VLDL,SCN2A,Sodium channel protein type 2 subunit alpha,24101,0.00708800225491158,0.00334777985948086,0.000526353730329082,0.0136496507794941,0.0342510014664396
NMR metabolomics,X23412.Phospholipids in VLDL,FDX1,"Adrenodoxin, mitochondrial",24111,0.00905237977416549,0.00427898277448023,0.000665573536184242,0.0174391860121467,0.0343937718220046
NMR metabolomics,X23412.Phospholipids in VLDL,FCAR,Immunoglobulin alpha Fc receptor,29434,0.00680886056994148,0.00323779360534233,0.000462785103470525,0.0131549360364124,0.0354801643841272
NMR metabolomics,X23412.Phospholipids in VLDL,DPEP1,Dipeptidase 1,29163,-0.00690251460888466,0.00329553668579216,-0.0133617665130373,-0.000443262704732016,0.0362237229602041
NMR metabolomics,X23412.Phospholipids in VLDL,ADRA2A,Alpha-2A adrenergic receptor,24111,-0.0100918038521217,0.00481889870137105,-0.019536845306809,-0.00064676239743444,0.0362513641971386
NMR metabolomics,X23412.Phospholipids in VLDL,PTK7,Inactive tyrosine-protein kinase 7,28774,0.00543122821328239,0.00260590378831396,0.000323656788187028,0.0105387996383778,0.037150658403925
NMR metabolomics,X23412.Phospholipids in VLDL,TCL1B,T-cell leukemia/lymphoma protein 1B,28916,0.0110421895645217,0.00530062965931977,0.000652955432254972,0.0214314236967885,0.0372431762511206
NMR metabolomics,X23412.Phospholipids in VLDL,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,24445,0.00625408425893625,0.00301252239668571,0.00034954036143226,0.0121586281564402,0.0379016891348225
NMR metabolomics,X23412.Phospholipids in VLDL,PADI2,Protein-arginine deiminase type-2,28931,0.00792972448456637,0.00382910244262444,0.000424683697022465,0.0154347652721103,0.0383761082270838
NMR metabolomics,X23412.Phospholipids in VLDL,DCUN1D1,DCN1-like protein 1,24101,-0.0105525851721322,0.00510410792475084,-0.0205566367046438,-0.00054853363962052,0.038700632208954
NMR metabolomics,X23412.Phospholipids in VLDL,SOX2,Transcription factor SOX-2,24826,0.00334219552740803,0.00162187584660331,0.000163318868065548,0.00652107218675052,0.0393423060517043
NMR metabolomics,X23412.Phospholipids in VLDL,GAL,Galanin peptides,29581,-0.00900843421558752,0.00437160744690744,-0.0175767848115261,-0.000440083619648948,0.0393433938035416
NMR metabolomics,X23412.Phospholipids in VLDL,IL36G,Interleukin-36 gamma,24149,0.00954616486585905,0.00463850659513394,0.000454691939396521,0.0186376377923216,0.0395983988597297
NMR metabolomics,X23412.Phospholipids in VLDL,PALM3,Paralemmin-3,24111,0.0103176481914724,0.00503331883369847,0.000452343277423392,0.0201829531055214,0.0403879383117682
NMR metabolomics,X23412.Phospholipids in VLDL,HIF1A,Hypoxia-inducible factor 1-alpha,24229,0.00915380821934201,0.00447240038632349,0.000387903462147973,0.0179197129765361,0.0406951067461253
NMR metabolomics,X23412.Phospholipids in VLDL,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,24111,-0.00468989535503779,0.00229493672455286,-0.0091879713351614,-0.000191819374914174,0.0410055389579395
NMR metabolomics,X23412.Phospholipids in VLDL,CHP1,Calcineurin B homologous protein 1,24101,0.0101780200073841,0.00498882663565058,0.00039991980150891,0.0199561202132592,0.041344967783627
NMR metabolomics,X23412.Phospholipids in VLDL,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,28797,0.00489763142152307,0.00240402502023484,0.000185742381862778,0.00960952046118336,0.0416328135827102
NMR metabolomics,X23412.Phospholipids in VLDL,PGM2,Phosphoglucomutase-2,24195,0.00832379248638332,0.00409870725047555,0.000290326275451242,0.0163572586973154,0.0422827932995018
NMR metabolomics,X23412.Phospholipids in VLDL,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,24793,0.0133402299243637,0.00661001452232841,0.000384601460600008,0.0262958583881274,0.0435827872260015
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINA11,Serpin A11,29820,-0.00559242587885212,0.00277657668319704,-0.0110345161779183,-0.000150335579785926,0.0440033606307726
NMR metabolomics,X23412.Phospholipids in VLDL,PTPRF,Receptor-type tyrosine-protein phosphatase F,29820,0.00393976430605276,0.00195738372778807,0.000103292199588153,0.00777623641251737,0.0441477498569727
NMR metabolomics,X23412.Phospholipids in VLDL,IL1A,Interleukin-1 alpha,28931,0.00747817549413862,0.00377717129948754,7.49197471430424e-05,0.0148814312411342,0.0477315508933736
NMR metabolomics,X23412.Phospholipids in VLDL,DENND2B,DENN domain-containing protein 2B,24111,-0.00684219341642238,0.00346470062083723,-0.0136330066332634,-5.13801995814158e-05,0.0482988830516554
NMR metabolomics,X23412.Phospholipids in VLDL,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,24195,-0.00636530618124654,0.00322399567128237,-0.01268433769696,-4.62746655331041e-05,0.0483529559822552
NMR metabolomics,X23412.Phospholipids in VLDL,CDH3,Cadherin-3,29694,0.00483929805546208,0.00245489176686505,2.77101924065831e-05,0.00965088591851758,0.0487002468904029
NMR metabolomics,X23412.Phospholipids in VLDL,SLAMF1,Signaling lymphocytic activation molecule,28931,-0.00794516495553776,0.00403860566073229,-0.015860832050573,-2.9497860502473e-05,0.0491577216211519
NMR metabolomics,X23412.Phospholipids in VLDL,MN1,Transcriptional activator MN1,24195,-0.00793082368083842,0.00403259263924276,-0.0158347052537542,-2.69421079226e-05,0.0492314065593377
NMR metabolomics,X23412.Phospholipids in VLDL,LRP1,Prolow-density lipoprotein receptor-related protein 1,29349,0.00353428187585988,0.00180181740924053,2.71975374844082e-06,0.00706584399797132,0.0498290671583058
NMR metabolomics,X23412.Phospholipids in VLDL,CCNE1,G1/S-specific cyclin-E1,24229,0.0123693766326394,0.00630632958293809,8.97065008070158e-06,0.024729782615198,0.0498412002056228
NMR metabolomics,X23412.Phospholipids in VLDL,CTNNA1,Catenin alpha-1,24101,-0.00468941221427356,0.00239303526247135,-0.00937976132871741,9.36900170296802e-07,0.0500530834618271
NMR metabolomics,X23412.Phospholipids in VLDL,GH2,Growth hormone variant,28797,0.0219642655428147,0.0112281073533329,-4.28248697178328e-05,0.0439713559553473,0.0504529135656318
NMR metabolomics,X23412.Phospholipids in VLDL,TLR1,Toll-like receptor 1,24229,0.00351609552875904,0.00179837945437619,-8.72820181829857e-06,0.00704091925933637,0.0505772525745594
NMR metabolomics,X23412.Phospholipids in VLDL,MORF4L2,Mortality factor 4-like protein 2,24016,-0.00492481392113669,0.00251991785486555,-0.00986385291667317,1.42250743997915e-05,0.0506708495294956
NMR metabolomics,X23412.Phospholipids in VLDL,KRT14,"Keratin, type I cytoskeletal 14",27986,0.00384687278278698,0.00197613000541065,-2.63420278178873e-05,0.00772008759339184,0.0515843203474423
NMR metabolomics,X23412.Phospholipids in VLDL,WNT9A,Protein Wnt-9a,28931,0.00381103011778118,0.00195841121937999,-2.74558722036062e-05,0.00764951610776596,0.0516667517561297
NMR metabolomics,X23412.Phospholipids in VLDL,EDDM3B,Epididymal secretory protein E3-beta,24793,0.00689321453486351,0.00354284378580521,-5.07592853146999e-05,0.0138371883550417,0.0517053565751682
NMR metabolomics,X23412.Phospholipids in VLDL,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,29820,0.00359270201213524,0.0018466064197868,-2.66465706468847e-05,0.00721205059491737,0.0517158042822684
NMR metabolomics,X23412.Phospholipids in VLDL,HCG22,Protein PBMUCL2,24111,-0.00727861738790895,0.00377945316867902,-0.0146863455985198,0.000129110822701922,0.0541362620048616
NMR metabolomics,X23412.Phospholipids in VLDL,POF1B,Protein POF1B,24229,-0.00599675750855838,0.00312702940823695,-0.0121257351487028,0.000132220131586031,0.0551586524138942
NMR metabolomics,X23412.Phospholipids in VLDL,TRPV3,Transient receptor potential cation channel subfamily V member 3,24111,-0.00652742786096359,0.00343286231103868,-0.0132558379905994,0.000200982268672223,0.0572545610308155
NMR metabolomics,X23412.Phospholipids in VLDL,PLIN3,Perilipin-3,29478,0.00548132826100337,0.00288519350848838,-0.000173651015633849,0.0111363075376406,0.0574674127287962
NMR metabolomics,X23412.Phospholipids in VLDL,C9orf40,Uncharacterized protein C9orf40,24805,0.0103620219694743,0.00545746316098076,-0.000334605826048023,0.0210586497649966,0.0576170582477983
NMR metabolomics,X23412.Phospholipids in VLDL,SPRING1,SREBP regulating gene protein,24016,0.00770672632664313,0.00406059673107374,-0.000252043266261403,0.0156654959195477,0.0577173558201429
NMR metabolomics,X23412.Phospholipids in VLDL,LCN15,Lipocalin-15,24867,-0.00801521631331348,0.00423703352971382,-0.0163198020315526,0.000289369404925613,0.0585419494293509
NMR metabolomics,X23412.Phospholipids in VLDL,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,24111,-0.00652368026247326,0.00346278082150951,-0.0133107306726319,0.000263370147685378,0.0595847704670943
NMR metabolomics,X23412.Phospholipids in VLDL,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,24229,0.00447163496088244,0.0023940330405796,-0.00022066979865358,0.00916393972041846,0.0617985255259287
NMR metabolomics,X23412.Phospholipids in VLDL,REXO2,"Oligoribonuclease, mitochondrial",24111,-0.00606612303003985,0.00325977264928331,-0.0124552774226351,0.000323031362555438,0.0627699453220397
NMR metabolomics,X23412.Phospholipids in VLDL,HIP1,Huntingtin-interacting protein 1,24111,0.0042311520339289,0.00228150762514198,-0.000240602911349385,0.00870290697920718,0.063673844850035
NMR metabolomics,X23412.Phospholipids in VLDL,CSRP3,Cysteine and glycine-rich protein 3,24111,-0.0124011315225697,0.0067158300394175,-0.025564158399828,0.000761895354688626,0.0648243042943707
NMR metabolomics,X23412.Phospholipids in VLDL,EDNRB,Endothelin receptor type B,24229,0.00574887655488267,0.00311538689413638,-0.000357281757624638,0.01185503486739,0.065003632899368
NMR metabolomics,X23412.Phospholipids in VLDL,PSMD5,26S proteasome non-ATPase regulatory subunit 5,24195,-0.00698849482999744,0.0037887653346649,-0.0144144748859406,0.000437485225945763,0.0651180260427489
NMR metabolomics,X23412.Phospholipids in VLDL,SEPTIN7,Septin-7,24445,0.00661955471840188,0.00358919147784338,-0.000415260578171137,0.0136543700149749,0.0651511704379443
NMR metabolomics,X23412.Phospholipids in VLDL,ACTN4,Alpha-actinin-4,28931,0.00397851834144559,0.00217223742104374,-0.000279067003800141,0.00823610368669131,0.0670317325706248
NMR metabolomics,X23412.Phospholipids in VLDL,COPE,Coatomer subunit epsilon,28774,0.00588483502935592,0.00321468366581301,-0.000415944955637577,0.0121856150143494,0.0671689791251327
NMR metabolomics,X23412.Phospholipids in VLDL,TP53INP1,Tumor protein p53-inducible nuclear protein 1,28916,0.00387577830239623,0.00212536623249649,-0.000289939513296889,0.00804149611808936,0.0682257054199386
NMR metabolomics,X23412.Phospholipids in VLDL,S100A3,Protein S100-A3,24793,0.00548918356836752,0.00302195408031681,-0.000433846429053424,0.0114122135657885,0.0693157268273398
NMR metabolomics,X23412.Phospholipids in VLDL,MSMB,Beta-microseminoprotein,29313,0.00856004207410562,0.00471830187582389,-0.000687829602509191,0.0178079137507204,0.0696539407646475
NMR metabolomics,X23412.Phospholipids in VLDL,TJP3,Tight junction protein ZO-3,24101,-0.00525970313718433,0.00291791026037742,-0.0109788072475241,0.000459400973155404,0.0714701179531165
NMR metabolomics,X23412.Phospholipids in VLDL,DOC2B,Double C2-like domain-containing protein beta,24195,0.00444799040566855,0.00246971034414127,-0.000392641868848334,0.00928862268018543,0.0717126488723397
NMR metabolomics,X23412.Phospholipids in VLDL,IL4,Interleukin-4,28931,0.0112087808681398,0.00623154240199322,-0.00100504223976688,0.0234226039760466,0.0720738920763794
NMR metabolomics,X23412.Phospholipids in VLDL,AKR1B10,Aldo-keto reductase family 1 member B10,24195,0.00761883785520718,0.00425036122133168,-0.000711870138602915,0.0159495458490173,0.0730629434779445
NMR metabolomics,X23412.Phospholipids in VLDL,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,24445,0.00442908086420113,0.00248069722234815,-0.000433085691601246,0.00929124742000351,0.0742059818313401
NMR metabolomics,X23412.Phospholipids in VLDL,OGN,Mimecan,29443,-0.00506717710594955,0.00285584500400464,-0.0106646333137986,0.000530279101899545,0.0760209065269202
NMR metabolomics,X23412.Phospholipids in VLDL,HDAC8,Histone deacetylase 8,24229,0.00741769670514546,0.00418233825350313,-0.000779686271720681,0.0156150796820116,0.0761457985309856
NMR metabolomics,X23412.Phospholipids in VLDL,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,24240,-0.00484991023578289,0.00274050536262712,-0.010221300746532,0.000521480274966257,0.0767874019641788
NMR metabolomics,X23412.Phospholipids in VLDL,CHRDL2,Chordin-like protein 2,29478,0.00640637767746777,0.003620232324487,-0.000689277678526759,0.0135020330334623,0.0768034699257661
NMR metabolomics,X23412.Phospholipids in VLDL,DBH,Dopamine beta-hydroxylase,24919,0.0131266138056792,0.00743498484109913,-0.00144595648287513,0.0276991840942335,0.0774886778126277
NMR metabolomics,X23412.Phospholipids in VLDL,PCNA,Proliferating cell nuclear antigen,24016,0.00761218604902089,0.00431650456770328,-0.000848162903677539,0.0160725350017193,0.0778277378450026
NMR metabolomics,X23412.Phospholipids in VLDL,TPSG1,Tryptase gamma,24229,0.0032066185147624,0.00182295458848997,-0.000366372478677937,0.00677960950820273,0.0785862801231178
NMR metabolomics,X23412.Phospholipids in VLDL,TMPRSS5,Transmembrane protease serine 5,29079,0.00454256264505803,0.00258594218166434,-0.000525884031004086,0.00961100932112014,0.0789901701544502
NMR metabolomics,X23412.Phospholipids in VLDL,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",24111,-0.0051043674188682,0.0029552635949091,-0.01089668406489,0.000687949227153636,0.0841423698019633
NMR metabolomics,X23412.Phospholipids in VLDL,DUSP29,Dual specificity phosphatase 29,24195,-0.00783180587040641,0.00455232533520324,-0.0167543635274048,0.00109075178659194,0.0853731348097866
NMR metabolomics,X23412.Phospholipids in VLDL,FBN2,Fibrillin-2,24195,0.00706691826647063,0.00411539717005401,-0.000999260186835237,0.0151330967197765,0.0859572934736271
NMR metabolomics,X23412.Phospholipids in VLDL,MBL2,Mannose-binding protein C,24610,-0.0125997980462833,0.00735905049651971,-0.0270235370194619,0.00182394092689532,0.0868816408529495
NMR metabolomics,X23412.Phospholipids in VLDL,MMP9,Matrix metalloproteinase-9,29411,-0.00698405072407965,0.00410312906620406,-0.0150261836938396,0.00105808224568031,0.0887419558071692
NMR metabolomics,X23412.Phospholipids in VLDL,GHRHR,Growth hormone-releasing hormone receptor,28774,0.00631149269568194,0.00373260484384089,-0.0010044127982462,0.0136273981896101,0.0908651437490328
NMR metabolomics,X23412.Phospholipids in VLDL,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,24867,0.00367675589118358,0.00218753559115751,-0.000610813867485135,0.00796432564985229,0.0928191250975594
NMR metabolomics,X23412.Phospholipids in VLDL,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",24101,-0.00521646663332662,0.00310395508844582,-0.0113002186066804,0.00086728534002718,0.0928561248959478
NMR metabolomics,X23412.Phospholipids in VLDL,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,24016,-0.00961765265278005,0.0057233728675386,-0.0208354634731557,0.00160015816759561,0.0928892372745713
NMR metabolomics,X23412.Phospholipids in VLDL,PRR5,Proline-rich protein 5,24229,0.00542819765960047,0.00324866089370507,-0.000939177692061458,0.0117955730112624,0.0947537354717067
NMR metabolomics,X23412.Phospholipids in VLDL,CD177,CD177 antigen,29413,-0.0145029688924927,0.00868426201797008,-0.031524122447714,0.00251818466272866,0.0949242835793907
NMR metabolomics,X23412.Phospholipids in VLDL,PRTN3,Myeloblastin,28671,-0.00537507814963735,0.00322115782452666,-0.0116885474857096,0.000938391186434903,0.0951919536755604
NMR metabolomics,X23412.Phospholipids in VLDL,SMC3,Structural maintenance of chromosomes protein 3,24016,0.00615098521321281,0.00368774376356364,-0.00107699256337192,0.0133789629897975,0.0953379972810806
NMR metabolomics,X23412.Phospholipids in VLDL,PXDNL,Peroxidasin-like protein,24793,0.00655630669951709,0.00393772901291162,-0.00116164216578969,0.0142742555648239,0.0959260115312644
NMR metabolomics,X23412.Phospholipids in VLDL,FAM3D,Protein FAM3D,24805,0.00955606998800909,0.00575215017709748,-0.00171814435910197,0.0208302843351202,0.0966650554271119
NMR metabolomics,X23412.Phospholipids in VLDL,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,24793,0.00701979380654431,0.0042425683636057,-0.00129564018612286,0.0153352277992115,0.0980164056538318
NMR metabolomics,X23412.Phospholipids in VLDL,CADPS,Calcium-dependent secretion activator 1,24195,-0.00483521992078664,0.0029352398588699,-0.0105882900441717,0.000917850202598373,0.0995094401759098
NMR metabolomics,X23412.Phospholipids in VLDL,SCG3,Secretogranin-3,29497,-0.00370002106970124,0.00225500462816404,-0.00811983014090275,0.000719788001500273,0.100848732693019
NMR metabolomics,X23412.Phospholipids in VLDL,CXCL14,C-X-C motif chemokine 14,28931,0.00661179209263,0.00403983166743569,-0.00130627797554395,0.014529862160804,0.101714421434628
NMR metabolomics,X23412.Phospholipids in VLDL,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,29694,0.00518751585892687,0.00318814950746411,-0.00106125717570279,0.0114362888935565,0.103721294748291
NMR metabolomics,X23412.Phospholipids in VLDL,RETN,Resistin,29362,-0.00464464652910652,0.00286305721824248,-0.0102562386768618,0.000966945618648736,0.104756687155942
NMR metabolomics,X23412.Phospholipids in VLDL,DLL1,Delta-like protein 1,29566,-0.00328815025310116,0.00202762477466175,-0.00726229481143818,0.000685994305235865,0.104883427304496
NMR metabolomics,X23412.Phospholipids in VLDL,TUBB3,Tubulin beta-3 chain,24101,-0.00309929337094424,0.00191623157540715,-0.00685510725874226,0.000656520516853776,0.105807264280185
NMR metabolomics,X23412.Phospholipids in VLDL,CORO6,Coronin-6,24101,-0.00413343008987576,0.00255996862601541,-0.00915096859686596,0.000884108417114442,0.106401577263186
NMR metabolomics,X23412.Phospholipids in VLDL,MUCL3,Mucin-like protein 3,24016,-0.00483228461521029,0.00299375809880919,-0.0107000504888763,0.00103548125845571,0.106514560212502
NMR metabolomics,X23412.Phospholipids in VLDL,EPHA2,Ephrin type-A receptor 2,28347,0.00343731902015987,0.00213541409392719,-0.000748092603937426,0.00762273064425717,0.107480340502536
NMR metabolomics,X23412.Phospholipids in VLDL,PSMG4,Proteasome assembly chaperone 4,24229,0.00615471169758953,0.00382368583191834,-0.00133971253297042,0.0136491359281495,0.107492131497378
NMR metabolomics,X23412.Phospholipids in VLDL,EPHA10,Ephrin type-A receptor 10,28774,0.0070767803537347,0.00444060616408853,-0.00162680772787882,0.0157803684353482,0.111025017005524
NMR metabolomics,X23412.Phospholipids in VLDL,MSLNL,Mesothelin-like protein,24195,-0.00407521654444355,0.00256594880525561,-0.00910447620274454,0.000954043113857442,0.11225625230843
NMR metabolomics,X23412.Phospholipids in VLDL,H2AP,Huntingtin-interacting protein M,24016,-0.00547719781306693,0.00349411915605235,-0.0123256713589295,0.00137127573279569,0.116999950780427
NMR metabolomics,X23412.Phospholipids in VLDL,GLI2,Zinc finger protein GLI2,24229,-0.00355895600499498,0.0022746777727508,-0.00801732443958656,0.000899412429596589,0.117690295348797
NMR metabolomics,X23412.Phospholipids in VLDL,ITGA11,Integrin alpha-11,29434,-0.00363373690695954,0.00232384484044024,-0.00818847279422242,0.00092099898030334,0.11790478608604
NMR metabolomics,X23412.Phospholipids in VLDL,LYPLA2,Acyl-protein thioesterase 2,24101,0.0115238438024531,0.00737142413666461,-0.00292414750540957,0.0259718351103157,0.117992109368805
NMR metabolomics,X23412.Phospholipids in VLDL,RTKN2,Rhotekin-2,24111,-0.00551537759304864,0.00352980642198623,-0.0124337981801417,0.00140304299404438,0.118179706018024
NMR metabolomics,X23412.Phospholipids in VLDL,TGFBR3,Transforming growth factor beta receptor type 3,29820,-0.00335381994763378,0.00214713105819663,-0.00756219682169918,0.00085455692643162,0.118298470059617
NMR metabolomics,X23412.Phospholipids in VLDL,DHODH,Dihydroorotate dehydrogenase,24111,0.00502670830446468,0.00323064120561844,-0.00130534845854747,0.0113587650674768,0.119733695049646
NMR metabolomics,X23412.Phospholipids in VLDL,APOH,Beta-2-glycoprotein 1,29443,-0.00377948950026149,0.00243728433322839,-0.00855656679338913,0.000997587792866146,0.120985067333591
NMR metabolomics,X23412.Phospholipids in VLDL,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,24195,-0.00520433232497153,0.00335616987005919,-0.0117824252702875,0.00137376062034448,0.12099241750316
NMR metabolomics,X23412.Phospholipids in VLDL,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,24111,-0.00215385305341086,0.00139266666914981,-0.00488347972494449,0.000575773618122773,0.121980696061076
NMR metabolomics,X23412.Phospholipids in VLDL,IL33,Interleukin-33,28931,0.00407674146876928,0.00264503921641474,-0.00110753539540361,0.00926101833294217,0.123260017331403
NMR metabolomics,X23412.Phospholipids in VLDL,PSMC3,26S proteasome regulatory subunit 6A,24016,-0.00317925390315763,0.00206277870604609,-0.00722230016700796,0.000863792360692699,0.123269581188646
NMR metabolomics,X23412.Phospholipids in VLDL,KIAA2013,Uncharacterized protein KIAA2013,24793,0.00582000212965877,0.00379165472685226,-0.00161164113497165,0.0132516453942892,0.12480876719534
NMR metabolomics,X23412.Phospholipids in VLDL,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,29434,0.0155092702935391,0.0101733100965853,-0.00443041749576804,0.0354489580828462,0.127393156883654
NMR metabolomics,X23412.Phospholipids in VLDL,CHGB,Secretogranin-1,29590,0.00424269428091465,0.00279183087871954,-0.00122929424137565,0.00971468280320495,0.128601683941756
NMR metabolomics,X23412.Phospholipids in VLDL,CEND1,Cell cycle exit and neuronal differentiation protein 1,24101,0.00608184829933874,0.00401546904029463,-0.00178847101963874,0.0139521676183162,0.129885661453089
NMR metabolomics,X23412.Phospholipids in VLDL,DUOX2,Dual oxidase 2,28916,0.00732181055947357,0.00484414114994662,-0.0021727060944218,0.0168163272133689,0.130677759256026
NMR metabolomics,X23412.Phospholipids in VLDL,CDH4,Cadherin-4,24101,0.00494317480528485,0.00327737983317684,-0.00148048966774174,0.0113668392783115,0.131498465779925
NMR metabolomics,X23412.Phospholipids in VLDL,F3,Tissue factor,29541,-0.00279312426553228,0.00185302534699218,-0.00642505394563694,0.000838805414572386,0.131736296440438
NMR metabolomics,X23412.Phospholipids in VLDL,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,24867,-0.00244042216554839,0.00162070617526578,-0.00561700626906931,0.000736161937972527,0.132137125172227
NMR metabolomics,X23412.Phospholipids in VLDL,COMMD9,COMM domain-containing protein 9,24793,0.00404105252310206,0.00268447376381354,-0.00122051605397247,0.0093026211001766,0.132248782877895
NMR metabolomics,X23412.Phospholipids in VLDL,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",24111,-0.00623309588337429,0.00415793225516153,-0.0143826431034909,0.0019164513367423,0.133864557111106
NMR metabolomics,X23412.Phospholipids in VLDL,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,24016,0.0058472576786106,0.00391496467136624,-0.00182607307726723,0.0135205884344884,0.13530226629777
NMR metabolomics,X23412.Phospholipids in VLDL,AOC3,Membrane primary amine oxidase,29594,-0.00305442082159813,0.0020470050794436,-0.00706655077730759,0.00095770913411133,0.135672771300134
NMR metabolomics,X23412.Phospholipids in VLDL,DEFB116,Beta-defensin 116,24101,-0.00783615793355481,0.0052581587837444,-0.0181421491496938,0.00246983328258421,0.136162270402954
NMR metabolomics,X23412.Phospholipids in VLDL,RELB,Transcription factor RelB,24229,0.00500850392846064,0.00336672960030046,-0.00159028608812827,0.0116072939450496,0.136857131571862
NMR metabolomics,X23412.Phospholipids in VLDL,FZD8,Frizzled-8,24101,0.00445900806248652,0.00299788852955133,-0.00141685345543409,0.0103348695804071,0.136926806928124
NMR metabolomics,X23412.Phospholipids in VLDL,RAB6B,Ras-related protein Rab-6B,28774,0.0047900213881223,0.00326101147138521,-0.0016015610957927,0.0111816038720373,0.141877370886402
NMR metabolomics,X23412.Phospholipids in VLDL,SIGLEC15,Sialic acid-binding Ig-like lectin 15,28774,0.00782313711570598,0.00532640079326804,-0.00261660843909939,0.0182628826705113,0.14191226316159
NMR metabolomics,X23412.Phospholipids in VLDL,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,29536,0.00643236110712125,0.00438732336343139,-0.00216679268520427,0.0150315148994468,0.142625095471054
NMR metabolomics,X23412.Phospholipids in VLDL,FGF5,Fibroblast growth factor 5,28931,-0.00328572298644197,0.00224672839688281,-0.00768931064433228,0.00111786467144833,0.143629408348289
NMR metabolomics,X23412.Phospholipids in VLDL,ENDOU,Poly(U)-specific endoribonuclease,23037,0.00529704623906089,0.00362237077221774,-0.00180280047448589,0.0123968929526077,0.14366862576615
NMR metabolomics,X23412.Phospholipids in VLDL,RAC3,Ras-related C3 botulinum toxin substrate 3,24195,0.00690535834482891,0.00473483019972803,-0.00237490884663802,0.0161856255362958,0.144738538956514
NMR metabolomics,X23412.Phospholipids in VLDL,SLC51B,Organic solute transporter subunit beta,24111,-0.00754719982494833,0.00520724853715087,-0.017753406957764,0.00265900730786737,0.147248902811179
NMR metabolomics,X23412.Phospholipids in VLDL,GID8,Glucose-induced degradation protein 8 homolog,24867,0.00332219185544792,0.00230170774377994,-0.00118915532236076,0.00783353903325659,0.148931816257681
NMR metabolomics,X23412.Phospholipids in VLDL,ICAM3,Intercellular adhesion molecule 3,29820,-0.00255235117352889,0.00176887026072798,-0.00601933688455573,0.000914634537497951,0.149051462992622
NMR metabolomics,X23412.Phospholipids in VLDL,OTOA,Otoancorin,24101,-0.00524921010899958,0.0036589673324264,-0.0124207860805553,0.00192236586255617,0.151409766863531
NMR metabolomics,X23412.Phospholipids in VLDL,GFRA3,GDNF family receptor alpha-3,29157,0.00274246055360163,0.00191185936603873,-0.00100478380383428,0.00648970491103753,0.151455529942035
NMR metabolomics,X23412.Phospholipids in VLDL,HDDC2,5'-deoxynucleotidase HDDC2,24805,0.00425232790543383,0.00296502792511769,-0.00155912682779683,0.0100637826386645,0.151538889302482
NMR metabolomics,X23412.Phospholipids in VLDL,DPP6,Dipeptidyl aminopeptidase-like protein 6,29349,-0.00326086127642789,0.00227470783566921,-0.00771928863433954,0.00119756608148375,0.151717170987286
NMR metabolomics,X23412.Phospholipids in VLDL,FHIP2A,FHF complex subunit HOOK interacting protein 2A,24111,0.00453278439080441,0.00319430797647059,-0.00172805924307795,0.0107936280246868,0.155906348902473
NMR metabolomics,X23412.Phospholipids in VLDL,IL25,Interleukin-25,23913,0.00334742213400098,0.00235948273562649,-0.00127716402782693,0.00797200829582889,0.155996573738342
NMR metabolomics,X23412.Phospholipids in VLDL,ENPEP,Glutamyl aminopeptidase,24111,0.00430233679281979,0.003036618561445,-0.00164943558761241,0.010254109173252,0.156548981209598
NMR metabolomics,X23412.Phospholipids in VLDL,MFAP3,Microfibril-associated glycoprotein 3,28916,0.00467993380954467,0.00331284110518744,-0.0018132347566227,0.011173102375712,0.157765092410328
NMR metabolomics,X23412.Phospholipids in VLDL,BEX3,Protein BEX3,24016,-0.0045469246952212,0.00322106287439837,-0.010860207929042,0.0017663585385996,0.158074118759553
NMR metabolomics,X23412.Phospholipids in VLDL,BTLA,B- and T-lymphocyte attenuator,24016,0.00840163587770828,0.00595258440618333,-0.00326542955841105,0.0200687013138276,0.158131831097833
NMR metabolomics,X23412.Phospholipids in VLDL,IL20,Interleukin-20,28931,0.00468107725983149,0.0033247039370442,-0.00183534245677515,0.0111974969764381,0.159151250643771
NMR metabolomics,X23412.Phospholipids in VLDL,TFF2,Trefoil factor 2,29536,0.00549864015006788,0.00390871535536606,-0.0021624419464496,0.0131597222465854,0.159507899741217
NMR metabolomics,X23412.Phospholipids in VLDL,CLEC11A,C-type lectin domain family 11 member A,29388,0.00458393404232902,0.00326586895512686,-0.00181716910971963,0.0109850371943777,0.160452181228166
NMR metabolomics,X23412.Phospholipids in VLDL,FGF12,Fibroblast growth factor 12,24229,0.00447358762684499,0.00319147340252771,-0.00178170024210932,0.0107288754957993,0.161008367558227
NMR metabolomics,X23412.Phospholipids in VLDL,IFNW1,Interferon omega-1,24111,-0.00341479416945219,0.00245731262924262,-0.00823112692276772,0.00140153858386335,0.164649299871774
NMR metabolomics,X23412.Phospholipids in VLDL,HRAS,GTPase Hras,24421,0.00931394352995353,0.00671061651417016,-0.00383886483781999,0.022466751897727,0.165167511612027
NMR metabolomics,X23412.Phospholipids in VLDL,ERCC1,DNA excision repair protein ERCC-1,24016,0.00314507892471842,0.00228132694908815,-0.00132632189549436,0.0076164797449312,0.168025340721186
NMR metabolomics,X23412.Phospholipids in VLDL,LAMA1,Laminin subunit alpha-1,24111,-0.00506991323518374,0.0036848788977384,-0.012292275874751,0.00215244940438353,0.168874763836883
NMR metabolomics,X23412.Phospholipids in VLDL,FOLR1,Folate receptor alpha,29383,0.00268877714900786,0.00195879030712208,-0.00115045185295142,0.00652800615096714,0.169864733329051
NMR metabolomics,X23412.Phospholipids in VLDL,FLT3,Receptor-type tyrosine-protein kinase FLT3,28797,0.00284871384960911,0.00207588721395093,-0.00122002508973471,0.00691745278895293,0.169984682943849
NMR metabolomics,X23412.Phospholipids in VLDL,PSCA,Prostate stem cell antigen,24805,0.0241162144576672,0.0176530090396333,-0.010483683260014,0.0587161121753485,0.17191216918201
NMR metabolomics,X23412.Phospholipids in VLDL,HLA_A,,24867,0.00302942794842323,0.00222433017501026,-0.00133025919459688,0.00738911509144334,0.173225801206856
NMR metabolomics,X23412.Phospholipids in VLDL,DTX2,Probable E3 ubiquitin-protein ligase DTX2,24195,-0.00583038171171608,0.00429161193279433,-0.014241941099993,0.00258117767656081,0.174300991122979
NMR metabolomics,X23412.Phospholipids in VLDL,SPINK8,Serine protease inhibitor Kazal-type 8,24111,0.00347315579628141,0.00255754058830031,-0.0015396237567872,0.00848593534935003,0.1744744539863
NMR metabolomics,X23412.Phospholipids in VLDL,DKKL1,Dickkopf-like protein 1,29349,-0.0078887440051696,0.00582778303652998,-0.0193111987567684,0.00353371074642915,0.17586038591109
NMR metabolomics,X23412.Phospholipids in VLDL,IMPG1,Interphotoreceptor matrix proteoglycan 1,24101,-0.00276069911054432,0.00204926475790365,-0.00677725803603548,0.00125585981494684,0.177939557941896
NMR metabolomics,X23412.Phospholipids in VLDL,STC2,Stanniocalcin-2,29396,-0.00236885033334764,0.00175969545891472,-0.00581785343282049,0.0010801527661252,0.178257882150385
NMR metabolomics,X23412.Phospholipids in VLDL,OLR1,Oxidized low-density lipoprotein receptor 1,29216,0.00529787027070303,0.00395801176936232,-0.00245983279724712,0.0130555733386532,0.180738034910764
NMR metabolomics,X23412.Phospholipids in VLDL,TCN2,Transcobalamin-2,29757,-0.00272158735565695,0.0020344631523319,-0.00670913513422748,0.00126596042291358,0.180990694859583
NMR metabolomics,X23412.Phospholipids in VLDL,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",24111,-0.0061055214592151,0.00456792457845621,-0.0150586536329893,0.00284761071455908,0.181363465670479
NMR metabolomics,X23412.Phospholipids in VLDL,CD70,CD70 antigen,29434,0.00385827059717891,0.00289895943236165,-0.00182368989024992,0.00954023108460775,0.183227067642031
NMR metabolomics,X23412.Phospholipids in VLDL,AKAP12,A-kinase anchor protein 12,24381,0.00195139428331907,0.00146663397372103,-0.000923208305174149,0.00482599687181229,0.183357555679167
NMR metabolomics,X23412.Phospholipids in VLDL,CDAN1,Codanin-1,24845,0.00204245298028667,0.00153570315091838,-0.00096752519551336,0.0050524311560867,0.183537397913999
NMR metabolomics,X23412.Phospholipids in VLDL,CLEC7A,C-type lectin domain family 7 member A,29786,0.00530727624144095,0.0039943593283415,-0.0025216680421084,0.0131362205249903,0.183959544544735
NMR metabolomics,X23412.Phospholipids in VLDL,MAPT,Microtubule-associated protein tau,28774,0.00476549550502027,0.00359044898949344,-0.00227178451438688,0.0118027755244274,0.184429894715554
NMR metabolomics,X23412.Phospholipids in VLDL,BOC,Brother of CDO,28916,-0.0021085403910153,0.00158999176993899,-0.00522492426009571,0.00100784347806511,0.184806161098995
NMR metabolomics,X23412.Phospholipids in VLDL,ARHGAP30,Rho GTPase-activating protein 30,24445,0.00350167255458917,0.00264055160141704,-0.00167380858418823,0.00867715369336656,0.184814323334785
NMR metabolomics,X23412.Phospholipids in VLDL,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,29454,0.00348710279122442,0.00263830604909386,-0.00168397706499954,0.00865818264744838,0.186271560407928
NMR metabolomics,X23412.Phospholipids in VLDL,SHH,Sonic hedgehog protein,24229,-0.00385761955149534,0.0029309229018675,-0.00960222843915563,0.00188698933616495,0.188126385746564
NMR metabolomics,X23412.Phospholipids in VLDL,GUCY2C,Heat-stable enterotoxin receptor,24445,-0.00746831145884293,0.00567789673751145,-0.0185969890643654,0.00366036614667952,0.188411154426725
NMR metabolomics,X23412.Phospholipids in VLDL,IL5,Interleukin-5,28931,0.0126271328708749,0.00964861802352551,-0.00628415845523514,0.0315384241969849,0.190646867707938
NMR metabolomics,X23412.Phospholipids in VLDL,ZNF830,Zinc finger protein 830,24793,-0.00702584025810694,0.00539267198724797,-0.017595477353113,0.00354379683689909,0.192638238565153
NMR metabolomics,X23412.Phospholipids in VLDL,KRT6C,"Keratin, type II cytoskeletal 6C",24111,-0.00351417203701715,0.00271237061237512,-0.00883041843727239,0.0018020743632381,0.19512260431496
NMR metabolomics,X23412.Phospholipids in VLDL,ACRV1,Acrosomal protein SP-10,24229,-0.00676675298758469,0.00523394453739314,-0.0170252842808752,0.00349177830570588,0.196072119590517
NMR metabolomics,X23412.Phospholipids in VLDL,TNR,Tenascin-R,29218,0.003694033748799,0.0028636553440225,-0.0019187307254851,0.00930679822308311,0.197070771765154
NMR metabolomics,X23412.Phospholipids in VLDL,S100A16,Protein S100-A16,28722,-0.0053716583299108,0.00417425565027723,-0.0135531994044542,0.00280988274463256,0.198155494646079
NMR metabolomics,X23412.Phospholipids in VLDL,CALY,Neuron-specific vesicular protein calcyon,24111,-0.00332719236289223,0.00262061081950646,-0.0084635895691249,0.00180920484334043,0.204230588968307
NMR metabolomics,X23412.Phospholipids in VLDL,PLXDC1,Plexin domain-containing protein 1,28797,0.00285459498738618,0.00225094305223742,-0.00155725339499915,0.00726644336977152,0.204744882407647
NMR metabolomics,X23412.Phospholipids in VLDL,HNF1A,Hepatocyte nuclear factor 1-alpha,24195,0.00615790793822396,0.00485601383113525,-0.00335987917080114,0.0156756950472491,0.204774686061713
NMR metabolomics,X23412.Phospholipids in VLDL,ZPR1,Zinc finger protein ZPR1,24101,0.00832060544984777,0.00658497684573648,-0.00458594916779573,0.0212271600674913,0.206395204332663
NMR metabolomics,X23412.Phospholipids in VLDL,SLC44A4,Choline transporter-like protein 4,24195,-0.00593926094075947,0.0047245186212244,-0.0151993174383593,0.00332079555684035,0.2087243133608
NMR metabolomics,X23412.Phospholipids in VLDL,ZP4,Zona pellucida sperm-binding protein 4,24016,-0.00272954086525958,0.00217497250884706,-0.00699248698259981,0.00153340525208065,0.209499263221655
NMR metabolomics,X23412.Phospholipids in VLDL,UPK3BL1,Uroplakin-3b-like protein 1,24404,-0.00463218737438879,0.00370105443062289,-0.0118862540584097,0.00262187930963208,0.210732814855068
NMR metabolomics,X23412.Phospholipids in VLDL,MORF4L1,Mortality factor 4-like protein 1,24445,-0.00341992094988983,0.00273347669846375,-0.00877753527887878,0.00193769337909911,0.210900867482979
NMR metabolomics,X23412.Phospholipids in VLDL,ICAM2,Intercellular adhesion molecule 2,29820,-0.00268358133921589,0.00215913624371189,-0.00691548837689119,0.00154832569845942,0.213916015826279
NMR metabolomics,X23412.Phospholipids in VLDL,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,24101,-0.00549048540482299,0.00442807053084284,-0.0141695036452749,0.00318853283562897,0.215014375427382
NMR metabolomics,X23412.Phospholipids in VLDL,MMP13,Collagenase 3,28774,-0.00272584437310146,0.00222195480147028,-0.0070808757839832,0.00162918703778029,0.21991623588158
NMR metabolomics,X23412.Phospholipids in VLDL,DNAJA1,DnaJ homolog subfamily A member 1,24016,-0.00391020333529402,0.00319315073807488,-0.0101687787819208,0.00234837211133275,0.220753222435674
NMR metabolomics,X23412.Phospholipids in VLDL,SMPD3,Sphingomyelin phosphodiesterase 3,24229,0.00481794822624682,0.00393871771744717,-0.00290193849994963,0.0125378349524433,0.22125564685794
NMR metabolomics,X23412.Phospholipids in VLDL,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,29434,0.00702145584598416,0.00576545286428695,-0.00427883176801827,0.0183217434599866,0.223290807816162
NMR metabolomics,X23412.Phospholipids in VLDL,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,28797,-0.00635253859561696,0.00524834787200426,-0.0166393004247453,0.0039342232335114,0.226139887890427
NMR metabolomics,X23412.Phospholipids in VLDL,TSLP,Thymic stromal lymphopoietin,28916,0.00494552173489455,0.00410565382334588,-0.00310155975886336,0.0129926032286525,0.228381624505301
NMR metabolomics,X23412.Phospholipids in VLDL,HSP90B1,Endoplasmin,28626,0.00547507406538704,0.00455376916910694,-0.00345031350606255,0.0144004616368366,0.229250684708069
NMR metabolomics,X23412.Phospholipids in VLDL,IL18RAP,Interleukin-18 receptor accessory protein,29038,0.0139937960580264,0.0116674519884209,-0.00887440983927862,0.0368620019553314,0.23038709739185
NMR metabolomics,X23412.Phospholipids in VLDL,TFF1,Trefoil factor 1,29319,-0.00641204961309065,0.00535354045666715,-0.0169049889081583,0.00408088968197697,0.231035208601528
NMR metabolomics,X23412.Phospholipids in VLDL,CLEC6A,C-type lectin domain family 6 member A,28797,0.00380214589795317,0.00319128717777373,-0.00245277697048334,0.0100570687663897,0.233500717482796
NMR metabolomics,X23412.Phospholipids in VLDL,CD160,CD160 antigen,29786,0.00378479526892974,0.00317986251410987,-0.00244773525872561,0.0100173257965851,0.23396209636547
NMR metabolomics,X23412.Phospholipids in VLDL,ALPI,Intestinal-type alkaline phosphatase,24229,-0.00995459132830397,0.00837909899487021,-0.0263776253582496,0.00646844270164164,0.234834636799589
NMR metabolomics,X23412.Phospholipids in VLDL,OSMR,Oncostatin-M-specific receptor subunit beta,29628,0.00163022806977948,0.00137257149733848,-0.00106001206500394,0.00432046820456291,0.234953999367319
NMR metabolomics,X23412.Phospholipids in VLDL,IDI2,Isopentenyl-diphosphate delta-isomerase 2,28774,-0.00382433132740547,0.00322726558903985,-0.0101497718819236,0.00250110922711263,0.236024591818989
NMR metabolomics,X23412.Phospholipids in VLDL,USP28,Ubiquitin carboxyl-terminal hydrolase 28,24845,0.00298043739947484,0.00251603902899358,-0.00195099909735257,0.00791187389630226,0.236196790919554
NMR metabolomics,X23412.Phospholipids in VLDL,FABP1,"Fatty acid-binding protein, liver",29454,0.00753986664804292,0.00636912113516597,-0.00494361077688239,0.0200233440729682,0.236495518712907
NMR metabolomics,X23412.Phospholipids in VLDL,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",24195,0.00625482967512511,0.00529442751047348,-0.00412224824540292,0.0166319075956531,0.237456000646103
NMR metabolomics,X23412.Phospholipids in VLDL,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",24229,0.00393578914053949,0.00333578346550506,-0.00260234645185042,0.0104739247329294,0.238063716448183
NMR metabolomics,X23412.Phospholipids in VLDL,OSCAR,Osteoclast-associated immunoglobulin-like receptor,29497,0.00271672707802439,0.00230282914177947,-0.00179681803986337,0.00723027219591214,0.238115330846905
NMR metabolomics,X23412.Phospholipids in VLDL,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,24938,-0.0110549552536795,0.0093836544597266,-0.0294469179947436,0.00733700748738467,0.238764934373381
NMR metabolomics,X23412.Phospholipids in VLDL,TG,Thyroglobulin,24793,-0.00895002578578227,0.00759797392964433,-0.0238420546878852,0.00594200311632061,0.238828251844044
NMR metabolomics,X23412.Phospholipids in VLDL,UBQLN3,Ubiquilin-3,24111,-0.00403244260235388,0.00343204245149692,-0.0107592458072878,0.00269436060258008,0.240030488966385
NMR metabolomics,X23412.Phospholipids in VLDL,RPGR,X-linked retinitis pigmentosa GTPase regulator,24195,0.00332822393436028,0.00284199959314576,-0.00224209526820542,0.00889854313692598,0.241576033427448
NMR metabolomics,X23412.Phospholipids in VLDL,TGFBR1,TGF-beta receptor type-1,24229,0.00172118126906736,0.00147853644117988,-0.00117675015564519,0.00461911269377992,0.244390299538069
NMR metabolomics,X23412.Phospholipids in VLDL,RASA1,Ras GTPase-activating protein 1,28774,0.00255984731201023,0.00220775761688182,-0.00176735761707814,0.00688705224109859,0.246270854198592
NMR metabolomics,X23412.Phospholipids in VLDL,PYDC1,Pyrin domain-containing protein 1,24240,-0.0033104726093096,0.00285790633220325,-0.00891196902042797,0.00229102380180878,0.24673025413582
NMR metabolomics,X23412.Phospholipids in VLDL,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",24016,-0.00434512906502873,0.00375433095751924,-0.0117036177417664,0.00301335961170899,0.247135022216214
NMR metabolomics,X23412.Phospholipids in VLDL,CPLX2,Complexin-2,24016,-0.00242242050764032,0.00209913403309372,-0.00653672321250402,0.00169188219722337,0.248507785664901
NMR metabolomics,X23412.Phospholipids in VLDL,SOD3,Extracellular superoxide dismutase,24951,-0.00469494921030997,0.00407510938289842,-0.0126821636007909,0.00329226518017093,0.249289445868036
NMR metabolomics,X23412.Phospholipids in VLDL,TFRC,Transferrin receptor protein 1,29565,-0.00300105271332155,0.00261457324680531,-0.00812561627705996,0.00212351085041685,0.251053237173111
NMR metabolomics,X23412.Phospholipids in VLDL,ADGRV1,Adhesion G-protein coupled receptor V1,24101,-0.00547151637375777,0.00477835521706095,-0.0148370925991972,0.00389405985168169,0.252194558438657
NMR metabolomics,X23412.Phospholipids in VLDL,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,24111,0.00202001953105048,0.00176440775333359,-0.00143821966548336,0.00547825872758431,0.252273908006158
NMR metabolomics,X23412.Phospholipids in VLDL,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,24867,0.00895321183692473,0.00785718144967498,-0.00644686380443823,0.0243532874782877,0.254508113504935
NMR metabolomics,X23412.Phospholipids in VLDL,IL20RB,Interleukin-20 receptor subunit beta,24229,0.00326782778309968,0.00287947673774143,-0.00237594662287353,0.00891160218907289,0.256441604214365
NMR metabolomics,X23412.Phospholipids in VLDL,SPINK4,Serine protease inhibitor Kazal-type 4,29434,-0.00502981214209719,0.00444446718398508,-0.013740967822708,0.00368134353851357,0.257768989192866
NMR metabolomics,X23412.Phospholipids in VLDL,CEP350,Centrosome-associated protein 350,24016,0.0028539935153595,0.00252304293570133,-0.00209117063861512,0.00779915766933411,0.257994341473007
NMR metabolomics,X23412.Phospholipids in VLDL,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",29632,-0.00544175345588864,0.00482573489829412,-0.0149001938565451,0.00401668694476784,0.259475714755021
NMR metabolomics,X23412.Phospholipids in VLDL,SLK,STE20-like serine/threonine-protein kinase,24445,0.0059541421272478,0.00531989280474331,-0.00447284777004909,0.0163811320245447,0.26305636053463
NMR metabolomics,X23412.Phospholipids in VLDL,NXPE4,NXPE family member 4,24111,-0.00261502051897166,0.00234428867343145,-0.0072098263188973,0.00197978528095398,0.2646534620463
NMR metabolomics,X23412.Phospholipids in VLDL,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,29632,0.0025924091302582,0.00233537500079184,-0.0019849258712938,0.0071697441318102,0.266981675910663
NMR metabolomics,X23412.Phospholipids in VLDL,TNPO1,Transportin-1,24445,0.00266618446425548,0.00241114588705435,-0.00205966147437104,0.007392030402882,0.268834875052878
NMR metabolomics,X23412.Phospholipids in VLDL,ARNT,Aryl hydrocarbon receptor nuclear translocator,28931,0.00279445294526303,0.00252723898156251,-0.00215893545859949,0.00774784134912555,0.268851060729254
NMR metabolomics,X23412.Phospholipids in VLDL,CA11,Carbonic anhydrase-related protein 11,28797,0.00238704562099121,0.00216380442481262,-0.00185401105164153,0.00662810229362394,0.269962270152953
NMR metabolomics,X23412.Phospholipids in VLDL,TEX33,Testis-expressed protein 33,24445,-0.00292846781956019,0.00265581338759584,-0.00813386205924803,0.00227692642012765,0.270184293719879
NMR metabolomics,X23412.Phospholipids in VLDL,ATRAID,All-trans retinoic acid-induced differentiation factor,24805,0.00211810487614236,0.00192787835641682,-0.0016605367024346,0.00589674645471933,0.271922077141739
NMR metabolomics,X23412.Phospholipids in VLDL,IL13RA2,Interleukin-13 receptor subunit alpha-2,24101,-0.00213306252651069,0.0019676153748422,-0.00598958866120141,0.00172346360818003,0.278337915814806
NMR metabolomics,X23412.Phospholipids in VLDL,MMP15,Matrix metalloproteinase-15,24922,0.0036306171927395,0.00334945477068607,-0.0029343141578052,0.0101955485432842,0.278400678250935
NMR metabolomics,X23412.Phospholipids in VLDL,CD209,CD209 antigen,29527,0.00285251000098651,0.00263751251955218,-0.00231701453733577,0.00802203453930879,0.279476819532093
NMR metabolomics,X23412.Phospholipids in VLDL,SCN3A,Sodium channel protein type 3 subunit alpha,24195,-0.00278016652937835,0.00257416189102285,-0.00782552383578314,0.00226519077702643,0.280140551062395
NMR metabolomics,X23412.Phospholipids in VLDL,OSTN,Osteocrin,24195,-0.00307515121874475,0.0028479654692614,-0.0086571635384971,0.0025068611010076,0.280254828822653
NMR metabolomics,X23412.Phospholipids in VLDL,KCNIP4,Kv channel-interacting protein 4,28774,0.00373387333385257,0.00346526802582364,-0.00305805199676175,0.0105257986644669,0.281259927758501
NMR metabolomics,X23412.Phospholipids in VLDL,LSM8,U6 snRNA-associated Sm-like protein LSm8,24445,0.00633773276567216,0.00588455969081568,-0.00519600422832657,0.0178714697596709,0.281486194877873
NMR metabolomics,X23412.Phospholipids in VLDL,IZUMO1,Izumo sperm-egg fusion protein 1,24016,-0.00359692466662657,0.00334388537835747,-0.0101509400082072,0.00295709067495406,0.282084680221647
NMR metabolomics,X23412.Phospholipids in VLDL,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,24101,0.00539593947522774,0.0050203270236103,-0.00444390149104845,0.0152357804415039,0.282466841393532
NMR metabolomics,X23412.Phospholipids in VLDL,CRTAM,Cytotoxic and regulatory T-cell molecule,29218,0.00369116441805678,0.00344511993537325,-0.00306127065527479,0.0104435994913884,0.283990258645977
NMR metabolomics,X23412.Phospholipids in VLDL,GAMT,Guanidinoacetate N-methyltransferase,24111,-0.00270903077410297,0.00254187928950094,-0.00769111418152481,0.00227305263331887,0.28654326944326
NMR metabolomics,X23412.Phospholipids in VLDL,PPT1,Palmitoyl-protein thioesterase 1,24195,0.00549318242003567,0.00528724974811436,-0.00486982708626848,0.0158561919263398,0.29883888095086
NMR metabolomics,X23412.Phospholipids in VLDL,CDH22,Cadherin-22,24445,-0.00202142165268856,0.00194615564293142,-0.00583588671283414,0.00179304340745703,0.298966564131767
NMR metabolomics,X23412.Phospholipids in VLDL,CDC123,Cell division cycle protein 123 homolog,24016,0.00446572936594093,0.00432315226236465,-0.00400764906829378,0.0129391078001757,0.301623715799939
NMR metabolomics,X23412.Phospholipids in VLDL,GPHA2,Glycoprotein hormone alpha-2,24805,0.00326892377593872,0.00316947737092632,-0.00294325187107686,0.00948109942295431,0.302374461985298
NMR metabolomics,X23412.Phospholipids in VLDL,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,24016,-0.00310790124241622,0.00301830787765033,-0.00902378468261087,0.00280798219777843,0.303169069185948
NMR metabolomics,X23412.Phospholipids in VLDL,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,24016,0.00404951417092293,0.00393476738129029,-0.00366262989640604,0.0117616582382519,0.303413794587248
NMR metabolomics,X23412.Phospholipids in VLDL,CHEK2,Serine/threonine-protein kinase Chk2,28916,0.00232783499283788,0.00226588357991808,-0.00211329682380155,0.00676896680947731,0.30426854329012
NMR metabolomics,X23412.Phospholipids in VLDL,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,24101,-0.00397003129727541,0.00390442224046611,-0.011622698888589,0.00368263629403817,0.309256995972532
NMR metabolomics,X23412.Phospholipids in VLDL,TPPP2,Tubulin polymerization-promoting protein family member 2,24445,-0.00549115913314178,0.00541776090049988,-0.0161099704981215,0.00512765223183799,0.310808658755413
NMR metabolomics,X23412.Phospholipids in VLDL,VSTM2B,V-set and transmembrane domain-containing protein 2B,24445,0.00282781588088968,0.00279535833836169,-0.00265108646229923,0.0083067182240786,0.311733993821354
NMR metabolomics,X23412.Phospholipids in VLDL,NEB,Nebulin,24111,-0.00261439911339395,0.0025844123265333,-0.00767984727339921,0.00245104904661132,0.311738095816746
NMR metabolomics,X23412.Phospholipids in VLDL,ZNF75D,Zinc finger protein 75D,24445,0.0041415602673699,0.00409555163530533,-0.00388572093782856,0.0121688414725683,0.311914554015289
NMR metabolomics,X23412.Phospholipids in VLDL,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,24445,0.00434232305789907,0.00429544384241742,-0.00407674687323907,0.0127613929890372,0.312067744648913
NMR metabolomics,X23412.Phospholipids in VLDL,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,24445,-0.00438595242021923,0.00439503917568294,-0.0130002292045578,0.00422832436411932,0.318321976096596
NMR metabolomics,X23412.Phospholipids in VLDL,TAP1,Antigen peptide transporter 1,24445,-0.00406446733049935,0.00408994436518371,-0.0120807582862594,0.00395182362526071,0.320344301746841
NMR metabolomics,X23412.Phospholipids in VLDL,CSH1,Chorionic somatomammotropin hormone 1,24951,0.00216201903212437,0.00218696146496304,-0.0021244254392032,0.00644846350345193,0.322870956145014
NMR metabolomics,X23412.Phospholipids in VLDL,IL3RA,Interleukin-3 receptor subunit alpha,28931,0.002113474564448,0.00214618110061787,-0.00209304039276302,0.00631998952165902,0.324749922811849
NMR metabolomics,X23412.Phospholipids in VLDL,ESR1,Estrogen receptor,24229,0.00384222110302457,0.00392649383620603,-0.00385370681593924,0.0115381490219884,0.327818374768086
NMR metabolomics,X23412.Phospholipids in VLDL,SPARCL1,SPARC-like protein 1,29489,-0.00181792340148601,0.00186305452611178,-0.0054695102726651,0.00183366346969307,0.329183619449107
NMR metabolomics,X23412.Phospholipids in VLDL,PRAME,Melanoma antigen preferentially expressed in tumors,24016,-0.00168544600792967,0.00173430108820141,-0.00508467614080443,0.0017137841249451,0.331144869844971
NMR metabolomics,X23412.Phospholipids in VLDL,KCNC4,Potassium voltage-gated channel subfamily C member 4,24101,0.00370547129280705,0.00382243512954715,-0.00378650156110537,0.0111974441467195,0.332355036586101
NMR metabolomics,X23412.Phospholipids in VLDL,REST,RE1-silencing transcription factor,24016,-0.00230716205209717,0.00239148664167976,-0.00699447586978951,0.00238015176559516,0.334684936118633
NMR metabolomics,X23412.Phospholipids in VLDL,BHLHE40,Class E basic helix-loop-helix protein 40,24101,-0.00462425003588047,0.00482459122155556,-0.0140804488301294,0.00483194875836843,0.337832915922877
NMR metabolomics,X23412.Phospholipids in VLDL,BRME1,Break repair meiotic recombinase recruitment factor 1,24101,-0.00269163886261926,0.0028095614515606,-0.00819837930767803,0.0028151015824395,0.338058197020034
NMR metabolomics,X23412.Phospholipids in VLDL,IL15,Interleukin-15,29434,0.00213100188415268,0.00222452819124902,-0.0022290733706954,0.00649107713900075,0.338092420121301
NMR metabolomics,X23412.Phospholipids in VLDL,TCP11,T-complex protein 11 homolog,24445,-0.00383300515537104,0.00404294285436893,-0.0117571731499341,0.00409116283919206,0.343101645329576
NMR metabolomics,X23412.Phospholipids in VLDL,LRP2,Low-density lipoprotein receptor-related protein 2,24195,0.00234018442618266,0.00247000933871686,-0.00250103387770239,0.00718140273006771,0.343424336278472
NMR metabolomics,X23412.Phospholipids in VLDL,FH,"Fumarate hydratase, mitochondrial",24101,0.00538819464023615,0.00572014156903373,-0.00582328283506995,0.0165996721155422,0.346218083225085
NMR metabolomics,X23412.Phospholipids in VLDL,SCN3B,Sodium channel subunit beta-3,24101,0.00294637053133072,0.00314274415957942,-0.00321340802144494,0.00910614908410639,0.348502990379548
NMR metabolomics,X23412.Phospholipids in VLDL,CDSN,Corneodesmosin,29676,0.00274788715321248,0.0029418997862179,-0.00301823642777461,0.00851401073419958,0.350284713252545
NMR metabolomics,X23412.Phospholipids in VLDL,TSPAN15,Tetraspanin-15,24111,-0.0032137636991057,0.003448933448392,-0.00997367325795402,0.00354614585974261,0.351442109586881
NMR metabolomics,X23412.Phospholipids in VLDL,HBQ1,Hemoglobin subunit theta-1,29725,-0.00379504625816665,0.00407924893005912,-0.0117903741610825,0.00420028164474923,0.352207985817831
NMR metabolomics,X23412.Phospholipids in VLDL,PITHD1,PITH domain-containing protein 1,23970,-0.00504457944101864,0.00544110372393048,-0.0157091427399224,0.00561998385788511,0.353871344870736
NMR metabolomics,X23412.Phospholipids in VLDL,ESPL1,Separin,24016,-0.0035059395994601,0.00378236617965434,-0.0109193773115826,0.0039074981126624,0.353978938127223
NMR metabolomics,X23412.Phospholipids in VLDL,CINP,Cyclin-dependent kinase 2-interacting protein,24445,0.00275357783145321,0.00297196238366734,-0.00307146844053478,0.0085786241034412,0.354185791859301
NMR metabolomics,X23412.Phospholipids in VLDL,TNNI3,"Troponin I, cardiac muscle",28916,0.00528943133516717,0.00571604092261713,-0.00591400887316242,0.0164928715434968,0.354783156149635
NMR metabolomics,X23412.Phospholipids in VLDL,CA8,Carbonic anhydrase-related protein,24229,0.00170829461047525,0.00185674796433743,-0.0019309313996261,0.00534752062057661,0.357557584509783
NMR metabolomics,X23412.Phospholipids in VLDL,DCLRE1C,Protein artemis,24016,-0.00194614271722195,0.00212172226028629,-0.00610471834738307,0.00221243291293918,0.359022602611715
NMR metabolomics,X23412.Phospholipids in VLDL,TMED10,Transmembrane emp24 domain-containing protein 10,24111,-0.00309970192636181,0.00338500622162886,-0.00973431412075436,0.00353491026803075,0.359825411083969
NMR metabolomics,X23412.Phospholipids in VLDL,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,24101,-0.00203360587691982,0.00223298589351403,-0.00641025822820732,0.00234304647436768,0.362456529715048
NMR metabolomics,X23412.Phospholipids in VLDL,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,24938,-0.00157180527411134,0.0017292598742161,-0.00496115462757489,0.00181754407935221,0.363386983629264
NMR metabolomics,X23412.Phospholipids in VLDL,ACTA2,"Actin, aortic smooth muscle",28916,-0.00266749061213479,0.00295684973055046,-0.00846291608401369,0.00312793485974411,0.36699034464816
NMR metabolomics,X23412.Phospholipids in VLDL,NENF,Neudesin,24793,0.00668048343787826,0.00747925023108827,-0.00797884701505476,0.0213398138908113,0.371757526180177
NMR metabolomics,X23412.Phospholipids in VLDL,CNTNAP4,Contactin-associated protein-like 4,24195,0.00627270886044748,0.00702480411747108,-0.00749590720979583,0.0200413249306908,0.371899694912945
NMR metabolomics,X23412.Phospholipids in VLDL,FZD10,Frizzled-10,24195,0.00361430110860998,0.00410193692166604,-0.00442549525785546,0.0116540974750754,0.378261307857092
NMR metabolomics,X23412.Phospholipids in VLDL,CA3,Carbonic anhydrase 3,29761,0.00358418879818602,0.00406936379870422,-0.00439176424727425,0.0115601418436463,0.378447408126121
NMR metabolomics,X23412.Phospholipids in VLDL,MEGF11,Multiple epidermal growth factor-like domains protein 11,24111,0.00194803334473731,0.00221887688261322,-0.0024009653451846,0.00629703203465921,0.379986849872374
NMR metabolomics,X23412.Phospholipids in VLDL,TP73,Tumor protein p73,24195,0.00206437142226549,0.00235542715509205,-0.00255226580171492,0.00668100864624591,0.380804006314255
NMR metabolomics,X23412.Phospholipids in VLDL,CBX2,Chromobox protein homolog 2,24111,-0.00240357312700971,0.00274699828174984,-0.00778768975923939,0.00298054350521997,0.381592603493632
NMR metabolomics,X23412.Phospholipids in VLDL,PMCH,Pro-MCH,24111,-0.00495815477248567,0.00570484402986192,-0.016139649071015,0.0062233395260437,0.38479391954606
NMR metabolomics,X23412.Phospholipids in VLDL,NRN1,Neuritin,24867,-0.00210992332055331,0.00243122160619031,-0.00687511766868633,0.0026552710275797,0.385487614647011
NMR metabolomics,X23412.Phospholipids in VLDL,CNTNAP2,Contactin-associated protein-like 2,29434,0.00243231189471437,0.00280755406014339,-0.00307049406316667,0.00793511785259541,0.386307773250557
NMR metabolomics,X23412.Phospholipids in VLDL,ART5,Ecto-ADP-ribosyltransferase 5,24101,-0.00370673411188783,0.00427922553486333,-0.01209401616022,0.0046805479364443,0.386380286399011
NMR metabolomics,X23412.Phospholipids in VLDL,DNAJA4,DnaJ homolog subfamily A member 4,24845,0.00411476251275872,0.00477312328989061,-0.00524055913542688,0.0134700841609443,0.388657771364702
NMR metabolomics,X23412.Phospholipids in VLDL,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,24111,-0.00216169025920961,0.00253109025902013,-0.00712262716688906,0.00279924664846985,0.393083012789035
NMR metabolomics,X23412.Phospholipids in VLDL,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,24111,-0.00382234521080044,0.00448706014349054,-0.0126169830920419,0.00497229267044101,0.394300493765349
NMR metabolomics,X23412.Phospholipids in VLDL,RSPO1,R-spondin-1,29218,0.00202170026983028,0.00237900227787779,-0.00264114419481019,0.00668454473447075,0.395437615123211
NMR metabolomics,X23412.Phospholipids in VLDL,FGF7,Fibroblast growth factor 7,24016,-0.00457565733848076,0.00541600036253686,-0.015191018049053,0.00603970337209148,0.398208228600274
NMR metabolomics,X23412.Phospholipids in VLDL,VNN2,Vascular non-inflammatory molecule 2,29349,-0.00259367920783036,0.00311805844741719,-0.00870507376476805,0.00351771534910734,0.405514458070183
NMR metabolomics,X23412.Phospholipids in VLDL,NGFR,Tumor necrosis factor receptor superfamily member 16,24922,-0.00167671754937589,0.00202242200250319,-0.00564066467428215,0.00228722957553037,0.407076061170298
NMR metabolomics,X23412.Phospholipids in VLDL,HTR1A,5-hydroxytryptamine receptor 1A,24101,-0.00435064685396777,0.00524863789024256,-0.0146379771188432,0.00593668341090765,0.407163720382643
NMR metabolomics,X23412.Phospholipids in VLDL,OMD,Osteomodulin,29581,-0.00242206195284107,0.00292370189298346,-0.00815251766308865,0.00330839375740651,0.40743766087714
NMR metabolomics,X23412.Phospholipids in VLDL,TSPAN1,Tetraspanin-1,28916,-0.00315623438701685,0.00385084132434105,-0.0107038833827253,0.00439141460869161,0.412438369172047
NMR metabolomics,X23412.Phospholipids in VLDL,DCUN1D2,DCN1-like protein 2,24016,-0.00447801311806305,0.00547233711193847,-0.0152037938574624,0.00624776762133634,0.413194065326421
NMR metabolomics,X23412.Phospholipids in VLDL,GIPR,Gastric inhibitory polypeptide receptor,24229,0.00260484834491456,0.00321437055073658,-0.00369531793452913,0.00890501462435826,0.417732143377464
NMR metabolomics,X23412.Phospholipids in VLDL,MAG,Myelin-associated glycoprotein,24195,0.0026138153264759,0.00323183492218294,-0.00372058112100267,0.00894821177395446,0.418654665382563
NMR metabolomics,X23412.Phospholipids in VLDL,FGF3,Fibroblast growth factor 3,24229,0.00165477863887694,0.00204689423689607,-0.00235713406543937,0.00566669134319324,0.418848800127946
NMR metabolomics,X23412.Phospholipids in VLDL,BRD2,Bromodomain-containing protein 2,24101,0.0018939766694822,0.00236407274426291,-0.00273960590927311,0.00652755924823751,0.423052766958181
NMR metabolomics,X23412.Phospholipids in VLDL,DIPK1C,Divergent protein kinase domain 1C,24195,0.00231162106370059,0.00289001010726066,-0.0033527987465303,0.00797604087393148,0.423796248092768
NMR metabolomics,X23412.Phospholipids in VLDL,PON1,Serum paraoxonase/arylesterase 1,24951,-0.00143741343784146,0.00179883383864609,-0.00496312776158781,0.00208830088590488,0.42425121930429
NMR metabolomics,X23412.Phospholipids in VLDL,STEAP4,Metalloreductase STEAP4,24101,0.00403013470026698,0.00504703865094336,-0.005862061055582,0.013922330456116,0.424579722130543
NMR metabolomics,X23412.Phospholipids in VLDL,PDCL2,Phosducin-like protein 2,24016,0.00287156335658424,0.00361852387711901,-0.00422074344256901,0.00996387015573749,0.42745181914729
NMR metabolomics,X23412.Phospholipids in VLDL,FOS,Proto-oncogene c-Fos,23970,-0.00190324920561916,0.00242056552999453,-0.00664755764440845,0.00284105923317013,0.431709564752561
NMR metabolomics,X23412.Phospholipids in VLDL,IL36A,Interleukin-36 alpha,24229,-0.00311713438200688,0.00397035603019757,-0.0108990322011941,0.00466476343718037,0.432401459700545
NMR metabolomics,X23412.Phospholipids in VLDL,WFDC12,WAP four-disulfide core domain protein 12,29662,-0.00338946166680059,0.00432185704902181,-0.0118603014828833,0.00508137814928214,0.432893551645285
NMR metabolomics,X23412.Phospholipids in VLDL,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,29527,0.00304316180829103,0.00388934615411861,-0.00457995665378145,0.0106662802703635,0.433965060088223
NMR metabolomics,X23412.Phospholipids in VLDL,THSD1,Thrombospondin type-1 domain-containing protein 1,24059,0.00182816737691743,0.0023480131928487,-0.00277393848106603,0.00643027323490089,0.436221960558014
NMR metabolomics,X23412.Phospholipids in VLDL,ATP2B4,Plasma membrane calcium-transporting ATPase 4,24111,-0.00331090018319016,0.00426668235658548,-0.0116735976020977,0.00505179723571738,0.437762874099386
NMR metabolomics,X23412.Phospholipids in VLDL,THY1,Thy-1 membrane glycoprotein,29694,-0.00150259920553317,0.00193652071990517,-0.00529817981654731,0.00229298140548096,0.437798121944064
NMR metabolomics,X23412.Phospholipids in VLDL,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,24240,0.00110834352815844,0.00142952580635526,-0.00169352705229788,0.00391021410861476,0.438156682525533
NMR metabolomics,X23412.Phospholipids in VLDL,LELP1,Late cornified envelope-like proline-rich protein 1,24101,-0.00384241465205838,0.00499418780627154,-0.0136310227523506,0.00594619344823384,0.441676913957361
NMR metabolomics,X23412.Phospholipids in VLDL,NPHS2,Podocin,24229,-0.00539462451626222,0.00704348455503908,-0.0191998542441388,0.00841060521161437,0.443741607400643
NMR metabolomics,X23412.Phospholipids in VLDL,PGR,Progesterone receptor,24229,0.00529439565215899,0.00694139482892158,-0.0083107382125273,0.0188995295168453,0.445633104682067
NMR metabolomics,X23412.Phospholipids in VLDL,ITGAX,Integrin alpha-X,24445,0.00274253258741873,0.00364626584283522,-0.0044041484645383,0.00988921363937578,0.451969137776861
NMR metabolomics,X23412.Phospholipids in VLDL,ARMCX2,Armadillo repeat-containing X-linked protein 2,24101,-0.00320432473419304,0.00426203009114698,-0.0115579037128411,0.00514925424445505,0.452160270378261
NMR metabolomics,X23412.Phospholipids in VLDL,HBZ,Hemoglobin subunit zeta,24922,0.00540861900307149,0.00720617613055357,-0.00871548621281352,0.0195327242189565,0.452928647922792
NMR metabolomics,X23412.Phospholipids in VLDL,KDM3A,Lysine-specific demethylase 3A,24229,-0.00460024443957101,0.0061791152815683,-0.0167113103914449,0.00751082151230286,0.456591727059518
NMR metabolomics,X23412.Phospholipids in VLDL,UGDH,UDP-glucose 6-dehydrogenase,24111,0.00495425315612011,0.00669113917307017,-0.00816037962309742,0.0180688859353376,0.459052411010499
NMR metabolomics,X23412.Phospholipids in VLDL,CGN,Cingulin,24195,0.00201255111153256,0.00271835249884882,-0.00331541978621112,0.00734052200927624,0.459090633568815
NMR metabolomics,X23412.Phospholipids in VLDL,CD99,CD99 antigen,29443,-0.000975802301040824,0.00133409877948996,-0.00359063590884115,0.0016390313067595,0.464521257867978
NMR metabolomics,X23412.Phospholipids in VLDL,TPT1,Translationally-controlled tumor protein,28931,0.00323929479788769,0.00443219728540541,-0.00544781188150692,0.0119264014772823,0.464873473985345
NMR metabolomics,X23412.Phospholipids in VLDL,CLINT1,Clathrin interactor 1,24016,0.00237696273944616,0.00325326168112387,-0.00399943015555663,0.00875335563444895,0.465006275041706
NMR metabolomics,X23412.Phospholipids in VLDL,ANXA5,Annexin A5,28650,0.0015061195518494,0.00206608835057387,-0.00254341361527538,0.00555565271897418,0.466025049632327
NMR metabolomics,X23412.Phospholipids in VLDL,ATP5F1D,"ATP synthase subunit delta, mitochondrial",24111,-0.00253300488096984,0.0034967740100451,-0.00938668194065822,0.00432067217871855,0.468837450048152
NMR metabolomics,X23412.Phospholipids in VLDL,MED21,Mediator of RNA polymerase II transcription subunit 21,24111,0.00239645682302151,0.00331365783087138,-0.0040983125254864,0.00889122617152941,0.469560427256253
NMR metabolomics,X23412.Phospholipids in VLDL,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",24229,-0.00217445424425766,0.00302428225350056,-0.00810204746111876,0.00375313897260344,0.472148814468999
NMR metabolomics,X23412.Phospholipids in VLDL,TPRKB,EKC/KEOPS complex subunit TPRKB,24016,-0.00316213619202439,0.0044947592722053,-0.0119718643655468,0.005647591981498,0.481740907080342
NMR metabolomics,X23412.Phospholipids in VLDL,GSTM4,Glutathione S-transferase Mu 4,24111,-0.0034898199691069,0.00496784569902477,-0.0132267975391955,0.00624715760098166,0.482385686613144
NMR metabolomics,X23412.Phospholipids in VLDL,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,24381,-0.0019553933666094,0.00278854680564812,-0.00742094510567971,0.00351015837246091,0.483170507794628
NMR metabolomics,X23412.Phospholipids in VLDL,RBM25,RNA-binding protein 25,24016,-0.00220707160222056,0.00316869462259754,-0.00841771306251174,0.00400356985807062,0.48610752721069
NMR metabolomics,X23412.Phospholipids in VLDL,PLAUR,Urokinase plasminogen activator surface receptor,29278,-0.00129661593729098,0.00186466920220544,-0.00495136757361365,0.00235813569903169,0.486835390506483
NMR metabolomics,X23412.Phospholipids in VLDL,FAM171A2,Protein FAM171A2,24867,0.0074340897391421,0.0107806008086916,-0.0136958878458934,0.0285640673241776,0.490464609488693
NMR metabolomics,X23412.Phospholipids in VLDL,TAGLN3,Transgelin-3,24016,-0.00283191174811474,0.00412228245589241,-0.0109115853616639,0.00524776186543438,0.492104086691005
NMR metabolomics,X23412.Phospholipids in VLDL,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",29497,-0.0015612862233462,0.00228575070370609,-0.00604135760261014,0.00291878515591774,0.494579453161411
NMR metabolomics,X23412.Phospholipids in VLDL,CD82,CD82 antigen,24445,-0.00193131753116858,0.00283263111580397,-0.00748327451814437,0.0036206394558072,0.495365270991933
NMR metabolomics,X23412.Phospholipids in VLDL,CREB3,Cyclic AMP-responsive element-binding protein 3,24016,-0.00262843022790742,0.0038746701577187,-0.0102227837370361,0.00496592328122122,0.497548535235979
NMR metabolomics,X23412.Phospholipids in VLDL,ANK2,Ankyrin-2,24111,0.00329787486950836,0.00491912666425752,-0.00634361339243637,0.0129393631314531,0.502597294634166
NMR metabolomics,X23412.Phospholipids in VLDL,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,24101,0.00223810381580095,0.00334590656753261,-0.00431987305656296,0.00879608068816487,0.503560549560694
NMR metabolomics,X23412.Phospholipids in VLDL,UHRF2,E3 ubiquitin-protein ligase UHRF2,24111,-0.00160837262664382,0.00240685270237974,-0.00632580392330811,0.00310905867002046,0.503982198859647
NMR metabolomics,X23412.Phospholipids in VLDL,CD2,T-cell surface antigen CD2,24111,0.0017455693146131,0.00261976316391624,-0.00338916648666273,0.00688030511588893,0.505220592878424
NMR metabolomics,X23412.Phospholipids in VLDL,S100G,Protein S100-G,24867,-0.00208732259248682,0.00315983994100679,-0.00828060887686013,0.00410596369188649,0.508888729749562
NMR metabolomics,X23412.Phospholipids in VLDL,PALLD,Palladin,24229,0.00179106612102814,0.00272208136217417,-0.00354421334883322,0.00712634559088951,0.510559355941794
NMR metabolomics,X23412.Phospholipids in VLDL,ZP3,Zona pellucida sperm-binding protein 3,24240,-0.0117667551078444,0.0179712239586859,-0.0469903540668688,0.02345684385118,0.51263149583317
NMR metabolomics,X23412.Phospholipids in VLDL,RRP15,RRP15-like protein,24101,-0.00402870338758834,0.0062017480428389,-0.0161841295515526,0.00812672277637589,0.515951841561815
NMR metabolomics,X23412.Phospholipids in VLDL,PHLDB2,Pleckstrin homology-like domain family B member 2,24016,-0.00407161497916826,0.0063790872869493,-0.0165746260615889,0.00843139610325237,0.523300462244559
NMR metabolomics,X23412.Phospholipids in VLDL,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,24195,-0.00179332644370492,0.00282327233982568,-0.00732694022976326,0.00374028734235343,0.525307723140263
NMR metabolomics,X23412.Phospholipids in VLDL,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,24445,0.00297238821941998,0.00468317630070519,-0.00620663732996219,0.0121514137688021,0.52563334919428
NMR metabolomics,X23412.Phospholipids in VLDL,SHD,SH2 domain-containing adapter protein D,24059,0.00367760990473826,0.00581212089269775,-0.00771414704494933,0.0150693668544259,0.526904007579834
NMR metabolomics,X23412.Phospholipids in VLDL,OPTC,Opticin,29349,0.0019311482829905,0.00306350977509116,-0.00407333087618817,0.00793562744216918,0.528456670152211
NMR metabolomics,X23412.Phospholipids in VLDL,KRT17,"Keratin, type I cytoskeletal 17",24111,0.00167124795986269,0.00267066014505323,-0.00356324592444163,0.00690574184416701,0.531464624814024
NMR metabolomics,X23412.Phospholipids in VLDL,ZNF174,Zinc finger protein 174,24229,0.00158872027047645,0.00257832232415433,-0.00346479148486604,0.00664223202581894,0.537779056484134
NMR metabolomics,X23412.Phospholipids in VLDL,KLK1,Kallikrein-1,29199,-0.00532401154125499,0.00864915991906517,-0.0222763649826227,0.0116283419001127,0.538194745178438
NMR metabolomics,X23412.Phospholipids in VLDL,UPK3A,Uroplakin-3a,24101,0.00205410222019793,0.00335560634244408,-0.00452288621099247,0.00863109065138833,0.54045064595103
NMR metabolomics,X23412.Phospholipids in VLDL,PDIA2,Protein disulfide-isomerase A2,24016,0.00169457661391338,0.00278171958040937,-0.00375759376368898,0.00714674699151574,0.54240883327038
NMR metabolomics,X23412.Phospholipids in VLDL,IL19,Interleukin-19,28654,-0.00284004484590945,0.00477456887189559,-0.0121981998348248,0.00651811014300591,0.551963485332973
NMR metabolomics,X23412.Phospholipids in VLDL,TGOLN2,Trans-Golgi network integral membrane protein 2,24951,0.00104244434798688,0.00176489230252434,-0.00241674456496083,0.00450163326093459,0.554756242109687
NMR metabolomics,X23412.Phospholipids in VLDL,PROK1,Prokineticin-1,29434,0.00245942205183256,0.00416421090094826,-0.00570243131402603,0.0106212754176911,0.554786709886383
NMR metabolomics,X23412.Phospholipids in VLDL,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,24793,0.00179178321133711,0.00303646182982071,-0.00415968197511149,0.0077432483977857,0.555136256586613
NMR metabolomics,X23412.Phospholipids in VLDL,IGFL4,Insulin growth factor-like family member 4,24229,0.00302817327194514,0.00513652487068624,-0.00703941547459989,0.0130957620184902,0.555506363324004
NMR metabolomics,X23412.Phospholipids in VLDL,RGS8,Regulator of G-protein signaling 8,28931,0.00259943679270135,0.00442543137344526,-0.00607440869925135,0.0112732822846541,0.556949025833666
NMR metabolomics,X23412.Phospholipids in VLDL,CHIT1,Chitotriosidase-1,29579,0.00606661876279168,0.0103384871460969,-0.0141968160435583,0.0263300535691417,0.557342874284342
NMR metabolomics,X23412.Phospholipids in VLDL,MAMDC2,MAM domain-containing protein 2,24922,-0.00138001429624847,0.00235790967523848,-0.00600151725971588,0.00324148866721895,0.55837134273229
NMR metabolomics,X23412.Phospholipids in VLDL,TBR1,T-box brain protein 1,24195,0.00192043150007272,0.00329130936855383,-0.00453053486229278,0.00837139786243822,0.559571914957483
NMR metabolomics,X23412.Phospholipids in VLDL,CCDC50,Coiled-coil domain-containing protein 50,24867,0.00297967848076597,0.00520463007750924,-0.00722139647115214,0.0131807534326841,0.566984852008862
NMR metabolomics,X23412.Phospholipids in VLDL,CNTN4,Contactin-4,29443,-0.000928071343124822,0.00163250354601175,-0.00412777829330784,0.0022716356070582,0.569702722157477
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINB5,Serpin B5,28916,0.00186766465435567,0.00330304265207575,-0.0046062989437128,0.00834162825242413,0.571780515515791
NMR metabolomics,X23412.Phospholipids in VLDL,IFNL1,Interferon lambda-1,28774,0.00170478341070868,0.00307515665194915,-0.00432252362711165,0.007732090448529,0.579328001642883
NMR metabolomics,X23412.Phospholipids in VLDL,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,24111,0.00180305850427135,0.00332073420902507,-0.00470558054541779,0.0083116975539605,0.587155594004578
NMR metabolomics,X23412.Phospholipids in VLDL,TPBGL,Trophoblast glycoprotein-like,24195,-0.00152270151165034,0.00280475528166568,-0.00702002186371507,0.00397461884041439,0.587203691904099
NMR metabolomics,X23412.Phospholipids in VLDL,ERVV_1,,24111,-0.00169311717723897,0.00314653209649693,-0.00786032008637296,0.00447408573189502,0.590519946739586
NMR metabolomics,X23412.Phospholipids in VLDL,GAD2,Glutamate decarboxylase 2,24229,-0.00169612024715724,0.00315920532369549,-0.00788816268160041,0.00449592218728593,0.591354107174178
NMR metabolomics,X23412.Phospholipids in VLDL,SEZ6,Seizure protein 6 homolog,24195,-0.00113410258539024,0.00212690353937168,-0.00530283352255873,0.00303462835177825,0.59388780002943
NMR metabolomics,X23412.Phospholipids in VLDL,CRYBB2,Beta-crystallin B2,24845,0.00248573477275526,0.00470693969128265,-0.00673986702215873,0.0117113365676693,0.597434661613121
NMR metabolomics,X23412.Phospholipids in VLDL,IL2RB,Interleukin-2 receptor subunit beta,28931,0.0013120602734292,0.00255631116977372,-0.0036983096193273,0.00632243016618569,0.607771192003694
NMR metabolomics,X23412.Phospholipids in VLDL,CNGB3,Cyclic nucleotide-gated cation channel beta-3,24101,0.00189760338763849,0.00369920229355705,-0.00535283310773333,0.00914803988301031,0.607972550213042
NMR metabolomics,X23412.Phospholipids in VLDL,FCRL6,Fc receptor-like protein 6,29434,0.00235282482949736,0.00460744508609937,-0.00667776753925741,0.0113834171982521,0.609594973843193
NMR metabolomics,X23412.Phospholipids in VLDL,SHC1,SHC-transforming protein 1,24016,-0.00406110036429559,0.00795767598775269,-0.0196581453002909,0.0115359445716997,0.60981973744205
NMR metabolomics,X23412.Phospholipids in VLDL,BSND,Barttin,24016,-0.00116628411476782,0.00231135147784951,-0.00569653301135285,0.00336396478181722,0.613851688236788
NMR metabolomics,X23412.Phospholipids in VLDL,ECSCR,Endothelial cell-specific chemotaxis regulator,24101,0.00172244903393224,0.00342115449403364,-0.00498301377437369,0.00842791184223817,0.614638393190893
NMR metabolomics,X23412.Phospholipids in VLDL,PFDN4,Prefoldin subunit 4,24016,0.00181441267363445,0.00365121636666325,-0.00534197140502551,0.00897079675229441,0.619240315765417
NMR metabolomics,X23412.Phospholipids in VLDL,KLK14,Kallikrein-14,29725,0.00154387522346672,0.00312679635631055,-0.00458464563490195,0.00767239608183539,0.621481988682572
NMR metabolomics,X23412.Phospholipids in VLDL,GAD1,Glutamate decarboxylase 1,24016,-0.00087618446203315,0.0017749019085355,-0.00435499220276273,0.00260262327869643,0.621556253990016
NMR metabolomics,X23412.Phospholipids in VLDL,CTAG1A_CTAG1B,Cancer/testis antigen 1,24396,-0.00169128422422534,0.00343381357609388,-0.00842155883336934,0.00503899038491867,0.622343386661273
NMR metabolomics,X23412.Phospholipids in VLDL,GFRAL,GDNF family receptor alpha-like,24025,-0.00208319024638816,0.00426788204162949,-0.010448239047982,0.00628185855520565,0.625477324224402
NMR metabolomics,X23412.Phospholipids in VLDL,RAP1A,Ras-related protein Rap-1A,24229,-0.00230491291227542,0.00472500533857354,-0.0115659233758796,0.00695609755132873,0.625687635995529
NMR metabolomics,X23412.Phospholipids in VLDL,TOP1MT,"DNA topoisomerase I, mitochondrial",24016,-0.00162470705553966,0.00333083965920907,-0.00815315278758943,0.00490373867651012,0.625712242907198
NMR metabolomics,X23412.Phospholipids in VLDL,ARHGEF5,Rho guanine nucleotide exchange factor 5,24101,-0.00242759998655359,0.0050798148483092,-0.0123840370892396,0.00752883711613245,0.632731817482914
NMR metabolomics,X23412.Phospholipids in VLDL,RANGAP1,Ran GTPase-activating protein 1,28797,-0.00158426564254801,0.00332325160846143,-0.00809783879513242,0.0049293075100364,0.633564037621527
NMR metabolomics,X23412.Phospholipids in VLDL,VCAN,Versican core protein,29694,-0.000969196060063189,0.0020377934046497,-0.0049632711331766,0.00302487901305022,0.634355351889188
NMR metabolomics,X23412.Phospholipids in VLDL,BTN1A1,Butyrophilin subfamily 1 member A1,24751,0.00129610284877094,0.00274504814539087,-0.00408419151619516,0.00667639721373704,0.636816515136774
NMR metabolomics,X23412.Phospholipids in VLDL,CNTN1,Contactin-1,29820,-0.000869827456932129,0.00184843946682067,-0.00449276881190064,0.00275311389803638,0.637948459016361
NMR metabolomics,X23412.Phospholipids in VLDL,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,24805,-0.00549029795478532,0.0117390623937856,-0.0284988602466052,0.0175182643370346,0.64000700082414
NMR metabolomics,X23412.Phospholipids in VLDL,MMP8,Neutrophil collagenase,29640,0.00227495155578699,0.00490947152208447,-0.00734761262749857,0.0118975157390725,0.643095322145121
NMR metabolomics,X23412.Phospholipids in VLDL,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,24111,0.0016434212273605,0.00357915465798833,-0.00537172190229662,0.00865856435701762,0.64612008915483
NMR metabolomics,X23412.Phospholipids in VLDL,HYAL1,Hyaluronidase-1,29265,0.000703657083232886,0.00156015395994166,-0.00235424467825278,0.00376155884471855,0.651980120381594
NMR metabolomics,X23412.Phospholipids in VLDL,POLR2A,DNA-directed RNA polymerase II subunit RPB1,24229,0.000907365171139989,0.00201436421221099,-0.00304078868479354,0.00485551902707352,0.652391888772508
NMR metabolomics,X23412.Phospholipids in VLDL,PFDN6,Prefoldin subunit 6,24195,0.00199572364859447,0.00445655578865781,-0.00673912569717484,0.0107305729943638,0.654288928080573
NMR metabolomics,X23412.Phospholipids in VLDL,GAGE2A,G antigen 2A,24016,0.00193060028642624,0.00433490405175826,-0.00656581165501996,0.0104270122278724,0.656062394222115
NMR metabolomics,X23412.Phospholipids in VLDL,KLK12,Kallikrein-12,28797,-0.00418471818906929,0.00940363112963687,-0.0226158352031575,0.014246398825019,0.656315236002749
NMR metabolomics,X23412.Phospholipids in VLDL,BCL7A,B-cell CLL/lymphoma 7 protein family member A,24016,0.00192846124251195,0.00435221511721978,-0.00660188038723881,0.0104588028722627,0.657698275451441
NMR metabolomics,X23412.Phospholipids in VLDL,PSAPL1,Proactivator polypeptide-like 1,24805,0.00150193542668944,0.00342717989573371,-0.00521533716894863,0.00821920802232751,0.661214418575259
NMR metabolomics,X23412.Phospholipids in VLDL,MAPRE3,Microtubule-associated protein RP/EB family member 3,24016,-0.00427558054425762,0.00979390908679152,-0.023471642354369,0.0149204812658538,0.662437988875965
NMR metabolomics,X23412.Phospholipids in VLDL,CAPN3,Calpain-3,24793,0.00112697971938285,0.00258194927826365,-0.0039336408660139,0.0061876003047796,0.662489360451399
NMR metabolomics,X23412.Phospholipids in VLDL,IL21R,Interleukin-21 receptor,24229,0.00160321771932432,0.00375241435850022,-0.00575151442333611,0.00895794986198475,0.669201300830781
NMR metabolomics,X23412.Phospholipids in VLDL,CHL1,Neural cell adhesion molecule L1-like protein,29542,0.000892911075701787,0.0020961162224312,-0.00321547672026336,0.00500129887166693,0.670122921656565
NMR metabolomics,X23412.Phospholipids in VLDL,IKZF2,Zinc finger protein Helios,28797,0.00262203740267649,0.00619939950782484,-0.0095287856326602,0.0147728604380132,0.672334738830894
NMR metabolomics,X23412.Phospholipids in VLDL,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,24195,-0.00146360263670716,0.00349402464850966,-0.0083118909477861,0.00538468567437178,0.675302201713279
NMR metabolomics,X23412.Phospholipids in VLDL,TOP1,DNA topoisomerase 1,24805,0.0032153717345708,0.00770837246172195,-0.0118930382904042,0.0183237817595458,0.676588990770383
NMR metabolomics,X23412.Phospholipids in VLDL,SIGLEC5,Sialic acid-binding Ig-like lectin 5,29443,0.00335328076010499,0.00805612498832205,-0.0124367242170062,0.0191432857372162,0.677237491949753
NMR metabolomics,X23412.Phospholipids in VLDL,TPSD1,Tryptase delta,24867,-0.00105686350641912,0.0025448975997819,-0.00604486280199164,0.00393113578915341,0.677935224369314
NMR metabolomics,X23412.Phospholipids in VLDL,DNLZ,DNL-type zinc finger protein,24101,-0.00254061685676893,0.0061529025103565,-0.0146003057770677,0.00951907206352981,0.679673623976379
NMR metabolomics,X23412.Phospholipids in VLDL,TMED4,Transmembrane emp24 domain-containing protein 4,24111,-0.00158564333637305,0.00386646514761226,-0.00916391502569308,0.00599262835294697,0.68173510416549
NMR metabolomics,X23412.Phospholipids in VLDL,MYL6B,Myosin light chain 6B,24195,-0.00255404669475681,0.00625044777114262,-0.0148049243261963,0.00969683093668272,0.682823493330758
NMR metabolomics,X23412.Phospholipids in VLDL,EVPL,Envoplakin,24445,0.000942196791380735,0.00231131473321404,-0.00358798008571878,0.00547237366848025,0.683537608798427
NMR metabolomics,X23412.Phospholipids in VLDL,CD200,OX-2 membrane glycoprotein,29434,0.000718049524153707,0.00179958566505861,-0.00280913837936117,0.00424523742766859,0.689890022586036
NMR metabolomics,X23412.Phospholipids in VLDL,RNF168,E3 ubiquitin-protein ligase RNF168,24229,0.0011013989969556,0.00278332236769049,-0.00435391284371775,0.00655671083762896,0.692319679615009
NMR metabolomics,X23412.Phospholipids in VLDL,DCDC2C,Doublecortin domain-containing protein 2C,24016,0.00170575210905271,0.00432182106699837,-0.0067650171822641,0.0101765214003695,0.693079878292747
NMR metabolomics,X23412.Phospholipids in VLDL,DDX1,ATP-dependent RNA helicase DDX1,24805,0.00133643788149075,0.00340744602591374,-0.00534215632930017,0.00801503209228167,0.694905673980909
NMR metabolomics,X23412.Phospholipids in VLDL,KCNH2,Potassium voltage-gated channel subfamily H member 2,24195,0.00208144777405863,0.00532595272258179,-0.00835741956220169,0.0125203151103189,0.695939433723899
NMR metabolomics,X23412.Phospholipids in VLDL,ZCCHC8,Zinc finger CCHC domain-containing protein 8,24111,0.00153738509747196,0.00405562328970215,-0.00641163655034426,0.00948640674528817,0.704635565552392
NMR metabolomics,X23412.Phospholipids in VLDL,KLHL41,Kelch-like protein 41,24867,0.00127264983298812,0.00338345214423176,-0.00535891636970612,0.00790421603568237,0.70681643698921
NMR metabolomics,X23412.Phospholipids in VLDL,KIT,Mast/stem cell growth factor receptor Kit,29545,-0.00073989537299439,0.00199303721846938,-0.00464624832119437,0.00316645757520559,0.710461357709464
NMR metabolomics,X23412.Phospholipids in VLDL,COL4A4,Collagen alpha-4(IV) chain,24405,-0.00132271134099992,0.00360108546784445,-0.00838083885797505,0.00573541617597521,0.713391678812569
NMR metabolomics,X23412.Phospholipids in VLDL,FOLR3,Folate receptor gamma,29461,-0.00464015297018965,0.0127170875072614,-0.029565644484422,0.0202853385440427,0.715207004467767
NMR metabolomics,X23412.Phospholipids in VLDL,TMPRSS11B,Transmembrane protease serine 11B,24101,0.00191152987177559,0.00526338784778264,-0.00840471030987839,0.0122277700534296,0.716477491890567
NMR metabolomics,X23412.Phospholipids in VLDL,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",24101,-0.00138844567224161,0.00384786838475135,-0.00893026770635426,0.00615337636187103,0.718225944884942
NMR metabolomics,X23412.Phospholipids in VLDL,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,24793,-0.00187137334756044,0.00521622667145104,-0.0120951776236045,0.00835243092848359,0.719777714266546
NMR metabolomics,X23412.Phospholipids in VLDL,ANKRA2,Ankyrin repeat family A protein 2,24016,0.00134863803696928,0.00379921577060165,-0.00609782487340996,0.00879510094734851,0.722609187595513
NMR metabolomics,X23412.Phospholipids in VLDL,KHDC3L,KH domain-containing protein 3,24016,-0.0016322069267735,0.00460988509571426,-0.0106675817143735,0.00740316786082646,0.723291987289977
NMR metabolomics,X23412.Phospholipids in VLDL,CBLN1,Cerebellin-1,24101,0.0023006760175154,0.00650877003803607,-0.0104565132570353,0.0150578652920661,0.723736782390024
NMR metabolomics,X23412.Phospholipids in VLDL,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,24101,-0.00143323037764812,0.00405770265158326,-0.0093863275747513,0.00651986681945507,0.723932398440295
NMR metabolomics,X23412.Phospholipids in VLDL,HEBP1,Heme-binding protein 1,28916,-0.00126693619711795,0.00361595523640021,-0.00835420846046237,0.00582033606622646,0.726060693963184
NMR metabolomics,X23412.Phospholipids in VLDL,PCARE,Photoreceptor cilium actin regulator,24101,0.00201276238483204,0.00577039148868521,-0.00929720493299097,0.0133227297026551,0.727236028273824
NMR metabolomics,X23412.Phospholipids in VLDL,HMCN2,Hemicentin-2,24343,-0.00133062491383592,0.00392529344745154,-0.00902420007084094,0.0063629502431691,0.734622168180429
NMR metabolomics,X23412.Phospholipids in VLDL,HDAC9,Histone deacetylase 9,24101,-0.00147746981038114,0.0044170163653679,-0.0101348218865022,0.00717988226573994,0.738008989101591
NMR metabolomics,X23412.Phospholipids in VLDL,CA14,Carbonic anhydrase 14,29725,0.000794701829035801,0.00241211962045785,-0.00393305262706159,0.00552245628513319,0.741808810795596
NMR metabolomics,X23412.Phospholipids in VLDL,CASQ2,Calsequestrin-2,24111,0.00107908813727636,0.00333301429013018,-0.00545361987137879,0.00761179614593151,0.746124498138713
NMR metabolomics,X23412.Phospholipids in VLDL,FGF6,Fibroblast growth factor 6,24229,0.00090847241900592,0.00280758325110183,-0.00459439075315367,0.00641133559116551,0.746260274130582
NMR metabolomics,X23412.Phospholipids in VLDL,CD164L2,CD164 sialomucin-like 2 protein,24195,0.00080378868105958,0.00249556513989409,-0.00408751899313284,0.005695096355252,0.747389694654018
NMR metabolomics,X23412.Phospholipids in VLDL,RICTOR,Rapamycin-insensitive companion of mTOR,24229,-0.0010613840658234,0.00329568123237405,-0.00752091928127653,0.00539815114962974,0.747415314772127
NMR metabolomics,X23412.Phospholipids in VLDL,AMY2A,Pancreatic alpha-amylase,28334,0.00104318157417816,0.00325173073900972,-0.00533021067428088,0.0074165738226372,0.748358184544733
NMR metabolomics,X23412.Phospholipids in VLDL,IGLON5,IgLON family member 5,24016,-0.001963350278496,0.00636525950461102,-0.0144392589075336,0.0105125583505416,0.757744292898794
NMR metabolomics,X23412.Phospholipids in VLDL,ADGRB3,Adhesion G protein-coupled receptor B3,29169,-0.000699526809374441,0.00228203323014598,-0.00517231194046057,0.00377325832171169,0.759198272380683
NMR metabolomics,X23412.Phospholipids in VLDL,EPB41L5,Band 4.1-like protein 5,24195,0.00131232543632838,0.00428387316613157,-0.00708406596928949,0.00970871684194625,0.759347761064274
NMR metabolomics,X23412.Phospholipids in VLDL,EPGN,Epigen,24793,-0.000995926554616719,0.00326593049095074,-0.00739715031688016,0.00540529720764672,0.760411213848636
NMR metabolomics,X23412.Phospholipids in VLDL,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,24445,-0.00146685270068261,0.00486885731955479,-0.01100981304701,0.00807610764564479,0.76320929132315
NMR metabolomics,X23412.Phospholipids in VLDL,CPE,Carboxypeptidase E,29468,-0.000784796870346022,0.00261931356043919,-0.00591865144880684,0.0043490577081148,0.764469682392092
NMR metabolomics,X23412.Phospholipids in VLDL,TGM2,Protein-glutamine gamma-glutamyltransferase 2,29427,0.00147299044120205,0.00499327425929454,-0.00831382710701524,0.0112598079894193,0.767999857662639
NMR metabolomics,X23412.Phospholipids in VLDL,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,24101,-0.000633695084171334,0.00217658908301298,-0.00489980968687678,0.00363241951853411,0.770945723065064
NMR metabolomics,X23412.Phospholipids in VLDL,SKIV2L,Helicase SKI2W,24111,-0.000792992368566766,0.00272970554418049,-0.00614321523516052,0.00455723049802699,0.771432633642001
NMR metabolomics,X23412.Phospholipids in VLDL,IFNL2,Interferon lambda-2,24101,-0.00120652098284692,0.00421815852390111,-0.0094741116896931,0.00706106972399927,0.774857404312693
NMR metabolomics,X23412.Phospholipids in VLDL,RBP1,Retinol-binding protein 1,24195,0.00134780363519554,0.00472601718648496,-0.00791519005031498,0.0106107973207061,0.775502516051356
NMR metabolomics,X23412.Phospholipids in VLDL,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",24867,0.000787741131261982,0.00287374905489573,-0.00484480701633366,0.00642028927885762,0.783997613376628
NMR metabolomics,X23412.Phospholipids in VLDL,SLC1A4,Neutral amino acid transporter A,24195,-0.000962158706532518,0.00351856524143469,-0.00785854657974451,0.00593422916667947,0.784508119609056
NMR metabolomics,X23412.Phospholipids in VLDL,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",24111,0.00160729437704307,0.00588441199076339,-0.00992615312485318,0.0131407418789393,0.784744532984613
NMR metabolomics,X23412.Phospholipids in VLDL,PRG3,Proteoglycan 3,24938,-0.000923451723731724,0.00339635388821669,-0.00758030534463643,0.00573340189717298,0.785704989103978
NMR metabolomics,X23412.Phospholipids in VLDL,AMY2B,Alpha-amylase 2B,27585,-0.000903283068460981,0.0033301189840408,-0.00743031627718094,0.00562375014025898,0.786203493562048
NMR metabolomics,X23412.Phospholipids in VLDL,ARID3A,AT-rich interactive domain-containing protein 3A,24101,0.000728099475335218,0.00273586333212896,-0.00463419265563755,0.00609039160630799,0.79014019616127
NMR metabolomics,X23412.Phospholipids in VLDL,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,29443,-0.000494670288117977,0.00187724135510163,-0.00417406334411717,0.00318472276788122,0.792160011060112
NMR metabolomics,X23412.Phospholipids in VLDL,SUSD4,Sushi domain-containing protein 4,24793,0.000750917350282472,0.00285089582334039,-0.0048368384634647,0.00633867316402964,0.79224680816265
NMR metabolomics,X23412.Phospholipids in VLDL,LRP2BP,LRP2-binding protein,24195,-0.00146745940700835,0.00563207305303577,-0.0125063225909585,0.00957140377694176,0.794438652337343
NMR metabolomics,X23412.Phospholipids in VLDL,TP53BP1,TP53-binding protein 1,24229,0.00154282205772848,0.00595868759925044,-0.0101362056368024,0.0132218497522593,0.795699340219741
NMR metabolomics,X23412.Phospholipids in VLDL,TFAP2A,Transcription factor AP-2-alpha,24101,0.00104579454641131,0.0040898609953428,-0.00697033300446058,0.0090619220972832,0.798181451797521
NMR metabolomics,X23412.Phospholipids in VLDL,CD3G,T-cell surface glycoprotein CD3 gamma chain,24229,0.00158055034697696,0.0061849895756963,-0.0105420292213878,0.0137031299153417,0.798303465279637
NMR metabolomics,X23412.Phospholipids in VLDL,CTLA4,Cytotoxic T-lymphocyte protein 4,24938,0.000512576664868504,0.00202812448877235,-0.0034625473331253,0.0044877006628623,0.800475608824771
NMR metabolomics,X23412.Phospholipids in VLDL,IL31,Interleukin-31,24229,-0.000977675640502783,0.00388050015593314,-0.00858345594613173,0.00662810466512617,0.801085111132113
NMR metabolomics,X23412.Phospholipids in VLDL,IL3,Interleukin-3,24016,0.00103016131121155,0.00413058290710284,-0.00706578118671001,0.00912610380913311,0.803054655118531
NMR metabolomics,X23412.Phospholipids in VLDL,CRX,Cone-rod homeobox protein,28916,0.00180720264229724,0.00728380134273381,-0.012469047989461,0.0160834532740555,0.804049075881836
NMR metabolomics,X23412.Phospholipids in VLDL,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,29508,-0.000816476044064281,0.00333933231911493,-0.00736156738952955,0.00572861530140099,0.806843147994143
NMR metabolomics,X23412.Phospholipids in VLDL,VWA5A,von Willebrand factor A domain-containing protein 5A,24016,0.00132903256100047,0.00544023208527605,-0.00933382232614059,0.0119918874481415,0.807002868828659
NMR metabolomics,X23412.Phospholipids in VLDL,PGLYRP1,Peptidoglycan recognition protein 1,29673,-0.000693761911703176,0.00287362587220725,-0.00632606862122938,0.00493854479782303,0.809228274371059
NMR metabolomics,X23412.Phospholipids in VLDL,RLN2,Prorelaxin H2,24326,-0.00183542769873374,0.0077274606941817,-0.0169812506593299,0.0133103952618624,0.812255282817572
NMR metabolomics,X23412.Phospholipids in VLDL,EPO,Erythropoietin,29434,0.00121435542090501,0.00514668231558178,-0.00887314191763528,0.0113018527594453,0.81347375546067
NMR metabolomics,X23412.Phospholipids in VLDL,TLR2,Toll-like receptor 2,24445,0.000368404869153253,0.00156711577893461,-0.00270314205755858,0.00343995179586509,0.814145000304595
NMR metabolomics,X23412.Phospholipids in VLDL,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,24322,0.000774426343543589,0.00332109162030326,-0.0057349132322508,0.00728376591933798,0.815620279039942
NMR metabolomics,X23412.Phospholipids in VLDL,ALMS1,Alstrom syndrome protein 1,24445,-0.000709427069587468,0.00304257281817965,-0.00667286979321959,0.00525401565404465,0.815633812545221
NMR metabolomics,X23412.Phospholipids in VLDL,MLLT1,Protein ENL,24016,0.00106028844021033,0.00471812208206254,-0.00818723084063225,0.0103078077210529,0.822193733584672
NMR metabolomics,X23412.Phospholipids in VLDL,IL10,Interleukin-10,28931,0.00124237351923465,0.00555386526780668,-0.00964320240566643,0.0121279494441357,0.822995988900391
NMR metabolomics,X23412.Phospholipids in VLDL,PRC1,Protein regulator of cytokinesis 1,24793,0.000671307249806876,0.00309112964303772,-0.00538730685054705,0.0067299213501608,0.82807598105292
NMR metabolomics,X23412.Phospholipids in VLDL,PCDH17,Protocadherin-17,29478,-0.000529747501324466,0.0024438789080213,-0.00531975016104622,0.00426025515839729,0.828392961505827
NMR metabolomics,X23412.Phospholipids in VLDL,TSPAN7,Tetraspanin-7,24101,-0.00137981749238662,0.00641687870730574,-0.0139568997587059,0.0111972647739326,0.829746227683092
NMR metabolomics,X23412.Phospholipids in VLDL,CDC25A,M-phase inducer phosphatase 1,24016,-0.000570717989598075,0.00276065247837182,-0.00598159684720685,0.0048401608680107,0.83622013154676
NMR metabolomics,X23412.Phospholipids in VLDL,THRAP3,Thyroid hormone receptor-associated protein 3,24111,0.00158176592965022,0.00772618528194395,-0.0135615572229599,0.0167250890822604,0.837786425677816
NMR metabolomics,X23412.Phospholipids in VLDL,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,24111,-0.000942676999745583,0.00472900485803057,-0.0102115265214855,0.00832617252199433,0.841998941284509
NMR metabolomics,X23412.Phospholipids in VLDL,KRT8,"Keratin, type II cytoskeletal 8",24101,0.000972159273278312,0.0049533643552214,-0.00873643486295564,0.0106807534095123,0.844406429876596
NMR metabolomics,X23412.Phospholipids in VLDL,PSMA1,Proteasome subunit alpha type-1,28797,-0.000613681170001966,0.00314566566489046,-0.00677918587318726,0.00555182353318333,0.845325546481973
NMR metabolomics,X23412.Phospholipids in VLDL,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,24445,0.000626995036288659,0.00335834858034489,-0.00595536818118733,0.00720935825376465,0.851899424395074
NMR metabolomics,X23412.Phospholipids in VLDL,LYPD1,Ly6/PLAUR domain-containing protein 1,28774,-0.000796258619993759,0.00428580142584518,-0.00919642941465032,0.0076039121746628,0.852610835213568
NMR metabolomics,X23412.Phospholipids in VLDL,CNTF,Ciliary neurotrophic factor,24101,-0.000424677192176938,0.00232458324531332,-0.00498086035299104,0.00413150596863716,0.855043110929643
NMR metabolomics,X23412.Phospholipids in VLDL,SLC34A3,Sodium-dependent phosphate transport protein 2C,24016,-0.000613758427833089,0.00337069352900874,-0.00722031774469023,0.00599280088902405,0.855516231641364
NMR metabolomics,X23412.Phospholipids in VLDL,ADGRE5,Adhesion G protein-coupled receptor E5,29673,0.000374567159162713,0.00206430307567653,-0.00367146686916329,0.00442060118748872,0.856015856784701
NMR metabolomics,X23412.Phospholipids in VLDL,PKLR,Pyruvate kinase PKLR,29491,0.000790054063634967,0.00437534178137204,-0.00778561582785423,0.00936572395512417,0.856706598138637
NMR metabolomics,X23412.Phospholipids in VLDL,SLC39A14,Zinc transporter ZIP14,28774,0.000410433524097379,0.00227441727844479,-0.00404742434165442,0.00486829138984917,0.856795423986046
NMR metabolomics,X23412.Phospholipids in VLDL,EFNB2,Ephrin-B2,24195,-0.000689433438031036,0.00393429278711526,-0.00840064730077695,0.00702178042471488,0.860894924904192
NMR metabolomics,X23412.Phospholipids in VLDL,FBLN2,Fibulin-2,24938,-0.000364567991650893,0.00213681232028984,-0.00455272013941898,0.0038235841561172,0.864529448668193
NMR metabolomics,X23412.Phospholipids in VLDL,MORC3,MORC family CW-type zinc finger protein 3,24845,0.000323280946926758,0.00191319320952283,-0.00342657774373798,0.0040731396375915,0.865818042090291
NMR metabolomics,X23412.Phospholipids in VLDL,IL12RB2,Interleukin-12 receptor subunit beta-2,24229,-0.000473736181402923,0.0028395014863803,-0.00603915909470831,0.00509168673190247,0.867499068361272
NMR metabolomics,X23412.Phospholipids in VLDL,TXK,Tyrosine-protein kinase TXK,24445,0.000840716662801429,0.00507609261805209,-0.00910842486858066,0.0107898581941835,0.868455175210281
NMR metabolomics,X23412.Phospholipids in VLDL,CSF2RB,Cytokine receptor common subunit beta,24229,0.000484343815146217,0.00295984097559683,-0.00531694449702357,0.006285632127316,0.870017132790515
NMR metabolomics,X23412.Phospholipids in VLDL,SPINK1,Serine protease inhibitor Kazal-type 1,29443,0.000459584510154845,0.00290078392181333,-0.00522595197659928,0.00614512099690897,0.874115446516372
NMR metabolomics,X23412.Phospholipids in VLDL,CASP4,Caspase-4,24445,-0.00181008411853787,0.0114646655461027,-0.0242808285888991,0.0206606603518234,0.874549726490198
NMR metabolomics,X23412.Phospholipids in VLDL,TMED1,Transmembrane emp24 domain-containing protein 1,24445,-0.000571800784077145,0.00367766851193007,-0.00778003106746008,0.00663642949930579,0.876444872325042
NMR metabolomics,X23412.Phospholipids in VLDL,NLGN1,Neuroligin-1,24195,-0.000717283047585287,0.00466104086935513,-0.00985292315152134,0.00841835705635076,0.877698519855237
NMR metabolomics,X23412.Phospholipids in VLDL,TEX101,Testis-expressed protein 101,24195,0.000521577456040003,0.00344933785308065,-0.00623912473599807,0.00728227964807807,0.879810619315283
NMR metabolomics,X23412.Phospholipids in VLDL,RUVBL1,RuvB-like 1,28797,0.00104106344715353,0.00702041722528479,-0.0127189543144047,0.0148010812087117,0.882114296375911
NMR metabolomics,X23412.Phospholipids in VLDL,TET2,Methylcytosine dioxygenase TET2,24421,-0.00100872347320233,0.00683632734979031,-0.0144079250787913,0.0123904781323867,0.882696437731892
NMR metabolomics,X23412.Phospholipids in VLDL,MFAP3L,Microfibrillar-associated protein 3-like,24195,-0.000612680675793805,0.00448232978997405,-0.00939804706414294,0.00817268571255533,0.891278556312427
NMR metabolomics,X23412.Phospholipids in VLDL,DLGAP5,Disks large-associated protein 5,24867,-0.000479658939747788,0.00352028428259781,-0.0073794161336395,0.00642009825414392,0.891620215491217
NMR metabolomics,X23412.Phospholipids in VLDL,CYTH3,Cytohesin-3,24016,0.000680578307538946,0.00500233588325206,-0.00912400002363509,0.010485156638713,0.891781234075922
NMR metabolomics,X23412.Phospholipids in VLDL,OFD1,Oral-facial-digital syndrome 1 protein,24445,0.000609971099058782,0.0045635224174415,-0.00833453283912655,0.00955447503724412,0.893670684679468
NMR metabolomics,X23412.Phospholipids in VLDL,CLNS1A,Methylosome subunit pICln,24195,-0.000304273722582383,0.00228323185539338,-0.00477940815915341,0.00417086071398864,0.893985321017444
NMR metabolomics,X23412.Phospholipids in VLDL,MORN4,MORN repeat-containing protein 4,24016,-0.000705437642324456,0.00535169944477413,-0.0111947685540817,0.00978389326943283,0.895131227086038
NMR metabolomics,X23412.Phospholipids in VLDL,IL2,Interleukin-2,28931,-0.000279713304128849,0.00214338461674596,-0.00448074715295093,0.00392132054469323,0.896171167053891
NMR metabolomics,X23412.Phospholipids in VLDL,MAGEA3,Melanoma-associated antigen 3,24445,-0.000741197970812445,0.00579581666358317,-0.0121009986314355,0.0106186026898106,0.898241040302673
NMR metabolomics,X23412.Phospholipids in VLDL,SUSD5,Sushi domain-containing protein 5,24273,-0.000275918812259898,0.00233601677894436,-0.00485451169899084,0.00430267407447104,0.905977451691135
NMR metabolomics,X23412.Phospholipids in VLDL,KIRREL1,Kin of IRRE-like protein 1,24101,-0.000472276828926213,0.0040215998024504,-0.008354612441729,0.00741005878387658,0.906516278635042
NMR metabolomics,X23412.Phospholipids in VLDL,COL5A1,Collagen alpha-1(V) chain,24381,-0.00031792063862098,0.00274976463150805,-0.00570745931637675,0.00507161803913479,0.907956724520142
NMR metabolomics,X23412.Phospholipids in VLDL,GPA33,Cell surface A33 antigen,29349,0.00101419091105227,0.00915643262984328,-0.0169324170434406,0.0189607988655451,0.911805307182616
NMR metabolomics,X23412.Phospholipids in VLDL,CLEC2L,C-type lectin domain family 2 member L,24195,0.000369895256655788,0.00342240320092558,-0.00633801501715836,0.00707780553046993,0.913932684908058
NMR metabolomics,X23412.Phospholipids in VLDL,NCLN,Nicalin,28931,-0.000365272902782867,0.00355141880596182,-0.00732605376246804,0.00659550795690231,0.918080616298228
NMR metabolomics,X23412.Phospholipids in VLDL,SPRR1B,Cornifin-B,24445,0.000590069288821716,0.00582852652440444,-0.010833842699011,0.0120139812766544,0.91936223742931
NMR metabolomics,X23412.Phospholipids in VLDL,IL9,Interleukin-9,24445,-0.000360838430696495,0.00386693510752762,-0.00794003124145062,0.00721835438005763,0.925655029863681
NMR metabolomics,X23412.Phospholipids in VLDL,MRPL28,"39S ribosomal protein L28, mitochondrial",24867,-0.000222207618056394,0.0024855695220847,-0.0050939238813424,0.00464950864522961,0.928765478321077
NMR metabolomics,X23412.Phospholipids in VLDL,OMP,Olfactory marker protein,24101,-0.000292214332429656,0.00336303466520131,-0.00688376227622423,0.00629933361136492,0.930759611381989
NMR metabolomics,X23412.Phospholipids in VLDL,EVI2B,Protein EVI2B,24016,-0.000218500197171228,0.00280252029026544,-0.00571143996609148,0.00527443957174903,0.937856060764779
NMR metabolomics,X23412.Phospholipids in VLDL,DDX4,Probable ATP-dependent RNA helicase DDX4,24229,0.0002866275579006,0.00371228476393151,-0.00698945057940516,0.00756270569520636,0.93845668488232
NMR metabolomics,X23412.Phospholipids in VLDL,SAP18,Histone deacetylase complex subunit SAP18,24445,0.000323047617449749,0.00500279673113414,-0.00948243397557317,0.0101285292104727,0.948514188871611
NMR metabolomics,X23412.Phospholipids in VLDL,IL17F,Interleukin-17F,28931,0.000326093186045929,0.0052027775454311,-0.00987135080299902,0.0105235371750909,0.950024345214717
NMR metabolomics,X23412.Phospholipids in VLDL,DAND5,DAN domain family member 5,24229,-0.000228046174587308,0.00371092314140564,-0.00750145553174237,0.00704536318256775,0.950999205705679
NMR metabolomics,X23412.Phospholipids in VLDL,LTBR,Tumor necrosis factor receptor superfamily member 3,29326,-0.000110340392043984,0.00193084891810014,-0.00389480427152026,0.00367412348743229,0.954429241923151
NMR metabolomics,X23412.Phospholipids in VLDL,CLEC1A,C-type lectin domain family 1 member A,28916,0.000123836817122598,0.00227274280146225,-0.00433073907374341,0.0045784127079886,0.956546883250416
NMR metabolomics,X23412.Phospholipids in VLDL,PPIE,Peptidyl-prolyl cis-trans isomerase E,24445,0.000230041942154291,0.00428895285316069,-0.00817630565004066,0.00863638953434924,0.957225674349118
NMR metabolomics,X23412.Phospholipids in VLDL,NOS2,"Nitric oxide synthase, inducible",24111,-0.0001407888776438,0.00270442015688986,-0.00544145238514792,0.00515987462986032,0.958482269954344
NMR metabolomics,X23412.Phospholipids in VLDL,ADGRE2,Adhesion G protein-coupled receptor E2,29581,9.82600474948796e-05,0.00191312418860018,-0.00365146336216147,0.00384798345715123,0.959038176509649
NMR metabolomics,X23412.Phospholipids in VLDL,GJA8,Gap junction alpha-8 protein,24016,-0.000193909851998726,0.00424297862430512,-0.00851014795563677,0.00812232825163931,0.963548667831811
NMR metabolomics,X23412.Phospholipids in VLDL,SCIN,Adseverin,24101,0.000227979802467317,0.00500515965117208,-0.00958213311382995,0.0100380927187646,0.96367013079707
NMR metabolomics,X23412.Phospholipids in VLDL,FGF20,Fibroblast growth factor 20,24229,-0.000132734223882514,0.0029939105583676,-0.00600079891828302,0.00573533047051799,0.96463795187583
NMR metabolomics,X23412.Phospholipids in VLDL,BTNL10,Butyrophilin-like protein 10,24016,-0.000112992440659793,0.0027894459742352,-0.00558030655016079,0.0053543216688412,0.967689162574695
NMR metabolomics,X23412.Phospholipids in VLDL,LMOD2,Leiomodin-2,24101,0.000166444735101783,0.00431514005694633,-0.00829122977651303,0.00862411924671659,0.969231733097107
NMR metabolomics,X23412.Phospholipids in VLDL,ARG2,"Arginase-2, mitochondrial",24793,-0.000100703018375686,0.00294976223086277,-0.00588223699086671,0.00568083095411534,0.97276629060886
NMR metabolomics,X23412.Phospholipids in VLDL,IL13,Interleukin-13,28931,-0.000107771113324542,0.00327016040334843,-0.00651728550388746,0.00630174327723837,0.973709974364897
NMR metabolomics,X23412.Phospholipids in VLDL,IL24,Interleukin-24,28931,-0.000102096693536032,0.00330855583537687,-0.00658686613087469,0.00638267274380263,0.975382690117317
NMR metabolomics,X23412.Phospholipids in VLDL,EXOSC10,Exosome component 10,24111,-0.000127508011110333,0.00413654088206447,-0.0082351281399567,0.00798011211773604,0.975409524164897
NMR metabolomics,X23412.Phospholipids in VLDL,ATF4,Cyclic AMP-dependent transcription factor ATF-4,24016,5.29732500768325e-05,0.00232054548545713,-0.00449529590141914,0.0046012424015728,0.9817877186113
NMR metabolomics,X23412.Phospholipids in VLDL,ANXA10,Annexin A10,28774,0.000110128304704344,0.00556982236122743,-0.0108067235233014,0.0110269801327101,0.984225136935868
NMR metabolomics,X23412.Phospholipids in VLDL,HK2,Hexokinase-2,28916,-3.10888561303279e-05,0.0018630071642309,-0.00368258289802289,0.00362040518576223,0.986686067026885
NMR metabolomics,X23412.Phospholipids in VLDL,NTRK3,NT-3 growth factor receptor,29694,-1.4958653927239e-05,0.00146853783969182,-0.00289329281972322,0.00286337551186874,0.991872887597282
NMR metabolomics,X23412.Phospholipids in VLDL,HMMR,Hyaluronan mediated motility receptor,23975,-2.31080712370526e-05,0.00330437431398989,-0.00649968172665723,0.00645346558418312,0.994420356513916
NMR metabolomics,X23412.Phospholipids in VLDL,RNF4,E3 ubiquitin-protein ligase RNF4,24445,1.53020286922006e-05,0.00451014928464111,-0.00882459056920438,0.00885519462658878,0.997292971182946
NMR metabolomics,X23412.Phospholipids in VLDL,ISM2,Isthmin-2,24938,-8.17783169737825e-06,0.0029925671014979,-0.00587360935063327,0.00585725368723851,0.997819633825662
